[
  {
    "type": "article-journal",
    "id": "Rt5Aik4p",
    "author": [
      {
        "family": "Fowler",
        "given": "Alpha A."
      },
      {
        "family": "Truwit",
        "given": "Jonathon D."
      },
      {
        "family": "Hite",
        "given": "R. Duncan"
      },
      {
        "family": "Morris",
        "given": "Peter E."
      },
      {
        "family": "DeWilde",
        "given": "Christine"
      },
      {
        "family": "Priday",
        "given": "Anna"
      },
      {
        "family": "Fisher",
        "given": "Bernard"
      },
      {
        "family": "Thacker",
        "given": "Leroy R."
      },
      {
        "family": "Natarajan",
        "given": "Ramesh"
      },
      {
        "family": "Brophy",
        "given": "Donald F."
      },
      {
        "family": "Sculthorpe",
        "given": "Robin"
      },
      {
        "family": "Nanchal",
        "given": "Rahul"
      },
      {
        "family": "Syed",
        "given": "Aamer"
      },
      {
        "family": "Sturgill",
        "given": "Jamie"
      },
      {
        "family": "Martin",
        "given": "Greg S."
      },
      {
        "family": "Sevransky",
        "given": "Jonathan"
      },
      {
        "family": "Kashiouris",
        "given": "Markos"
      },
      {
        "family": "Hamman",
        "given": "Stella"
      },
      {
        "family": "Egan",
        "given": "Katherine F."
      },
      {
        "family": "Hastings",
        "given": "Andrei"
      },
      {
        "family": "Spencer",
        "given": "Wendy"
      },
      {
        "family": "Tench",
        "given": "Shawnda"
      },
      {
        "family": "Mehkri",
        "given": "Omar"
      },
      {
        "family": "Bindas",
        "given": "James"
      },
      {
        "family": "Duggal",
        "given": "Abhijit"
      },
      {
        "family": "Graf",
        "given": "Jeanette"
      },
      {
        "family": "Zellner",
        "given": "Stephanie"
      },
      {
        "family": "Yanny",
        "given": "Lynda"
      },
      {
        "family": "McPolin",
        "given": "Catherine"
      },
      {
        "family": "Hollrith",
        "given": "Tonya"
      },
      {
        "family": "Kramer",
        "given": "David"
      },
      {
        "family": "Ojielo",
        "given": "Charles"
      },
      {
        "family": "Damm",
        "given": "Tessa"
      },
      {
        "family": "Cassity",
        "given": "Evan"
      },
      {
        "family": "Wieliczko",
        "given": "Aleksandra"
      },
      {
        "family": "Halquist",
        "given": "Matthew"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          10,
          1
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2019.11825",
    "volume": "322",
    "issue": "13",
    "page": "1261",
    "publisher": "American Medical Association (AMA)",
    "title": "Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure",
    "URL": "https://doi.org/ggqmh8",
    "PMCID": "PMC6777268",
    "PMID": "31573637",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.2019.11825"
  },
  {
    "type": "article-journal",
    "id": "VRoblZFJ",
    "author": [
      {
        "family": "Wang",
        "given": "Dawei"
      },
      {
        "family": "Hu",
        "given": "Bo"
      },
      {
        "family": "Hu",
        "given": "Chang"
      },
      {
        "family": "Zhu",
        "given": "Fangfang"
      },
      {
        "family": "Liu",
        "given": "Xing"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      },
      {
        "family": "Wang",
        "given": "Binbin"
      },
      {
        "family": "Xiang",
        "given": "Hui"
      },
      {
        "family": "Cheng",
        "given": "Zhenshun"
      },
      {
        "family": "Xiong",
        "given": "Yong"
      },
      {
        "family": "Zhao",
        "given": "Yan"
      },
      {
        "family": "Li",
        "given": "Yirong"
      },
      {
        "family": "Wang",
        "given": "Xinghuan"
      },
      {
        "family": "Peng",
        "given": "Zhiyong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          7
        ]
      ]
    },
    "container-title": "JAMA",
    "DOI": "10.1001/jama.2020.1585",
    "publisher": "American Medical Association (AMA)",
    "title": "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China",
    "URL": "https://doi.org/ggkh48",
    "PMCID": "PMC7042881",
    "PMID": "32031570",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1001/jama.2020.1585"
  },
  {
    "type": "article-journal",
    "id": "Pb5PCH7y",
    "author": [
      {
        "family": "Hemilä",
        "given": "Harri"
      },
      {
        "family": "Chalker",
        "given": "Elizabeth"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          1,
          31
        ]
      ]
    },
    "container-title": "Cochrane Database of Systematic Reviews",
    "DOI": "10.1002/14651858.cd000980.pub4",
    "publisher": "Wiley",
    "title": "Vitamin C for preventing and treating the common cold",
    "URL": "https://doi.org/xz5",
    "PMID": "23440782",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/14651858.cd000980.pub4"
  },
  {
    "type": "article-journal",
    "id": "18GflyMj",
    "author": [
      {
        "family": "Chen",
        "given": "Yu"
      },
      {
        "family": "Liu",
        "given": "Qianyun"
      },
      {
        "family": "Guo",
        "given": "Deyin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          7
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25681",
    "publisher": "Wiley",
    "title": "Emerging coronaviruses: Genome structure, replication, and pathogenesis",
    "URL": "https://doi.org/ggjvwj",
    "PMID": "31967327",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.25681"
  },
  {
    "type": "article-journal",
    "id": "2hMFPQJR",
    "author": [
      {
        "family": "Zhang",
        "given": "Lei"
      },
      {
        "family": "Liu",
        "given": "Yunhui"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          3
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25707",
    "publisher": "Wiley",
    "title": "Potential interventions for novel coronavirus in China: A systematic review",
    "URL": "https://doi.org/ggpx57",
    "PMID": "32052466",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.25707"
  },
  {
    "type": "article-journal",
    "id": "Sh1FwWps",
    "author": [
      {
        "family": "Lung",
        "given": "Jrhau"
      },
      {
        "family": "Lin",
        "given": "Yu‐Shih"
      },
      {
        "family": "Yang",
        "given": "Yao‐Hsu"
      },
      {
        "family": "Chou",
        "given": "Yu‐Lun"
      },
      {
        "family": "Shu",
        "given": "Li‐Hsin"
      },
      {
        "family": "Cheng",
        "given": "Yu‐Ching"
      },
      {
        "family": "Liu",
        "given": "Hung Te"
      },
      {
        "family": "Wu",
        "given": "Ching‐Yuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          13
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25761",
    "publisher": "Wiley",
    "title": "The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase",
    "URL": "https://doi.org/ggp6fm",
    "PMID": "32167173",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.25761"
  },
  {
    "type": "article-journal",
    "id": "FFMfMDRN",
    "author": [
      {
        "family": "Du",
        "given": "Zhe"
      },
      {
        "family": "Zhu",
        "given": "Fengxue"
      },
      {
        "family": "Guo",
        "given": "Fuzheng"
      },
      {
        "family": "Yang",
        "given": "Bo"
      },
      {
        "family": "Wang",
        "given": "Tianbing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          10
        ]
      ]
    },
    "container-title": "Journal of Medical Virology",
    "DOI": "10.1002/jmv.25820",
    "publisher": "Wiley",
    "title": "Detection of antibodies against SARS-CoV-2 in patients with COVID-19",
    "URL": "https://doi.org/ggq7m2",
    "PMID": "32243608",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/jmv.25820"
  },
  {
    "type": "article-journal",
    "id": "1FE1YGsaV",
    "author": [
      {
        "family": "Hamming",
        "given": "I"
      },
      {
        "family": "Timens",
        "given": "W"
      },
      {
        "family": "Bulthuis",
        "given": "MLC"
      },
      {
        "family": "Lely",
        "given": "AT"
      },
      {
        "family": "Navis",
        "given": "GJ"
      },
      {
        "family": "van Goor",
        "given": "H"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          6
        ]
      ]
    },
    "container-title": "The Journal of Pathology",
    "DOI": "10.1002/path.1570",
    "volume": "203",
    "issue": "2",
    "page": "631-637",
    "publisher": "Wiley",
    "title": "Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis",
    "URL": "https://doi.org/bhpzc3",
    "PMID": "15141377",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/path.1570"
  },
  {
    "type": "article-journal",
    "id": "NNFGje9g",
    "author": [
      {
        "family": "He",
        "given": "L"
      },
      {
        "family": "Ding",
        "given": "Y"
      },
      {
        "family": "Zhang",
        "given": "Q"
      },
      {
        "family": "Che",
        "given": "X"
      },
      {
        "family": "He",
        "given": "Y"
      },
      {
        "family": "Shen",
        "given": "H"
      },
      {
        "family": "Wang",
        "given": "H"
      },
      {
        "family": "Li",
        "given": "Z"
      },
      {
        "family": "Zhao",
        "given": "L"
      },
      {
        "family": "Geng",
        "given": "J"
      },
      {
        "family": "Deng",
        "given": "Y"
      },
      {
        "family": "Yang",
        "given": "L"
      },
      {
        "family": "Li",
        "given": "J"
      },
      {
        "family": "Cai",
        "given": "J"
      },
      {
        "family": "Qiu",
        "given": "L"
      },
      {
        "family": "Wen",
        "given": "K"
      },
      {
        "family": "Xu",
        "given": "X"
      },
      {
        "family": "Jiang",
        "given": "S"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          11
        ]
      ]
    },
    "container-title": "The Journal of Pathology",
    "DOI": "10.1002/path.2067",
    "volume": "210",
    "issue": "3",
    "page": "288-297",
    "publisher": "Wiley",
    "title": "Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2 <sup>+</sup> cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS",
    "URL": "https://doi.org/bwb8ns",
    "PMID": "17031779",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/path.2067"
  },
  {
    "type": "article-journal",
    "id": "8vUHj9cm",
    "author": [
      {
        "family": "Ray",
        "given": "Sandipan"
      },
      {
        "family": "Patel",
        "given": "Sandip K."
      },
      {
        "family": "Kumar",
        "given": "Vipin"
      },
      {
        "family": "Damahe",
        "given": "Jagruti"
      },
      {
        "family": "Srivastava",
        "given": "Sanjeeva"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          2
        ]
      ]
    },
    "container-title": "PROTEOMICS - Clinical Applications",
    "DOI": "10.1002/prca.201300074",
    "volume": "8",
    "issue": "1-2",
    "page": "53-72",
    "publisher": "Wiley",
    "title": "Differential expression of serum/plasma proteins in various infectious diseases: Specific or nonspecific signatures",
    "URL": "https://doi.org/f2px3h",
    "PMID": "24293340",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1002/prca.201300074"
  },
  {
    "type": "book",
    "id": "tn6j6IZ0",
    "issued": {
      "date-parts": [
        [
          2015
        ]
      ]
    },
    "container-title": "Methods in Molecular Biology",
    "DOI": "10.1007/978-1-4939-2438-7",
    "volume": "1282",
    "publisher": "Springer New York",
    "title": "Coronaviruses",
    "URL": "https://doi.org/ggqfqx",
    "PMID": "25870870",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1007/978-1-4939-2438-7"
  },
  {
    "type": "chapter",
    "id": "47hnjvDb",
    "author": [
      {
        "family": "Fehr",
        "given": "Anthony R."
      },
      {
        "family": "Perlman",
        "given": "Stanley"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015
        ]
      ]
    },
    "container-title": "Methods in Molecular Biology",
    "DOI": "10.1007/978-1-4939-2438-7_1",
    "publisher": "Springer New York",
    "title": "Coronaviruses: An Overview of Their Replication and Pathogenesis",
    "URL": "https://doi.org/ggpc6n",
    "PMCID": "PMC4369385",
    "PMID": "25720466",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1007/978-1-4939-2438-7_1"
  },
  {
    "type": "article-journal",
    "id": "RjFxOURM",
    "author": [
      {
        "family": "Hagel",
        "given": "Alexander F."
      },
      {
        "family": "Layritz",
        "given": "Christian M."
      },
      {
        "family": "Hagel",
        "given": "Wolfgang H."
      },
      {
        "family": "Hagel",
        "given": "Hans-Jürgen"
      },
      {
        "family": "Hagel",
        "given": "Edith"
      },
      {
        "family": "Dauth",
        "given": "Wolfgang"
      },
      {
        "family": "Kressel",
        "given": "Jürgen"
      },
      {
        "family": "Regnet",
        "given": "Tanja"
      },
      {
        "family": "Rosenberg",
        "given": "Andreas"
      },
      {
        "family": "Neurath",
        "given": "Markus F."
      },
      {
        "family": "Molderings",
        "given": "Gerhard J."
      },
      {
        "family": "Raithel",
        "given": "Martin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          5,
          11
        ]
      ]
    },
    "container-title": "Naunyn-Schmiedeberg's Archives of Pharmacology",
    "DOI": "10.1007/s00210-013-0880-1",
    "volume": "386",
    "issue": "9",
    "page": "789-793",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Intravenous infusion of ascorbic acid decreases serum histamine concentrations in patients with allergic and non-allergic diseases",
    "URL": "https://doi.org/f48jsb",
    "PMID": "23666445",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s00210-013-0880-1"
  },
  {
    "type": "article-journal",
    "id": "suIFBW",
    "author": [
      {
        "family": "Channappanavar",
        "given": "Rudragouda"
      },
      {
        "family": "Perlman",
        "given": "Stanley"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          5,
          2
        ]
      ]
    },
    "container-title": "Seminars in Immunopathology",
    "DOI": "10.1007/s00281-017-0629-x",
    "volume": "39",
    "issue": "5",
    "page": "529-539",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
    "URL": "https://doi.org/ggqf2w",
    "PMCID": "PMC7079893",
    "PMID": "28466096",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1007/s00281-017-0629-x"
  },
  {
    "type": "article-journal",
    "id": "1Bj8VMlSk",
    "author": [
      {
        "family": "Davies",
        "given": "J.E.W."
      },
      {
        "family": "Hughes",
        "given": "R.E."
      },
      {
        "family": "Jones",
        "given": "Eleri"
      },
      {
        "family": "Reed",
        "given": "Sylvia E."
      },
      {
        "family": "Craig",
        "given": "J.W."
      },
      {
        "family": "Tyrrell",
        "given": "D.A.J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1979,
          2
        ]
      ]
    },
    "container-title": "Biochemical Medicine",
    "DOI": "10.1016/0006-2944(79)90058-9",
    "volume": "21",
    "issue": "1",
    "page": "78-85",
    "publisher": "Elsevier BV",
    "title": "Metabolism of ascorbic acid (vitamin C) in subjects infected with common cold viruses",
    "URL": "https://doi.org/fd22sv",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/0006-2944(79)90058-9"
  },
  {
    "type": "article-journal",
    "id": "VMI1lOFR",
    "author": [
      {
        "family": "Maares",
        "given": "Maria"
      },
      {
        "family": "Haase",
        "given": "Hajo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12
        ]
      ]
    },
    "container-title": "Archives of Biochemistry and Biophysics",
    "DOI": "10.1016/j.abb.2016.03.022",
    "volume": "611",
    "page": "58-65",
    "publisher": "Elsevier BV",
    "title": "Zinc and immunity: An essential interrelation",
    "URL": "https://doi.org/f9c9b5",
    "PMID": "27021581",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.abb.2016.03.022"
  },
  {
    "type": "article-journal",
    "id": "gY3NNmLM",
    "author": [
      {
        "family": "Oestereich",
        "given": "Lisa"
      },
      {
        "family": "Lüdtke",
        "given": "Anja"
      },
      {
        "family": "Wurr",
        "given": "Stephanie"
      },
      {
        "family": "Rieger",
        "given": "Toni"
      },
      {
        "family": "Muñoz-Fontela",
        "given": "César"
      },
      {
        "family": "Günther",
        "given": "Stephan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          5
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2014.02.014",
    "volume": "105",
    "page": "17-21",
    "publisher": "Elsevier BV",
    "title": "Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model",
    "URL": "https://doi.org/f524m3",
    "PMID": "24583123",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.antiviral.2014.02.014"
  },
  {
    "type": "article-journal",
    "id": "NB1udFHF",
    "author": [
      {
        "family": "Báez-Santos",
        "given": "Yahira M."
      },
      {
        "family": "St. John",
        "given": "Sarah E."
      },
      {
        "family": "Mesecar",
        "given": "Andrew D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          3
        ]
      ]
    },
    "container-title": "Antiviral Research",
    "DOI": "10.1016/j.antiviral.2014.12.015",
    "volume": "115",
    "page": "21-38",
    "publisher": "Elsevier BV",
    "title": "The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds",
    "URL": "https://doi.org/f63hjp",
    "PMCID": "PMC5896749",
    "PMID": "25554382",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.antiviral.2014.12.015"
  },
  {
    "type": "article-journal",
    "id": "rL8owM5Y",
    "author": [
      {
        "family": "Erkan",
        "given": "Doruk"
      },
      {
        "family": "Aguiar",
        "given": "Cassyanne L."
      },
      {
        "family": "Andrade",
        "given": "Danieli"
      },
      {
        "family": "Cohen",
        "given": "Hannah"
      },
      {
        "family": "Cuadrado",
        "given": "Maria J."
      },
      {
        "family": "Danowski",
        "given": "Adriana"
      },
      {
        "family": "Levy",
        "given": "Roger A."
      },
      {
        "family": "Ortel",
        "given": "Thomas L."
      },
      {
        "family": "Rahman",
        "given": "Anisur"
      },
      {
        "family": "Salmon",
        "given": "Jane E."
      },
      {
        "family": "Tektonidou",
        "given": "Maria G."
      },
      {
        "family": "Willis",
        "given": "Rohan"
      },
      {
        "family": "Lockshin",
        "given": "Michael D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          6
        ]
      ]
    },
    "container-title": "Autoimmunity Reviews",
    "DOI": "10.1016/j.autrev.2014.01.053",
    "volume": "13",
    "issue": "6",
    "page": "685-696",
    "publisher": "Elsevier BV",
    "title": "14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends",
    "URL": "https://doi.org/ggp8r8",
    "PMID": "24468415",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.autrev.2014.01.053"
  },
  {
    "type": "article-journal",
    "id": "JLTf2Fwb",
    "author": [
      {
        "family": "He",
        "given": "Runtao"
      },
      {
        "family": "Dobie",
        "given": "Frederick"
      },
      {
        "family": "Ballantine",
        "given": "Melissa"
      },
      {
        "family": "Leeson",
        "given": "Andrew"
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Bastien",
        "given": "Nathalie"
      },
      {
        "family": "Cutts",
        "given": "Todd"
      },
      {
        "family": "Andonov",
        "given": "Anton"
      },
      {
        "family": "Cao",
        "given": "Jingxin"
      },
      {
        "family": "Booth",
        "given": "Timothy F."
      },
      {
        "family": "Plummer",
        "given": "Frank A."
      },
      {
        "family": "Tyler",
        "given": "Shaun"
      },
      {
        "family": "Baker",
        "given": "Lindsay"
      },
      {
        "family": "Li",
        "given": "Xuguang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          4
        ]
      ]
    },
    "container-title": "Biochemical and Biophysical Research Communications",
    "DOI": "10.1016/j.bbrc.2004.02.074",
    "volume": "316",
    "issue": "2",
    "page": "476-483",
    "publisher": "Elsevier BV",
    "title": "Analysis of multimerization of the SARS coronavirus nucleocapsid protein",
    "URL": "https://doi.org/dbfwr9",
    "PMCID": "PMC7111152",
    "PMID": "15020242",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.bbrc.2004.02.074"
  },
  {
    "type": "article-journal",
    "id": "K9G9QT8y",
    "author": [
      {
        "family": "Lippi",
        "given": "Giuseppe"
      },
      {
        "family": "Plebani",
        "given": "Mario"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          6
        ]
      ]
    },
    "container-title": "Clinica Chimica Acta",
    "DOI": "10.1016/j.cca.2020.03.004",
    "volume": "505",
    "page": "190-191",
    "publisher": "Elsevier BV",
    "title": "Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis",
    "URL": "https://doi.org/ggpxp7",
    "PMCID": "PMC7094472",
    "PMID": "32145275",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cca.2020.03.004"
  },
  {
    "type": "article-journal",
    "id": "fIo3ESPM",
    "author": [
      {
        "family": "Morita",
        "given": "Masayuki"
      },
      {
        "family": "Kuba",
        "given": "Keiji"
      },
      {
        "family": "Ichikawa",
        "given": "Akihiko"
      },
      {
        "family": "Nakayama",
        "given": "Mizuho"
      },
      {
        "family": "Katahira",
        "given": "Jun"
      },
      {
        "family": "Iwamoto",
        "given": "Ryo"
      },
      {
        "family": "Watanebe",
        "given": "Tokiko"
      },
      {
        "family": "Sakabe",
        "given": "Saori"
      },
      {
        "family": "Daidoji",
        "given": "Tomo"
      },
      {
        "family": "Nakamura",
        "given": "Shota"
      },
      {
        "family": "Kadowaki",
        "given": "Ayumi"
      },
      {
        "family": "Ohto",
        "given": "Takayo"
      },
      {
        "family": "Nakanishi",
        "given": "Hiroki"
      },
      {
        "family": "Taguchi",
        "given": "Ryo"
      },
      {
        "family": "Nakaya",
        "given": "Takaaki"
      },
      {
        "family": "Murakami",
        "given": "Makoto"
      },
      {
        "family": "Yoneda",
        "given": "Yoshihiro"
      },
      {
        "family": "Arai",
        "given": "Hiroyuki"
      },
      {
        "family": "Kawaoka",
        "given": "Yoshihiro"
      },
      {
        "family": "Penninger",
        "given": "Josef M."
      },
      {
        "family": "Arita",
        "given": "Makoto"
      },
      {
        "family": "Imai",
        "given": "Yumiko"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          3
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2013.02.027",
    "volume": "153",
    "issue": "1",
    "page": "112-125",
    "publisher": "Elsevier BV",
    "title": "The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza",
    "URL": "https://doi.org/f4rbgb",
    "PMID": "23477864",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2013.02.027"
  },
  {
    "type": "article-journal",
    "id": "1272qWb3a",
    "author": [
      {
        "family": "Hsu",
        "given": "Patrick D."
      },
      {
        "family": "Lander",
        "given": "Eric S."
      },
      {
        "family": "Zhang",
        "given": "Feng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          6
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2014.05.010",
    "volume": "157",
    "issue": "6",
    "page": "1262-1278",
    "publisher": "Elsevier BV",
    "title": "Development and Applications of CRISPR-Cas9 for Genome Engineering",
    "URL": "https://doi.org/f6d3wg",
    "PMCID": "PMC4343198",
    "PMID": "24906146",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2014.05.010"
  },
  {
    "type": "article-journal",
    "id": "Ftbm1M9p",
    "author": [
      {
        "family": "Walls",
        "given": "Alexandra C."
      },
      {
        "family": "Xiong",
        "given": "Xiaoli"
      },
      {
        "family": "Park",
        "given": "Young-Jun"
      },
      {
        "family": "Tortorici",
        "given": "M. Alejandra"
      },
      {
        "family": "Snijder",
        "given": "Joost"
      },
      {
        "family": "Quispe",
        "given": "Joel"
      },
      {
        "family": "Cameroni",
        "given": "Elisabetta"
      },
      {
        "family": "Gopal",
        "given": "Robin"
      },
      {
        "family": "Dai",
        "given": "Mian"
      },
      {
        "family": "Lanzavecchia",
        "given": "Antonio"
      },
      {
        "family": "Zambon",
        "given": "Maria"
      },
      {
        "family": "Rey",
        "given": "Félix A."
      },
      {
        "family": "Corti",
        "given": "Davide"
      },
      {
        "family": "Veesler",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          2
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2018.12.028",
    "volume": "176",
    "issue": "5",
    "page": "1026-1039.e15",
    "publisher": "Elsevier BV",
    "title": "Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion",
    "URL": "https://doi.org/gft3jg",
    "PMCID": "PMC6751136",
    "PMID": "30712865",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2018.12.028"
  },
  {
    "type": "article-journal",
    "id": "15l3di3Wj",
    "author": [
      {
        "family": "Hoffmann",
        "given": "Markus"
      },
      {
        "family": "Kleine-Weber",
        "given": "Hannah"
      },
      {
        "family": "Schroeder",
        "given": "Simon"
      },
      {
        "family": "Krüger",
        "given": "Nadine"
      },
      {
        "family": "Herrler",
        "given": "Tanja"
      },
      {
        "family": "Erichsen",
        "given": "Sandra"
      },
      {
        "family": "Schiergens",
        "given": "Tobias S."
      },
      {
        "family": "Herrler",
        "given": "Georg"
      },
      {
        "family": "Wu",
        "given": "Nai-Huei"
      },
      {
        "family": "Nitsche",
        "given": "Andreas"
      },
      {
        "family": "Müller",
        "given": "Marcel A."
      },
      {
        "family": "Drosten",
        "given": "Christian"
      },
      {
        "family": "Pöhlmann",
        "given": "Stefan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2020.02.052",
    "publisher": "Elsevier BV",
    "title": "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor",
    "URL": "https://doi.org/ggnq74",
    "PMCID": "PMC7102627",
    "PMID": "32142651",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2020.02.052"
  },
  {
    "type": "article-journal",
    "id": "qcVbT0w4",
    "author": [
      {
        "family": "Walls",
        "given": "Alexandra C."
      },
      {
        "family": "Park",
        "given": "Young-Jun"
      },
      {
        "family": "Tortorici",
        "given": "M. Alejandra"
      },
      {
        "family": "Wall",
        "given": "Abigail"
      },
      {
        "family": "McGuire",
        "given": "Andrew T."
      },
      {
        "family": "Veesler",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "Cell",
    "DOI": "10.1016/j.cell.2020.02.058",
    "publisher": "Elsevier BV",
    "title": "Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein",
    "URL": "https://doi.org/dpvh",
    "PMCID": "PMC7102599",
    "PMID": "32155444",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cell.2020.02.058"
  },
  {
    "type": "article-journal",
    "id": "16FOT89K5",
    "author": [
      {
        "family": "Moorlag",
        "given": "S.J.C.F.M."
      },
      {
        "family": "Arts",
        "given": "R.J.W."
      },
      {
        "family": "van Crevel",
        "given": "R."
      },
      {
        "family": "Netea",
        "given": "M.G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12
        ]
      ]
    },
    "container-title": "Clinical Microbiology and Infection",
    "DOI": "10.1016/j.cmi.2019.04.020",
    "volume": "25",
    "issue": "12",
    "page": "1473-1478",
    "publisher": "Elsevier BV",
    "title": "Non-specific effects of BCG vaccine on viral infections",
    "URL": "https://doi.org/ggq62z",
    "PMID": "31055165",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cmi.2019.04.020"
  },
  {
    "type": "article-journal",
    "id": "H6tWVs5R",
    "author": [
      {
        "family": "Sardesai",
        "given": "Niranjan Y"
      },
      {
        "family": "Weiner",
        "given": "David B"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          6
        ]
      ]
    },
    "container-title": "Current Opinion in Immunology",
    "DOI": "10.1016/j.coi.2011.03.008",
    "volume": "23",
    "issue": "3",
    "page": "421-429",
    "publisher": "Elsevier BV",
    "title": "Electroporation delivery of DNA vaccines: prospects for success",
    "URL": "https://doi.org/cq8b4p",
    "PMCID": "PMC3109217",
    "PMID": "21530212",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.coi.2011.03.008"
  },
  {
    "type": "article-journal",
    "id": "nwEQBjV4",
    "author": [
      {
        "family": "Baeke",
        "given": "Femke"
      },
      {
        "family": "Takiishi",
        "given": "Tatiana"
      },
      {
        "family": "Korf",
        "given": "Hannelie"
      },
      {
        "family": "Gysemans",
        "given": "Conny"
      },
      {
        "family": "Mathieu",
        "given": "Chantal"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          8
        ]
      ]
    },
    "container-title": "Current Opinion in Pharmacology",
    "DOI": "10.1016/j.coph.2010.04.001",
    "volume": "10",
    "issue": "4",
    "page": "482-496",
    "publisher": "Elsevier BV",
    "title": "Vitamin D: modulator of the immune system",
    "URL": "https://doi.org/d43qtf",
    "PMID": "20427238",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.coph.2010.04.001"
  },
  {
    "type": "article-journal",
    "id": "1BxkPZYnj",
    "author": [
      {
        "family": "Garbers",
        "given": "Christoph"
      },
      {
        "family": "Hermanns",
        "given": "Heike M."
      },
      {
        "family": "Schaper",
        "given": "Fred"
      },
      {
        "family": "Müller-Newen",
        "given": "Gerhard"
      },
      {
        "family": "Grötzinger",
        "given": "Joachim"
      },
      {
        "family": "Rose-John",
        "given": "Stefan"
      },
      {
        "family": "Scheller",
        "given": "Jürgen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          6
        ]
      ]
    },
    "container-title": "Cytokine & Growth Factor Reviews",
    "DOI": "10.1016/j.cytogfr.2012.04.001",
    "volume": "23",
    "issue": "3",
    "page": "85-97",
    "publisher": "Elsevier BV",
    "title": "Plasticity and cross-talk of Interleukin 6-type cytokines",
    "URL": "https://doi.org/f3z743",
    "PMID": "22595692",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.cytogfr.2012.04.001"
  },
  {
    "type": "article-journal",
    "id": "13Oz7yRPx",
    "author": [
      {
        "family": "Cai",
        "given": "Qingxian"
      },
      {
        "family": "Yang",
        "given": "Minghui"
      },
      {
        "family": "Liu",
        "given": "Dongjing"
      },
      {
        "family": "Chen",
        "given": "Jun"
      },
      {
        "family": "Shu",
        "given": "Dan"
      },
      {
        "family": "Xia",
        "given": "Junxia"
      },
      {
        "family": "Liao",
        "given": "Xuejiao"
      },
      {
        "family": "Gu",
        "given": "Yuanbo"
      },
      {
        "family": "Cai",
        "given": "Qiue"
      },
      {
        "family": "Yang",
        "given": "Yang"
      },
      {
        "family": "Shen",
        "given": "Chenguang"
      },
      {
        "family": "Li",
        "given": "Xiaohe"
      },
      {
        "family": "Peng",
        "given": "Ling"
      },
      {
        "family": "Huang",
        "given": "Deliang"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      },
      {
        "family": "Zhang",
        "given": "Shurong"
      },
      {
        "family": "Wang",
        "given": "Fuxiang"
      },
      {
        "family": "Liu",
        "given": "Jiaye"
      },
      {
        "family": "Chen",
        "given": "Li"
      },
      {
        "family": "Chen",
        "given": "Shuyan"
      },
      {
        "family": "Wang",
        "given": "Zhaoqin"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Cao",
        "given": "Ruiyuan"
      },
      {
        "family": "Zhong",
        "given": "Wu"
      },
      {
        "family": "Liu",
        "given": "Yingxia"
      },
      {
        "family": "Liu",
        "given": "Lei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "Engineering",
    "DOI": "10.1016/j.eng.2020.03.007",
    "publisher": "Elsevier BV",
    "title": "TEMPORARY REMOVAL: Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study",
    "URL": "https://doi.org/ggpprd",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.eng.2020.03.007"
  },
  {
    "type": "article-journal",
    "id": "5MhhHQO0",
    "author": [
      {
        "family": "Hood",
        "given": "Leroy"
      },
      {
        "family": "Tian",
        "given": "Qiang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          8
        ]
      ]
    },
    "container-title": "Genomics, Proteomics & Bioinformatics",
    "DOI": "10.1016/j.gpb.2012.08.004",
    "volume": "10",
    "issue": "4",
    "page": "181-185",
    "publisher": "Elsevier BV",
    "title": "Systems Approaches to Biology and Disease Enable Translational Systems Medicine",
    "URL": "https://doi.org/f4f599",
    "PMCID": "PMC3844613",
    "PMID": "23084773",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.gpb.2012.08.004"
  },
  {
    "type": "article-journal",
    "id": "ovHLMvCi",
    "author": [
      {
        "family": "Gautret",
        "given": "Philippe"
      },
      {
        "family": "Lagier",
        "given": "Jean-Christophe"
      },
      {
        "family": "Parola",
        "given": "Philippe"
      },
      {
        "family": "Hoang",
        "given": "Van Thuan"
      },
      {
        "family": "Meddeb",
        "given": "Line"
      },
      {
        "family": "Mailhe",
        "given": "Morgane"
      },
      {
        "family": "Doudier",
        "given": "Barbara"
      },
      {
        "family": "Courjon",
        "given": "Johan"
      },
      {
        "family": "Giordanengo",
        "given": "Valérie"
      },
      {
        "family": "Vieira",
        "given": "Vera Esteves"
      },
      {
        "family": "Dupont",
        "given": "Hervé Tissot"
      },
      {
        "family": "Honoré",
        "given": "Stéphane"
      },
      {
        "family": "Colson",
        "given": "Philippe"
      },
      {
        "family": "Chabrière",
        "given": "Eric"
      },
      {
        "family": "La Scola",
        "given": "Bernard"
      },
      {
        "family": "Rolain",
        "given": "Jean-Marc"
      },
      {
        "family": "Brouqui",
        "given": "Philippe"
      },
      {
        "family": "Raoult",
        "given": "Didier"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "International Journal of Antimicrobial Agents",
    "DOI": "10.1016/j.ijantimicag.2020.105949",
    "page": "105949",
    "publisher": "Elsevier BV",
    "title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial",
    "URL": "https://doi.org/dp7d",
    "PMCID": "PMC7102549",
    "PMID": "32205204",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.ijantimicag.2020.105949"
  },
  {
    "type": "article-journal",
    "id": "10bBqMHH7",
    "author": [
      {
        "family": "Zhang",
        "given": "Sheng"
      },
      {
        "family": "Diao",
        "given": "MengYuan"
      },
      {
        "family": "Yu",
        "given": "Wenbo"
      },
      {
        "family": "Pei",
        "given": "Lei"
      },
      {
        "family": "Lin",
        "given": "Zhaofen"
      },
      {
        "family": "Chen",
        "given": "Dechang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    },
    "container-title": "International Journal of Infectious Diseases",
    "DOI": "10.1016/j.ijid.2020.02.033",
    "volume": "93",
    "page": "201-204",
    "publisher": "Elsevier BV",
    "title": "Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis",
    "URL": "https://doi.org/ggpx56",
    "PMCID": "PMC7110591",
    "PMID": "32097725",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.ijid.2020.02.033"
  },
  {
    "type": "article-journal",
    "id": "BIlqPh6M",
    "author": [
      {
        "family": "Thomé",
        "given": "Rodolfo"
      },
      {
        "family": "Lopes",
        "given": "Stefanie Costa Pinto"
      },
      {
        "family": "Costa",
        "given": "Fabio Trindade Maranhão"
      },
      {
        "family": "Verinaud",
        "given": "Liana"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          6
        ]
      ]
    },
    "container-title": "Immunology Letters",
    "DOI": "10.1016/j.imlet.2013.07.004",
    "volume": "153",
    "issue": "1-2",
    "page": "50-57",
    "publisher": "Elsevier BV",
    "title": "Chloroquine: Modes of action of an undervalued drug",
    "URL": "https://doi.org/f5b5cr",
    "PMID": "23891850",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.imlet.2013.07.004"
  },
  {
    "type": "article-journal",
    "id": "BIVORG2X",
    "author": [
      {
        "family": "Buckley",
        "given": "Christopher D."
      },
      {
        "family": "Gilroy",
        "given": "Derek W."
      },
      {
        "family": "Serhan",
        "given": "Charles N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          3
        ]
      ]
    },
    "container-title": "Immunity",
    "DOI": "10.1016/j.immuni.2014.02.009",
    "volume": "40",
    "issue": "3",
    "page": "315-327",
    "publisher": "Elsevier BV",
    "title": "Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation",
    "URL": "https://doi.org/f5wntr",
    "PMCID": "PMC4004957",
    "PMID": "24656045",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.immuni.2014.02.009"
  },
  {
    "type": "article-journal",
    "id": "LtFtUo2P",
    "author": [
      {
        "family": "Spiegel",
        "given": "Martin"
      },
      {
        "family": "Pichlmair",
        "given": "Andreas"
      },
      {
        "family": "Mühlberger",
        "given": "Elke"
      },
      {
        "family": "Haller",
        "given": "Otto"
      },
      {
        "family": "Weber",
        "given": "Friedemann"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          7
        ]
      ]
    },
    "container-title": "Journal of Clinical Virology",
    "DOI": "10.1016/j.jcv.2003.11.013",
    "volume": "30",
    "issue": "3",
    "page": "211-213",
    "publisher": "Elsevier BV",
    "title": "The antiviral effect of interferon-beta against SARS-Coronavirus is not mediated by MxA protein",
    "URL": "https://doi.org/cmc3ds",
    "PMCID": "PMC7128634",
    "PMID": "15135736",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.jcv.2003.11.013"
  },
  {
    "type": "article-journal",
    "id": "3Xht24k3",
    "author": [
      {
        "family": "Husson",
        "given": "Marie-Odile"
      },
      {
        "family": "Ley",
        "given": "Delphine"
      },
      {
        "family": "Portal",
        "given": "Céline"
      },
      {
        "family": "Gottrand",
        "given": "Madeleine"
      },
      {
        "family": "Hueso",
        "given": "Thomas"
      },
      {
        "family": "Desseyn",
        "given": "Jean-Luc"
      },
      {
        "family": "Gottrand",
        "given": "Frédéric"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12
        ]
      ]
    },
    "container-title": "Journal of Infection",
    "DOI": "10.1016/j.jinf.2016.10.001",
    "volume": "73",
    "issue": "6",
    "page": "523-535",
    "publisher": "Elsevier BV",
    "title": "Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids",
    "URL": "https://doi.org/f9pp2h",
    "PMID": "27746159",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.jinf.2016.10.001"
  },
  {
    "type": "article-journal",
    "id": "iWLsflrG",
    "author": [
      {
        "family": "Jolliffe",
        "given": "David A."
      },
      {
        "family": "Griffiths",
        "given": "Christopher J."
      },
      {
        "family": "Martineau",
        "given": "Adrian R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          7
        ]
      ]
    },
    "container-title": "The Journal of Steroid Biochemistry and Molecular Biology",
    "DOI": "10.1016/j.jsbmb.2012.11.017",
    "volume": "136",
    "page": "321-329",
    "publisher": "Elsevier BV",
    "title": "Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies",
    "URL": "https://doi.org/ggqmh9",
    "PMID": "23220552",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.jsbmb.2012.11.017"
  },
  {
    "type": "article-journal",
    "id": "18KmvBOFr",
    "author": [
      {
        "family": "Molina",
        "given": "Jean Michel"
      },
      {
        "family": "Delaugerre",
        "given": "Constance"
      },
      {
        "family": "Goff",
        "given": "Jerome Le"
      },
      {
        "family": "Mela-Lima",
        "given": "Breno"
      },
      {
        "family": "Ponscarme",
        "given": "Diane"
      },
      {
        "family": "Goldwirt",
        "given": "Lauriane"
      },
      {
        "family": "de Castro",
        "given": "Nathalie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "Médecine et Maladies Infectieuses",
    "DOI": "10.1016/j.medmal.2020.03.006",
    "publisher": "Elsevier BV",
    "title": "No Evidence of Rapid Antiviral Clearance or Clinical Benefit with the Combination of Hydroxychloroquine and Azithromycin in Patients with Severe COVID-19 Infection",
    "URL": "https://doi.org/ggqzrb",
    "PMID": "32240719",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.medmal.2020.03.006"
  },
  {
    "type": "article-journal",
    "id": "oGHFF5Cm",
    "author": [
      {
        "family": "Dashti",
        "given": "Amir"
      },
      {
        "family": "DeVico",
        "given": "Anthony L."
      },
      {
        "family": "Lewis",
        "given": "George K."
      },
      {
        "family": "Sajadi",
        "given": "Mohammad M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          3
        ]
      ]
    },
    "container-title": "Trends in Molecular Medicine",
    "DOI": "10.1016/j.molmed.2019.01.007",
    "volume": "25",
    "issue": "3",
    "page": "228-240",
    "publisher": "Elsevier BV",
    "title": "Broadly Neutralizing Antibodies against HIV: Back to Blood",
    "URL": "https://doi.org/ggqbpr",
    "PMCID": "PMC6401214",
    "PMID": "30792120",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.molmed.2019.01.007"
  },
  {
    "type": "article-journal",
    "id": "eyBAUUCl",
    "author": [
      {
        "family": "McCarty",
        "given": "Mark F."
      },
      {
        "family": "DiNicolantonio",
        "given": "James J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "Progress in Cardiovascular Diseases",
    "DOI": "10.1016/j.pcad.2020.02.007",
    "publisher": "Elsevier BV",
    "title": "Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus",
    "URL": "https://doi.org/ggpwx2",
    "PMCID": "PMC7130854",
    "PMID": "32061635",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.pcad.2020.02.007"
  },
  {
    "type": "article-journal",
    "id": "QkTGQUcj",
    "author": [
      {
        "family": "Wang",
        "given": "Wei"
      },
      {
        "family": "Ye",
        "given": "Linbai"
      },
      {
        "family": "Ye",
        "given": "Li"
      },
      {
        "family": "Li",
        "given": "Baozong"
      },
      {
        "family": "Gao",
        "given": "Bo"
      },
      {
        "family": "Zeng",
        "given": "Yingchun"
      },
      {
        "family": "Kong",
        "given": "Lingbao"
      },
      {
        "family": "Fang",
        "given": "Xiaonan"
      },
      {
        "family": "Zheng",
        "given": "Hong"
      },
      {
        "family": "Wu",
        "given": "Zhenghui"
      },
      {
        "family": "She",
        "given": "Yinglong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          9
        ]
      ]
    },
    "container-title": "Virus Research",
    "DOI": "10.1016/j.virusres.2007.02.007",
    "volume": "128",
    "issue": "1-2",
    "page": "1-8",
    "publisher": "Elsevier BV",
    "title": "Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway",
    "URL": "https://doi.org/bm7m55",
    "PMCID": "PMC7114322",
    "PMID": "17532082",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.virusres.2007.02.007"
  },
  {
    "type": "article-journal",
    "id": "Nfu9kiae",
    "author": [
      {
        "family": "DeDiego",
        "given": "Marta L."
      },
      {
        "family": "Nieto-Torres",
        "given": "Jose L."
      },
      {
        "family": "Jimenez-Guardeño",
        "given": "Jose M."
      },
      {
        "family": "Regla-Nava",
        "given": "Jose A."
      },
      {
        "family": "Castaño-Rodriguez",
        "given": "Carlos"
      },
      {
        "family": "Fernandez-Delgado",
        "given": "Raul"
      },
      {
        "family": "Usera",
        "given": "Fernando"
      },
      {
        "family": "Enjuanes",
        "given": "Luis"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          12
        ]
      ]
    },
    "container-title": "Virus Research",
    "DOI": "10.1016/j.virusres.2014.07.024",
    "volume": "194",
    "page": "124-137",
    "publisher": "Elsevier BV",
    "title": "Coronavirus virulence genes with main focus on SARS-CoV envelope gene",
    "URL": "https://doi.org/f6wm24",
    "PMCID": "PMC4261026",
    "PMID": "25093995",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.virusres.2014.07.024"
  },
  {
    "type": "article-journal",
    "id": "34nQJalJ",
    "author": [
      {
        "family": "Su",
        "given": "Hongyan"
      },
      {
        "family": "Yang",
        "given": "Yi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          6
        ]
      ]
    },
    "container-title": "Experimental and Molecular Pathology",
    "DOI": "10.1016/j.yexmp.2018.05.001",
    "volume": "104",
    "issue": "3",
    "page": "222-226",
    "publisher": "Elsevier BV",
    "title": "The roles of CyPA and CD147 in cardiac remodelling",
    "URL": "https://doi.org/ggq622",
    "PMID": "29772453",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/j.yexmp.2018.05.001"
  },
  {
    "type": "article-journal",
    "id": "vasHgjGH",
    "author": [
      {
        "family": "Huang",
        "given": "Chaolin"
      },
      {
        "family": "Wang",
        "given": "Yeming"
      },
      {
        "family": "Li",
        "given": "Xingwang"
      },
      {
        "family": "Ren",
        "given": "Lili"
      },
      {
        "family": "Zhao",
        "given": "Jianping"
      },
      {
        "family": "Hu",
        "given": "Yi"
      },
      {
        "family": "Zhang",
        "given": "Li"
      },
      {
        "family": "Fan",
        "given": "Guohui"
      },
      {
        "family": "Xu",
        "given": "Jiuyang"
      },
      {
        "family": "Gu",
        "given": "Xiaoying"
      },
      {
        "family": "Cheng",
        "given": "Zhenshun"
      },
      {
        "family": "Yu",
        "given": "Ting"
      },
      {
        "family": "Xia",
        "given": "Jiaan"
      },
      {
        "family": "Wei",
        "given": "Yuan"
      },
      {
        "family": "Wu",
        "given": "Wenjuan"
      },
      {
        "family": "Xie",
        "given": "Xuelei"
      },
      {
        "family": "Yin",
        "given": "Wen"
      },
      {
        "family": "Li",
        "given": "Hui"
      },
      {
        "family": "Liu",
        "given": "Min"
      },
      {
        "family": "Xiao",
        "given": "Yan"
      },
      {
        "family": "Gao",
        "given": "Hong"
      },
      {
        "family": "Guo",
        "given": "Li"
      },
      {
        "family": "Xie",
        "given": "Jungang"
      },
      {
        "family": "Wang",
        "given": "Guangfa"
      },
      {
        "family": "Jiang",
        "given": "Rongmeng"
      },
      {
        "family": "Gao",
        "given": "Zhancheng"
      },
      {
        "family": "Jin",
        "given": "Qi"
      },
      {
        "family": "Wang",
        "given": "Jianwei"
      },
      {
        "family": "Cao",
        "given": "Bin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30183-5",
    "volume": "395",
    "issue": "10223",
    "page": "497-506",
    "publisher": "Elsevier BV",
    "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
    "URL": "https://doi.org/ggjfnn",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30183-5"
  },
  {
    "type": "article-journal",
    "id": "1Fqilxaum",
    "author": [
      {
        "family": "Lu",
        "given": "Roujian"
      },
      {
        "family": "Zhao",
        "given": "Xiang"
      },
      {
        "family": "Li",
        "given": "Juan"
      },
      {
        "family": "Niu",
        "given": "Peihua"
      },
      {
        "family": "Yang",
        "given": "Bo"
      },
      {
        "family": "Wu",
        "given": "Honglong"
      },
      {
        "family": "Wang",
        "given": "Wenling"
      },
      {
        "family": "Song",
        "given": "Hao"
      },
      {
        "family": "Huang",
        "given": "Baoying"
      },
      {
        "family": "Zhu",
        "given": "Na"
      },
      {
        "family": "Bi",
        "given": "Yuhai"
      },
      {
        "family": "Ma",
        "given": "Xuejun"
      },
      {
        "family": "Zhan",
        "given": "Faxian"
      },
      {
        "family": "Wang",
        "given": "Liang"
      },
      {
        "family": "Hu",
        "given": "Tao"
      },
      {
        "family": "Zhou",
        "given": "Hong"
      },
      {
        "family": "Hu",
        "given": "Zhenhong"
      },
      {
        "family": "Zhou",
        "given": "Weimin"
      },
      {
        "family": "Zhao",
        "given": "Li"
      },
      {
        "family": "Chen",
        "given": "Jing"
      },
      {
        "family": "Meng",
        "given": "Yao"
      },
      {
        "family": "Wang",
        "given": "Ji"
      },
      {
        "family": "Lin",
        "given": "Yang"
      },
      {
        "family": "Yuan",
        "given": "Jianying"
      },
      {
        "family": "Xie",
        "given": "Zhihao"
      },
      {
        "family": "Ma",
        "given": "Jinmin"
      },
      {
        "family": "Liu",
        "given": "William J"
      },
      {
        "family": "Wang",
        "given": "Dayan"
      },
      {
        "family": "Xu",
        "given": "Wenbo"
      },
      {
        "family": "Holmes",
        "given": "Edward C"
      },
      {
        "family": "Gao",
        "given": "George F"
      },
      {
        "family": "Wu",
        "given": "Guizhen"
      },
      {
        "family": "Chen",
        "given": "Weijun"
      },
      {
        "family": "Shi",
        "given": "Weifeng"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30251-8",
    "volume": "395",
    "issue": "10224",
    "page": "565-574",
    "publisher": "Elsevier BV",
    "title": "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding",
    "URL": "https://doi.org/ggjr43",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30251-8"
  },
  {
    "type": "article-journal",
    "id": "1E0r4uZy9",
    "author": [
      {
        "family": "Wu",
        "given": "Joseph T"
      },
      {
        "family": "Leung",
        "given": "Kathy"
      },
      {
        "family": "Leung",
        "given": "Gabriel M"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30260-9",
    "publisher": "Elsevier BV",
    "title": "Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study",
    "URL": "https://doi.org/ggjvr7",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30260-9"
  },
  {
    "type": "article-journal",
    "id": "GT7yDBjv",
    "author": [
      {
        "family": "Zumla",
        "given": "Alimuddin"
      },
      {
        "family": "Hui",
        "given": "David S"
      },
      {
        "family": "Azhar",
        "given": "Esam I"
      },
      {
        "family": "Memish",
        "given": "Ziad A"
      },
      {
        "family": "Maeurer",
        "given": "Markus"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30305-6",
    "volume": "395",
    "issue": "10224",
    "page": "e35-e36",
    "publisher": "Elsevier BV",
    "title": "Reducing mortality from 2019-nCoV: host-directed therapies should be an option",
    "URL": "https://doi.org/ggkd3b",
    "PMCID": "PMC7133595",
    "PMID": "32035018",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30305-6"
  },
  {
    "type": "article-journal",
    "id": "10THxyeCg",
    "author": [
      {
        "family": "Zhou",
        "given": "Fei"
      },
      {
        "family": "Yu",
        "given": "Ting"
      },
      {
        "family": "Du",
        "given": "Ronghui"
      },
      {
        "family": "Fan",
        "given": "Guohui"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Liu",
        "given": "Zhibo"
      },
      {
        "family": "Xiang",
        "given": "Jie"
      },
      {
        "family": "Wang",
        "given": "Yeming"
      },
      {
        "family": "Song",
        "given": "Bin"
      },
      {
        "family": "Gu",
        "given": "Xiaoying"
      },
      {
        "family": "Guan",
        "given": "Lulu"
      },
      {
        "family": "Wei",
        "given": "Yuan"
      },
      {
        "family": "Li",
        "given": "Hui"
      },
      {
        "family": "Wu",
        "given": "Xudong"
      },
      {
        "family": "Xu",
        "given": "Jiuyang"
      },
      {
        "family": "Tu",
        "given": "Shengjin"
      },
      {
        "family": "Zhang",
        "given": "Yi"
      },
      {
        "family": "Chen",
        "given": "Hua"
      },
      {
        "family": "Cao",
        "given": "Bin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet",
    "DOI": "10.1016/s0140-6736(20)30566-3",
    "publisher": "Elsevier BV",
    "title": "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study",
    "URL": "https://doi.org/ggnxb3",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s0140-6736(20)30566-3"
  },
  {
    "type": "article-journal",
    "id": "1GLr0EJU",
    "author": [
      {
        "family": "Oudit",
        "given": "Gavin Y."
      },
      {
        "family": "Crackower",
        "given": "Michael A."
      },
      {
        "family": "Backx",
        "given": "Peter H."
      },
      {
        "family": "Penninger",
        "given": "Josef M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2003,
          4
        ]
      ]
    },
    "container-title": "Trends in Cardiovascular Medicine",
    "DOI": "10.1016/s1050-1738(02)00233-5",
    "volume": "13",
    "issue": "3",
    "page": "93-101",
    "publisher": "Elsevier BV",
    "title": "The Role of ACE2 in Cardiovascular Physiology",
    "URL": "https://doi.org/bsbp49",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1050-1738(02)00233-5"
  },
  {
    "type": "article-journal",
    "id": "8Vf8rD2W",
    "author": [
      {
        "family": "Savarino",
        "given": "Andrea"
      },
      {
        "family": "Di Trani",
        "given": "Livia"
      },
      {
        "family": "Donatelli",
        "given": "Isabella"
      },
      {
        "family": "Cauda",
        "given": "Roberto"
      },
      {
        "family": "Cassone",
        "given": "Antonio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          2
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(06)70361-9",
    "volume": "6",
    "issue": "2",
    "page": "67-69",
    "publisher": "Elsevier BV",
    "title": "New insights into the antiviral effects of chloroquine",
    "URL": "https://doi.org/dh8phb",
    "PMCID": "PMC7129107",
    "PMID": "16439323",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1473-3099(06)70361-9"
  },
  {
    "type": "article-journal",
    "id": "tiRfUgvs",
    "author": [
      {
        "family": "Kucharski",
        "given": "Adam J"
      },
      {
        "family": "Russell",
        "given": "Timothy W"
      },
      {
        "family": "Diamond",
        "given": "Charlie"
      },
      {
        "family": "Liu",
        "given": "Yang"
      },
      {
        "family": "Edmunds",
        "given": "John"
      },
      {
        "family": "Funk",
        "given": "Sebastian"
      },
      {
        "family": "Eggo",
        "given": "Rosalind M"
      },
      {
        "family": "Sun",
        "given": "Fiona"
      },
      {
        "family": "Jit",
        "given": "Mark"
      },
      {
        "family": "Munday",
        "given": "James D"
      },
      {
        "family": "Davies",
        "given": "Nicholas"
      },
      {
        "family": "Gimma",
        "given": "Amy"
      },
      {
        "family": "van Zandvoort",
        "given": "Kevin"
      },
      {
        "family": "Gibbs",
        "given": "Hamish"
      },
      {
        "family": "Hellewell",
        "given": "Joel"
      },
      {
        "family": "Jarvis",
        "given": "Christopher I"
      },
      {
        "family": "Clifford",
        "given": "Sam"
      },
      {
        "family": "Quilty",
        "given": "Billy J"
      },
      {
        "family": "Bosse",
        "given": "Nikos I"
      },
      {
        "family": "Abbott",
        "given": "Sam"
      },
      {
        "family": "Klepac",
        "given": "Petra"
      },
      {
        "family": "Flasche",
        "given": "Stefan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30144-4",
    "publisher": "Elsevier BV",
    "title": "Early dynamics of transmission and control of COVID-19: a mathematical modelling study",
    "URL": "https://doi.org/ggptcf",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1473-3099(20)30144-4"
  },
  {
    "type": "article-journal",
    "id": "fCZXxoas",
    "author": [
      {
        "family": "To",
        "given": "Kelvin Kai-Wang"
      },
      {
        "family": "Tsang",
        "given": "Owen Tak-Yin"
      },
      {
        "family": "Leung",
        "given": "Wai-Shing"
      },
      {
        "family": "Tam",
        "given": "Anthony Raymond"
      },
      {
        "family": "Wu",
        "given": "Tak-Chiu"
      },
      {
        "family": "Lung",
        "given": "David Christopher"
      },
      {
        "family": "Yip",
        "given": "Cyril Chik-Yan"
      },
      {
        "family": "Cai",
        "given": "Jian-Piao"
      },
      {
        "family": "Chan",
        "given": "Jacky Man-Chun"
      },
      {
        "family": "Chik",
        "given": "Thomas Shiu-Hong"
      },
      {
        "family": "Lau",
        "given": "Daphne Pui-Ling"
      },
      {
        "family": "Choi",
        "given": "Chris Yau-Chung"
      },
      {
        "family": "Chen",
        "given": "Lin-Lei"
      },
      {
        "family": "Chan",
        "given": "Wan-Mui"
      },
      {
        "family": "Chan",
        "given": "Kwok-Hung"
      },
      {
        "family": "Ip",
        "given": "Jonathan Daniel"
      },
      {
        "family": "Ng",
        "given": "Anthony Chin-Ki"
      },
      {
        "family": "Poon",
        "given": "Rosana Wing-Shan"
      },
      {
        "family": "Luo",
        "given": "Cui-Ting"
      },
      {
        "family": "Cheng",
        "given": "Vincent Chi-Chung"
      },
      {
        "family": "Chan",
        "given": "Jasper Fuk-Woo"
      },
      {
        "family": "Hung",
        "given": "Ivan Fan-Ngai"
      },
      {
        "family": "Chen",
        "given": "Zhiwei"
      },
      {
        "family": "Chen",
        "given": "Honglin"
      },
      {
        "family": "Yuen",
        "given": "Kwok-Yung"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "container-title": "The Lancet Infectious Diseases",
    "DOI": "10.1016/s1473-3099(20)30196-1",
    "publisher": "Elsevier BV",
    "title": "Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study",
    "URL": "https://doi.org/ggp4qx",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1016/s1473-3099(20)30196-1"
  },
  {
    "type": "article-journal",
    "id": "Fdc7seLs",
    "author": [
      {
        "family": "Sheridan",
        "given": "Cormac"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          19
        ]
      ]
    },
    "container-title": "Nature Biotechnology",
    "DOI": "10.1038/d41587-020-00002-2",
    "volume": "38",
    "issue": "4",
    "page": "382-384",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Coronavirus and the race to distribute reliable diagnostics",
    "URL": "https://doi.org/ggm4nt",
    "PMID": "32265548",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/d41587-020-00002-2"
  },
  {
    "type": "article-journal",
    "id": "2QTH37Xi",
    "author": [
      {
        "family": "Li",
        "given": "Wenhui"
      },
      {
        "family": "Moore",
        "given": "Michael J."
      },
      {
        "family": "Vasilieva",
        "given": "Natalya"
      },
      {
        "family": "Sui",
        "given": "Jianhua"
      },
      {
        "family": "Wong",
        "given": "Swee Kee"
      },
      {
        "family": "Berne",
        "given": "Michael A."
      },
      {
        "family": "Somasundaran",
        "given": "Mohan"
      },
      {
        "family": "Sullivan",
        "given": "John L."
      },
      {
        "family": "Luzuriaga",
        "given": "Katherine"
      },
      {
        "family": "Greenough",
        "given": "Thomas C."
      },
      {
        "family": "Choe",
        "given": "Hyeryun"
      },
      {
        "family": "Farzan",
        "given": "Michael"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2003,
          11
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/nature02145",
    "volume": "426",
    "issue": "6965",
    "page": "450-454",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
    "URL": "https://doi.org/bqvpjh",
    "PMCID": "PMC7095016",
    "PMID": "14647384",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nature02145"
  },
  {
    "type": "article-journal",
    "id": "YcyNaIVC",
    "author": [
      {
        "family": "Crosnier",
        "given": "Cécile"
      },
      {
        "family": "Bustamante",
        "given": "Leyla Y."
      },
      {
        "family": "Bartholdson",
        "given": "S. Josefin"
      },
      {
        "family": "Bei",
        "given": "Amy K."
      },
      {
        "family": "Theron",
        "given": "Michel"
      },
      {
        "family": "Uchikawa",
        "given": "Makoto"
      },
      {
        "family": "Mboup",
        "given": "Souleymane"
      },
      {
        "family": "Ndir",
        "given": "Omar"
      },
      {
        "family": "Kwiatkowski",
        "given": "Dominic P."
      },
      {
        "family": "Duraisingh",
        "given": "Manoj T."
      },
      {
        "family": "Rayner",
        "given": "Julian C."
      },
      {
        "family": "Wright",
        "given": "Gavin J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          11,
          9
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/nature10606",
    "volume": "480",
    "issue": "7378",
    "page": "534-537",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum",
    "URL": "https://doi.org/dm59hf",
    "PMCID": "PMC3245779",
    "PMID": "22080952",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nature10606"
  },
  {
    "type": "article-journal",
    "id": "2Us0gNMr",
    "author": [
      {
        "family": "Moss",
        "given": "Joe W. E."
      },
      {
        "family": "Ramji",
        "given": "Dipak P."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          7,
          7
        ]
      ]
    },
    "container-title": "Nature Reviews Cardiology",
    "DOI": "10.1038/nrcardio.2016.103",
    "volume": "13",
    "issue": "9",
    "page": "513-532",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Nutraceutical therapies for atherosclerosis",
    "URL": "https://doi.org/f9g389",
    "PMCID": "PMC5228762",
    "PMID": "27383080",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nrcardio.2016.103"
  },
  {
    "type": "article-journal",
    "id": "uPOTvvjR",
    "author": [
      {
        "family": "Basil",
        "given": "Maria C."
      },
      {
        "family": "Levy",
        "given": "Bruce D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          12,
          21
        ]
      ]
    },
    "container-title": "Nature Reviews Immunology",
    "DOI": "10.1038/nri.2015.4",
    "volume": "16",
    "issue": "1",
    "page": "51-67",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Specialized pro-resolving mediators: endogenous regulators of infection and inflammation",
    "URL": "https://doi.org/f9fgtd",
    "PMCID": "PMC5242505",
    "PMID": "26688348",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nri.2015.4"
  },
  {
    "type": "article-journal",
    "id": "G5NJrE75",
    "author": [
      {
        "family": "de Wit",
        "given": "Emmie"
      },
      {
        "family": "van Doremalen",
        "given": "Neeltje"
      },
      {
        "family": "Falzarano",
        "given": "Darryl"
      },
      {
        "family": "Munster",
        "given": "Vincent J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          6,
          27
        ]
      ]
    },
    "container-title": "Nature Reviews Microbiology",
    "DOI": "10.1038/nrmicro.2016.81",
    "volume": "14",
    "issue": "8",
    "page": "523-534",
    "publisher": "Springer Science and Business Media LLC",
    "title": "SARS and MERS: recent insights into emerging coronaviruses",
    "URL": "https://doi.org/f8v5cv",
    "PMCID": "PMC7097822",
    "PMID": "27344959",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/nrmicro.2016.81"
  },
  {
    "type": "article-journal",
    "id": "vP6yTZ0y",
    "author": [
      {
        "family": "Peng",
        "given": "Xian"
      },
      {
        "family": "Xu",
        "given": "Xin"
      },
      {
        "family": "Li",
        "given": "Yuqing"
      },
      {
        "family": "Cheng",
        "given": "Lei"
      },
      {
        "family": "Zhou",
        "given": "Xuedong"
      },
      {
        "family": "Ren",
        "given": "Biao"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          3
        ]
      ]
    },
    "container-title": "International Journal of Oral Science",
    "DOI": "10.1038/s41368-020-0075-9",
    "volume": "12",
    "issue": "1",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Transmission routes of 2019-nCoV and controls in dental practice",
    "URL": "https://doi.org/ggnf47",
    "PMCID": "PMC7054527",
    "PMID": "32127517",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41368-020-0075-9"
  },
  {
    "type": "article-journal",
    "id": "IhdcvbzC",
    "author": [
      {
        "family": "Wang",
        "given": "Manli"
      },
      {
        "family": "Cao",
        "given": "Ruiyuan"
      },
      {
        "family": "Zhang",
        "given": "Leike"
      },
      {
        "family": "Yang",
        "given": "Xinglou"
      },
      {
        "family": "Liu",
        "given": "Jia"
      },
      {
        "family": "Xu",
        "given": "Mingyue"
      },
      {
        "family": "Shi",
        "given": "Zhengli"
      },
      {
        "family": "Hu",
        "given": "Zhihong"
      },
      {
        "family": "Zhong",
        "given": "Wu"
      },
      {
        "family": "Xiao",
        "given": "Gengfu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          4
        ]
      ]
    },
    "container-title": "Cell Research",
    "DOI": "10.1038/s41422-020-0282-0",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
    "URL": "https://doi.org/ggkbsg",
    "PMCID": "PMC7054408",
    "PMID": "32020029",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41422-020-0282-0"
  },
  {
    "type": "article-journal",
    "id": "8esIIWt9",
    "author": [
      {
        "family": "Eckhardt",
        "given": "Manon"
      },
      {
        "family": "Hultquist",
        "given": "Judd F."
      },
      {
        "family": "Kaake",
        "given": "Robyn M."
      },
      {
        "family": "Hüttenhain",
        "given": "Ruth"
      },
      {
        "family": "Krogan",
        "given": "Nevan J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          14
        ]
      ]
    },
    "container-title": "Nature Reviews Genetics",
    "DOI": "10.1038/s41576-020-0212-5",
    "publisher": "Springer Science and Business Media LLC",
    "title": "A systems approach to infectious disease",
    "URL": "https://doi.org/ggnv63",
    "PMID": "32060427",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41576-020-0212-5"
  },
  {
    "type": "article-journal",
    "id": "UBTUyMGV",
    "author": [
      {
        "family": "Cui",
        "given": "Jie"
      },
      {
        "family": "Li",
        "given": "Fang"
      },
      {
        "family": "Shi",
        "given": "Zheng-Li"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          10
        ]
      ]
    },
    "container-title": "Nature Reviews Microbiology",
    "DOI": "10.1038/s41579-018-0118-9",
    "volume": "17",
    "issue": "3",
    "page": "181-192",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Origin and evolution of pathogenic coronaviruses",
    "URL": "https://doi.org/ggh4vb",
    "PMCID": "PMC7097006",
    "PMID": "30531947",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41579-018-0118-9"
  },
  {
    "type": "article-journal",
    "id": "vHq0hOWQ",
    "author": [
      {
        "family": "Wu",
        "given": "Fan"
      },
      {
        "family": "Zhao",
        "given": "Su"
      },
      {
        "family": "Yu",
        "given": "Bin"
      },
      {
        "family": "Chen",
        "given": "Yan-Mei"
      },
      {
        "family": "Wang",
        "given": "Wen"
      },
      {
        "family": "Song",
        "given": "Zhi-Gang"
      },
      {
        "family": "Hu",
        "given": "Yi"
      },
      {
        "family": "Tao",
        "given": "Zhao-Wu"
      },
      {
        "family": "Tian",
        "given": "Jun-Hua"
      },
      {
        "family": "Pei",
        "given": "Yuan-Yuan"
      },
      {
        "family": "Yuan",
        "given": "Ming-Li"
      },
      {
        "family": "Zhang",
        "given": "Yu-Ling"
      },
      {
        "family": "Dai",
        "given": "Fa-Hui"
      },
      {
        "family": "Liu",
        "given": "Yi"
      },
      {
        "family": "Wang",
        "given": "Qi-Min"
      },
      {
        "family": "Zheng",
        "given": "Jiao-Jiao"
      },
      {
        "family": "Xu",
        "given": "Lin"
      },
      {
        "family": "Holmes",
        "given": "Edward C."
      },
      {
        "family": "Zhang",
        "given": "Yong-Zhen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          3
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/s41586-020-2008-3",
    "publisher": "Springer Science and Business Media LLC",
    "title": "A new coronavirus associated with human respiratory disease in China",
    "URL": "https://doi.org/dk2w",
    "PMCID": "PMC7094943",
    "PMID": "32015508",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41586-020-2008-3"
  },
  {
    "type": "article-journal",
    "id": "VSkK7CeP",
    "author": [
      {
        "family": "Zhou",
        "given": "Peng"
      },
      {
        "family": "Yang",
        "given": "Xing-Lou"
      },
      {
        "family": "Wang",
        "given": "Xian-Guang"
      },
      {
        "family": "Hu",
        "given": "Ben"
      },
      {
        "family": "Zhang",
        "given": "Lei"
      },
      {
        "family": "Zhang",
        "given": "Wei"
      },
      {
        "family": "Si",
        "given": "Hao-Rui"
      },
      {
        "family": "Zhu",
        "given": "Yan"
      },
      {
        "family": "Li",
        "given": "Bei"
      },
      {
        "family": "Huang",
        "given": "Chao-Lin"
      },
      {
        "family": "Chen",
        "given": "Hui-Dong"
      },
      {
        "family": "Chen",
        "given": "Jing"
      },
      {
        "family": "Luo",
        "given": "Yun"
      },
      {
        "family": "Guo",
        "given": "Hua"
      },
      {
        "family": "Jiang",
        "given": "Ren-Di"
      },
      {
        "family": "Liu",
        "given": "Mei-Qin"
      },
      {
        "family": "Chen",
        "given": "Ying"
      },
      {
        "family": "Shen",
        "given": "Xu-Rui"
      },
      {
        "family": "Wang",
        "given": "Xi"
      },
      {
        "family": "Zheng",
        "given": "Xiao-Shuang"
      },
      {
        "family": "Zhao",
        "given": "Kai"
      },
      {
        "family": "Chen",
        "given": "Quan-Jiao"
      },
      {
        "family": "Deng",
        "given": "Fei"
      },
      {
        "family": "Liu",
        "given": "Lin-Lin"
      },
      {
        "family": "Yan",
        "given": "Bing"
      },
      {
        "family": "Zhan",
        "given": "Fa-Xian"
      },
      {
        "family": "Wang",
        "given": "Yan-Yi"
      },
      {
        "family": "Xiao",
        "given": "Geng-Fu"
      },
      {
        "family": "Shi",
        "given": "Zheng-Li"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          3
        ]
      ]
    },
    "container-title": "Nature",
    "DOI": "10.1038/s41586-020-2012-7",
    "publisher": "Springer Science and Business Media LLC",
    "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
    "URL": "https://doi.org/ggj5cg",
    "PMCID": "PMC7095418",
    "PMID": "32015507",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41586-020-2012-7"
  },
  {
    "type": "article-journal",
    "id": "NEIoHDjq",
    "author": [
      {
        "family": "Andersen",
        "given": "Kristian G."
      },
      {
        "family": "Rambaut",
        "given": "Andrew"
      },
      {
        "family": "Lipkin",
        "given": "W. Ian"
      },
      {
        "family": "Holmes",
        "given": "Edward C."
      },
      {
        "family": "Garry",
        "given": "Robert F."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "container-title": "Nature Medicine",
    "DOI": "10.1038/s41591-020-0820-9",
    "publisher": "Springer Science and Business Media LLC",
    "title": "The proximal origin of SARS-CoV-2",
    "URL": "https://doi.org/ggn4dn",
    "PMCID": "PMC7095063",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/s41591-020-0820-9"
  },
  {
    "type": "article-journal",
    "id": "L6kwccjn",
    "author": [
      {
        "family": "Olnes",
        "given": "Matthew J."
      },
      {
        "family": "Kotliarov",
        "given": "Yuri"
      },
      {
        "family": "Biancotto",
        "given": "Angélique"
      },
      {
        "family": "Cheung",
        "given": "Foo"
      },
      {
        "family": "Chen",
        "given": "Jinguo"
      },
      {
        "family": "Shi",
        "given": "Rongye"
      },
      {
        "family": "Zhou",
        "given": "Huizhi"
      },
      {
        "family": "Wang",
        "given": "Ena"
      },
      {
        "family": "Tsang",
        "given": "John S."
      },
      {
        "family": "Nussenblatt",
        "given": "Robert"
      },
      {
        "literal": "The CHI Consortium"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          3,
          14
        ]
      ]
    },
    "container-title": "Scientific Reports",
    "DOI": "10.1038/srep23002",
    "volume": "6",
    "issue": "1",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Effects of Systemically Administered Hydrocortisone on the Human Immunome",
    "URL": "https://doi.org/f8dmvw",
    "PMCID": "PMC4789739",
    "PMID": "26972611",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1038/srep23002"
  },
  {
    "type": "article-journal",
    "id": "1EEloBjzn",
    "author": [
      {
        "family": "Rose-John",
        "given": "S"
      },
      {
        "family": "Heinrich",
        "given": "P C"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1994,
          6,
          1
        ]
      ]
    },
    "container-title": "Biochemical Journal",
    "DOI": "10.1042/bj3000281",
    "volume": "300",
    "issue": "2",
    "page": "281-290",
    "publisher": "Portland Press Ltd.",
    "title": "Soluble receptors for cytokines and growth factors: generation and biological function",
    "URL": "https://doi.org/ggqmgd",
    "PMCID": "PMC1138158",
    "PMID": "8002928",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1042/bj3000281"
  },
  {
    "type": "article-journal",
    "id": "8OnbWuhF",
    "author": [
      {
        "family": "Zhang",
        "given": "Yan"
      },
      {
        "family": "Xiao",
        "given": "Meng"
      },
      {
        "family": "Zhang",
        "given": "Shulan"
      },
      {
        "family": "Xia",
        "given": "Peng"
      },
      {
        "family": "Cao",
        "given": "Wei"
      },
      {
        "family": "Jiang",
        "given": "Wei"
      },
      {
        "family": "Chen",
        "given": "Huan"
      },
      {
        "family": "Ding",
        "given": "Xin"
      },
      {
        "family": "Zhao",
        "given": "Hua"
      },
      {
        "family": "Zhang",
        "given": "Hongmin"
      },
      {
        "family": "Wang",
        "given": "Chunyao"
      },
      {
        "family": "Zhao",
        "given": "Jing"
      },
      {
        "family": "Sun",
        "given": "Xuefeng"
      },
      {
        "family": "Tian",
        "given": "Ran"
      },
      {
        "family": "Wu",
        "given": "Wei"
      },
      {
        "family": "Wu",
        "given": "Dong"
      },
      {
        "family": "Ma",
        "given": "Jie"
      },
      {
        "family": "Chen",
        "given": "Yu"
      },
      {
        "family": "Zhang",
        "given": "Dong"
      },
      {
        "family": "Xie",
        "given": "Jing"
      },
      {
        "family": "Yan",
        "given": "Xiaowei"
      },
      {
        "family": "Zhou",
        "given": "Xiang"
      },
      {
        "family": "Liu",
        "given": "Zhengyin"
      },
      {
        "family": "Wang",
        "given": "Jinglan"
      },
      {
        "family": "Du",
        "given": "Bin"
      },
      {
        "family": "Qin",
        "given": "Yan"
      },
      {
        "family": "Gao",
        "given": "Peng"
      },
      {
        "family": "Qin",
        "given": "Xuzhen"
      },
      {
        "family": "Xu",
        "given": "Yingchun"
      },
      {
        "family": "Zhang",
        "given": "Wen"
      },
      {
        "family": "Li",
        "given": "Taisheng"
      },
      {
        "family": "Zhang",
        "given": "Fengchun"
      },
      {
        "family": "Zhao",
        "given": "Yongqiang"
      },
      {
        "family": "Li",
        "given": "Yongzhe"
      },
      {
        "family": "Zhang",
        "given": "Shuyang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          8
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmc2007575",
    "publisher": "Massachusetts Medical Society",
    "title": "Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19",
    "URL": "https://doi.org/ggrgz7",
    "PMID": "32268022",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmc2007575"
  },
  {
    "type": "article-journal",
    "id": "4GFhOcA1",
    "author": [
      {
        "family": "Yu",
        "given": "Ignatius T.S."
      },
      {
        "family": "Li",
        "given": "Yuguo"
      },
      {
        "family": "Wong",
        "given": "Tze Wai"
      },
      {
        "family": "Tam",
        "given": "Wilson"
      },
      {
        "family": "Chan",
        "given": "Andy T."
      },
      {
        "family": "Lee",
        "given": "Joseph H.W."
      },
      {
        "family": "Leung",
        "given": "Dennis Y.C."
      },
      {
        "family": "Ho",
        "given": "Tommy"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          4,
          22
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa032867",
    "volume": "350",
    "issue": "17",
    "page": "1731-1739",
    "publisher": "Massachusetts Medical Society",
    "title": "Evidence of Airborne Transmission of the Severe Acute Respiratory Syndrome Virus",
    "URL": "https://doi.org/bz7skr",
    "PMID": "15102999",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa032867"
  },
  {
    "type": "article-journal",
    "id": "gnfviuGp",
    "author": [
      {
        "family": "Mulangu",
        "given": "Sabue"
      },
      {
        "family": "Dodd",
        "given": "Lori E."
      },
      {
        "family": "Davey",
        "given": "Richard T."
      },
      {
        "family": "Tshiani Mbaya",
        "given": "Olivier"
      },
      {
        "family": "Proschan",
        "given": "Michael"
      },
      {
        "family": "Mukadi",
        "given": "Daniel"
      },
      {
        "family": "Lusakibanza Manzo",
        "given": "Mariano"
      },
      {
        "family": "Nzolo",
        "given": "Didier"
      },
      {
        "family": "Tshomba Oloma",
        "given": "Antoine"
      },
      {
        "family": "Ibanda",
        "given": "Augustin"
      },
      {
        "family": "Ali",
        "given": "Rosine"
      },
      {
        "family": "Coulibaly",
        "given": "Sinaré"
      },
      {
        "family": "Levine",
        "given": "Adam C."
      },
      {
        "family": "Grais",
        "given": "Rebecca"
      },
      {
        "family": "Diaz",
        "given": "Janet"
      },
      {
        "family": "Lane",
        "given": "H. Clifford"
      },
      {
        "family": "Muyembe-Tamfum",
        "given": "Jean-Jacques"
      },
      {
        "family": "the PALM Writing Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          12,
          12
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa1910993",
    "volume": "381",
    "issue": "24",
    "page": "2293-2303",
    "publisher": "Massachusetts Medical Society",
    "title": "A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics",
    "URL": "https://doi.org/ggqmx4",
    "PMID": "31774950",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa1910993"
  },
  {
    "type": "article-journal",
    "id": "gleq16qf",
    "author": [
      {
        "family": "Holshue",
        "given": "Michelle L."
      },
      {
        "family": "DeBolt",
        "given": "Chas"
      },
      {
        "family": "Lindquist",
        "given": "Scott"
      },
      {
        "family": "Lofy",
        "given": "Kathy H."
      },
      {
        "family": "Wiesman",
        "given": "John"
      },
      {
        "family": "Bruce",
        "given": "Hollianne"
      },
      {
        "family": "Spitters",
        "given": "Christopher"
      },
      {
        "family": "Ericson",
        "given": "Keith"
      },
      {
        "family": "Wilkerson",
        "given": "Sara"
      },
      {
        "family": "Tural",
        "given": "Ahmet"
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Cohn",
        "given": "Amanda"
      },
      {
        "family": "Fox",
        "given": "LeAnne"
      },
      {
        "family": "Patel",
        "given": "Anita"
      },
      {
        "family": "Gerber",
        "given": "Susan I."
      },
      {
        "family": "Kim",
        "given": "Lindsay"
      },
      {
        "family": "Tong",
        "given": "Suxiang"
      },
      {
        "family": "Lu",
        "given": "Xiaoyan"
      },
      {
        "family": "Lindstrom",
        "given": "Steve"
      },
      {
        "family": "Pallansch",
        "given": "Mark A."
      },
      {
        "family": "Weldon",
        "given": "William C."
      },
      {
        "family": "Biggs",
        "given": "Holly M."
      },
      {
        "family": "Uyeki",
        "given": "Timothy M."
      },
      {
        "family": "Pillai",
        "given": "Satish K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          31
        ]
      ]
    },
    "container-title": "New England Journal of Medicine",
    "DOI": "10.1056/nejmoa2001191",
    "publisher": "Massachusetts Medical Society",
    "title": "First Case of 2019 Novel Coronavirus in the United States",
    "URL": "https://doi.org/ggjvr6",
    "PMCID": "PMC7092802",
    "PMID": "32004427",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1056/nejmoa2001191"
  },
  {
    "type": "article-journal",
    "id": "1CEzU1G34",
    "author": [
      {
        "family": "Prasad",
        "given": "Ananda S."
      },
      {
        "family": "Bao",
        "given": "Bin"
      },
      {
        "family": "Beck",
        "given": "Frances W.J."
      },
      {
        "family": "Sarkar",
        "given": "Fazlul H."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          10
        ]
      ]
    },
    "container-title": "Journal of Laboratory and Clinical Medicine",
    "DOI": "10.1067/mlc.2001.118108",
    "volume": "138",
    "issue": "4",
    "page": "250-256",
    "publisher": "Elsevier BV",
    "title": "Zinc activates NF-κB in HUT-78 cells",
    "URL": "https://doi.org/cnc6fr",
    "PMID": "11574819",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1067/mlc.2001.118108"
  },
  {
    "type": "article-journal",
    "id": "GpnngtWK",
    "author": [
      {
        "family": "Chen",
        "given": "J.-H."
      },
      {
        "family": "Chang",
        "given": "Y.-W."
      },
      {
        "family": "Yao",
        "given": "C.-W."
      },
      {
        "family": "Chiueh",
        "given": "T.-S."
      },
      {
        "family": "Huang",
        "given": "S.-C."
      },
      {
        "family": "Chien",
        "given": "K.-Y."
      },
      {
        "family": "Chen",
        "given": "A."
      },
      {
        "family": "Chang",
        "given": "F.-Y."
      },
      {
        "family": "Wong",
        "given": "C.-H."
      },
      {
        "family": "Chen",
        "given": "Y.-J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          11,
          30
        ]
      ]
    },
    "container-title": "Proceedings of the National Academy of Sciences",
    "DOI": "10.1073/pnas.0407992101",
    "volume": "101",
    "issue": "49",
    "page": "17039-17044",
    "publisher": "Proceedings of the National Academy of Sciences",
    "title": "Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry",
    "URL": "https://doi.org/dtv8sx",
    "PMCID": "PMC535397",
    "PMID": "15572443",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1073/pnas.0407992101"
  },
  {
    "type": "article-journal",
    "id": "yP8TXdq2",
    "author": [
      {
        "family": "Pushkarsky",
        "given": "T."
      },
      {
        "family": "Zybarth",
        "given": "G."
      },
      {
        "family": "Dubrovsky",
        "given": "L."
      },
      {
        "family": "Yurchenko",
        "given": "V."
      },
      {
        "family": "Tang",
        "given": "H."
      },
      {
        "family": "Guo",
        "given": "H."
      },
      {
        "family": "Toole",
        "given": "B."
      },
      {
        "family": "Sherry",
        "given": "B."
      },
      {
        "family": "Bukrinsky",
        "given": "M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          5,
          15
        ]
      ]
    },
    "container-title": "Proceedings of the National Academy of Sciences",
    "DOI": "10.1073/pnas.111583198",
    "volume": "98",
    "issue": "11",
    "page": "6360-6365",
    "publisher": "Proceedings of the National Academy of Sciences",
    "title": "CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A",
    "URL": "https://doi.org/cc4c7p",
    "PMCID": "PMC33473",
    "PMID": "11353871",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1073/pnas.111583198"
  },
  {
    "type": "article-journal",
    "id": "Ou3P9pGV",
    "author": [
      {
        "family": "Tang",
        "given": "X.-C."
      },
      {
        "family": "Agnihothram",
        "given": "S. S."
      },
      {
        "family": "Jiao",
        "given": "Y."
      },
      {
        "family": "Stanhope",
        "given": "J."
      },
      {
        "family": "Graham",
        "given": "R. L."
      },
      {
        "family": "Peterson",
        "given": "E. C."
      },
      {
        "family": "Avnir",
        "given": "Y."
      },
      {
        "family": "Tallarico",
        "given": "A. S. C."
      },
      {
        "family": "Sheehan",
        "given": "J."
      },
      {
        "family": "Zhu",
        "given": "Q."
      },
      {
        "family": "Baric",
        "given": "R. S."
      },
      {
        "family": "Marasco",
        "given": "W. A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          4,
          28
        ]
      ]
    },
    "container-title": "Proceedings of the National Academy of Sciences",
    "DOI": "10.1073/pnas.1402074111",
    "volume": "111",
    "issue": "19",
    "page": "E2018-E2026",
    "publisher": "Proceedings of the National Academy of Sciences",
    "title": "Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution",
    "URL": "https://doi.org/smr",
    "PMCID": "PMC4024880",
    "PMID": "24778221",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1073/pnas.1402074111"
  },
  {
    "type": "article-journal",
    "id": "YaxKcqq8",
    "author": [
      {
        "family": "Gordon",
        "given": "Calvin J"
      },
      {
        "family": "Tchesnokov",
        "given": "Egor P"
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Porter",
        "given": "Danielle P"
      },
      {
        "family": "Gotte",
        "given": "Matthias"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          24
        ]
      ]
    },
    "abstract": "Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including SARS-CoV and Middle East respiratory syndrome (MERS-CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogues. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i+3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3’–5’ exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays.",
    "container-title": "Journal of Biological Chemistry",
    "DOI": "10.1074/jbc.ac120.013056",
    "page": "jbc.AC120.013056",
    "publisher": "American Society for Biochemistry & Molecular Biology (ASBMB)",
    "title": "The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus",
    "URL": "https://doi.org/ggqm6x",
    "PMID": "32094225",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1074/jbc.ac120.013056"
  },
  {
    "type": "article-journal",
    "id": "gZRPoTM9",
    "author": [
      {
        "family": "Hemilä",
        "given": "Harri"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          3,
          9
        ]
      ]
    },
    "abstract": "The effect of vitamin C on the common cold has been the subject of several studies. These studies do not support a considerable decrease in the incidence of the common cold with supplemental vitamin C. However, vitamin C has consistently decreased the duration of cold episodes and the severity of symptoms. The benefits that have been observed in different studies show a large variation and, therefore, the clinical significance may not be clearly inferred from them. The biochemical explanation for the benefits may be based on the antioxidant property of vitamin C. In an infection, phagocytic leucocytes become activated and they produce oxidizing compounds which are released from the cell. By reacting with these oxidants, vitamin C may decrease the inflammatory effects caused by them. Scurvy, which is caused by a deficiency in vitamin C, is mostly attributed to the decreased synthesis of collagen. However, vitamin C also participates in several other reactions, such as the destruction of oxidizing substances. The common cold studies indicate that the amounts of vitamin C which safely protect from scurvy may still be too low to provide an efficient rate for other reactions, possibly antioxidant in nature, in infected people.",
    "container-title": "British Journal of Nutrition",
    "DOI": "10.1079/bjn19920004",
    "volume": "67",
    "issue": "1",
    "page": "3-16",
    "publisher": "Cambridge University Press (CUP)",
    "title": "Vitamin C and the common cold",
    "URL": "https://doi.org/fszhc6",
    "PMID": "1547201",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1079/bjn19920004"
  },
  {
    "type": "article-journal",
    "id": "xLPeszeO",
    "author": [
      {
        "family": "McClements",
        "given": "David Julian"
      },
      {
        "family": "Decker",
        "given": "Eric Andrew"
      },
      {
        "family": "Park",
        "given": "Yeonhwa"
      },
      {
        "family": "Weiss",
        "given": "Jochen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          6,
          16
        ]
      ]
    },
    "container-title": "Critical Reviews in Food Science and Nutrition",
    "DOI": "10.1080/10408390902841529",
    "volume": "49",
    "issue": "6",
    "page": "577-606",
    "publisher": "Informa UK Limited",
    "title": "Structural Design Principles for Delivery of Bioactive Components in Nutraceuticals and Functional Foods",
    "URL": "https://doi.org/dt68m4",
    "PMID": "19484636",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1080/10408390902841529"
  },
  {
    "type": "article-journal",
    "id": "lMhFSIiF",
    "author": [
      {
        "family": "Domínguez Díaz",
        "given": "Laura"
      },
      {
        "family": "Fernández-Ruiz",
        "given": "Virginia"
      },
      {
        "family": "Cámara",
        "given": "Montaña"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          3,
          29
        ]
      ]
    },
    "container-title": "Critical Reviews in Food Science and Nutrition",
    "DOI": "10.1080/10408398.2019.1592107",
    "page": "1-9",
    "publisher": "Informa UK Limited",
    "title": "The frontier between nutrition and pharma: The international regulatory framework of functional foods, food supplements and nutraceuticals",
    "URL": "https://doi.org/ggqs3w",
    "PMID": "30924346",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1080/10408398.2019.1592107"
  },
  {
    "type": "article-journal",
    "id": "cwbHiM1o",
    "author": [
      {
        "family": "Resch",
        "given": "Bernhard"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          6,
          12
        ]
      ]
    },
    "container-title": "Human Vaccines & Immunotherapeutics",
    "DOI": "10.1080/21645515.2017.1337614",
    "volume": "13",
    "issue": "9",
    "page": "2138-2149",
    "publisher": "Informa UK Limited",
    "title": "Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection",
    "URL": "https://doi.org/ggqbps",
    "PMCID": "PMC5612471",
    "PMID": "28605249",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1080/21645515.2017.1337614"
  },
  {
    "type": "article-journal",
    "id": "KULxo48U",
    "author": [
      {
        "family": "Nie",
        "given": "Yuchun"
      },
      {
        "family": "Wang",
        "given": "Guangwen"
      },
      {
        "family": "Shi",
        "given": "Xuanling"
      },
      {
        "family": "Zhang",
        "given": "Hong"
      },
      {
        "family": "Qiu",
        "given": "Yan"
      },
      {
        "family": "He",
        "given": "Zhongping"
      },
      {
        "family": "Wang",
        "given": "Wei"
      },
      {
        "family": "Lian",
        "given": "Gewei"
      },
      {
        "family": "Yin",
        "given": "Xiaolei"
      },
      {
        "family": "Du",
        "given": "Liying"
      },
      {
        "family": "Ren",
        "given": "Lili"
      },
      {
        "family": "Wang",
        "given": "Jianwei"
      },
      {
        "family": "He",
        "given": "Xiong"
      },
      {
        "family": "Li",
        "given": "Taisheng"
      },
      {
        "family": "Deng",
        "given": "Hongkui"
      },
      {
        "family": "Ding",
        "given": "Mingxiao"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          9,
          15
        ]
      ]
    },
    "container-title": "The Journal of Infectious Diseases",
    "DOI": "10.1086/423286",
    "volume": "190",
    "issue": "6",
    "page": "1119-1126",
    "publisher": "Oxford University Press (OUP)",
    "title": "Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome–Associated Coronavirus Infection",
    "URL": "https://doi.org/cgqj5b",
    "PMID": "15319862",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1086/423286"
  },
  {
    "type": "article-journal",
    "id": "m9yLJ5Da",
    "author": [
      {
        "family": "Chen",
        "given": "Zhinan"
      },
      {
        "family": "Mi",
        "given": "Li"
      },
      {
        "family": "Xu",
        "given": "Jing"
      },
      {
        "family": "Yu",
        "given": "Jiyun"
      },
      {
        "family": "Wang",
        "given": "Xianhui"
      },
      {
        "family": "Jiang",
        "given": "Jianli"
      },
      {
        "family": "Xing",
        "given": "Jinliang"
      },
      {
        "family": "Shang",
        "given": "Peng"
      },
      {
        "family": "Qian",
        "given": "Airong"
      },
      {
        "family": "Li",
        "given": "Yu"
      },
      {
        "family": "Shaw",
        "given": "Peter X."
      },
      {
        "family": "Wang",
        "given": "Jianwei"
      },
      {
        "family": "Duan",
        "given": "Shumin"
      },
      {
        "family": "Ding",
        "given": "Jin"
      },
      {
        "family": "Fan",
        "given": "Chunmei"
      },
      {
        "family": "Zhang",
        "given": "Yang"
      },
      {
        "family": "Yang",
        "given": "Yong"
      },
      {
        "family": "Yu",
        "given": "Xiaoling"
      },
      {
        "family": "Feng",
        "given": "Qiang"
      },
      {
        "family": "Li",
        "given": "Biehu"
      },
      {
        "family": "Yao",
        "given": "Xiying"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Li",
        "given": "Ling"
      },
      {
        "family": "Xue",
        "given": "Xiaoping"
      },
      {
        "family": "Zhu",
        "given": "Ping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          3
        ]
      ]
    },
    "container-title": "The Journal of Infectious Diseases",
    "DOI": "10.1086/427811",
    "volume": "191",
    "issue": "5",
    "page": "755-760",
    "publisher": "Oxford University Press (OUP)",
    "title": "Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus",
    "URL": "https://doi.org/cd8snd",
    "PMCID": "PMC7110046",
    "PMID": "15688292",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1086/427811"
  },
  {
    "type": "article-journal",
    "id": "IAOnO0Gj",
    "author": [
      {
        "family": "Read",
        "given": "Scott A"
      },
      {
        "family": "Obeid",
        "given": "Stephanie"
      },
      {
        "family": "Ahlenstiel",
        "given": "Chantelle"
      },
      {
        "family": "Ahlenstiel",
        "given": "Golo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          7
        ]
      ]
    },
    "abstract": "Zinc is an essential trace element that is crucial for growth, development, and the maintenance of immune function. Its influence reaches all organs and cell types, representing an integral component of approximately 10% of the human proteome, and encompassing hundreds of key enzymes and transcription factors. Zinc deficiency is strikingly common, affecting up to a quarter of the population in developing countries, but also affecting distinct populations in the developed world as a result of lifestyle, age, and disease-mediated factors. Consequently, zinc status is a critical factor that can influence antiviral immunity, particularly as zinc-deficient populations are often most at risk of acquiring viral infections such as HIV or hepatitis C virus. This review summarizes current basic science and clinical evidence examining zinc as a direct antiviral, as well as a stimulant of antiviral immunity. An abundance of evidence has accumulated over the past 50 y to demonstrate the antiviral activity of zinc against a variety of viruses, and via numerous mechanisms. The therapeutic use of zinc for viral infections such as herpes simplex virus and the common cold has stemmed from these findings; however, there remains much to be learned regarding the antiviral mechanisms and clinical benefit of zinc supplementation as a preventative and therapeutic treatment for viral infections.",
    "container-title": "Advances in Nutrition",
    "DOI": "10.1093/advances/nmz013",
    "volume": "10",
    "issue": "4",
    "page": "696-710",
    "publisher": "Oxford University Press (OUP)",
    "title": "The Role of Zinc in Antiviral Immunity",
    "URL": "https://doi.org/ggqmgr",
    "PMCID": "PMC6628855",
    "PMID": "31305906",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/advances/nmz013"
  },
  {
    "type": "article-journal",
    "id": "kxuSwrCI",
    "author": [
      {
        "family": "Prasad",
        "given": "Ananda S"
      },
      {
        "family": "Beck",
        "given": "Frances WJ"
      },
      {
        "family": "Bao",
        "given": "Bin"
      },
      {
        "family": "Fitzgerald",
        "given": "James T"
      },
      {
        "family": "Snell",
        "given": "Diane C"
      },
      {
        "family": "Steinberg",
        "given": "Joel D"
      },
      {
        "family": "Cardozo",
        "given": "Lavoisier J"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          3
        ]
      ]
    },
    "container-title": "The American Journal of Clinical Nutrition",
    "DOI": "10.1093/ajcn/85.3.837",
    "volume": "85",
    "issue": "3",
    "page": "837-844",
    "publisher": "Oxford University Press (OUP)",
    "title": "Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress",
    "URL": "https://doi.org/ggqmgs",
    "PMID": "17344507",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/ajcn/85.3.837"
  },
  {
    "type": "article-journal",
    "id": "1GBsnkeLK",
    "author": [
      {
        "family": "Yao",
        "given": "Xueting"
      },
      {
        "family": "Ye",
        "given": "Fei"
      },
      {
        "family": "Zhang",
        "given": "Miao"
      },
      {
        "family": "Cui",
        "given": "Cheng"
      },
      {
        "family": "Huang",
        "given": "Baoying"
      },
      {
        "family": "Niu",
        "given": "Peihua"
      },
      {
        "family": "Liu",
        "given": "Xu"
      },
      {
        "family": "Zhao",
        "given": "Li"
      },
      {
        "family": "Dong",
        "given": "Erdan"
      },
      {
        "family": "Song",
        "given": "Chunli"
      },
      {
        "family": "Zhan",
        "given": "Siyan"
      },
      {
        "family": "Lu",
        "given": "Roujian"
      },
      {
        "family": "Li",
        "given": "Haiyan"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      },
      {
        "family": "Liu",
        "given": "Dongyang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          9
        ]
      ]
    },
    "container-title": "Clinical Infectious Diseases",
    "DOI": "10.1093/cid/ciaa237",
    "publisher": "Oxford University Press (OUP)",
    "title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",
    "URL": "https://doi.org/ggpx7z",
    "PMCID": "PMC7108130",
    "PMID": "32150618",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cid/ciaa237"
  },
  {
    "type": "article-journal",
    "id": "6Y81C4P3",
    "author": [
      {
        "family": "Qin",
        "given": "Chuan"
      },
      {
        "family": "Zhou",
        "given": "Luoqi"
      },
      {
        "family": "Hu",
        "given": "Ziwei"
      },
      {
        "family": "Zhang",
        "given": "Shuoqi"
      },
      {
        "family": "Yang",
        "given": "Sheng"
      },
      {
        "family": "Tao",
        "given": "Yu"
      },
      {
        "family": "Xie",
        "given": "Cuihong"
      },
      {
        "family": "Ma",
        "given": "Ke"
      },
      {
        "family": "Shang",
        "given": "Ke"
      },
      {
        "family": "Wang",
        "given": "Wei"
      },
      {
        "family": "Tian",
        "given": "Dai-Shi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "container-title": "Clinical Infectious Diseases",
    "DOI": "10.1093/cid/ciaa248",
    "publisher": "Oxford University Press (OUP)",
    "title": "Dysregulation of immune response in patients with COVID-19 in Wuhan, China",
    "URL": "https://doi.org/ggpxcf",
    "PMCID": "PMC7108125",
    "PMID": "32161940",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/cid/ciaa248"
  },
  {
    "type": "article-journal",
    "id": "COEfjKo5",
    "author": [
      {
        "family": "Chu",
        "given": "Daniel K W"
      },
      {
        "family": "Pan",
        "given": "Yang"
      },
      {
        "family": "Cheng",
        "given": "Samuel M S"
      },
      {
        "family": "Hui",
        "given": "Kenrie P Y"
      },
      {
        "family": "Krishnan",
        "given": "Pavithra"
      },
      {
        "family": "Liu",
        "given": "Yingzhi"
      },
      {
        "family": "Ng",
        "given": "Daisy Y M"
      },
      {
        "family": "Wan",
        "given": "Carrie K C"
      },
      {
        "family": "Yang",
        "given": "Peng"
      },
      {
        "family": "Wang",
        "given": "Quanyi"
      },
      {
        "family": "Peiris",
        "given": "Malik"
      },
      {
        "family": "Poon",
        "given": "Leo L M"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          31
        ]
      ]
    },
    "container-title": "Clinical Chemistry",
    "DOI": "10.1093/clinchem/hvaa029",
    "publisher": "Oxford University Press (OUP)",
    "title": "Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia",
    "URL": "https://doi.org/ggnbpp",
    "PMCID": "PMC7108203",
    "PMID": "32031583",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/clinchem/hvaa029"
  },
  {
    "type": "article-journal",
    "id": "RRx6YovP",
    "author": [
      {
        "family": "Mair-Jenkins",
        "given": "John"
      },
      {
        "family": "Saavedra-Campos",
        "given": "Maria"
      },
      {
        "family": "Baillie",
        "given": "J. Kenneth"
      },
      {
        "family": "Cleary",
        "given": "Paul"
      },
      {
        "family": "Khaw",
        "given": "Fu-Meng"
      },
      {
        "family": "Lim",
        "given": "Wei Shen"
      },
      {
        "family": "Makki",
        "given": "Sophia"
      },
      {
        "family": "Rooney",
        "given": "Kevin D."
      },
      {
        "family": "Nguyen-Van-Tam",
        "given": "Jonathan S."
      },
      {
        "family": "Beck",
        "given": "Charles R."
      },
      {
        "literal": "Convalescent Plasma Study Group"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          1,
          1
        ]
      ]
    },
    "container-title": "Journal of Infectious Diseases",
    "DOI": "10.1093/infdis/jiu396",
    "volume": "211",
    "issue": "1",
    "page": "80-90",
    "publisher": "Oxford University Press (OUP)",
    "title": "The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis",
    "URL": "https://doi.org/f632n7",
    "PMCID": "PMC4264590",
    "PMID": "25030060",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/infdis/jiu396"
  },
  {
    "type": "article-journal",
    "id": "LHtuVmaq",
    "author": [
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Gayle",
        "given": "Albert A"
      },
      {
        "family": "Wilder-Smith",
        "given": "Annelies"
      },
      {
        "family": "Rocklöv",
        "given": "Joacim"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          13
        ]
      ]
    },
    "abstract": "Teaser: Our review found the average R0 for 2019-nCoV to be 3.28, which exceeds WHO estimates of 1.4 to 2.5.",
    "container-title": "Journal of Travel Medicine",
    "DOI": "10.1093/jtm/taaa021",
    "publisher": "Oxford University Press (OUP)",
    "title": "The reproductive number of COVID-19 is higher compared to SARS coronavirus",
    "URL": "https://doi.org/ggnntv",
    "PMCID": "PMC7074654",
    "PMID": "32052846",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/jtm/taaa021"
  },
  {
    "type": "article-journal",
    "id": "BcOf65BE",
    "author": [
      {
        "family": "Kosugi",
        "given": "Tomoki"
      },
      {
        "family": "Maeda",
        "given": "Kayaho"
      },
      {
        "family": "Sato",
        "given": "Waichi"
      },
      {
        "family": "Maruyama",
        "given": "Shoichi"
      },
      {
        "family": "Kadomatsu",
        "given": "Kenji"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          7
        ]
      ]
    },
    "container-title": "Nephrology Dialysis Transplantation",
    "DOI": "10.1093/ndt/gfu302",
    "volume": "30",
    "issue": "7",
    "page": "1097-1103",
    "publisher": "Oxford University Press (OUP)",
    "title": "CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint",
    "URL": "https://doi.org/ggq624",
    "PMID": "25248362",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/ndt/gfu302"
  },
  {
    "type": "article-journal",
    "id": "TgV8gb30",
    "author": [
      {
        "family": "Lang",
        "given": "Veronika R."
      },
      {
        "family": "Englbrecht",
        "given": "Matthias"
      },
      {
        "family": "Rech",
        "given": "Jürgen"
      },
      {
        "family": "Nüsslein",
        "given": "Hubert"
      },
      {
        "family": "Manger",
        "given": "Karin"
      },
      {
        "family": "Schuch",
        "given": "Florian"
      },
      {
        "family": "Tony",
        "given": "Hans-Peter"
      },
      {
        "family": "Fleck",
        "given": "Martin"
      },
      {
        "family": "Manger",
        "given": "Bernhard"
      },
      {
        "family": "Schett",
        "given": "Georg"
      },
      {
        "family": "Zwerina",
        "given": "Jochen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          5
        ]
      ]
    },
    "container-title": "Rheumatology",
    "DOI": "10.1093/rheumatology/ker223",
    "volume": "51",
    "issue": "5",
    "page": "852-857",
    "publisher": "Oxford University Press (OUP)",
    "title": "Risk of infections in rheumatoid arthritis patients treated with tocilizumab",
    "URL": "https://doi.org/d3b3rh",
    "PMID": "21865281",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1093/rheumatology/ker223"
  },
  {
    "type": "article-journal",
    "id": "JARvpqRw",
    "author": [
      {
        "family": "HEMILÄ",
        "given": "HARRI"
      }
    ],
    "issued": {
      "date-parts": [
        [
          1997,
          9
        ]
      ]
    },
    "container-title": "The Pediatric Infectious Disease Journal",
    "DOI": "10.1097/00006454-199709000-00003",
    "volume": "16",
    "issue": "9",
    "page": "836-837",
    "publisher": "Ovid Technologies (Wolters Kluwer Health)",
    "title": "Vitamin C intake and susceptibility to pneumonia",
    "URL": "https://doi.org/fkvs9d",
    "PMID": "9306475",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1097/00006454-199709000-00003"
  },
  {
    "type": "article-journal",
    "id": "ZzrrVDoE",
    "author": [
      {
        "family": "Read",
        "given": "Jonathan M"
      },
      {
        "family": "Bridgen",
        "given": "Jessica RE"
      },
      {
        "family": "Cummings",
        "given": "Derek AT"
      },
      {
        "family": "Ho",
        "given": "Antonia"
      },
      {
        "family": "Jewell",
        "given": "Chris P"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          28
        ]
      ]
    },
    "abstract": "Since first identified, the epidemic scale of the recently emerged novel coronavirus (2019-nCoV) in Wuhan, China, has increased rapidly, with cases arising across China and other countries and regions. using a transmission model, we estimate a basic reproductive number of 3.11 (95%CI, 2.39-4.13); 58-76% of transmissions must be prevented to stop increasing; Wuhan case ascertainment of 5.0% (3.6-7.4); 21022 (11090-33490) total infections in Wuhan 1 to 22 January.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.01.23.20018549",
    "publisher": "medRxiv",
    "title": "Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions",
    "URL": "https://doi.org/dkzb",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.01.23.20018549"
  },
  {
    "type": "article-journal",
    "id": "Yj8Xh4Wz",
    "author": [
      {
        "family": "Shen",
        "given": "Mingwang"
      },
      {
        "family": "Peng",
        "given": "Zhihang"
      },
      {
        "family": "Xiao",
        "given": "Yanni"
      },
      {
        "family": "Zhang",
        "given": "Lei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          25
        ]
      ]
    },
    "abstract": "We present a timely evaluation of the Chinese 2019-nCov epidemic in its initial phase, where 2019-nCov demonstrates comparable transmissibility but lower fatality rates than SARS and MERS. A quick diagnosis that leads to case isolation and integrated interventions will have a major impact on its future trend. Nevertheless, as China is facing its Spring Festival travel rush and the epidemic has spread beyond its borders, further investigation on its potential spatiotemporal transmission pattern and novel intervention strategies are warranted.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.01.23.916726",
    "publisher": "bioRxiv",
    "title": "Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China",
    "URL": "https://doi.org/ggqhzw",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.01.23.916726"
  },
  {
    "type": "article-journal",
    "id": "WLc2UMgQ",
    "author": [
      {
        "family": "Liu",
        "given": "Tao"
      },
      {
        "family": "Hu",
        "given": "Jianxiong"
      },
      {
        "family": "Xiao",
        "given": "Jianpeng"
      },
      {
        "family": "He",
        "given": "Guanhao"
      },
      {
        "family": "Kang",
        "given": "Min"
      },
      {
        "family": "Rong",
        "given": "Zuhua"
      },
      {
        "family": "Lin",
        "given": "Lifeng"
      },
      {
        "family": "Zhong",
        "given": "Haojie"
      },
      {
        "family": "Huang",
        "given": "Qiong"
      },
      {
        "family": "Deng",
        "given": "Aiping"
      },
      {
        "family": "Zeng",
        "given": "Weilin"
      },
      {
        "family": "Tan",
        "given": "Xiaohua"
      },
      {
        "family": "Zeng",
        "given": "Siqing"
      },
      {
        "family": "Zhu",
        "given": "Zhihua"
      },
      {
        "family": "Li",
        "given": "Jiansen"
      },
      {
        "family": "Gong",
        "given": "Dexin"
      },
      {
        "family": "Wan",
        "given": "Donghua"
      },
      {
        "family": "Chen",
        "given": "Shaowei"
      },
      {
        "family": "Guo",
        "given": "Lingchuan"
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Sun",
        "given": "Limei"
      },
      {
        "family": "Liang",
        "given": "Wenjia"
      },
      {
        "family": "Song",
        "given": "Tie"
      },
      {
        "family": "He",
        "given": "Jianfeng"
      },
      {
        "family": "Ma",
        "given": "Wenjun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          13
        ]
      ]
    },
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.01.25.919787",
    "publisher": "bioRxiv",
    "title": "Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China",
    "URL": "https://doi.org/dkx9",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.01.25.919787"
  },
  {
    "type": "article-journal",
    "id": "1HLSeqnY8",
    "author": [
      {
        "family": "Tian",
        "given": "Xiaolong"
      },
      {
        "family": "Li",
        "given": "Cheng"
      },
      {
        "family": "Huang",
        "given": "Ailing"
      },
      {
        "family": "Xia",
        "given": "Shuai"
      },
      {
        "family": "Lu",
        "given": "Sicong"
      },
      {
        "family": "Shi",
        "given": "Zhengli"
      },
      {
        "family": "Lu",
        "given": "Lu"
      },
      {
        "family": "Jiang",
        "given": "Shibo"
      },
      {
        "family": "Yang",
        "given": "Zhenlin"
      },
      {
        "family": "Wu",
        "given": "Yanling"
      },
      {
        "family": "Ying",
        "given": "Tianlei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          28
        ]
      ]
    },
    "abstract": "The newly identified 2019 novel coronavirus (2019-nCoV) has caused more than 800 laboratory-confirmed human infections, including 25 deaths, posing a serious threat to human health. Currently, however, there is no specific antiviral treatment or vaccine. Considering the relatively high identity of receptor binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-SARS-CoV antibodies with 2019-nCoV spike protein, which could have important implications for rapid development of vaccines and therapeutic antibodies against 2019-nCoV. Here, we report for the first time that a SARS-CoV-specific human monoclonal antibody, CR3022, could bind potently with 2019-nCoV RBD (KD of 6.3 nM). The epitope of CR3022 does not overlap with the ACE2 binding site within 2019-nCoV RBD. Therefore, CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections. Interestingly, some of the most potent SARS-CoV-specific neutralizing antibodies (e.g., m396, CR3014) that target the ACE2 binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that the difference in the RBD of SARS-CoV and 2019-nCoV has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.01.28.923011",
    "publisher": "bioRxiv",
    "title": "Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody",
    "URL": "https://doi.org/ggjqfd",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.01.28.923011"
  },
  {
    "type": "article-journal",
    "id": "lOQPScZt",
    "author": [
      {
        "family": "He",
        "given": "Xiang"
      },
      {
        "family": "Zhang",
        "given": "Lei"
      },
      {
        "family": "Ran",
        "given": "Qin"
      },
      {
        "family": "Xiong",
        "given": "Anying"
      },
      {
        "family": "Wang",
        "given": "Junyi"
      },
      {
        "family": "Wu",
        "given": "Dehong"
      },
      {
        "family": "Chen",
        "given": "Feng"
      },
      {
        "family": "Li",
        "given": "Guoping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          5
        ]
      ]
    },
    "abstract": "The 2019-nCoV is reported to share the same entry (ACE2) as SARS-CoV according to the updated findings. Analyzing the distribution and expression level of the route of coronavirus may help reveal underlying mechanisms of viral susceptibility and post-infection modulation. In this study, we found that the expression of ACE2 in healthy populations and patients with underlying diseases was not significantly different, suggesting relatively similar susceptibility, which was consistent with current clinical observations. Moreover, based on the expression of ACE2 in smoking individuals, we inferred that long-term smoking might be a risk factor for 2019-nCoV. Analyzing the ACE2 in SARS-CoV infected cells suggested that ACE2 was more than just a receptor but also participated in post-infection regulation, including immune response, cytokine secretion, and viral genome replication. We also constructed Protein-protein interaction (PPI) networks and identified hub genes in viral activity and cytokine secretion. Our findings could explain the clinical symptoms so far and help clinicians and researchers understand the pathogenesis and design therapeutic strategies for 2019-nCoV.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.03.20020206",
    "publisher": "medRxiv",
    "title": "Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of 2019-nCoV",
    "URL": "https://doi.org/ggrbd8",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.03.20020206"
  },
  {
    "type": "article-journal",
    "id": "rL9IRhVy",
    "author": [
      {
        "family": "Liang",
        "given": "Weicheng"
      },
      {
        "family": "Feng",
        "given": "Zhijie"
      },
      {
        "family": "Rao",
        "given": "Shitao"
      },
      {
        "family": "Xiao",
        "given": "Cuicui"
      },
      {
        "family": "Lin",
        "given": "Zexiao"
      },
      {
        "family": "Zhang",
        "given": "Qi"
      },
      {
        "family": "Qi",
        "given": "Wei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          17
        ]
      ]
    },
    "abstract": "The outbreak of pneumonia caused by the 2019 Novel Coronavirus (2019-nCoV) was reported in Wuhan City, China. However, the clinical symptoms varied in different reports. Based on the results of inter-group difference test, we found that the incidence of diarrhea differed in three recent reports. As 2019-nCoV utilizes the same cell entry receptor ACE2 as severe acute respiratory syndrome coronavirus (SARS-CoV) and ACE2 tightly controls intestinal inflammation, to trace the route of infection mediated by 2019-nCoV, we used the single-cell RNA sequencing data for analysis. We found that the ACE2 mRNA was highly expressed in the healthy human small intestine rather than the lung. Besides, single-cell RNA sequencing data showed that ACE2 was significantly elevated in the proximal and distal enterocytes, where the small intestinal epithelium is exposed to the foreign pathogen. Thus, we suspect that ACE2-expressing small intestinal epithelium cells might be vulnerable to 2019-nCoV infection when people eat infected wild animals and diarrhea may serve as an indicator for infection, suggesting that clinicians should pay more attention to patients with diarrhea during the outbreak of pneumonia.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.03.20020289",
    "publisher": "medRxiv",
    "title": "Diarrhea may be underestimated: a missing link in 2019 novel coronavirus",
    "URL": "https://doi.org/ggrbdw",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.03.20020289"
  },
  {
    "type": "article-journal",
    "id": "BHQvMYPG",
    "author": [
      {
        "family": "Chai",
        "given": "Xiaoqiang"
      },
      {
        "family": "Hu",
        "given": "Longfei"
      },
      {
        "family": "Zhang",
        "given": "Yan"
      },
      {
        "family": "Han",
        "given": "Weiyu"
      },
      {
        "family": "Lu",
        "given": "Zhou"
      },
      {
        "family": "Ke",
        "given": "Aiwu"
      },
      {
        "family": "Zhou",
        "given": "Jian"
      },
      {
        "family": "Shi",
        "given": "Guoming"
      },
      {
        "family": "Fang",
        "given": "Nan"
      },
      {
        "family": "Fan",
        "given": "Jia"
      },
      {
        "family": "Cai",
        "given": "Jiabin"
      },
      {
        "family": "Fan",
        "given": "Jue"
      },
      {
        "family": "Lan",
        "given": "Fei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          4
        ]
      ]
    },
    "abstract": "A newly identified coronavirus, 2019-nCoV, has been posing significant threats to public health since December 2019. ACE2, the host cell receptor for severe acute respiratory syndrome coronavirus (SARS), has recently been demonstrated in mediating 2019-nCoV infection. Interestingly, besides the respiratory system, substantial proportion of SARS and 2019-nCoV patients showed signs of various degrees of liver damage, the mechanism and implication of which have not yet been determined. Here, we performed an unbiased evaluation of cell type specific expression of ACE2 in healthy liver tissues using single cell RNA-seq data of two independent cohorts, and identified specific expression in cholangiocytes. The results indicated that virus might directly bind to ACE2 positive cholangiocytes but not necessarily hepatocytes. This finding suggested the liver abnormalities of SARS and 2019-nCoV patients may not be due to hepatocyte damage, but cholangiocyte dysfunction and other causes such as drug induced and systemic inflammatory response induced liver injury. Our findings indicate that special care of liver dysfunction should be installed in treating 2019-nCoV patients during the hospitalization and shortly after cure.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.03.931766",
    "publisher": "bioRxiv",
    "title": "Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection",
    "URL": "https://doi.org/ggq626",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.03.931766"
  },
  {
    "type": "article-journal",
    "id": "ViWCb8MJ",
    "author": [
      {
        "family": "Wang",
        "given": "Jun"
      },
      {
        "family": "Zhao",
        "given": "Shanmeizi"
      },
      {
        "family": "Liu",
        "given": "Ming"
      },
      {
        "family": "Zhao",
        "given": "Zhiyao"
      },
      {
        "family": "Xu",
        "given": "Yiping"
      },
      {
        "family": "Wang",
        "given": "Ping"
      },
      {
        "family": "Lin",
        "given": "Meng"
      },
      {
        "family": "Xu",
        "given": "Yanhui"
      },
      {
        "family": "Huang",
        "given": "Bing"
      },
      {
        "family": "Zuo",
        "given": "Xiaoyu"
      },
      {
        "family": "Chen",
        "given": "Zhanghua"
      },
      {
        "family": "Bai",
        "given": "Fan"
      },
      {
        "family": "Cui",
        "given": "Jun"
      },
      {
        "family": "Lew",
        "given": "Andrew M"
      },
      {
        "family": "Zhao",
        "given": "Jincun"
      },
      {
        "family": "Zhang",
        "given": "Yan"
      },
      {
        "family": "Luo",
        "given": "Haibin"
      },
      {
        "family": "Zhang",
        "given": "Yuxia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          7
        ]
      ]
    },
    "abstract": "Respiratory disease caused by the 2019 novel coronavirus (2019-nCoV) pneumonia first emerged in Wuhan, Hubei Province, China, in December 2019 and spread rapidly to other provinces and other countries. Angiotensin-converting enzyme 2 (ACE2) is the receptor for SARS-CoV and has been suggested to be also the receptor for 2019-nCoV. Paradoxically, ACE2 expression in the lung protects mice from SARS-CoV spike protein induced lung injury by attenuating the renin-angiotensin system. In the intestine, ACE2 also suppresses intestinal inflammation by maintaining amino acid homeostasis, antimicrobial peptide expression and ecology of the gut microbiome. Upon analysis of single cell-RNA sequencing data from control subjects and those with colitis or inflammatory bowel disease (IBD), we found that ACE2 expression in the colonocytes was positively associated with genes regulating viral infection, innate and cellular immunity, but was negatively associated with viral transcription, protein translation, humoral immunity, phagocytosis and complement activation. In summary, we suggest that ACE2 may play dual roles in mediating the susceptibility and immunity of 2019-nCoV infection.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.05.20020545",
    "publisher": "medRxiv",
    "title": "ACE2 expression by colonic epithelial cells is associated with viral infection, immunity and energy metabolism",
    "URL": "https://doi.org/ggrfbx",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.05.20020545"
  },
  {
    "type": "article-journal",
    "id": "7zBwK1wn",
    "author": [
      {
        "family": "Nguyen",
        "given": "Duc Duy"
      },
      {
        "family": "Gao",
        "given": "Kaifu"
      },
      {
        "family": "Chen",
        "given": "Jiahui"
      },
      {
        "family": "Wang",
        "given": "Rui"
      },
      {
        "family": "Wei",
        "given": "Guo-Wei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          13
        ]
      ]
    },
    "abstract": "The World Health Organization (WHO) has declared the 2019 novel coronavirus (2019-nCoV) infection outbreak a global health emergency. Currently, there is no effective anti-2019-nCoV medication. The sequence identity of the 3CL proteases of 2019-nCoV and SARS is 96%, which provides a sound foundation for structural-based drug repositioning (SBDR). Based on a SARS 3CL protease X-ray crystal structure, we construct a 3D homology structure of 2019-nCoV 3CL protease. Based on this structure and existing experimental datasets for SARS 3CL protease inhibitors, we develop an SBDR model based on machine learning and mathematics to screen 1465 drugs in the DrugBank that have been approved by the U.S. Food and Drug Administration (FDA). We found that many FDA approved drugs are potentially highly potent to 2019-nCoV.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.05.936013",
    "publisher": "bioRxiv",
    "title": "Potentially highly potent drugs for 2019-nCoV",
    "URL": "https://doi.org/ggrbj5",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.05.936013"
  },
  {
    "type": "article-journal",
    "id": "bgrzawWp",
    "author": [
      {
        "family": "Guan",
        "given": "Wei-jie"
      },
      {
        "family": "Ni",
        "given": "Zheng-yi"
      },
      {
        "family": "Hu",
        "given": "Yu"
      },
      {
        "family": "Liang",
        "given": "Wen-hua"
      },
      {
        "family": "Ou",
        "given": "Chun-quan"
      },
      {
        "family": "He",
        "given": "Jian-xing"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Shan",
        "given": "Hong"
      },
      {
        "family": "Lei",
        "given": "Chun-liang"
      },
      {
        "family": "Hui",
        "given": "David SC"
      },
      {
        "family": "Du",
        "given": "Bin"
      },
      {
        "family": "Li",
        "given": "Lan-juan"
      },
      {
        "family": "Zeng",
        "given": "Guang"
      },
      {
        "family": "Yuen",
        "given": "Kowk-Yung"
      },
      {
        "family": "Chen",
        "given": "Ru-chong"
      },
      {
        "family": "Tang",
        "given": "Chun-li"
      },
      {
        "family": "Wang",
        "given": "Tao"
      },
      {
        "family": "Chen",
        "given": "Ping-yan"
      },
      {
        "family": "Xiang",
        "given": "Jie"
      },
      {
        "family": "Li",
        "given": "Shi-yue"
      },
      {
        "family": "Wang",
        "given": "Jin-lin"
      },
      {
        "family": "Liang",
        "given": "Zi-jing"
      },
      {
        "family": "Peng",
        "given": "Yi-xiang"
      },
      {
        "family": "Wei",
        "given": "Li"
      },
      {
        "family": "Liu",
        "given": "Yong"
      },
      {
        "family": "Hu",
        "given": "Ya-hua"
      },
      {
        "family": "Peng",
        "given": "Peng"
      },
      {
        "family": "Wang",
        "given": "Jian-ming"
      },
      {
        "family": "Liu",
        "given": "Ji-yang"
      },
      {
        "family": "Chen",
        "given": "Zhong"
      },
      {
        "family": "Li",
        "given": "Gang"
      },
      {
        "family": "Zheng",
        "given": "Zhi-jian"
      },
      {
        "family": "Qiu",
        "given": "Shao-qin"
      },
      {
        "family": "Luo",
        "given": "Jie"
      },
      {
        "family": "Ye",
        "given": "Chang-jiang"
      },
      {
        "family": "Zhu",
        "given": "Shao-yong"
      },
      {
        "family": "Zhong",
        "given": "Nan-shan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          9
        ]
      ]
    },
    "abstract": "Background: Since December 2019, acute respiratory disease (ARD) due to 2019 novel coronavirus (2019-nCoV) emerged in Wuhan city and rapidly spread throughout China. We sought to delineate the clinical characteristics of these cases. Methods: We extracted the data on 1,099 patients with laboratory-confirmed 2019-nCoV ARD from 552 hospitals in 31 provinces/provincial municipalities through January 29th, 2020. Results: The median age was 47.0 years, and 41.90% were females. Only 1.18% of patients had a direct contact with wildlife, whereas 31.30% had been to Wuhan and 71.80% had contacted with people from Wuhan. Fever (87.9%) and cough (67.7%) were the most common symptoms. Diarrhea is uncommon. The median incubation period was 3.0 days (range, 0 to 24.0 days). On admission, ground-glass opacity was the typical radiological finding on chest computed tomography (50.00%). Significantly more severe cases were diagnosed by symptoms plus reverse-transcriptase polymerase-chain-reaction without abnormal radiological findings than non-severe cases (23.87% vs. 5.20%, P&lt;0.001). Lymphopenia was observed in 82.1% of patients. 55 patients (5.00%) were admitted to intensive care unit and 15 (1.36%) succumbed. Severe pneumonia was independently associated with either the admission to intensive care unit, mechanical ventilation, or death in multivariate competing-risk model (sub-distribution hazards ratio, 9.80; 95% confidence interval, 4.06 to 23.67). Conclusions: The 2019-nCoV epidemic spreads rapidly by human-to-human transmission. Normal radiologic findings are present among some patients with 2019-nCoV infection. The disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.06.20020974",
    "publisher": "medRxiv",
    "title": "Clinical characteristics of 2019 novel coronavirus infection in China",
    "URL": "https://doi.org/ggkj9s",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.06.20020974"
  },
  {
    "type": "article-journal",
    "id": "MgLBA5m",
    "author": [
      {
        "family": "Bao",
        "given": "Linlin"
      },
      {
        "family": "Deng",
        "given": "Wei"
      },
      {
        "family": "Huang",
        "given": "Baoying"
      },
      {
        "family": "Gao",
        "given": "Hong"
      },
      {
        "family": "Liu",
        "given": "Jiangning"
      },
      {
        "family": "Ren",
        "given": "Lili"
      },
      {
        "family": "Wei",
        "given": "Qiang"
      },
      {
        "family": "Yu",
        "given": "Pin"
      },
      {
        "family": "Xu",
        "given": "Yanfeng"
      },
      {
        "family": "Qi",
        "given": "Feifei"
      },
      {
        "family": "Qu",
        "given": "Yajin"
      },
      {
        "family": "Li",
        "given": "Fengdi"
      },
      {
        "family": "Lv",
        "given": "Qi"
      },
      {
        "family": "Wang",
        "given": "Wenling"
      },
      {
        "family": "Xue",
        "given": "Jing"
      },
      {
        "family": "Gong",
        "given": "Shuran"
      },
      {
        "family": "Liu",
        "given": "Mingya"
      },
      {
        "family": "Wang",
        "given": "Guanpeng"
      },
      {
        "family": "Wang",
        "given": "Shunyi"
      },
      {
        "family": "Song",
        "given": "Zhiqi"
      },
      {
        "family": "Zhao",
        "given": "Linna"
      },
      {
        "family": "Liu",
        "given": "Peipei"
      },
      {
        "family": "Zhao",
        "given": "Li"
      },
      {
        "family": "Ye",
        "given": "Fei"
      },
      {
        "family": "Wang",
        "given": "Huijuan"
      },
      {
        "family": "Zhou",
        "given": "Weimin"
      },
      {
        "family": "Zhu",
        "given": "Na"
      },
      {
        "family": "Zhen",
        "given": "Wei"
      },
      {
        "family": "Yu",
        "given": "Haisheng"
      },
      {
        "family": "Zhang",
        "given": "Xiaojuan"
      },
      {
        "family": "Guo",
        "given": "Li"
      },
      {
        "family": "Chen",
        "given": "Lan"
      },
      {
        "family": "Wang",
        "given": "Conghui"
      },
      {
        "family": "Wang",
        "given": "Ying"
      },
      {
        "family": "Wang",
        "given": "Xinming"
      },
      {
        "family": "Xiao",
        "given": "Yan"
      },
      {
        "family": "Sun",
        "given": "Qiangming"
      },
      {
        "family": "Liu",
        "given": "Hongqi"
      },
      {
        "family": "Zhu",
        "given": "Fanli"
      },
      {
        "family": "Ma",
        "given": "Chunxia"
      },
      {
        "family": "Yan",
        "given": "Lingmei"
      },
      {
        "family": "Yang",
        "given": "Mengli"
      },
      {
        "family": "Han",
        "given": "Jun"
      },
      {
        "family": "Xu",
        "given": "Wenbo"
      },
      {
        "family": "Tan",
        "given": "Wenjie"
      },
      {
        "family": "Peng",
        "given": "Xiaozhong"
      },
      {
        "family": "Jin",
        "given": "Qi"
      },
      {
        "family": "Wu",
        "given": "Guizhen"
      },
      {
        "family": "Qin",
        "given": "Chuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          28
        ]
      ]
    },
    "abstract": "Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the Corona Virus Disease 2019 (COVID-19) cases in China has become a public health emergency of international concern (PHEIC). Based on angiotensin converting enzyme 2 (ACE2) as cell entry receptor of SARS-CoV, we used the hACE2 transgenic mice infected with SARS-CoV-2 to study the pathogenicity of the virus. Weight loss and virus replication in lung were observed in hACE2 mice infected with SARS-CoV-2. The typical histopathology was interstitial pneumonia with infiltration of significant lymphocytes and monocytes in alveolar interstitium, and accumulation of macrophages in alveolar cavities. Viral antigens were observed in the bronchial epithelial cells, alveolar macrophages and alveolar epithelia. The phenomenon was not found in wild type mice with SARS-CoV-2 infection. The pathogenicity of SARS-CoV-2 in hACE2 mice was clarified and the Koch’s postulates were fulfilled as well, and the mouse model may facilitate the development of therapeutics and vaccines against SARS-CoV-2.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.07.939389",
    "publisher": "bioRxiv",
    "title": "The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice",
    "URL": "https://doi.org/dph2",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.07.939389"
  },
  {
    "type": "article-journal",
    "id": "1Acv5UMSt",
    "author": [
      {
        "family": "Li",
        "given": "Zhen"
      },
      {
        "family": "Wu",
        "given": "Ming"
      },
      {
        "family": "Yao",
        "given": "Jiwei"
      },
      {
        "family": "Guo",
        "given": "Jie"
      },
      {
        "family": "Liao",
        "given": "Xiang"
      },
      {
        "family": "Song",
        "given": "Siji"
      },
      {
        "family": "Li",
        "given": "Jiali"
      },
      {
        "family": "Duan",
        "given": "Guangjie"
      },
      {
        "family": "Zhou",
        "given": "Yuanxiu"
      },
      {
        "family": "Wu",
        "given": "Xiaojun"
      },
      {
        "family": "Zhou",
        "given": "Zhansong"
      },
      {
        "family": "Wang",
        "given": "Taojiao"
      },
      {
        "family": "Hu",
        "given": "Ming"
      },
      {
        "family": "Chen",
        "given": "Xianxiang"
      },
      {
        "family": "Fu",
        "given": "Yu"
      },
      {
        "family": "Lei",
        "given": "Chong"
      },
      {
        "family": "Dong",
        "given": "Hailong"
      },
      {
        "family": "Xu",
        "given": "Chuou"
      },
      {
        "family": "Hu",
        "given": "Yahua"
      },
      {
        "family": "Han",
        "given": "Min"
      },
      {
        "family": "Zhou",
        "given": "Yi"
      },
      {
        "family": "Jia",
        "given": "Hongbo"
      },
      {
        "family": "Chen",
        "given": "Xiaowei"
      },
      {
        "family": "Yan",
        "given": "Junan"
      },
      {
        "literal": "Anti-2019-nCoV Volunteers"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "Summary Background: To date, large amounts of epidemiological and case study data have been available for the Coronavirus Disease 2019 (COVID-19), which suggested that the mortality was related to not just respiratory complications. Here, we specifically analyzed kidney functions in COVID-19 patients and their relations to mortality. Methods: In this multi-centered, retrospective, observational study, we included 193 adult patients with laboratory-confirmed COVID-19 from 2 hospitals in Wuhan, 1 hospital in Huangshi (Hubei province, 83 km from Wuhan) and 1 hospital in Chongqing (754 km from Wuhan). Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were all collected, including data regarding to kidney functions. Data were compared among three groups: non-severe COVID-19 patients (128), severe COVID-19 patients (65) and a control group of other pneumonia (28). For the data from computed tomographic (CT) scans, we also included a control group of healthy subjects (110 cases, without abnormalities in the lung and without kidney diseases). The primary outcome was a common presence of kidney dysfunctions in COVID-19 patients and the occurrence of acute kidney injury (AKI) in a fraction of COVID-19 patients. Secondary outcomes included a survival analysis of COVID-19 patients in conditions of AKI or comorbid chronic illnesses. Findings: We included 193 COVID-19 patients (128 non-severe, 65 severe (including 32 non-survivors), between January 6th and February 21th,2020; the final date of follow-up was March 4th, 2020) and 28 patients of other pneumonia (15 of viral pneumonia, 13 of mycoplasma pneumonia) before the COVID-19 outbreak. On hospital admission, a remarkable fraction of patients had signs of kidney dysfunctions, including 59% with proteinuria, 44% with hematuria, 14% with increased levels of blood urea nitrogen, and 10% with increased levels of serum creatinine, although mild but worse than that in cases with other pneumonia. While these kidney dysfunctions might not be readily diagnosed as AKI at admission, over the progress during hospitalization they could be gradually worsened and diagnosed as AKI. A univariate Cox regression analysis showed that proteinuria, hematuria, and elevated levels of blood urea nitrogen, serum creatinine, uric acid as well as D-dimer were significantly associated with the death of COVID-19 patients respectively. Importantly, the Cox regression analysis also suggested that COVID-19 patients that developed AKI had a ~5.3-times mortality risk of those without AKI, much higher than that of comorbid chronic illnesses (~1.5 times risk of those without comorbid chronic illnesses). Interpretation: To prevent fatality in such conditions, we suggested a high degree of caution in monitoring the kidney functions of severe COVID-19 patients regardless of the past disease history. In addition, upon day-by-day monitoring, clinicians should consider any potential interventions to protect kidney functions at the early stage of the disease and renal replacement therapies in severely ill patients, particularly for those with strong inflammatory reactions or a cytokine storm. Funding: None.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.08.20021212",
    "publisher": "medRxiv",
    "title": "Caution on Kidney Dysfunctions of COVID-19 Patients",
    "URL": "https://doi.org/ggq627",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.08.20021212"
  },
  {
    "type": "article-journal",
    "id": "QhE5mVCc",
    "author": [
      {
        "family": "Zhu",
        "given": "James"
      },
      {
        "family": "Kim",
        "given": "Jiwoong"
      },
      {
        "family": "Xiao",
        "given": "Xue"
      },
      {
        "family": "Wang",
        "given": "Yunguan"
      },
      {
        "family": "Luo",
        "given": "Danni"
      },
      {
        "family": "Chen",
        "given": "Ran"
      },
      {
        "family": "Xu",
        "given": "Lin"
      },
      {
        "family": "Zhang",
        "given": "He"
      },
      {
        "family": "Xiao",
        "given": "Guanghua"
      },
      {
        "family": "Schoggins",
        "given": "John W."
      },
      {
        "family": "Zhan",
        "given": "Xiaowei"
      },
      {
        "family": "Wang",
        "given": "Tao"
      },
      {
        "family": "Xie",
        "given": "Yang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "abstract": "The outbreak of the 2019 Novel Coronavirus (SARS-CoV-2) rapidly spread from Wuhan, China to more than 150 countries, areas or territories, causing staggering number of infections and deaths. A systematic profiling of the immune vulnerability landscape of SARS-CoV-2, which can bring critical insights into the immune clearance mechanism, peptide vaccine development, and antiviral antibody development, is lacking. In this study, we investigated the potential of the SARS-CoV-2 viral proteins to induce class I and II MHC presentation and to form linear antibody epitopes. We created an online database to broadly share the predictions as a resource for the research community. Using this resource, we showed that genetic variations in SARS- CoV-2, though still few for the moment, already follow the pattern of mutations in related coronaviruses, and could alter the immune vulnerability landscape of this virus. Importantly, we discovered evidence that SARS-CoV-2, along with related coronaviruses, used mutations to evade attack from the human immune system. Overall, we present an immunological resource for SARS-CoV-2 that could promote both therapeutic development and mechanistic research.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.08.939553",
    "publisher": "bioRxiv",
    "title": "The immune vulnerability landscape of the 2019 Novel Coronavirus, SARS-CoV-2",
    "URL": "https://doi.org/ggq628",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.08.939553"
  },
  {
    "type": "article-journal",
    "id": "16Xj27QYj",
    "author": [
      {
        "family": "Lin",
        "given": "Wei"
      },
      {
        "family": "Hu",
        "given": "Longfei"
      },
      {
        "family": "Zhang",
        "given": "Yan"
      },
      {
        "family": "Ooi",
        "given": "Joshua D."
      },
      {
        "family": "Meng",
        "given": "Ting"
      },
      {
        "family": "Jin",
        "given": "Peng"
      },
      {
        "family": "Ding",
        "given": "Xiang"
      },
      {
        "family": "Peng",
        "given": "Longkai"
      },
      {
        "family": "Song",
        "given": "Lei"
      },
      {
        "family": "Xiao",
        "given": "Zhou"
      },
      {
        "family": "Ao",
        "given": "Xiang"
      },
      {
        "family": "Xiao",
        "given": "Xiangcheng"
      },
      {
        "family": "Zhou",
        "given": "Qiaoling"
      },
      {
        "family": "Xiao",
        "given": "Ping"
      },
      {
        "family": "Fan",
        "given": "Jue"
      },
      {
        "family": "Zhong",
        "given": "Yong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          18
        ]
      ]
    },
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.08.939892",
    "publisher": "bioRxiv",
    "title": "Single-cell Analysis of ACE2 Expression in Human Kidneys and Bladders Reveals a Potential Route of 2019-nCoV Infection",
    "URL": "https://doi.org/ggq629",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.08.939892"
  },
  {
    "type": "article-journal",
    "id": "gK5e7Yhl",
    "author": [
      {
        "family": "Liu",
        "given": "Jingyuan"
      },
      {
        "family": "Liu",
        "given": "Yao"
      },
      {
        "family": "Xiang",
        "given": "Pan"
      },
      {
        "family": "Pu",
        "given": "Lin"
      },
      {
        "family": "Xiong",
        "given": "Haofeng"
      },
      {
        "family": "Li",
        "given": "Chuansheng"
      },
      {
        "family": "Zhang",
        "given": "Ming"
      },
      {
        "family": "Tan",
        "given": "Jianbo"
      },
      {
        "family": "Xu",
        "given": "Yanli"
      },
      {
        "family": "Song",
        "given": "Rui"
      },
      {
        "family": "Song",
        "given": "Meihua"
      },
      {
        "family": "Wang",
        "given": "Lin"
      },
      {
        "family": "Zhang",
        "given": "Wei"
      },
      {
        "family": "Han",
        "given": "Bing"
      },
      {
        "family": "Yang",
        "given": "Li"
      },
      {
        "family": "Wang",
        "given": "Xiaojing"
      },
      {
        "family": "Zhou",
        "given": "Guiqin"
      },
      {
        "family": "Zhang",
        "given": "Ting"
      },
      {
        "family": "Li",
        "given": "Ben"
      },
      {
        "family": "Wang",
        "given": "Yanbin"
      },
      {
        "family": "Chen",
        "given": "Zhihai"
      },
      {
        "family": "Wang",
        "given": "Xianbo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          12
        ]
      ]
    },
    "abstract": "Background: Severe ill patients with 2019 novel coronavirus (2019-nCoV) infection progressed rapidly to acute respiratory failure. We aimed to select the most useful prognostic factor for severe illness incidence. Methods: The study prospectively included 61 patients with 2019-nCoV infection treated at Beijing Ditan Hospital from January 13, 2020 to January 31, 2020. Prognostic factor of severe illness was selected by the LASSO COX regression analyses, to predict the severe illness probability of 2019-CoV pneumonia. The predictive accuracy was evaluated by concordance index, calibration curve, decision curve and clinical impact curve. Results: The neutrophil-to-lymphocyte ratio (NLR) was identified as the independent risk factor for severe illness in patients with 2019-nCoV infection. The NLR had a c-index of 0.807 (95% confidence interval, 0.676-0.38), the calibration curves fitted well, and the decision curve and clinical impact curve showed that the NLR had superior standardized net benefit. In addition, the incidence of severe illness was 9.1% in age ≥ 50 and NLR &lt; 3.13 patients, and half of patients with age ≥ 50 and NLR ≥ 3.13 would develop severe illness. Based on the risk stratification of NLR with age, the study developed a 2019-nCoV pneumonia management process. Conclusions: The NLR was the early identification of risk factors for 2019-nCoV severe illness. Patients with age ≥ 50 and NLR ≥ 3.13 facilitated severe illness, and they should rapidly access to intensive care unit if necessary.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.10.20021584",
    "publisher": "medRxiv",
    "title": "Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage",
    "URL": "https://doi.org/ggrbdx",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.10.20021584"
  },
  {
    "type": "article-journal",
    "id": "P4assQHj",
    "author": [
      {
        "family": "Wan",
        "given": "Suxin"
      },
      {
        "family": "Yi",
        "given": "Qingjie"
      },
      {
        "family": "Fan",
        "given": "Shibing"
      },
      {
        "family": "Lv",
        "given": "Jinglong"
      },
      {
        "family": "Zhang",
        "given": "Xianxiang"
      },
      {
        "family": "Guo",
        "given": "Lian"
      },
      {
        "family": "Lang",
        "given": "Chunhui"
      },
      {
        "family": "Xiao",
        "given": "Qing"
      },
      {
        "family": "Xiao",
        "given": "Kaihu"
      },
      {
        "family": "Yi",
        "given": "Zhengjun"
      },
      {
        "family": "Qiang",
        "given": "Mao"
      },
      {
        "family": "Xiang",
        "given": "Jianglin"
      },
      {
        "family": "Zhang",
        "given": "Bangshuo"
      },
      {
        "family": "Chen",
        "given": "Yongping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          12
        ]
      ]
    },
    "abstract": "Background: To explore the cellular immunity and cytokines status of NCP patients and to predict the correlation between the cellular immunity levels, cytokines and the severity of patients. Methods: 123 NCP patients were divided into mild and severe groups. Peripheral blood was collected, lymphocyte subsets and cytokines were detected. Correlation analysis was performed on the lymphocyte subsets and cytokines, and the differences between the indexes of the two groups were analyzed. Results: 102 mild and 21 severe patients were included. Lymphocyte subsets were reduced in two groups. The proportion of CD8 + T reduction in the mild and severe group was 28.43% and 61.9%, respectively; The proportion of B cell reduction was 25.49% and 28.57%; The proportion of NK cell reduction was 34.31% and 47.62%; The detection value of IL-6 was 0 in 55.88% of the mild group, mild group has a significantly lower proportion of patients with IL-6 higher than normal than severe group; There was no significant linear correlation between the lymphocyte subsets and cytokines, while significant differences were noticed between the two groups in CD4 + T, CD8 + T, IL-6 and IL-10. Conclusions: Low levels of CD4+T and CD8+T are common in severe NCP. IL-6 and IL-10 levels were higher in severe patients. T cell subsets and cytokines can be used as one of the basis for predicting the transition from mild to severe. Large number of samples are still needed to confirm the \"warning value\" of CD4 + T, CD8 + T IL-6 and IL-10.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.10.20021832",
    "publisher": "medRxiv",
    "title": "Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)",
    "URL": "https://doi.org/ggq63b",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.10.20021832"
  },
  {
    "type": "article-journal",
    "id": "TXlNzmXd",
    "author": [
      {
        "family": "Li",
        "given": "Jie"
      },
      {
        "family": "Li",
        "given": "Shilin"
      },
      {
        "family": "Cai",
        "given": "Yurui"
      },
      {
        "family": "Liu",
        "given": "Qin"
      },
      {
        "family": "Li",
        "given": "Xue"
      },
      {
        "family": "Zeng",
        "given": "Zhaoping"
      },
      {
        "family": "Chu",
        "given": "Yanpeng"
      },
      {
        "family": "Zhu",
        "given": "Fangcheng"
      },
      {
        "family": "Zeng",
        "given": "Fanxin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          12
        ]
      ]
    },
    "abstract": "An increasing number of cases of novel coronavirus pneumonia (NCP) infected with 2019-nCoV have been identified in Wuhan and other cities in China, since December 2019. We analyzed data on the 17 confirmed cases in Dazhou to provide the epidemiologic characteristics of NCP outside Wuhan. Among them, 12 patients were still quarantined in the hospital, 5 patients were discharged NCP patients according to the national standards. Compared with non-discharged NCP patients, the discharged NCP patients had younger ages. Moreover, discharged NCP patients had higher heart rate, lymphocytes levels and monocytes levels than non-discharged NCP patients on admission to the hospital. Notably, all of 17 patients had abnormal increased C-reactive protein levels, and 16 patients had abnormal computed tomography images. This study provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019-nCoV may contributed to faster recovery and better therapeutic outcome.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.11.20022053",
    "publisher": "medRxiv",
    "title": "Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China",
    "URL": "https://doi.org/ggq63c",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.11.20022053"
  },
  {
    "type": "article-journal",
    "id": "15K5Ovntj",
    "author": [
      {
        "family": "Fan",
        "given": "Caibin"
      },
      {
        "family": "Li",
        "given": "Kai"
      },
      {
        "family": "Ding",
        "given": "Yanhong"
      },
      {
        "family": "Lu",
        "given": "Wei Lu"
      },
      {
        "family": "Wang",
        "given": "Jianqing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          13
        ]
      ]
    },
    "abstract": "In December 2019 and January 2020, novel coronavirus (2019-nCoV) - infected pneumonia (NCIP) occurred in Wuhan, and has already posed a serious threat to public health. ACE2 (Angiotensin Converting Enzyme 2) has been shown to be one of the major receptors that mediate the entry of 2019-nCoV into human cells, which also happens in severe acute respiratory syndrome coronavirus (SARS). Several researches have indicated that some patients have abnormal renal function or even kidney damage in addition to injury in respiratory system, and the related mechanism is unknown. This arouses our interest in whether coronavirus infection will affect the urinary and male reproductive systems. Here in this study, we used the online datasets to analyze ACE2 expression in different human organs. The results indicate that ACE2 highly expresses in renal tubular cells, Leydig cells and cells in seminiferous ducts in testis. Therefore, virus might directly bind to such ACE2 positive cells and damage the kidney and testicular tissue of patients. Our results indicate that renal function evaluation and special care should be performed in 2019-nCoV patients during clinical work, because of the kidney damage caused by virus and antiviral drugs with certain renal toxicity. In addition, due to the potential pathogenicity of the virus to testicular tissues, clinicians should pay attention to the risk of testicular lesions in patients during hospitalization and later clinical follow-up, especially the assessment and appropriate intervention in young patients' fertility.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.12.20022418",
    "publisher": "medRxiv",
    "title": "ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection",
    "URL": "https://doi.org/ggq63d",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.12.20022418"
  },
  {
    "type": "article-journal",
    "id": "Bgo7Cmj3",
    "author": [
      {
        "family": "Zhou",
        "given": "Yonggang"
      },
      {
        "family": "Fu",
        "given": "Binqing"
      },
      {
        "family": "Zheng",
        "given": "Xiaohu"
      },
      {
        "family": "Wang",
        "given": "Dongsheng"
      },
      {
        "family": "Zhao",
        "given": "Changcheng"
      },
      {
        "family": "qi",
        "given": "Yingjie"
      },
      {
        "family": "Sun",
        "given": "Rui"
      },
      {
        "family": "Tian",
        "given": "Zhigang"
      },
      {
        "family": "Xu",
        "given": "Xiaoling"
      },
      {
        "family": "Wei",
        "given": "Haiming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "Pathogenic human coronavirus infections, such as severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV), cause high morbidity and mortality . Recently, a severe pneumonia-associated respiratory syndrome caused by a new coronavirus was reported at December 2019 (2019-nCoV) in the city Wuhan, Hubei province, China , which was also named as pneumonia-associated respiratory syndrome (PARS) . Up to 9th of February 2020, at least 37, 251 cases have been reported with 812 fatal cases according to the report from China CDC. However, the immune mechanism that potential orchestrated acute mortality from patients of 2019-nCoV is still unknown. Here we show that after the 2019-nCoV infection, CD4 T lymphocytes are rapidly activated to become pathogenic T helper (Th) 1 cells and generate GM-CSF etc. The cytokines environment induces inflammatory CD14 CD16 monocytes with high expression of IL-6 and accelerates the inflammation. These aberrant and excessive immune cells may enter the pulmonary circulation in huge numbers and play an immune damaging role to causing lung functional disability and quick mortality. Our results demonstrate that excessive non-effective host immune responses by pathogenic T cells and inflammatory monocytes may associate with severe lung pathology. Therefore, we suggest that monoclonal antibody that targets the GM-CSF or interleukin 6 receptor may potentially curb immunopathology caused by 2019-nCoV and consequently win more time for virus clearance.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.12.945576",
    "publisher": "bioRxiv",
    "title": "Aberrant pathogenic GM-CSF <sup>+</sup> T cells and inflammatory CD14 <sup>+</sup> CD16 <sup>+</sup> monocytes in severe pulmonary syndrome patients of a new coronavirus",
    "URL": "https://doi.org/ggq63f",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.12.945576"
  },
  {
    "type": "article-journal",
    "id": "4Z1pEioX",
    "author": [
      {
        "family": "Qian",
        "given": "Kai"
      },
      {
        "family": "Deng",
        "given": "Yi"
      },
      {
        "family": "Tai",
        "given": "Yonghang"
      },
      {
        "family": "Peng",
        "given": "Jun"
      },
      {
        "family": "Peng",
        "given": "Hao"
      },
      {
        "family": "Jiang",
        "given": "Lihong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          17
        ]
      ]
    },
    "abstract": "Background:A Novel pneumonia associated with the 2019 coronavirus infected pneumonia (NCIP) suddenly broke out in Wuhan, China in December 2019. 37287 confirmed cases and 813 death case in China (Until 8th/Feb/2019) have been reported in just fortnight. Although this risky pneumonia with high infection rates and high mortality rates need to be resolved immediately, major gaps in our knowledge of clinical characters of it were still not be established. The aim of this study is to summaries and analysis the clinical characteristics of 2019-nCoV pneumonia. Methods: Literature have been systematically performed a search on PubMed, Embase, Web of Science, GreyNet International, and The Cochrane Library from inception up to February 8, 2020. The Newcastle-Ottawa Scale was used to assess quality, and publication bias was analyzed by Egger test. In the single-arm meta-analysis, A fix-effects model was used to obtain a pooled incidence rate. We conducted subgroup analysis according to geographic region and research scale. Results: A total of nine studies including 356 patients were included in this study, the mean age was 52.4 years and 221 (62.1%) were male. The pooled incidences rate of symptoms as follows: pharyngalgia (12.2%, 95% CI: 0.087-0.167), diarrhea (9.2%, 95% CI: 0.062-0.133) and headache (8.9%, 95% CI: 0.063-0.125). Meanwhile, 5.7% (95% CI: 0.027-0.114) of patients were found without any symptoms although they were diagnosed by RT-PCR. In the terms of CT imaging examination, the most of patients showed bilateral mottling or ground-glass opacity, 8.6% (95% CI: 0.048-0.148) of patients with crazy-paving pattern, and 11.5% (95% CI: 0.064-0.197) of patients without obvious CT imaging presentations. The pooled incidence of mortality was 8.9% (95% CI: 0.062-0.126). Conclusions: To our knowledge, this is the first evidence-based medicine research to further elaborate the clinical characteristics of NCIP, which is beneficial to the next step of prevention and treatment.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.14.20021535",
    "publisher": "medRxiv",
    "title": "Clinical Characteristics of 2019 Novel Infected Coronavirus Pneumonia：A Systemic Review and Meta-analysis",
    "URL": "https://doi.org/ggrgbq",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.14.20021535"
  },
  {
    "type": "article-journal",
    "id": "zTGzuiTI",
    "author": [
      {
        "family": "Liu",
        "given": "Jing"
      },
      {
        "family": "Li",
        "given": "Sumeng"
      },
      {
        "family": "Liu",
        "given": "Jia"
      },
      {
        "family": "Liang",
        "given": "Boyun"
      },
      {
        "family": "Wang",
        "given": "Xiaobei"
      },
      {
        "family": "Wang",
        "given": "Hua"
      },
      {
        "family": "Li",
        "given": "Wei"
      },
      {
        "family": "Tong",
        "given": "Qiaoxia"
      },
      {
        "family": "Yi",
        "given": "Jianhua"
      },
      {
        "family": "Zhao",
        "given": "Lei"
      },
      {
        "family": "Xiong",
        "given": "Lijuan"
      },
      {
        "family": "Guo",
        "given": "Chunxia"
      },
      {
        "family": "Tian",
        "given": "Jin"
      },
      {
        "family": "Luo",
        "given": "Jinzhuo"
      },
      {
        "family": "Yao",
        "given": "Jinghong"
      },
      {
        "family": "Pang",
        "given": "Ran"
      },
      {
        "family": "Shen",
        "given": "Hui"
      },
      {
        "family": "Peng",
        "given": "Cheng"
      },
      {
        "family": "Liu",
        "given": "Ting"
      },
      {
        "family": "Zhang",
        "given": "Qian"
      },
      {
        "family": "Wu",
        "given": "Jun"
      },
      {
        "family": "Xu",
        "given": "Ling"
      },
      {
        "family": "Lu",
        "given": "Sihong"
      },
      {
        "family": "Wang",
        "given": "Baoju"
      },
      {
        "family": "Weng",
        "given": "Zhihong"
      },
      {
        "family": "Han",
        "given": "Chunrong"
      },
      {
        "family": "Zhu",
        "given": "Huabing"
      },
      {
        "family": "Zhou",
        "given": "Ruxia"
      },
      {
        "family": "Zhou",
        "given": "Helong"
      },
      {
        "family": "Chen",
        "given": "Xiliu"
      },
      {
        "family": "Ye",
        "given": "Pian"
      },
      {
        "family": "Zhu",
        "given": "Bin"
      },
      {
        "family": "He",
        "given": "Shengsong"
      },
      {
        "family": "He",
        "given": "Yongwen"
      },
      {
        "family": "Jie",
        "given": "Shenghua"
      },
      {
        "family": "Wei",
        "given": "Ping"
      },
      {
        "family": "Zhang",
        "given": "Jianao"
      },
      {
        "family": "Lu",
        "given": "Yinping"
      },
      {
        "family": "Wang",
        "given": "Weixian"
      },
      {
        "family": "Zhang",
        "given": "Li"
      },
      {
        "family": "Li",
        "given": "Ling"
      },
      {
        "family": "Zhou",
        "given": "Fengqin"
      },
      {
        "family": "Wang",
        "given": "Jun"
      },
      {
        "family": "Dittmer",
        "given": "Ulf"
      },
      {
        "family": "Lu",
        "given": "Mengji"
      },
      {
        "family": "Hu",
        "given": "Yu"
      },
      {
        "family": "Yang",
        "given": "Dongliang"
      },
      {
        "family": "Zheng",
        "given": "Xin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          22
        ]
      ]
    },
    "abstract": "Background: The dynamic changes of lymphocyte subsets and cytokines profiles of patients with novel coronavirus disease (COVID-19) and their correlation with the disease severity remain unclear. Method: Peripheral blood samples were longitudinally collected from 40 confirmed COVID-19 patients and examined for lymphocyte subsets by flow cytometry and cytokine profiles by specific immunoassays. Findings: Of the 40 COVID-19 patients enrolled, 13 severe cases showed significant and sustained decreases in lymphocyte counts but increases in neutrophil counts than 27 mild cases. Further analysis demonstrated significant decreases in the counts of T cells, especially CD8 + T cells, as well as increases in IL-6, IL-10, IL-2 and IFN-γ levels in the peripheral blood in the severe cases compared to those in the mild cases. T cell counts and cytokine levels in severe COVID-19 patients who survived the disease gradually recovered at later time points to levels that were comparable to those of the mild cases. Moreover, the neutrophil-to-CD8+ T cell ratio (N8R) were identified as the most powerful prognostic factor affecting the prognosis for severe COVID-19. Conclusion: The degree of lymphopenia and a proinflammatory cytokine storm is higher in severe COVID-19 patients than in mild cases, and is associated with the disease severity. N8R may serve as a useful prognostic factor for early identification of severe COVID-19 cases.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.16.20023671",
    "publisher": "medRxiv",
    "title": "Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients",
    "URL": "https://doi.org/ggq63g",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.16.20023671"
  },
  {
    "type": "article-journal",
    "id": "1EIEx8Qe4",
    "author": [
      {
        "family": "Chen",
        "given": "Guang"
      },
      {
        "family": "Wu",
        "given": "Di"
      },
      {
        "family": "Guo",
        "given": "Wei"
      },
      {
        "family": "Cao",
        "given": "Yong"
      },
      {
        "family": "Huang",
        "given": "Da"
      },
      {
        "family": "Wang",
        "given": "Hongwu"
      },
      {
        "family": "Wang",
        "given": "Tao"
      },
      {
        "family": "Zhang",
        "given": "Xiaoyun"
      },
      {
        "family": "Chen",
        "given": "Huilong"
      },
      {
        "family": "Yu",
        "given": "Haijing"
      },
      {
        "family": "Zhang",
        "given": "Xiaoping"
      },
      {
        "family": "Zhang",
        "given": "Minxia"
      },
      {
        "family": "Wu",
        "given": "Shiji"
      },
      {
        "family": "Song",
        "given": "Jianxin"
      },
      {
        "family": "Chen",
        "given": "Tao"
      },
      {
        "family": "Han",
        "given": "Meifang"
      },
      {
        "family": "Li",
        "given": "Shusheng"
      },
      {
        "family": "Luo",
        "given": "Xiaoping"
      },
      {
        "family": "Zhao",
        "given": "Jianping"
      },
      {
        "family": "Ning",
        "given": "Qin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          19
        ]
      ]
    },
    "abstract": "Background Since late December, 2019, an outbreak of pneumonia cases caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and continued to spread throughout China and across the globe. To date, few data on immunologic features of Coronavirus Disease 2019 (COVID-19) have been reported. Methods In this single-centre retrospective study, a total of 21 patients with pneumonia who were laboratory-confirmed to be infected with SARS-CoV-2 in Wuhan Tongji hospital were included from Dec 19, 2019 to Jan 27, 2020. The immunologic characteristics as well as their clinical, laboratory, radiological features were compared between 11 severe cases and 10 moderate cases. Results Of the 21 patients with COVID-19, only 4 (19%) had a history of exposure to the Huanan seafood market. 7 (33.3%) patients had underlying conditions. The average age of severe and moderate cases was 63.9 and 51.4 years, 10 (90.9%) severe cases and 7 (70.0%) moderate cases were male. Common clinical manifestations including fever (100%, 100%), cough (70%, 90%), fatigue (100%, 70%) and myalgia (50%, 30%) in severe cases and moderate cases. PaO2/FiO2 ratio was significantly lower in severe cases (122.9) than moderate cases (366.2). Lymphocyte counts were significantly lower in severe cases (7000 million/L) than moderate cases (11000 million/L). Alanine aminotransferase, lactate dehydrogenase levels, high-sensitivity C-reactive protein and ferritin were significantly higher in severe cases (41.4 U/L, 567.2 U/L, 135.2 mg/L and 1734.4 ug/L) than moderate cases (17.6 U/L, 234.4 U/L, 51.4 mg/L and 880.2 ug /L). IL-2R, TNF-α and IL-10 concentrations on admission were significantly higher in severe cases (1202.4 pg/mL, 10.9 pg/mL and 10.9 pg/mL) than moderate cases (441.7 pg/mL, 7.5 pg/mL and 6.6 pg/mL). Absolute number of total T lymphocytes, CD4+T cells and CD8+T cells decreased in nearly all the patients, and were significantly lower in severe cases (332.5, 185.6 and 124.3 million/L) than moderate cases (676.5, 359.2 and 272.0 million/L). The expressions of IFN-γ by CD4+T cells tended to be lower in severe cases (14.6%) than moderate cases (23.6%). Conclusion The SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+T cells, resulting in significant decrease in number as well as IFN-γ production, which may be associated with disease severity. Together with clinical characteristics, early immunologic indicators including diminished T lymphocytes and elevated cytokines may serve as potential markers for prognosis in COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.16.20023903",
    "publisher": "medRxiv",
    "title": "Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019",
    "URL": "https://doi.org/ggq63h",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.16.20023903"
  },
  {
    "type": "article-journal",
    "id": "41WAtZmB",
    "author": [
      {
        "family": "Sun",
        "given": "Chunyun"
      },
      {
        "family": "Chen",
        "given": "Long"
      },
      {
        "family": "Yang",
        "given": "Ji"
      },
      {
        "family": "Luo",
        "given": "Chunxia"
      },
      {
        "family": "Zhang",
        "given": "Yanjing"
      },
      {
        "family": "Li",
        "given": "Jing"
      },
      {
        "family": "Yang",
        "given": "Jiahui"
      },
      {
        "family": "Zhang",
        "given": "Jie"
      },
      {
        "family": "Xie",
        "given": "Liangzhi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "SARS-CoV-2 and SARS-CoV share a common human receptor ACE2. Protein-protein interaction structure modeling indicates that spike-RBD of the two viruses also has similar overall binding conformation and binding free energy to ACE2. assays using recombinant ACE2 proteins and ACE2 expressing cells confirmed the two coronaviruses’ similar binding affinities to ACE2. The above studies provide experimental supporting evidences and possible explanation for the high transmissibility observed in the SARS-CoV-2 outbreak. Potent ACE2-blocking SARS-CoV neutralizing antibodies showed limited cross-binding and neutralizing activities to SARS-CoV-2. ACE2-non-blocking SARS-CoV RBD antibodies, though with weaker neutralizing activities against SARS-CoV, showed positive cross-neutralizing activities to SARS-CoV-2 with an unknown mechanism. These findings suggest a trade-off between the efficacy and spectrum for therapeutic antibodies to different coronaviruses, and hence highlight the possibilities and challenges in developing broadly protecting antibodies and vaccines against SARS-CoV-2 and its future mutants.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.16.951723",
    "publisher": "bioRxiv",
    "title": "SARS-CoV-2 and SARS-CoV Spike-RBD Structure and Receptor Binding Comparison and Potential Implications on Neutralizing Antibody and Vaccine Development",
    "URL": "https://doi.org/ggq63j",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.16.951723"
  },
  {
    "type": "article-journal",
    "id": "NPxs7bbq",
    "author": [
      {
        "family": "Chen",
        "given": "Yiyou"
      },
      {
        "family": "Wei",
        "given": "Qiang"
      },
      {
        "family": "Li",
        "given": "Ruobing"
      },
      {
        "family": "Gao",
        "given": "Hong"
      },
      {
        "family": "Zhu",
        "given": "Hua"
      },
      {
        "family": "Deng",
        "given": "Wei"
      },
      {
        "family": "Bao",
        "given": "Linlin"
      },
      {
        "family": "Tong",
        "given": "Wei"
      },
      {
        "family": "Cong",
        "given": "Zhe"
      },
      {
        "family": "Jiang",
        "given": "Hong"
      },
      {
        "family": "Qin",
        "given": "Chuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          21
        ]
      ]
    },
    "abstract": "A recombinant adenovirus vaccine against the SARS Coronavirus (SARS-CoV) was constructed, which contains fragments from the S, N, and Orf8 genes. Rhesus Macaques immunized with the recombinant adenovirus generated antigen-specific humoral and cellular response. Furthermore, the vaccine provided significant protection against subsequent live SARS-CoV challenge. In contrast, three out of four monkeys immunized with placebo suffered severe alveolar damage and pulmonary destruction.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.17.951939",
    "publisher": "bioRxiv",
    "title": "Protection of Rhesus Macaque from SARS-Coronavirus challenge by recombinant adenovirus vaccine",
    "URL": "https://doi.org/ggq63k",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.17.951939"
  },
  {
    "type": "article-journal",
    "id": "f50ahNxF",
    "author": [
      {
        "family": "Diao",
        "given": "Bo"
      },
      {
        "family": "Wang",
        "given": "Chenhui"
      },
      {
        "family": "Tan",
        "given": "Yingjun"
      },
      {
        "family": "Chen",
        "given": "Xiewan"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Ning",
        "given": "Lifeng"
      },
      {
        "family": "Chen",
        "given": "Li"
      },
      {
        "family": "Li",
        "given": "Min"
      },
      {
        "family": "Liu",
        "given": "Yueping"
      },
      {
        "family": "Wang",
        "given": "Gang"
      },
      {
        "family": "Yuan",
        "given": "Zilin"
      },
      {
        "family": "Feng",
        "given": "Zeqing"
      },
      {
        "family": "Wu",
        "given": "Yuzhang"
      },
      {
        "family": "Chen",
        "given": "Yongwen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "BACKGROUND The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health, which has been declared a public health emergency of international concern (PHEIC) by the WHO. T cells play a critical role in antiviral immunity but their numbers and functional state in COVID-19 patients remain largely unclear. METHODS We retrospectively reviewed the counts of total T cells, CD4+, CD8+ T cell subsets, and serum cytokine concentration from inpatient data of 522 patients with laboratory-confirmed COVID-19, admitted into two hospitals in Wuhan from December 2019 to January 2020, and 40 healthy controls, who came to the hospitals for routine physical examination. In addition, the expression of T cell exhaustion markers PD-1 and Tim-3 were measured by flow cytometry in the peripheral blood of 14 COVID-19 cases. RESULTS The number of total T cells, CD4+ and CD8+ T cells were dramatically reduced in COVID-19 patients, especially among elderly patients (≥60 years of age) and in patients requiring Intensive Care Unit (ICU) care. Counts of total T cells, CD8+T cells or CD4+T cells lower than 800/μL, 300/μL, or 400/μL, respectively, are negatively correlated with patient survival. Statistical analysis demonstrated that T cell numbers are negatively correlated to serum IL-6, IL-10 and TNF-α concentration, with patients in decline period showing reduced IL-6, IL-10 and TNF-α concentrations and restored T cell counts. Finally, T cells from COVID-19 patients have significantly higher levels of the exhausted marker PD-1 as compared to health controls. Moreover, increasing PD-1 and Tim-3 expression on T cells could be seen as patients progressed from prodromal to overtly symptomatic stages, further indicative of T cell exhaustion. CONCLUSIONS T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted. Non-ICU patients, with total T cells, CD8+T cells CD4+T cells counts lower than 800/μL, 300/μL, and 400/μL, respectively, may still require aggressive intervention even in the immediate absence of more severe symptoms due to a high risk for further deterioration in condition.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.18.20024364",
    "publisher": "medRxiv",
    "title": "Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19)",
    "URL": "https://doi.org/ggq63m",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.18.20024364"
  },
  {
    "type": "article-journal",
    "id": "EwNi3WJq",
    "author": [
      {
        "family": "Li",
        "given": "Xun"
      },
      {
        "family": "Wang",
        "given": "Luwen"
      },
      {
        "family": "Yan",
        "given": "Shaonan"
      },
      {
        "family": "Yang",
        "given": "Fan"
      },
      {
        "family": "Xiang",
        "given": "Longkui"
      },
      {
        "family": "Zhu",
        "given": "Jiling"
      },
      {
        "family": "Shen",
        "given": "Bo"
      },
      {
        "family": "Gong",
        "given": "Zuojiong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          25
        ]
      ]
    },
    "abstract": "Summary Background The pneumonia caused by the 2019 novel coronavirus (SARS-CoV-2) is a highly infectious disease, which was occurred in Wuhan, Hubei Province, China in December 2019. As of February 13, 2020, a total of 59883 cases of COVID-19 in China have been confirmed and 1368 patients have died from the disease. However, the clinical characteristics of the dyed patients were still not clearly clarified. This study aims to summarize the clinical characteristics of death cases with COVID-19 and to identify critically ill patients of COVID-19 early and reduce their mortality. Methods The clinical records, laboratory findings and radiologic assessments included chest X-ray or computed tomography were extracted from electronic medical records of 25 died patients with COVID-19 in Renmin Hospital of Wuhan University from Jan 14 to Feb 13, 2020. Two experienced clinicians reviewed and abstracted the data. Findings The mean age of the dead was 71.48 years, the average course of the disease was 10.56 days, all patients eventually died of respiratory failure. All of those who died had underlying diseases, the most common of which was hypertension (16/25, 64%), followed by diabetes (10/25, 40%), heart diseases (8/25, 32%), kidney diseases (5/25, 20%), cerebral infarction (4/25, 16%), chronic obstructive pulmonary disease (COPD, 2/25, 8%), malignant tumors (2/25, 8%) and acute pancreatitis (1/25, 4%). The most common organ damage outside the lungs was the heart, followed by kidney and liver. In the patients' last examination before death, white blood cell and neutrophil counts were elevated in 17 patients (17/25, 68%) and 18 patients (18/25, 72%), lymphocyte counts were decreased in 22 patients (22/25, 88%). Most patients' PCT, CRP and SAA levels were elevated, the percentages were 90.5% (19/21), 85% (19/20) and 100% (21/21) respectively. The levels of the last test of neutrophils (15/16, 93.8%), PCT (11/11, 100%), CRP (11/13, 84.6%), cTnI (8/9, 88.9%), D-Dimer (11/12, 91.6%) and LDH (9/9, 100%) were increased as compared to the first test, while the levels of lymphocytes were decreased (14/16, 87.5%). Interpretation The age and underlying diseases (hypertension, diabetes, etc.) were the most important risk factors for death of COVID-19 pneumonia. Bacterial infections may play an important role in promoting the death of patients. Malnutrition was common to severe patients. Multiple organ dysfunction can be observed, the most common organ damage was lung, followed by heart, kidney and liver. The rising of neutrophils, SAA, PCT, CRP, cTnI, D-Dimer and LDH levels can be used as indicators of disease progression, as well as the decline of lymphocytes counts.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.19.20025239",
    "publisher": "medRxiv",
    "title": "Clinical characteristics of 25 death cases infected with COVID-19 pneumonia: a retrospective review of medical records in a single medical center, Wuhan, China",
    "URL": "https://doi.org/ggq63n",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.19.20025239"
  },
  {
    "type": "article-journal",
    "id": "KG5Lg65z",
    "author": [
      {
        "family": "Wang",
        "given": "Lunwen"
      },
      {
        "family": "Li",
        "given": "Xun"
      },
      {
        "family": "Chen",
        "given": "Hui"
      },
      {
        "family": "Yan",
        "given": "Shaonan"
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Li",
        "given": "Dong"
      },
      {
        "family": "Gong",
        "given": "Zuojiong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          23
        ]
      ]
    },
    "abstract": "Summary Background Whether the patients with COVID-19 infected by SARS-CoV-2 would commonly develop acute renal function damage is a problem worthy of clinical attention. This study aimed to explore the effects of SARS-CoV-2 infection on renal function through analyzing the clinical data of 116 hospitalized COVID-19-confirmed patients. Methods 116 hospitalized COVID-19-confirmed patients enrolled in this study were hospitalized in the Department of Infectious Diseases, Renmin Hospital of Wuhan University from January 14 to February 13, 2020. The recorded information includes demographic data, medical history, contact history, potential comorbidities, symptoms, signs, laboratory test results, chest computer tomography (CT) scans, and treatment measures. SARS-CoV-2 RNA in 53 urine sediments of enrolled patients was examined by real-time RT-PCR. Findings 12 (10.8%) and 8 (7.2%) patients showed mild elevation of blood urea nitrogen or creatinine, and trace or 1+ albuminuria respectively in 111 COVID-19-confirmed patients without basic kidney disease. In addition, 5 patients with chronic renal failure (CRF) were undergone regular continuous renal replacement therapy (CRRT) were confirmed infection of SARS-CoV-2, and diagnosed as COVID-19. Beside the treatment of COVID-19, CRRT was also applied three times weekly. The course of treatment, the renal function indicators showed stable, without exacerbation of CRF, and pulmonary inflammation was gradually absorbed. All 5 patients with CRF were survived. Moreover, SARS-CoV-2 RNA in urine sediments was positive only in 3 patients from 48 cases without renal illness before, and one patient had a positive for SARS-CoV-2 ORF 1ab from 5 cases with CRF. Interpretation Acute renal impairment was uncommon in COVID-19. SARS-CoV-2 infection does not significantly cause obvious acute renal injury, or aggravate CRF in the COVID-19 patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.19.20025288",
    "publisher": "medRxiv",
    "title": "SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China",
    "URL": "https://doi.org/ggq63p",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.19.20025288"
  },
  {
    "type": "article-journal",
    "id": "eQIU1Nbs",
    "author": [
      {
        "family": "Zhang",
        "given": "Tao"
      },
      {
        "family": "Wu",
        "given": "Qunfu"
      },
      {
        "family": "Zhang",
        "given": "Zhigang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "To explore potential intermediate host of a novel coronavirus is vital to rapidly control continuous COVID-19 spread. We found genomic and evolutionary evidences of the occurrence of 2019-nCoV-like coronavirus (named as Pangolin-CoV) from dead Malayan Pangolins. Pangolin-CoV is 91.02% and 90.55% identical at the whole genome level to 2019-nCoV and BatCoV RaTG13, respectively. Pangolin-CoV is the lowest common ancestor of 2019-nCoV and RaTG13. The S1 protein of Pangolin-CoV is much more closely related to 2019-nCoV than RaTG13. Five key amino-acid residues involved in the interaction with human ACE2 are completely consistent between Pangolin-CoV and 2019-nCoV but four amino-acid mutations occur in RaTG13. It indicates Pangolin-CoV has similar pathogenic potential to 2019-nCoV, and would be helpful to trace the origin and probable intermediate host of 2019-nCoV.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.19.950253",
    "publisher": "bioRxiv",
    "title": "Pangolin homology associated with 2019-nCoV",
    "URL": "https://doi.org/ggpvpt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.19.950253"
  },
  {
    "type": "article-journal",
    "id": "hdSafq1o",
    "author": [
      {
        "family": "Fast",
        "given": "Ethan"
      },
      {
        "family": "Altman",
        "given": "Russ B."
      },
      {
        "family": "Chen",
        "given": "Binbin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          18
        ]
      ]
    },
    "abstract": "As of early March, 2019-nCoV has infected more than one hundred thousand people and claimed thousands of lives. 2019-nCoV is a novel form of coronavirus that causes COVID-19 and has high similarity with SARS-CoV. No approved vaccine yet exists for any form of coronavirus. Here we use computational tools from structural biology and machine learning to identify 2019-nCoV T-cell and B-cell epitopes based on viral protein antigen presentation and antibody binding properties. These epitopes can be used to develop more effective vaccines and identify neutralizing antibodies. We identified 405 viral peptides with good antigen presentation scores for both human MHC-I and MHC-II alleles, and two potential neutralizing B-cell epitopes near the 2019-nCoV spike protein receptor binding domain (440-460 and 494-506). Analyzing mutation profiles of 68 viral genomes from four continents, we identified 96 coding-change mutations. These mutations are more likely to occur in regions with good MHC-I presentation scores (p=0.02). No mutations are present near the spike protein receptor binding domain. Based on these findings, the spike protein is likely immunogenic and a potential vaccine candidate. We validated our computational pipeline with SARS-CoV experimental data.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.19.955484",
    "publisher": "bioRxiv",
    "title": "Potential T-cell and B-cell Epitopes of 2019-nCoV",
    "URL": "https://doi.org/ggq63q",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.19.955484"
  },
  {
    "type": "article-journal",
    "id": "8xnxgpag",
    "author": [
      {
        "family": "Walls",
        "given": "Alexandra C."
      },
      {
        "family": "Park",
        "given": "Young-Jun"
      },
      {
        "family": "Tortorici",
        "given": "M. Alexandra"
      },
      {
        "family": "Wall",
        "given": "Abigail"
      },
      {
        "family": "McGuire",
        "given": "Andrew T."
      },
      {
        "family": "Veesler",
        "given": "David"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          20
        ]
      ]
    },
    "abstract": "The recent emergence of a novel coronavirus associated with an ongoing outbreak of pneumonia (Covid-2019) resulted in infections of more than 72,000 people and claimed over 1,800 lives. Coronavirus spike (S) glycoprotein trimers promote entry into cells and are the main target of the humoral immune response. We show here that SARS-CoV-2 S mediates entry in VeroE6 cells and in BHK cells transiently transfected with human ACE2, establishing ACE2 as a functional receptor for this novel coronavirus. We further demonstrate that the receptor-binding domains of SARS-CoV-2 S and SARS-CoV S bind with similar affinities to human ACE2, which correlates with the efficient spread of SARS-CoV-2 among humans. We found that the SARS-CoV-2 S glycoprotein harbors a furin cleavage site at the boundary between the S /S subunits, which is processed during biogenesis and sets this virus apart from SARS-CoV and other SARS-related CoVs. We determined a cryo-electron microscopy structure of the SARS-CoV-2 S ectodomain trimer, demonstrating spontaneous opening of the receptor-binding domain, and providing a blueprint for the design of vaccines and inhibitors of viral entry. Finally, we demonstrate that SARS-CoV S murine polyclonal sera potently inhibited SARS-CoV-2 S-mediated entry into target cells, thereby indicating that cross-neutralizing antibodies targeting conserved S epitopes can be elicited upon vaccination.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.19.956581",
    "publisher": "bioRxiv",
    "title": "Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein",
    "URL": "https://doi.org/ggrgbr",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.19.956581"
  },
  {
    "type": "article-journal",
    "id": "QdimT8mN",
    "author": [
      {
        "family": "Thevarajan",
        "given": "Irani"
      },
      {
        "family": "Nguyen",
        "given": "Thi HO"
      },
      {
        "family": "Koutsakos",
        "given": "Marios"
      },
      {
        "family": "Druce",
        "given": "Julian"
      },
      {
        "family": "Caly",
        "given": "Leon"
      },
      {
        "family": "van de Sandt",
        "given": "Carolien E"
      },
      {
        "family": "Jia",
        "given": "Xiaoxiao"
      },
      {
        "family": "Nicholson",
        "given": "Suellen"
      },
      {
        "family": "Catton",
        "given": "Mike"
      },
      {
        "family": "Cowie",
        "given": "Benjamin"
      },
      {
        "family": "Tong",
        "given": "Steven"
      },
      {
        "family": "Lewin",
        "given": "Sharon"
      },
      {
        "family": "Kedzierska",
        "given": "Katherine"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          23
        ]
      ]
    },
    "abstract": "We report the kinetics of the immune response in relation to clinical and virological features of a patient with mild-to-moderate coronavirus disease-19 (COVID-19) requiring hospitalisation. Increased antibody-secreting cells, follicular T-helper cells, activated CD4+ and CD8+ T-cells and IgM/IgG SARS-CoV-2-binding antibodies were detected in blood, prior to symptomatic recovery. These immunological changes persisted for at least 7 days following full resolution of symptoms, indicating substantial anti-viral immunity in this non-severe COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.20.20025841",
    "publisher": "medRxiv",
    "title": "Breadth of concomitant immune responses underpinning viral clearance and patient recovery in a non-severe case of COVID-19",
    "URL": "https://doi.org/ggq63r",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.20.20025841"
  },
  {
    "type": "article-journal",
    "id": "tVkKuIJt",
    "author": [
      {
        "family": "Liao",
        "given": "Minfeng"
      },
      {
        "family": "Liu",
        "given": "Yang"
      },
      {
        "family": "Yuan",
        "given": "Jin"
      },
      {
        "family": "Wen",
        "given": "Yanling"
      },
      {
        "family": "Xu",
        "given": "Gang"
      },
      {
        "family": "Zhao",
        "given": "Juanjuan"
      },
      {
        "family": "Chen",
        "given": "Lin"
      },
      {
        "family": "Li",
        "given": "Jinxiu"
      },
      {
        "family": "Wang",
        "given": "Xin"
      },
      {
        "family": "Wang",
        "given": "Fuxiang"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Zhang",
        "given": "Shuye"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          26
        ]
      ]
    },
    "abstract": "The novel coronavirus SARS-CoV-2, etiological agent of recently named Coronavirus infected disease (COVID-19) by WHO, has caused more than 2, 000 deaths worldwide since its emergency in Wuhan City, Hubei province, China, in December, 2019. The symptoms of COVID-19 varied from modest, mild to acute respiratory distress syndrome (ARDS), and the latter of which is generally associated with deregulated immune cytokine production; however, we currently know little as to the interplay between the extent of clinical symptoms and the compositions of lung immune microenvironment. Here, we comprehensively characterized the lung immune microenvironment with the bronchoalveolar lavage fluid (BALF) from 3 severe and 3 mild COVID-19 patients and 8 previously reported healthy lung controls through single-cell RNA sequence (scRNA-seq) combined with TCR-seq. Our data shows that monocyte-derived FCN1+ macrophages, whereas notFABP4+ alveolar macrophages that represent a predominant macrophage subset in BALF from patients with mild diseases, overwhelm in the severely damaged lungs from patients with ARDS. These cells are highly inflammatory and enormous chemokine producers implicated in cytokine storm. Furthermore, the formation of tissue resident, highly expanded clonal CD8+ T cells in the lung microenvironment of mild symptom patients suggests a robust adaptive immune response connected to a better control of COVID-19. This study first reported the cellular atlas of lung bronchoalveolar immune microenvironment in COVID-19 patients at the single-cell resolution, and unveiled the potential immune mechanisms underlying disease progression and protection in COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.23.20026690",
    "publisher": "medRxiv",
    "title": "The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing",
    "URL": "https://doi.org/ggq63s",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.23.20026690"
  },
  {
    "type": "article-journal",
    "id": "FOVDaThy",
    "author": [
      {
        "family": "Pan",
        "given": "Yunbao"
      },
      {
        "family": "Ye",
        "given": "Guangming"
      },
      {
        "family": "Zeng",
        "given": "Xiantao"
      },
      {
        "family": "Liu",
        "given": "Guohong"
      },
      {
        "family": "Zeng",
        "given": "Xiaojiao"
      },
      {
        "family": "Jiang",
        "given": "Xianghu"
      },
      {
        "family": "Zhao",
        "given": "Jin"
      },
      {
        "family": "Chen",
        "given": "Liangjun"
      },
      {
        "family": "Guo",
        "given": "Shuang"
      },
      {
        "family": "Deng",
        "given": "Qiaoling"
      },
      {
        "family": "Hong",
        "given": "Xiaoyue"
      },
      {
        "family": "Yang",
        "given": "Ying"
      },
      {
        "family": "Li",
        "given": "Yirong"
      },
      {
        "family": "Wang",
        "given": "Xinghuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          25
        ]
      ]
    },
    "abstract": "Background. The clinical presentation of 2019 Novel Coronavirus (2019-nCov) infected pneumonia (NCIP) resembles that of other etiologies of community-acquired pneumonia (CAP). We aimed to identify clinical laboratory features to distinguish NCIP from CAP. Methods. We compared the ability of the hematological and biochemical features of 84 patients with NCIP at hospital admission and 316 patients with CAP. Parameters independently predictive of NCIP were calculated by multivariate logistic regression. The receiver operating characteristic (ROC) curves were generated and the area under the ROC curve (AUC) was measured to evaluate the discriminative ability. Results. Most hematological and biochemical indexes of patients with NCIP were significantly different from patients with CAP. Nine laboratory parameters were identified to be highly predictive of a diagnosis of NCIP by multivariate analysis. The AUCs demonstrated good discriminatory ability for red cell distribution width (RDW) with an AUC of 0.88 and Hemoglobin (HGB) with an AUC of 0.82. Red blood cell (RBC), albumin (ALB), eosinophil (EO), hematocrit (HCT), alkaline phosphatase (ALP), and white blood cell (WBC) had fair discriminatory ability. Combinations of any two parameters performed better than did the RDW alone. Conclusions. Routine laboratory examinations may be helpful for the diagnosis of NCIP. Application of laboratory tests may help to optimize the use of isolation rooms for patients when they present with unexplained febrile respiratory illnesses.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.25.20024711",
    "publisher": "medRxiv",
    "title": "Can routine laboratory tests discriminate 2019 novel coronavirus infected pneumonia from other community-acquired pneumonia?",
    "URL": "https://doi.org/ggq63t",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.25.20024711"
  },
  {
    "type": "article-journal",
    "id": "1Du40IOOH",
    "author": [
      {
        "family": "Gong",
        "given": "Jing"
      },
      {
        "family": "Dong",
        "given": "Hui"
      },
      {
        "family": "Xia",
        "given": "Song Qing"
      },
      {
        "family": "Huang",
        "given": "Yi Zhao"
      },
      {
        "family": "Wang",
        "given": "Dingkun"
      },
      {
        "family": "Zhao",
        "given": "Yan"
      },
      {
        "family": "Liu",
        "given": "Wenhua"
      },
      {
        "family": "Tu",
        "given": "Shenghao"
      },
      {
        "family": "Zhang",
        "given": "Mingmin"
      },
      {
        "family": "Wang",
        "given": "Qi"
      },
      {
        "family": "Lu",
        "given": "Fuer"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          26
        ]
      ]
    },
    "abstract": "Aim: The new coronavirus pneumonia (COVID-19) outbreaking at the end of 2019 is highly contagious. Crude mortality rate reached 49% in critical patients. Inflammation matters on disease progression. This study analyzed blood inflammation indicators among mild, severe and critical patients, helping to identify severe or critical patients early. Methods: In this cross-sectional study, 100 patients were included and divided to mild, severe or critical groups. Correlation of peripheral blood inflammation-related indicators with disease criticality was analyzed. Cut-off values for critically ill patients were speculated through the ROC curve. Results：Significantly, disease severity were associated with age (R=-0.564, P&lt;0.001), interleukin-2 receptor (IL2R) (R=-0.534, P&lt;0.001), interleukin-6 (IL-6) (R=-0.535, P&lt;0.001), interleukin-8 (IL-8) (R=-0.308, P&lt;0.001), interleukin-10 (IL-10) (R=-0.422, P&lt;0.001), tumor necrosis factor α (TNFα) (R=-0.322, P&lt;0.001), C-reactive protein (CRP) (R=-0.604, P&lt;0.001), ferroprotein (R=-0.508, P&lt;0.001), procalcitonin (R=-0.650, P&lt;0.001), white cell counts (WBC) (R=-0.54, P&lt;0.001), lymphocyte counts (LC) (R=-0.56, P&lt;0.001), neutrophil count (NC) (R=-0.585, P&lt;0.001) and eosinophil counts (EC) (R=-0.299, P=0.01). Conclusion：With following parameters such as age &gt;67.5 years, IL2R &gt;793.5U/mL, CRP &gt;30.7ng/mL, ferroprotein &gt;2252μg/L, WBC&gt;9.5*10^9/L or NC &gt;7.305*10^9/L, the progress of COVID-19 to critical stage should be closely observed and possibly prevented. Inflammation is closely related to severity of COVID-19, and IL-6, TNFα and IL-8 might be promising therapeutic targets.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.25.20025643",
    "publisher": "medRxiv",
    "title": "Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia",
    "URL": "https://doi.org/ggq63v",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.25.20025643"
  },
  {
    "type": "article-journal",
    "id": "1DTLMIDoM",
    "author": [
      {
        "family": "Herst",
        "given": "CV"
      },
      {
        "family": "Burkholz",
        "given": "S"
      },
      {
        "family": "Sidney",
        "given": "J"
      },
      {
        "family": "Sette",
        "given": "A"
      },
      {
        "family": "Harris",
        "given": "PE"
      },
      {
        "family": "Massey",
        "given": "S"
      },
      {
        "family": "Brasel",
        "given": "T"
      },
      {
        "family": "Cunha-Neto",
        "given": "E"
      },
      {
        "family": "Rosa",
        "given": "DS"
      },
      {
        "family": "Chao",
        "given": "WCH"
      },
      {
        "family": "Carback",
        "given": "R"
      },
      {
        "family": "Hodge",
        "given": "T"
      },
      {
        "family": "Wang",
        "given": "L"
      },
      {
        "family": "Ciotlos",
        "given": "S"
      },
      {
        "family": "Lloyd",
        "given": "P"
      },
      {
        "family": "Rubsamen",
        "given": "R"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          6
        ]
      ]
    },
    "abstract": "The 2013-2016 West Africa EBOV epidemic was the biggest EBOV outbreak to date. An analysis of virus-specific CD8+ T-cell immunity in 30 survivors showed that 26 of those individuals had a CD8+ response to at least one EBOV protein. The dominant response (25/26 subjects) was specific to the EBOV nucleocapsid protein (NP). It has been suggested that epitopes on the EBOV NP could form an important part of an effective T-cell vaccine for Ebola Zaire. We show that a 9-amino-acid peptide NP44-52 (YQVNNLEEI) located in a conserved region of EBOV NP provides protection against morbidity and mortality after mouse adapted EBOV challenge. A single vaccination in a C57BL/6 mouse using an adjuvanted microsphere peptide vaccine formulation containing NP44-52 is enough to confer immunity in mice. Our work suggests that a peptide vaccine based on CD8+ T-cell immunity in EBOV survivors is conceptually sound and feasible. Nucleocapsid proteins within SARS-CoV-2 contain multiple class I epitopes with predicted HLA restrictions consistent with broad population coverage. A similar approach to a CTL vaccine design may be possible for that virus.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.25.963546",
    "publisher": "bioRxiv",
    "title": "An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design",
    "URL": "https://doi.org/ggq63x",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.25.963546"
  },
  {
    "type": "article-journal",
    "id": "9spK49tt",
    "author": [
      {
        "family": "Li",
        "given": "Lin"
      },
      {
        "family": "Sun",
        "given": "Ting"
      },
      {
        "family": "He",
        "given": "Yufei"
      },
      {
        "family": "Li",
        "given": "Wendong"
      },
      {
        "family": "Fan",
        "given": "Yubo"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          27
        ]
      ]
    },
    "abstract": "The outbreak of the 2019 novel coronavirus (SARS-CoV-2) has infected thousands of people with a large number of deaths across 26 countries. The sudden appearance of the virus leads to the limited existing therapies for SARS-CoV-2. Therefore, vaccines and antiviral medicines are in desperate need. This study took immune-informatics approaches to identify B- and T-cell epitopes for surface glycoprotein (S) of SARS-CoV-2, followed by estimating their antigenicity and interactions with the human leukocyte antigen (HLA) alleles. We identified four B cell epitopes, two MHC class-I and nine MHC class-II binding T-cell epitopes, which showed highly antigenic features. Allergenicity, toxicity and physiochemical properties analysis confirmed the specificity and selectivity of epitopes. The stability and safety of epitopes were confirmed by digestion analysis. No mutations were observed in all the selected B- and T-cell epitopes across all isolates from different locations worldwide. Epitopes were thus identified and some of them can be potential candidates for vaccine development.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.02.25.965434",
    "publisher": "bioRxiv",
    "title": "Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2",
    "URL": "https://doi.org/ggnqwt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.25.965434"
  },
  {
    "type": "article-journal",
    "id": "qg1bmQng",
    "author": [
      {
        "family": "Wang",
        "given": "Wenjun"
      },
      {
        "family": "He",
        "given": "Jianxing"
      },
      {
        "family": "Lie",
        "given": "puyi"
      },
      {
        "family": "Huang",
        "given": "liyan"
      },
      {
        "family": "Wu",
        "given": "Sipei"
      },
      {
        "family": "lin",
        "given": "yongping"
      },
      {
        "family": "liu",
        "given": "xiaoqing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          27
        ]
      ]
    },
    "abstract": "IMPORTANCE: COVID-19-infected pneumonia patients with severe immune abnormalities and risk of cytokine release syndrome. The definition, prevention, and treatment of COVID-19-infected pneumonia in critically ill patients with cytokine release syndrome symptoms is an important problem.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.26.20026989",
    "publisher": "medRxiv",
    "title": "The definition and risks of Cytokine Release Syndrome-Like in 11 COVID-19-Infected Pneumonia critically ill patients: Disease Characteristics and Retrospective Analysis",
    "URL": "https://doi.org/ggrgbs",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.26.20026989"
  },
  {
    "type": "article-journal",
    "id": "YODgfrtM",
    "author": [
      {
        "family": "Huang",
        "given": "Ying"
      },
      {
        "family": "Yang",
        "given": "Rui"
      },
      {
        "family": "Xu",
        "given": "Ying"
      },
      {
        "family": "Gong",
        "given": "Ping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          5
        ]
      ]
    },
    "abstract": "Background Although the outbreak of Coronavirus disease 2019 (COVID-19) has caused over 2200 deaths in China, there was no study about death yet. We aimed to describe the clinical characteristics of non-survivors with COVID-19. Methods For this retrospective, single-center study, we included 36 non-survivors with COVID-19 in the Fifth Hospital of Wuhan. Cases were confirmed by real-time RT-PCR between Jan 21 and Feb 10, 2020 according to the recommended protocol. The epidemiological, demographic, clinical, laboratory, radiological and treatment data were collected and analyzed. Outcomes were followed up until Feb 14, 2020. This study was approved by the ethics commissions of the Fifth Hospital of Wuhan, with a waiver of informed consent due to a public health outbreak investigation. Results We included 36 patients who died from COVID-19. The mean age of the patients was 69.22 years (SD 9.64, range 50-90). 25(69.44%) patients were males, and 11 (30.56%) female. 26 (72.22%) patients had chronic diseases, mainly including hypertension, cardiovascular disease and diabetes. Patients had common clinical symptoms of fever (34 [94.44%] patients), cough (28 [77.78%] patients), shortness of breath (21 [58.33%] patients), and fatigue (17 [47.22%] patient). Chest computed tomographic scans showed that 31 (96.88%) patients had bilateral pneumonia. Lymphopenia occurred in 24 patients (70.59%), decreased albumin (30.18, [SD, 4.76]) in 25 patients (80.65%), elevated D-dimer (8.64 [IQR, 2.39-20]) in 27 patients (100%), and elevated lactate dehydrogenase (502.5 U/L [IQR, 410-629]) in 26 patients (100%). Nearly all of the patients have elevated CRP (106.3 mg/L [IQR, 60.83-225.3]), PCT (0.61 ng/ml [IQR, 0.16-2.10]) and IL-6 (100.6 pg/ml [IQR, 51.51-919.5]). Most patients received antiviral therapy and antibiotic therapy, and more than half of patients received glucocorticoid therapy (25 [69.44%]). All the patients had acute respiratory distress syndrome (ARDS). The median time from onset to ARDS was 11 days. One (2.78%) patient presented with acute renal injury. The median time from onset to death was 17 days. Interpretation Lots of patients died from COVID-19 till now. The median survival time of these non-survivors from onset to death was about 2 weeks. Most patients were older males with comorbidities. They finally progressed to ARDS. The median time from onset to ARDS was 11 days. Gradually decreased lymphocytes and increased inflammation biomarkers were common, and need to be monitored in the routine treatment.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.27.20029009",
    "publisher": "medRxiv",
    "title": "Clinical characteristics of 36 non-survivors with COVID-19 in Wuhan, China",
    "URL": "https://doi.org/ggq63z",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.27.20029009"
  },
  {
    "type": "article-journal",
    "id": "5CGbn9Jj",
    "author": [
      {
        "family": "Li",
        "given": "Lu"
      },
      {
        "family": "Li",
        "given": "Shuang"
      },
      {
        "family": "Xu",
        "given": "Manman"
      },
      {
        "family": "Yu",
        "given": "Pengfei"
      },
      {
        "family": "Zheng",
        "given": "Sujun"
      },
      {
        "family": "Duan",
        "given": "Zhongping"
      },
      {
        "family": "Liu",
        "given": "Jing"
      },
      {
        "family": "Chen",
        "given": "Yu"
      },
      {
        "family": "Li",
        "given": "Junfeng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          10
        ]
      ]
    },
    "abstract": "Aims: Corona virus disease 2019 (COVID-19) has rapidly become the most severe public health issue all over the world. Despite respiratory symptoms, hepatic injury has also been observed in clinical settings. This study aimed to investigate the risk factors involved with hepatic injury in the patients with COVID-19. Methods: A total of 85 hospitalized patients who were diagnosed with COVID-19 in Beijing Youan Hospital were retrospectively analyzed. According to liver function, they were divided into ALT normal group (n=52) and ALT elevation group (n=33). Clinical features and laboratory data were compared between the two groups. The independent risk factors for liver injury were analyzed. Results: There were 33 patients with hepatic injury in our study, accounting for 38.8% (33/85). The patients in ALT elevation group were older than those in ALT normal group. The levels of lactic acid, CRP, myoglobin, and neutrophils were significantly higher in ALT elevation group. The lymphocytes and albumin were significantly lower in ALT elevation group. The proportion of severe and critical patients in ALT elevation group was significantly higher. Multivariate logistic regression analysis showed CRP ≥20 mg/L and lymphocyte count&lt; 1.1*10^9/L were independently related to hepatic injury. Conclusions: Lymphopenia and CRP may serve as the risk factors related to hepatic injury in patients with COVID-19, which might be related to inflammatory cytokine storm in liver injury. Early detection and timely treatment of hepatic injury in patients with COVID-19 are necessary.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.28.20028514",
    "publisher": "medRxiv",
    "title": "Risk factors related to hepatic injury in patients with corona virus disease 2019",
    "URL": "https://doi.org/ggq632",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.28.20028514"
  },
  {
    "type": "article-journal",
    "id": "T0BDaXkw",
    "author": [
      {
        "family": "Chen",
        "given": "Xiaohua"
      },
      {
        "family": "Zhao",
        "given": "Binghong"
      },
      {
        "family": "Qu",
        "given": "Yueming"
      },
      {
        "family": "Chen",
        "given": "Yurou"
      },
      {
        "family": "Xiong",
        "given": "Jie"
      },
      {
        "family": "Feng",
        "given": "Yong"
      },
      {
        "family": "Men",
        "given": "Dong"
      },
      {
        "family": "Huang",
        "given": "Qianchuan"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Yang",
        "given": "Bo"
      },
      {
        "family": "Ding",
        "given": "Jinya"
      },
      {
        "family": "Li",
        "given": "Feng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          3
        ]
      ]
    },
    "abstract": "Background: Although the SARS-CoV-2 viral load detection of respiratory specimen has been widely used for novel coronavirus disease (COVID-19) diagnosis, it is undeniable that serum SARS-CoV-2 nucleic acid (RNAaemia) could be detected in a fraction of the COVID-19 patients. However, it is not clear that if the incidence of RNAaemia could be correlated with the occurrence of cytokine storm or with the specific class of patients. Methods: This study enrolled 48 patients with COVID-19 admitted to the General Hospital of Central Theater Command, PLA, a designated hospital in Wuhan, China. The patients were divided into three groups according to the Diagnosis and Treatment of New Coronavirus Pneumonia (version 6) published by the National Health Commission of China. The clinical and laboratory data were collected. The serum viral load detection and serum IL-6 levels were determined. Except for routine statistical analysis, Generalized Linear Models (GLMs) analysis was used to establish a patient status prediction model based on real-time RT-PCR Ct value. Findings: The Result showed that cases with RNAaemia were exclusively confirmed in critically ill patients group and appeared to reflect the illness severity. Further more, the inflammatory cytokine IL-6 levels were significantly elevated in critically ill patients, which is almost 10-folds higher than those in other patients. More importantly, the extremely high IL-6 level was closely correlated with the incidence of RNAaemia (R=0.902) and the vital signs of COVID-19 patients (R= -0.682). Interpretation: Serum SARS-CoV-2 viral load (RNAaemia) is strongly associated with cytokine storm and can be used to predict the poor prognosis of COVID-19 patients. Moreover, our results strongly suggest that cytokine IL-6 should be considered as a therapeutic target in critically ill patients with excessive inflammatory response.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.02.29.20029520",
    "publisher": "medRxiv",
    "title": "Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients",
    "URL": "https://doi.org/ggq633",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.02.29.20029520"
  },
  {
    "type": "article-journal",
    "id": "uIwTzZkJ",
    "author": [
      {
        "family": "Tan",
        "given": "Li"
      },
      {
        "family": "Wang",
        "given": "Qi"
      },
      {
        "family": "Zhang",
        "given": "Duanyang"
      },
      {
        "family": "Ding",
        "given": "Jinya"
      },
      {
        "family": "Huang",
        "given": "Qianchuan"
      },
      {
        "family": "Tang",
        "given": "Yi-Quan"
      },
      {
        "family": "Wang",
        "given": "Qiongshu"
      },
      {
        "family": "Miao",
        "given": "Hongming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          3
        ]
      ]
    },
    "abstract": "Background: Coronavirus disease-2019 (COVID-19) is a rapidly escalating epidemic caused by SARS-CoV-2. Identification of a simple and effective indicator to assess disease severity and outcome is urgently needed. Methods: This study retrospectively analyzed dynamic changes of lymphocyte percentage (LYM%) in 15 death cases, 15 severe cases as well as 40 moderate cases of COVID-19 patients. Next, prognostic role of lymphopenia in COVID-19 were verified in 92 hospitalized cases. Results: Our results from death and severe cases showed that LYM% in blood test were inversely associated with the progression and severity of COVID-19. LYM% in patients with moderate COVID-19 remained higher than 20% 10-12 days after symptom onset. In contrast, LYM% was lower than 20% in severe cases. However, LYM% in severe cases was higher than 5% 17-19 days after the onset of the disease, while it fell below 5% in death cases. Therefore, we established a reliable Time from symptom onset-LYM% model (TLM), which could be used to evaluate disease severity and predict the outcomes of hospitalized patients with COVID-19. Conclusion: Lymphopenia can be used to indicate clinical course, treatment effect and outcomes of COVID-19 patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.01.20029074",
    "publisher": "medRxiv",
    "title": "Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study",
    "URL": "https://doi.org/ggq634",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.01.20029074"
  },
  {
    "type": "article-journal",
    "id": "1GMxHWnxN",
    "author": [
      {
        "family": "Liu",
        "given": "Tao"
      },
      {
        "family": "Zhang",
        "given": "Jieying"
      },
      {
        "family": "Yang",
        "given": "Yuhui"
      },
      {
        "family": "Ma",
        "given": "Hong"
      },
      {
        "family": "Li",
        "given": "Zhengyu"
      },
      {
        "family": "Zhang",
        "given": "Jiaoyue"
      },
      {
        "family": "Cheng",
        "given": "Ji"
      },
      {
        "family": "Zhang",
        "given": "Xiaoyun"
      },
      {
        "family": "Zhao",
        "given": "Yanxia"
      },
      {
        "family": "Xia",
        "given": "Zihan"
      },
      {
        "family": "Zhang",
        "given": "Liling"
      },
      {
        "family": "Wu",
        "given": "Gang"
      },
      {
        "family": "Yi",
        "given": "Jianhua"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          10
        ]
      ]
    },
    "abstract": "Abstract. Background: The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan City, China spreads rapidly since December, 2019. Most patients show mild symptoms, but some of them develop into severe disease. There is currently no specific medication. The purpose of this study is to to explore changes of markers in peripheral blood of severe COVID-19 patients, which may be of value in disease monitoring. Methods Clinical data of patients with nonsevere and severe type COVID-19 diagnosed by laboratory test in our institution were collected. The relationship between peripheral blood cells and cytokines, clinical manifestation and outcome was analyzed. Results A total of 69 severe type COVID-19 patients were included. On admission, the median age of severe cases was 56-year old, with 52.17% female patient. The most common symptoms were fever (79.72%), cough (63.77%), shortness of breath (57.97%) and fatigue (50.72%). Diarrhea is less common. The most common comorbidity is hypertension. Upon admission, the proportion of bilateral pulmonary involvement and interstitial abnormalities evidenced by chest computed tomography (CT) imaging in severe cases was 60.87% and 27.54%, respectively. Compared with patients with nonsevere disease, those with severe disease showed obvious lymphocytopenia. Elevated level of lactate dehydrogenase (LDH), C-reactive protein (CRP), ferritin and D-dimer was found in most cases. Two patients (2.9%) needed transfer to the intensive care unit. Baseline immunological parameters and most of the inflammatory parameters were basically within the normal range. However, baseline interleukin-6 (IL-6) was significantly increased in severe type, which was closely related to the maximal body temperature during hospitalization and to CT findings. Baseline IL-6 was also significantly related to the increase of baseline level of CRP, LDH, ferritin and D-dimer. The increase of baseline IL-6 level suggests that it may positively correlate with the severity of COVID-19. Among the 30 severe type patients whose IL-6 was assessed before and after treatment, significant decrease in IL-6 and improved CT assessment was found in 25 patients after treatment. Whereas the IL-6 level was further increased in 3 cases, which was closely related to disease progression. It is suggested that IL-6 may be used as a marker for disease monitoring in severe COVID-19 patients. Conclusions On admission, the baseline level of IL-6, CRP, LDH and ferritin was closely related to the severity of COVID-19, and the elevated IL-6 was significantly related to the clinical manifestation of severe type patients. The decrease of IL-6 was closely related to treatment effectiveness, while the increase of IL-6 indicated disease exacerbation. Collectively, the dynamic change of IL-6 level can be used as a marker for disease monitoring in patients with severe COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.01.20029769",
    "publisher": "medRxiv",
    "title": "The potential role of IL-6 in monitoring severe case of coronavirus disease 2019",
    "URL": "https://doi.org/ggq635",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.01.20029769"
  },
  {
    "type": "article-journal",
    "id": "1B0vBwv1q",
    "author": [
      {
        "family": "Zhao",
        "given": "Zonghao"
      },
      {
        "family": "Xie",
        "given": "Jiajia"
      },
      {
        "family": "Yin",
        "given": "Ming"
      },
      {
        "family": "Yang",
        "given": "Yun"
      },
      {
        "family": "He",
        "given": "Hongliang"
      },
      {
        "family": "Jin",
        "given": "Tengchuan"
      },
      {
        "family": "Li",
        "given": "Wenting"
      },
      {
        "family": "Zhu",
        "given": "Xiaowu"
      },
      {
        "family": "Xu",
        "given": "Jing"
      },
      {
        "family": "Zhao",
        "given": "Changcheng"
      },
      {
        "family": "Li",
        "given": "Lei"
      },
      {
        "family": "Li",
        "given": "Yi"
      },
      {
        "family": "Mengist",
        "given": "Hylemariam Mihiretie"
      },
      {
        "family": "Zahid",
        "given": "Ayesha"
      },
      {
        "family": "Yao",
        "given": "Ziqin"
      },
      {
        "family": "Ding",
        "given": "Chengchao"
      },
      {
        "family": "Qi",
        "given": "Yingjie"
      },
      {
        "family": "Gao",
        "given": "Yong"
      },
      {
        "family": "Ma",
        "given": "Xiaoling"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          6
        ]
      ]
    },
    "abstract": "The outbreak of the novel coronavirus disease 2019 (COVID-19) infection began in December 2019 in Wuhan, and rapidly spread to many provinces in China. The number of cases has increased markedly in Anhui, but information on the clinical characteristics of patients is limited. We reported 75 patients with COVID-19 in the First Affiliated Hospital of USTC from Jan 21 to Feb 16, 2020, Hefei, Anhui Province, China. COVID-19 infection was confirmed by real-time RT-PCR of respiratory nasopharyngeal swab samples. Epidemiological, clinical and laboratory data were collected and analyzed. Of the 75 patients with COVID-19, 61 (81.33%) had a direct or indirect exposure history to Wuhan. Common symptoms at onset included fever (66 [88.0%] of 75 patients) and dry cough (62 [82.67%]). Of the patients without fever, cough could be the only or primary symptom. The most prominent laboratory abnormalities were lymphopenia, decreased percentage of lymphocytes (LYM%), decreased CD4+ and CD8+ T cell counts, elevated C-reactive protein (CRP) and lactate dehydrogenase (LDH). Patients with elevated interleukin 6 (IL-6) showed significant decreases in the LYM%, CD4+ and CD8+ T cell counts. Besides, the percentage of neutrophils, CRP, LDH and Procalcitonin levels increased significantly. We concluded that COVID-19 could cause different degrees of hematological abnormalities and damage of internal organs. Hematological profiles including LYM, LDH, CRP and IL-6 could be indicators of diseases severity and evaluation of treatment effectiveness. Antiviral treatment requires a comprehensive and supportive approach. Further targeted therapy should be determined based on individual clinical manifestations and laboratory indicators.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.01.20029785",
    "publisher": "medRxiv",
    "title": "Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China",
    "URL": "https://doi.org/ggq636",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.01.20029785"
  },
  {
    "type": "article-journal",
    "id": "RyXNw87v",
    "author": [
      {
        "family": "Yang",
        "given": "Yang"
      },
      {
        "family": "Shen",
        "given": "Chenguang"
      },
      {
        "family": "Li",
        "given": "Jinxiu"
      },
      {
        "family": "Yuan",
        "given": "Jing"
      },
      {
        "family": "Yang",
        "given": "Minghui"
      },
      {
        "family": "Wang",
        "given": "Fuxiang"
      },
      {
        "family": "Li",
        "given": "Guobao"
      },
      {
        "family": "Li",
        "given": "Yanjie"
      },
      {
        "family": "Xing",
        "given": "Li"
      },
      {
        "family": "Peng",
        "given": "Ling"
      },
      {
        "family": "Wei",
        "given": "Jinli"
      },
      {
        "family": "Cao",
        "given": "Mengli"
      },
      {
        "family": "Zheng",
        "given": "Haixia"
      },
      {
        "family": "Wu",
        "given": "Weibo"
      },
      {
        "family": "Zou",
        "given": "Rongrong"
      },
      {
        "family": "Li",
        "given": "Delin"
      },
      {
        "family": "Xu",
        "given": "Zhixiang"
      },
      {
        "family": "Wang",
        "given": "Haiyan"
      },
      {
        "family": "Zhang",
        "given": "Mingxia"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Liu",
        "given": "Yingxia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          6
        ]
      ]
    },
    "abstract": "The outbreak of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, December 2019, and continuously poses a serious threat to public health. Our previous study has shown that cytokine storm occurred during SARS-CoV-2 infection, while the detailed role of cytokines in the disease severity and progression remained unclear due to the limited case number. In this study, we examined 48 cytokines in the plasma samples from 53 COVID-19 cases, among whom 34 were severe cases, and the others moderate. Results showed that 14 cytokines were significantly elevated upon admission in COVID-19 cases. Moreover, IP-10, MCP-3, and IL-1ra were significantly higher in severe cases, and highly associated with the PaO2/FaO2 and Murray score. Furthermore, the three cytokines were independent predictors for the progression of COVID-19, and the combination of IP-10, MCP-3 and IL-1ra showed the biggest area under the curve (AUC) of the receiver-operating characteristics (ROC) calculations. Serial detection of IP-10, MCP-3 and IL-1ra in 14 severe cases showed that the continuous high levels of these cytokines were associated with disease deterioration and fatal outcome. In conclusion, we report three cytokines that closely associated with disease severity and outcome of COVID-19. These findings add to our understanding of the immunopathologic mechanisms of SARS-CoV-2 infection, which suggested novel therapeutic targets and strategy.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.02.20029975",
    "publisher": "medRxiv",
    "title": "Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome",
    "URL": "https://doi.org/ggq637",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.02.20029975"
  },
  {
    "type": "article-journal",
    "id": "5HXuCa5t",
    "author": [
      {
        "family": "Zhao",
        "given": "Juanjuan"
      },
      {
        "family": "Yuan",
        "given": "Quan"
      },
      {
        "family": "Wang",
        "given": "Haiyan"
      },
      {
        "family": "Liu",
        "given": "Wei"
      },
      {
        "family": "Liao",
        "given": "Xuejiao"
      },
      {
        "family": "Su",
        "given": "Yingying"
      },
      {
        "family": "Wang",
        "given": "Xin"
      },
      {
        "family": "Yuan",
        "given": "Jing"
      },
      {
        "family": "Li",
        "given": "Tingdong"
      },
      {
        "family": "Li",
        "given": "Jinxiu"
      },
      {
        "family": "Qian",
        "given": "Shen"
      },
      {
        "family": "Hong",
        "given": "Congming"
      },
      {
        "family": "Wang",
        "given": "Fuxiang"
      },
      {
        "family": "Liu",
        "given": "Yingxia"
      },
      {
        "family": "Wang",
        "given": "Zhaoqin"
      },
      {
        "family": "He",
        "given": "Qing"
      },
      {
        "family": "Li",
        "given": "Zhiyong"
      },
      {
        "family": "He",
        "given": "Bin"
      },
      {
        "family": "Zhang",
        "given": "Tianying"
      },
      {
        "family": "Ge",
        "given": "Shengxiang"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Zhang",
        "given": "Jun"
      },
      {
        "family": "Xia",
        "given": "Ningshao"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          2
        ]
      ]
    },
    "abstract": "Summary Background The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clinical values of antibody testing have not been fully demonstrated. Methods A total of 173 patients with confirmed SARS-CoV-2 infection were enrolled. Their serial plasma samples (n = 535) collected during the hospitalization period were tested for total antibodies (Ab), IgM and IgG against SARS-CoV-2 using immunoassays. The dynamics of antibodies with the progress and severity of disease was analyzed. Findings Among 173 patients, the seroconversion rate for Ab, IgM and IgG was 93.1% (161/173), 82.7% (143/173) and 64.7% (112/173), respectively. Twelve patients who had not seroconverted were those only blood samples at the early stage of illness were collected. The seroconversion sequentially appeared for Ab, IgM and then IgG, with a median time of 11, 12 and 14 days, respectively. The presence of antibodies was &lt; 40% among patients in the first 7 days of illness, and then rapidly increased to 100.0%, 94.3% and 79.8% for Ab, IgM and IgG respectively since day 15 after onset. In contrast, the positive rate of RNA decreased from 66.7% (58/87) in samples collected before day 7 to 45.5% (25/55) during days 15 to 39. Combining RNA and antibody detections significantly improved the sensitivity of pathogenic diagnosis for COVID-19 patients (p &lt; 0.001), even in early phase of 1-week since onset (p = 0.007). Moreover, a higher titer of Ab was independently associated with a worse clinical classification (p = 0.006). Interpretation The antibody detection offers vital clinical information during the course of SARS-CoV-2 infection. The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.02.20030189",
    "publisher": "medRxiv",
    "title": "Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019",
    "URL": "https://doi.org/ggrbj6",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.02.20030189"
  },
  {
    "type": "article-journal",
    "id": "uCyoHtV3",
    "author": [
      {
        "family": "Chen",
        "given": "Xiaoping"
      },
      {
        "family": "Ling",
        "given": "Jiaxin"
      },
      {
        "family": "Mo",
        "given": "Pingzheng"
      },
      {
        "family": "Zhang",
        "given": "Yongxi"
      },
      {
        "family": "Jiang",
        "given": "Qunqun"
      },
      {
        "family": "Ma",
        "given": "Zhiyong"
      },
      {
        "family": "Cao",
        "given": "Qian"
      },
      {
        "family": "Hu",
        "given": "Wenjia"
      },
      {
        "family": "Zou",
        "given": "Shi"
      },
      {
        "family": "Chen",
        "given": "Liangjun"
      },
      {
        "family": "Yao",
        "given": "Lei"
      },
      {
        "family": "Luo",
        "given": "Mingqi"
      },
      {
        "family": "Chen",
        "given": "Tielong"
      },
      {
        "family": "Deng",
        "given": "Liping"
      },
      {
        "family": "Liang",
        "given": "Ke"
      },
      {
        "family": "Song",
        "given": "Shihui"
      },
      {
        "family": "Yang",
        "given": "Rongrong"
      },
      {
        "family": "Zheng",
        "given": "Ruiying"
      },
      {
        "family": "Gao",
        "given": "Shicheng"
      },
      {
        "family": "Gui",
        "given": "Xien"
      },
      {
        "family": "Ke",
        "given": "Hengning"
      },
      {
        "family": "Hou",
        "given": "Wei"
      },
      {
        "family": "Lundkvist",
        "given": "Åke"
      },
      {
        "family": "Xiong",
        "given": "Yong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          6
        ]
      ]
    },
    "abstract": "Background: Viral clearance is one important indicator for the recovery of SARS-CoV-2 infected patients. Suboptimal T and B cell responses can delay viral clearance in MERS and SARS patients. The role of leukomonocytes in viral clearance of COVID-19 patients is not yet well defined.Methods: From January 26 to February 28, 2020, an observational study was launched at Zhongnan Hospital of Wuhan University, Wuhan, China. We enrolled 25 laboratory-confirmed COVID-19 patients, whose throat-swab specimens were tested positive for SARS-CoV-2 infection by qRT-PCR. We comprehensively analyzed clinical records, counts of lymphocyte subsets including CD3+, CD4+, CD8+ T cells, B cells and NK cells in the patients who successfully cleared SARS-CoV-2, and compared to those that failed to, after a standardized treatment of 8-14 days. Findings: In 25 enrolled COVID-19 patients, lymphopeniawas a common feature. After the treatment, 14 patients were tested negative for SARS-CoV-2. The patients that cleared the infection had restored the numbers of CD3+, CD4+, CD8+ T cellsand B cells as compared to the still viral RNA positive patients, while the recovered patients had a higher count of leukomonocytes. Conclusions: By comparison of leukomonocytes counts in COVID-19 patients at different stages of the disease, we found that CD3+, CD4+, CD8+ T cells and B cells appear to play important roles in viral clearance. The restoration of leukomonocytes counts from peripheral blood can be used as prognosis for the recovery of an COVID-19 infection. We propose that restoration of leukomonocytes counts can be added to the COVID-19 diagnostic guidanceas a criterion for releasing and discharging patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.03.20030437",
    "publisher": "medRxiv",
    "title": "Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients",
    "URL": "https://doi.org/ggq639",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.03.20030437"
  },
  {
    "type": "article-journal",
    "id": "USOnp7c0",
    "author": [
      {
        "family": "Xu",
        "given": "Yonghao"
      },
      {
        "family": "Xu",
        "given": "Zhiheng"
      },
      {
        "family": "Liu",
        "given": "Xuesong"
      },
      {
        "family": "Cai",
        "given": "Lihua"
      },
      {
        "family": "Zheng",
        "given": "Haichong"
      },
      {
        "family": "Huang",
        "given": "Yongbo"
      },
      {
        "family": "Zhou",
        "given": "Lixin"
      },
      {
        "family": "Huang",
        "given": "Linxi"
      },
      {
        "family": "Lin",
        "given": "Yun"
      },
      {
        "family": "Deng",
        "given": "Liehua"
      },
      {
        "family": "Li",
        "given": "Jianwei"
      },
      {
        "family": "Chen",
        "given": "Sibei"
      },
      {
        "family": "Liu",
        "given": "Dongdong"
      },
      {
        "family": "Lin",
        "given": "Zhimin"
      },
      {
        "family": "Zhou",
        "given": "Liang"
      },
      {
        "family": "He",
        "given": "Weiqun"
      },
      {
        "family": "Liu",
        "given": "Xiaoqing"
      },
      {
        "family": "Li",
        "given": "Yimin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          6
        ]
      ]
    },
    "abstract": "Abstract Background In December 2019, human infection with a novel coronavirus, known as SARS-CoV-2, was identified in Wuhan, China. The mortality of critical illness was high in Wuhan. Information about critically ill patients with SARS-CoV-2 infection outside of Wuhan is scarce. We aimed to provide the clinical features, treatment, and prognosis of the critically ill patients with SARS-CoV-2 infection in Guangdong Province. Methods In this multi-centered, retrospective, observational study, we enrolled critically ill patients with SARS-CoV-2 pneumonia who were admitted to the intensive care unit (ICU) in Guangdong Province. Demographic data, symptoms, laboratory findings, comorbidities, treatments, and prognosis were collected. Data were compared between patients with and without intubation. Results Forty-five critically ill patients with SARS-CoV-2 pneumonia were identified in 7 ICUs in Guangdong Province. The mean age was 56.7 years, and 29 patients (64.4%) were men. The most common symptoms at the onset of illness were high fever and cough. Majority of patients presented with lymphopenia and elevated lactate dehydrogenase. Treatment with antiviral drugs was initiated in all the patients. Thirty-seven patients (82.2%) had developed acute respiratory distress syndrome, and 13 (28.9%) septic shock. A total of 20 (44.4%) patients required intubation and 9 (20%) required extracorporeal membrane oxygenation. As of February 28th 2020, only one patient (2.2%) had died and half of them had discharged of ICU. Conclusions Infection with SARS-CoV-2 in critical illness is characterized by fever, lymphopenia, acute respiratory failure and multiple organ dysfunction. Compared with critically ill patients infected with SARS-CoV-2 in Wuhan, the mortality of critically ill patients in Guangdong Province was relatively low. These data provide some general understandings and experience for the critical patients with SARS-CoV-2 outside of Wuhan.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.03.20030668",
    "publisher": "medRxiv",
    "title": "Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study",
    "URL": "https://doi.org/ggq64b",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.03.20030668"
  },
  {
    "type": "article-journal",
    "id": "14OLQIYK0",
    "author": [
      {
        "family": "Feng",
        "given": "Ye"
      },
      {
        "family": "Qiu",
        "given": "Min"
      },
      {
        "family": "Zou",
        "given": "Shengmei"
      },
      {
        "family": "Li",
        "given": "Yun"
      },
      {
        "family": "Luo",
        "given": "Kai"
      },
      {
        "family": "Chen",
        "given": "Rongchang"
      },
      {
        "family": "Sun",
        "given": "Yingqiang"
      },
      {
        "family": "Wang",
        "given": "Kui"
      },
      {
        "family": "Zhuang",
        "given": "Xinlei"
      },
      {
        "family": "Zhang",
        "given": "Shanshan"
      },
      {
        "family": "Chen",
        "given": "Shuqing"
      },
      {
        "family": "Mo",
        "given": "Fan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          3
        ]
      ]
    },
    "abstract": "A new coronavirus SARS-CoV-2, recently discovered in Wuhan, China, has caused over 74000 infection cases and 2000 deaths. Due to the rapidly growing cases and the unavailability of specific therapy, there is a desperate need for vaccines to combat the epidemic of SARS-CoV-2. In the present study, we performed an in silico approach based on the available virus genome to identify the antigenic B-cell epitopes and human-leukocyte-antigen (HLA) restricted T-cell epitopes. A total of 61 B-cell epitopes were initially identified, 19 of which with higher potential immunogenicity were used for vaccine design. 499 T-cell epitopes were predicted that showed affinity with the 34 most popular HLA alleles in Chinese population. Based on these epitopes, 30 vaccine candidates were designed and inspected against safety risks, including potential toxicity, human homologous, pharmaceutical peptides and bioactive peptides. Majority of vaccine peptides contained both B-cell and T-cell epitopes, which may interact with the most prevalent HLA alleles accounting for ~99% of Chinese population. Docking analysis showed stable hydrogen bonds of epitopes with their corresponding HLA alleles. In conclusion, these putative antigenic peptides may elicit the resistance response to the viral infection. In vitro and in vivo experiments are required to validate the effectiveness of these peptide vaccine.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.03.962332",
    "publisher": "bioRxiv",
    "title": "Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2)",
    "URL": "https://doi.org/ggq64c",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.03.962332"
  },
  {
    "type": "article-journal",
    "id": "12ilBRq6I",
    "author": [
      {
        "family": "Cao",
        "given": "Min"
      },
      {
        "family": "Zhang",
        "given": "Dandan"
      },
      {
        "family": "Wang",
        "given": "Youhua"
      },
      {
        "family": "Lu",
        "given": "Yunfei"
      },
      {
        "family": "Zhu",
        "given": "Xiangdong"
      },
      {
        "family": "Li",
        "given": "Ying"
      },
      {
        "family": "Xue",
        "given": "Honghao"
      },
      {
        "family": "Lin",
        "given": "Yunxiao"
      },
      {
        "family": "Zhang",
        "given": "Min"
      },
      {
        "family": "Sun",
        "given": "Yiguo"
      },
      {
        "family": "Yang",
        "given": "Zongguo"
      },
      {
        "family": "Shi",
        "given": "Jia"
      },
      {
        "family": "Wang",
        "given": "Yi"
      },
      {
        "family": "Zhou",
        "given": "Chang"
      },
      {
        "family": "Dong",
        "given": "Yidan"
      },
      {
        "family": "Liu",
        "given": "Ping"
      },
      {
        "family": "Dudek",
        "given": "Steven M"
      },
      {
        "family": "Xiao",
        "given": "Zhen"
      },
      {
        "family": "Lu",
        "given": "Hongzhou"
      },
      {
        "family": "Peng",
        "given": "Longping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          6
        ]
      ]
    },
    "abstract": "Background: Since mid-December 2019, a cluster of pneumonia-like diseases caused by a novel coronavirus, now designated COVID-19 by the WHO, emerged in Wuhan city and rapidly spread throughout China. Here we identify the clinical characteristics of COVID-19 in a cohort of patients in Shanghai. Methods: Cases were confirmed by real-time RT-PCR and were analysed for demographic, clinical, laboratory and radiological features. Results: Of 198 patients, the median duration from disease onset to hospital admission was 4 days. The mean age of the patients was 50.1 years, and 51.0% patients were male. The most common symptom was fever. Less than half of the patients presented with respiratory systems including cough, sputum production, itchy or sore throat, shortness of breath, and chest congestion. 5.6% patients had diarrhoea. On admission, T lymphocytes were decreased in 45.8% patients. Ground glass opacity was the most common radiological finding on chest computed tomography. 9.6% were admitted to the ICU because of the development of organ dysfunction. Compared with patients not treated in ICU, patients treated in the ICU were older, had longer waiting time to admission, fever over 38.5o C, dyspnoea, reduced T lymphocytes, elevated neutrophils and organ failure. Conclusions: In this single centre cohort of COVID-19 patients, the most common symptom was fever, and the most common laboratory abnormality was decreased blood T cell counts. Older age, male, fever over 38.5oC, symptoms of dyspnoea, and underlying comorbidity, were the risk factors most associated with severity of disease. Key words: 2019 novel coronavirus; acute respiratory infection; risk factors for disease severity",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.04.20030395",
    "publisher": "medRxiv",
    "title": "Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, China",
    "URL": "https://doi.org/ggq64d",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.04.20030395"
  },
  {
    "type": "article-journal",
    "id": "IPJURDxi",
    "author": [
      {
        "family": "Zhang",
        "given": "Jin"
      },
      {
        "family": "Liu",
        "given": "Jianhua"
      },
      {
        "family": "Li",
        "given": "Na"
      },
      {
        "family": "Liu",
        "given": "Yong"
      },
      {
        "family": "Ye",
        "given": "Rui"
      },
      {
        "family": "Qin",
        "given": "Xiaosong"
      },
      {
        "family": "Zheng",
        "given": "Rui"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          10
        ]
      ]
    },
    "abstract": "Corona Virus Disease 2019 (COVID-19) has spread rapidly to more than 70 countries and regions overseas and over 80000 cases have been infected, resulting in more than three thousand deaths. Rapid diagnosis of patients remains a bottleneck in containing the progress of the epidemic. We used automated chemiluminescent immunoassay to detect serum IgM and IgG antibodies to 2019-nCoV of 736 subjects. COVID-19 patients were becoming reactive(positive) for specific antibodies from 7-12 days after the onset of morbidity. Specific IgM and IgG increased with the progression of the disease. The areas under the ROC curves of IgM and IgG were 0.988 and 1.000, respectively. Specific antibody detection has good sensitivity and specificity. Detection of specific antibodies in patients with fever can be a good distinction between COVID-19 and other diseases, so as to be a complement to nucleic acid diagnosis to early diagnosis of suspected cases.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.04.20030916",
    "publisher": "medRxiv",
    "title": "Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing",
    "URL": "https://doi.org/ggq64f",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.04.20030916"
  },
  {
    "type": "article-journal",
    "id": "H0nvocJz",
    "author": [
      {
        "family": "Diao",
        "given": "Bo"
      },
      {
        "family": "Wang",
        "given": "Chenhui"
      },
      {
        "family": "Wang",
        "given": "Rongshuai"
      },
      {
        "family": "Feng",
        "given": "Zeqing"
      },
      {
        "family": "Tan",
        "given": "Yingjun"
      },
      {
        "family": "Wang",
        "given": "Huiming"
      },
      {
        "family": "Wang",
        "given": "Changsong"
      },
      {
        "family": "Liu",
        "given": "Liang"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Liu",
        "given": "Yueping"
      },
      {
        "family": "Wang",
        "given": "Gang"
      },
      {
        "family": "Yuan",
        "given": "Zilin"
      },
      {
        "family": "Ren",
        "given": "Liang"
      },
      {
        "family": "Wu",
        "given": "Yuzhang"
      },
      {
        "family": "Chen",
        "given": "Yongwen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          10
        ]
      ]
    },
    "abstract": "BACKGROUND The outbreak of a novel coronavirus (SARS-CoV-2, previously provisionally named 2019 novel coronavirus or 2019-nCoV) since December 2019 in Wuhan, China, has become an emergency of major international concern. Apart from the respiratory system, it is unclear whether SARS-CoV-2 can also directly infect other tissues such as the kidney or induce acute renal failure. METHODS We conducted a retrospective analysis of estimated glomerular filtration rate (eGFR) along with other clinical parameters from 85 patients with laboratory-confirmed COVID-19 admitted to a hospital in Wuhan from January 17, 2020 to March 3, 2020. Kidney tissues from six patients with postmortem examinations were analyzed by Hematoxylin and Eosin (H&amp;E) and in situ expression of viral nucleocaspid protein (NP) antigen, immune cell markers (CD8, CD68 and CD56) and the complement C5b-9 was detected by immunohistochemistry. Moreover, the viral particles in kidneys were also investigated by transmission electronic microscope (EM). RESULTS 27.06% (23/85) patients exhibited acute renal failure (ARF). The eldery patients and cases with comorbidities such as hypertension and heart failure more easily developed ARF (65.22% vs 24.19%, p&lt; 0.001; 69.57% vs 11.29%, p&lt; 0.001, respectively). H&amp;E staining demonstrated kidney tissues from postmortems have severe acute tubular necrosis and lymphocyte infiltration. Immunohistochemistry showed that SARS-CoV-2 NP antigen was accumulated in kidney tubules. EM observation also demonstrated that viruses- like particles are visible in the kidneys. Viral infection not only induces CD68+ macrophages infiltrated into tubulointerstitium, but also enhances complement C5b-9 deposition on tubules. CONCLUSIONS SARS-CoV-2 induces ARF in COVID-19 patients. Viruses directly infect human kidney tubules to induce acute tubular damage. The viruses not only have direct cytotoxicity, but also initiate CD68+ macrophage together with complement C5b-9 deposition to mediate tubular pathogenesis.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.04.20031120",
    "publisher": "medRxiv",
    "title": "Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection",
    "URL": "https://doi.org/ggq64g",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.04.20031120"
  },
  {
    "type": "article-journal",
    "id": "KHNnjP7M",
    "author": [
      {
        "family": "Song",
        "given": "Cong-Ying"
      },
      {
        "family": "Xu",
        "given": "Jia"
      },
      {
        "family": "He",
        "given": "Jian-Qin"
      },
      {
        "family": "Lu",
        "given": "Yuan-Qiang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          8
        ]
      ]
    },
    "abstract": "BACKGROUND Corona Virus Disease 2019 (COVID-19) is spreading worldwide. Effective screening for patients is important to limit the epidemic. However, some defects make the currently applied diagnosis methods are still not very ideal for early warning of patients. We aimed to develop a diagnostic model that allows for the quick screening of highly suspected patients using easy-to-get variables. METHODS A total of 1,311 patients receiving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleicacid detection were included, whom with a positive result were classified into COVID-19 group. Multivariate logistic regression analyses were performed to construct the diagnostic model. Receiver operating characteristic (ROC) curve analysis were used for model validation. RESULTS After analysis, signs of pneumonia on CT, history of close contact, fever, neutrophil-to-lymphocyte ratio (NLR), Tmax and sex were included in the diagnostic model. Age and meaningful respiratory symptoms were enrolled into COVID-19 early warning score (COVID-19 EWS). The areas under the ROC curve (AUROC) indicated that both of the diagnostic model (training dataset 0.956 [95%CI 0.935-0.977, P &lt; 0.001]; validation dataset 0.960 [95%CI 0.919-1.0, P &lt; 0.001] ) and COVID-19 EWS (training dataset 0.956 [95%CI 0.934-0.978, P &lt; 0.001] ; validate dataset 0.966 [95%CI 0.929-1, P &lt; 0.001]) had good discrimination capacity. In addition, we also obtained the cut-off values of disease severity predictors, such as CT score, CD8+ T cell count, CD4+ T cell count, and so on. CONCLUSIONS The new developed COVID-19 EWS was a considerable tool for early and relatively accurately warning of SARS-CoV-2 infected patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.05.20031906",
    "publisher": "medRxiv",
    "title": "COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients",
    "URL": "https://doi.org/ggq64h",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.05.20031906"
  },
  {
    "type": "article-journal",
    "id": "19xwRoatu",
    "author": [
      {
        "family": "Pfaender",
        "given": "Stephanie"
      },
      {
        "family": "Mar",
        "given": "Katrina B."
      },
      {
        "family": "Michailidis",
        "given": "Eleftherios"
      },
      {
        "family": "Kratzel",
        "given": "Annika"
      },
      {
        "family": "Hirt",
        "given": "Dagny"
      },
      {
        "family": "V’kovski",
        "given": "Philip"
      },
      {
        "family": "Fan",
        "given": "Wenchun"
      },
      {
        "family": "Ebert",
        "given": "Nadine"
      },
      {
        "family": "Stalder",
        "given": "Hanspeter"
      },
      {
        "family": "Kleine-Weber",
        "given": "Hannah"
      },
      {
        "family": "Hoffmann",
        "given": "Markus"
      },
      {
        "family": "Hoffmann",
        "given": "H. Heinrich"
      },
      {
        "family": "Saeed",
        "given": "Mohsan"
      },
      {
        "family": "Dijkman",
        "given": "Ronald"
      },
      {
        "family": "Steinmann",
        "given": "Eike"
      },
      {
        "family": "Wight-Carter",
        "given": "Mary"
      },
      {
        "family": "Hanners",
        "given": "Natasha W."
      },
      {
        "family": "Pöhlmann",
        "given": "Stefan"
      },
      {
        "family": "Gallagher",
        "given": "Tom"
      },
      {
        "family": "Todt",
        "given": "Daniel"
      },
      {
        "family": "Zimmer",
        "given": "Gert"
      },
      {
        "family": "Rice",
        "given": "Charles M."
      },
      {
        "family": "Schoggins",
        "given": "John W."
      },
      {
        "family": "Thiel",
        "given": "Volker"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          7
        ]
      ]
    },
    "abstract": "Zoonotic coronaviruses (CoVs) are significant threats to global health, as exemplified by the recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) . Host immune responses to CoV are complex and regulated in part through antiviral interferons. However, the interferon-stimulated gene products that inhibit CoV are not well characterized . Here, we show that interferon-inducible lymphocyte antigen 6 complex, locus E (LY6E) potently restricts cellular infection by multiple CoVs, including SARS-CoV, SARS-CoV-2, and Middle East respiratory syndrome coronavirus (MERS-CoV). Mechanistic studies revealed that LY6E inhibits CoV entry into cells by interfering with spike protein-mediated membrane fusion. Importantly, mice lacking Ly6e in hematopoietic cells were highly susceptible to murine CoV infection. Exacerbated viral pathogenesis in Ly6e knockout mice was accompanied by loss of hepatic and splenic immune cells and reduction in global antiviral gene pathways. Accordingly, we found that Ly6e directly protects primary B cells and dendritic cells from murine CoV infection. Our results demonstrate that LY6E is a critical antiviral immune effector that controls CoV infection and pathogenesis. These findings advance our understanding of immune-mediated control of CoV and , knowledge that could help inform strategies to combat infection by emerging CoV.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.05.979260",
    "publisher": "bioRxiv",
    "title": "LY6E impairs coronavirus fusion and confers immune control of viral disease",
    "URL": "https://doi.org/dpvn",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.05.979260"
  },
  {
    "type": "article-journal",
    "id": "574aSa8C",
    "author": [
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Liu",
        "given": "Wanbing"
      },
      {
        "family": "Wang",
        "given": "Shengdian"
      },
      {
        "family": "Zheng",
        "given": "Shangen"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          8
        ]
      ]
    },
    "abstract": "Background The outbreak of the recently emerged novel corona virus disease 2019 (COVID-19) poses a challenge for public health laboratories. We aimed to evaluate the diagnostic value of serological assay for SARS-CoV-2. Methods A newly-developed ELISA assay for IgM and IgG antibodies against N protein of SARS-CoV-2 were used to screen the serums of 238 admitted hospital patients with confirmed or suspected SARS-CoV-2 infection from February 6 to February 14, 2020. SARS-CoV-2 RNA was detected by real time RT-PCR on pharyngeal swab specimens. Findings Of the 238 patients, 194 (81.5%) were detected to be antibody (IgM and/or IgG) positive, which was significantly higher than the positive rate of viral RNA (64.3%). There was no difference in the positive rate of antibody between the confirmed patients (83.0%, 127/153) and the suspected patients (78.8%, 67/85) whose nucleic acid tests were negative. After the patients were defined to the different stages of disease based on the day when the test samples were collected, the analysis results showed that the antibody positive rates were very low in the first five days after initial onset of symptoms, and then rapidly increased as the disease progressed. After 10 days, the antibody positive rates jumped to above 80% from less than 50%. On the contrary, the positive rates of viral RNA kept above 60% in the first 11 days after initial onset of symptoms, and then rapidly decreased. In addition, half of the suspected patients with symptoms for 6-10 days were detected to be antibody positive. Interpretation The suspected patients were most likely infected by SARS-CoV-2. Before the 11th day after initial onset of symptoms, nucleic acid test is important for confirmation of viral infection. The combination of serological assay can greatly improve the diagnostic efficacy. After that, the diagnosis for viral infection should be majorly dependent on serological assay. Keywords. SARS-CoV-2; diagnosis; serological assay; nucleic acid test",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.06.20031856",
    "publisher": "medRxiv",
    "title": "A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients",
    "URL": "https://doi.org/ggq64j",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.06.20031856"
  },
  {
    "type": "article-journal",
    "id": "1dxrDub1",
    "author": [
      {
        "family": "Broughton",
        "given": "James P"
      },
      {
        "family": "Deng",
        "given": "Xianding"
      },
      {
        "family": "Yu",
        "given": "Guixia"
      },
      {
        "family": "Fasching",
        "given": "Clare L"
      },
      {
        "family": "Singh",
        "given": "Jasmeet"
      },
      {
        "family": "Streithorst",
        "given": "Jessica"
      },
      {
        "family": "Granados",
        "given": "Andrea"
      },
      {
        "family": "Sotomayor-Gonzalez",
        "given": "Alicia"
      },
      {
        "family": "Zorn",
        "given": "Kelsey"
      },
      {
        "family": "Gopez",
        "given": "Allan"
      },
      {
        "family": "Hsu",
        "given": "Elaine"
      },
      {
        "family": "Gu",
        "given": "Wei"
      },
      {
        "family": "Miller",
        "given": "Steven"
      },
      {
        "family": "Pan",
        "given": "Chao-Yang"
      },
      {
        "family": "Guevara",
        "given": "Hugo"
      },
      {
        "family": "Wadford",
        "given": "Debra"
      },
      {
        "family": "Chen",
        "given": "Janice"
      },
      {
        "family": "Chiu",
        "given": "Charles Y"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "An outbreak of novel betacoronavirus, SARS-CoV-2 (formerly named 2019-nCoV), began in Wuhan, China in December 2019 and the COVID-19 disease associated with infection has since spread rapidly to multiple countries. Here we report the development of SARS-CoV-2 DETECTR, a rapid (~30 min), low-cost, and accurate CRISPR-Cas12 based lateral flow assay for detection of SARS-CoV-2. We validated this method using contrived reference samples and clinical samples from infected US patients and demonstrated comparable performance to the US CDC SARS-CoV-2 real-time RT-PCR assay.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.06.20032334",
    "publisher": "medRxiv",
    "title": "Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay",
    "URL": "https://doi.org/ggrmwt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.06.20032334"
  },
  {
    "type": "article-journal",
    "id": "NT3T9a8H",
    "author": [
      {
        "family": "Zheng",
        "given": "Zhiqiang"
      },
      {
        "family": "Monteil",
        "given": "Vanessa M."
      },
      {
        "family": "Maurer-Stroh",
        "given": "Sebastian"
      },
      {
        "family": "Yew",
        "given": "Chow Wenn"
      },
      {
        "family": "Leong",
        "given": "Carol"
      },
      {
        "family": "Mohd-Ismail",
        "given": "Nur Khairiah"
      },
      {
        "family": "Arularasu",
        "given": "Suganya Cheyyatraivendran"
      },
      {
        "family": "Chow",
        "given": "Vincent Tak Kwong"
      },
      {
        "family": "Pin",
        "given": "Raymond Lin Tzer"
      },
      {
        "family": "Mirazimi",
        "given": "Ali"
      },
      {
        "family": "Hong",
        "given": "Wanjin"
      },
      {
        "family": "Tan",
        "given": "Yee-Joo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          7
        ]
      ]
    },
    "abstract": "The emergence of a novel coronavirus, SARS-CoV-2, at the end of 2019 has resulted in widespread human infections across the globe. While genetically distinct from SARS-CoV, the etiological agent that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003, both coronaviruses exhibit receptor binding domain (RBD) conservation and utilize the same host cell receptor, angiotensin-converting enzyme 2 (ACE2), for virus entry. Therefore, it will be important to test the cross-reactivity of antibodies that have been previously generated against the surface spike (S) glycoprotein of SARS-CoV in order to aid research on the newly emerged SARS-CoV-2. Here, we show that an immunogenic domain in the S2 subunit of SARS-CoV S is highly conserved in multiple strains of SARS-CoV-2. Consistently, four murine monoclonal antibodies (mAbs) raised against this immunogenic SARS-CoV fragment were able to recognise the S protein of SARS-CoV-2 expressed in a mammalian cell line. Importantly, one of them (mAb 1A9) was demonstrated to detect S in SARS-CoV-2-infected cells. To our knowledge, this is the first study showing that mAbs targeting the S2 domain of SARS-CoV can cross-react with SARS-CoV-2 and this observation is consistent with the high sequence conservation in the S2 subunit. These cross-reactive mAbs may serve as tools useful for SARS-CoV-2 research as well as for the development of diagnostic assays for its associated coronavirus disease COVID-19.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.06.980037",
    "publisher": "bioRxiv",
    "title": "Monoclonal antibodies for the S2 subunit of spike of SARS-CoV cross-react with the newly-emerged SARS-CoV-2",
    "URL": "https://doi.org/ggrbj7",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.06.980037"
  },
  {
    "type": "article-journal",
    "id": "1GEbBtBgh",
    "author": [
      {
        "family": "Zeng",
        "given": "Qiang"
      },
      {
        "family": "Li",
        "given": "Yong-zhe"
      },
      {
        "family": "Huang",
        "given": "Gang"
      },
      {
        "family": "Wu",
        "given": "Wei"
      },
      {
        "family": "Dong",
        "given": "Sheng-yong"
      },
      {
        "family": "Xu",
        "given": "Yang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          13
        ]
      ]
    },
    "abstract": "In December 2019, novel coronavirus (SARS-CoV-2) infected pneumonia occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in Chinese Han population is limited. Our objective is to describe the clinical characteristics of SARS-CoV-2 pneumonia compared to normal controls in the Chinese Han population. In this case series of 752 patients, the full spectrum of cases is described. Fever was present in 86-90% of the patients. The second most common symptom was cough (49.1-51.0%), fatigue (25.2-27.1%), sputum (20.0-23.1%), and headache (9.8-11.1%). the mortality rate is 4.6% in Wuhan, 1.9% in Beijing, and 0.9% in Shanghai. Our findings showed that the levels of lymphocytes were 0.8（IQR, 0.6-1.1）109/L in Wuhan, 1.0（IQR, 0.7-1.4）109/L in Beijing, and 1.1 (IQR, 0.8-1.5) 109/L in Shanghai before admission to hospitals, respectively, indicating that cellular immune function might relate to the mortality. Based on the reference ranges of normal Chinese Han population and the data of the critically ill patients we have observed, it is recommended that reference ranges of people at high risk of COVID-19 infection are CD3+ lymphocytes below 900 cells/mm3, CD4+ lymphocytes below 500 cells/mm3, and CD8+ lymphocytes below 300 cells/mm3.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.08.20031229",
    "publisher": "medRxiv",
    "title": "Mortality of COVID-19 is Associated with Cellular Immune Function Compared to Immune Function in Chinese Han Population",
    "URL": "https://doi.org/ggq64k",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.08.20031229"
  },
  {
    "type": "article-journal",
    "id": "zoLViMNg",
    "author": [
      {
        "family": "Kujawski",
        "given": "Stephanie A."
      },
      {
        "family": "Wong",
        "given": "Karen K"
      },
      {
        "family": "Collins",
        "given": "Jennifer P."
      },
      {
        "family": "Epstein",
        "given": "Lauren"
      },
      {
        "family": "Killerby",
        "given": "Marie E."
      },
      {
        "family": "Midgley",
        "given": "Claire M."
      },
      {
        "family": "Abedi",
        "given": "Glen R."
      },
      {
        "family": "Ahmed",
        "given": "N. Seema"
      },
      {
        "family": "Almendares",
        "given": "Olivia"
      },
      {
        "family": "Alvarez",
        "given": "Francisco N."
      },
      {
        "family": "Anderson",
        "given": "Kayla N."
      },
      {
        "family": "Balter",
        "given": "Sharon"
      },
      {
        "family": "Barry",
        "given": "Vaughn"
      },
      {
        "family": "Bartlett",
        "given": "Karri"
      },
      {
        "family": "Beer",
        "given": "Karlyn"
      },
      {
        "family": "Ben-Aderet",
        "given": "Michael A."
      },
      {
        "family": "Benowitz",
        "given": "Isaac"
      },
      {
        "family": "Biggs",
        "given": "Holly"
      },
      {
        "family": "Binder",
        "given": "Alison M."
      },
      {
        "family": "Black",
        "given": "Stephanie R."
      },
      {
        "family": "Bonin",
        "given": "Brandon"
      },
      {
        "family": "Brown",
        "given": "Catherine M."
      },
      {
        "family": "Bruce",
        "given": "Hollianne"
      },
      {
        "family": "Bryant-Genevier",
        "given": "Jonathan"
      },
      {
        "family": "Budd",
        "given": "Alicia"
      },
      {
        "family": "Buell",
        "given": "Diane"
      },
      {
        "family": "Bystritsky",
        "given": "Rachel"
      },
      {
        "family": "Cates",
        "given": "Jordan"
      },
      {
        "family": "Charles",
        "given": "E. Matt"
      },
      {
        "family": "Chatham-Stephens",
        "given": "Kevin"
      },
      {
        "family": "Chea",
        "given": "Nora"
      },
      {
        "family": "Chiou",
        "given": "Howard"
      },
      {
        "family": "Christiansen",
        "given": "Demian"
      },
      {
        "family": "Chu",
        "given": "Victoria"
      },
      {
        "family": "Cody",
        "given": "Sara"
      },
      {
        "family": "Cohen",
        "given": "Max"
      },
      {
        "family": "Conners",
        "given": "Erin"
      },
      {
        "family": "Curns",
        "given": "Aaron"
      },
      {
        "family": "Dasari",
        "given": "Vishal"
      },
      {
        "family": "Dawson",
        "given": "Patrick"
      },
      {
        "family": "DeSalvo",
        "given": "Traci"
      },
      {
        "family": "Diaz",
        "given": "George"
      },
      {
        "family": "Donahue",
        "given": "Matthew"
      },
      {
        "family": "Donovan",
        "given": "Suzanne"
      },
      {
        "family": "Duca",
        "given": "Lindsey M."
      },
      {
        "family": "Erickson",
        "given": "Keith"
      },
      {
        "family": "Esona",
        "given": "Mathew D."
      },
      {
        "family": "Evans",
        "given": "Suzanne"
      },
      {
        "family": "Falk",
        "given": "Jeremy"
      },
      {
        "family": "Feldstein",
        "given": "Leora R."
      },
      {
        "family": "Fenstersheib",
        "given": "Martin"
      },
      {
        "family": "Fischer",
        "given": "Marc"
      },
      {
        "family": "Fisher",
        "given": "Rebecca"
      },
      {
        "family": "Foo",
        "given": "Chelsea"
      },
      {
        "family": "Fricchione",
        "given": "Marielle J."
      },
      {
        "family": "Friedman",
        "given": "Oren"
      },
      {
        "family": "Fry",
        "given": "Alicia M."
      },
      {
        "family": "Galang",
        "given": "Romeo R."
      },
      {
        "family": "Garcia",
        "given": "Melissa M."
      },
      {
        "family": "Gerber",
        "given": "Susa I."
      },
      {
        "family": "Gerrard",
        "given": "Graham"
      },
      {
        "family": "Ghinai",
        "given": "Isaac"
      },
      {
        "family": "Gounder",
        "given": "Prabhu"
      },
      {
        "family": "Grein",
        "given": "Jonathan"
      },
      {
        "family": "Grigg",
        "given": "Cheri"
      },
      {
        "family": "Gunzenhauser",
        "given": "Jeffrey D."
      },
      {
        "family": "Gutkin",
        "given": "Gary I."
      },
      {
        "family": "Haddix",
        "given": "Meredith"
      },
      {
        "family": "Hall",
        "given": "Aron J."
      },
      {
        "family": "Han",
        "given": "George"
      },
      {
        "family": "Harcourt",
        "given": "Jennifer"
      },
      {
        "family": "Harriman",
        "given": "Kathleen"
      },
      {
        "family": "Haupt",
        "given": "Thomas"
      },
      {
        "family": "Haynes",
        "given": "Amber"
      },
      {
        "family": "Holshue",
        "given": "Michelle"
      },
      {
        "family": "Hoover",
        "given": "Cora"
      },
      {
        "family": "Hunter",
        "given": "Jennifer C."
      },
      {
        "family": "Jacobs",
        "given": "Max W."
      },
      {
        "family": "Jarashow",
        "given": "Claire"
      },
      {
        "family": "Jhung",
        "given": "Michael A."
      },
      {
        "family": "Joshi",
        "given": "Kiran"
      },
      {
        "family": "Kamali",
        "given": "Talar"
      },
      {
        "family": "Kamili",
        "given": "Shifaq"
      },
      {
        "family": "Kim",
        "given": "Lindsay"
      },
      {
        "family": "Kim",
        "given": "Moon"
      },
      {
        "family": "King",
        "given": "Jan"
      },
      {
        "family": "Kirking",
        "given": "Hannah L."
      },
      {
        "family": "Kita-Yarbro",
        "given": "Amanda"
      },
      {
        "family": "Klos",
        "given": "Rachel"
      },
      {
        "family": "Kobayashi",
        "given": "Miwako"
      },
      {
        "family": "Kocharian",
        "given": "Anna"
      },
      {
        "family": "Komatsu",
        "given": "Kenneth K."
      },
      {
        "family": "Koppaka",
        "given": "Ram"
      },
      {
        "family": "Layden",
        "given": "Jennifer E."
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Lindquist",
        "given": "Scott"
      },
      {
        "family": "Lindstrom",
        "given": "Stephen"
      },
      {
        "family": "Link-Gelles",
        "given": "Ruth"
      },
      {
        "family": "Lively",
        "given": "Joana"
      },
      {
        "family": "Livingston",
        "given": "Michelle"
      },
      {
        "family": "Lo",
        "given": "Kelly"
      },
      {
        "family": "Lo",
        "given": "Jennifer"
      },
      {
        "family": "Lu",
        "given": "Xiaoyan"
      },
      {
        "family": "Lynch",
        "given": "Brian"
      },
      {
        "family": "Madoff",
        "given": "Larry"
      },
      {
        "family": "Malapati",
        "given": "Lakshmi"
      },
      {
        "family": "Marks",
        "given": "Gregory"
      },
      {
        "family": "Marlow",
        "given": "Mariel"
      },
      {
        "family": "Mathisen",
        "given": "Glenn E."
      },
      {
        "family": "McClung",
        "given": "Nancy"
      },
      {
        "family": "McGovern",
        "given": "Olivia"
      },
      {
        "family": "McPherson",
        "given": "Tristan D."
      },
      {
        "family": "Mehta",
        "given": "Mitali"
      },
      {
        "family": "Meier",
        "given": "Audrey"
      },
      {
        "family": "Mello",
        "given": "Lynn"
      },
      {
        "family": "Moon",
        "given": "Sung-sil"
      },
      {
        "family": "Morgan",
        "given": "Margie"
      },
      {
        "family": "Moro",
        "given": "Ruth N."
      },
      {
        "family": "Murray",
        "given": "Janna'"
      },
      {
        "family": "Murthy",
        "given": "Rekha"
      },
      {
        "family": "Novosad",
        "given": "Shannon"
      },
      {
        "family": "Oliver",
        "given": "Sara E."
      },
      {
        "family": "O'Shea",
        "given": "Jennifer"
      },
      {
        "family": "Pacilli",
        "given": "Massimo"
      },
      {
        "family": "Paden",
        "given": "Clinton R."
      },
      {
        "family": "Pallansch",
        "given": "Mark A."
      },
      {
        "family": "Patel",
        "given": "Manisha"
      },
      {
        "family": "Patel",
        "given": "Sajan"
      },
      {
        "family": "Pedraza",
        "given": "Isabel"
      },
      {
        "family": "Pillai",
        "given": "Satish K."
      },
      {
        "family": "Pindyck",
        "given": "Talia"
      },
      {
        "family": "Pray",
        "given": "Ian"
      },
      {
        "family": "Queen",
        "given": "Krista"
      },
      {
        "family": "Quick",
        "given": "Nichole"
      },
      {
        "family": "Reese",
        "given": "Heather"
      },
      {
        "family": "Rha",
        "given": "Brian"
      },
      {
        "family": "Rhodes",
        "given": "Heather"
      },
      {
        "family": "Robinson",
        "given": "Susan"
      },
      {
        "family": "Robinson",
        "given": "Philip"
      },
      {
        "family": "Rolfes",
        "given": "Melissa"
      },
      {
        "family": "Routh",
        "given": "Janell"
      },
      {
        "family": "Rubin",
        "given": "Rachel"
      },
      {
        "family": "Rudman",
        "given": "Sarah L."
      },
      {
        "family": "Sakthivel",
        "given": "Senthilkumar K."
      },
      {
        "family": "Scott",
        "given": "Sarah"
      },
      {
        "family": "Shepherd",
        "given": "Christopher"
      },
      {
        "family": "Shetty",
        "given": "Varun"
      },
      {
        "family": "Smith",
        "given": "Ethan A."
      },
      {
        "family": "Smith",
        "given": "Shanon"
      },
      {
        "family": "Stierman",
        "given": "Bryan"
      },
      {
        "family": "Stoecker",
        "given": "William"
      },
      {
        "family": "Sunenshine",
        "given": "Rebecca"
      },
      {
        "family": "Sy-Santos",
        "given": "Regina"
      },
      {
        "family": "Tamin",
        "given": "Azaibi"
      },
      {
        "family": "Tao",
        "given": "Ying"
      },
      {
        "family": "Terashita",
        "given": "Dawn"
      },
      {
        "family": "Thornburg",
        "given": "Natalie J."
      },
      {
        "family": "Tong",
        "given": "Suxiang"
      },
      {
        "family": "Traub",
        "given": "Elizabeth"
      },
      {
        "family": "Tural",
        "given": "Ahmet"
      },
      {
        "family": "Uehara",
        "given": "Anna"
      },
      {
        "family": "Uyeki",
        "given": "Timothy M."
      },
      {
        "family": "Vahey",
        "given": "Grace"
      },
      {
        "family": "Verani",
        "given": "Jennifer R."
      },
      {
        "family": "Villarino",
        "given": "Elsa"
      },
      {
        "family": "Wallace",
        "given": "Megan"
      },
      {
        "family": "Wang",
        "given": "Lijuan"
      },
      {
        "family": "Watson",
        "given": "John T."
      },
      {
        "family": "Westercamp",
        "given": "Matthew"
      },
      {
        "family": "Whitaker",
        "given": "Brett"
      },
      {
        "family": "Wilkerson",
        "given": "Sarah"
      },
      {
        "family": "Woodruff",
        "given": "Rebecca C."
      },
      {
        "family": "Wortham",
        "given": "Jonathan M."
      },
      {
        "family": "Wu",
        "given": "Tiffany"
      },
      {
        "family": "Xie",
        "given": "Amy"
      },
      {
        "family": "Yousaf",
        "given": "Anna"
      },
      {
        "family": "Zahn",
        "given": "Matthew"
      },
      {
        "family": "Zhang",
        "given": "Jing"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "abstract": "Introduction: More than 93,000 cases of coronavirus disease (COVID-19) have been reported worldwide. We describe the epidemiology, clinical course, and virologic characteristics of the first 12 U.S. patients with COVID-19. Methods: We collected demographic, exposure, and clinical information from 12 patients confirmed by CDC during January 20-February 5, 2020 to have COVID-19. Respiratory, stool, serum, and urine specimens were submitted for SARS-CoV-2 rRT-PCR testing, virus culture, and whole genome sequencing. Results: Among the 12 patients, median age was 53 years (range: 21-68); 8 were male, 10 had traveled to China, and two were contacts of patients in this series. Commonly reported signs and symptoms at illness onset were fever (n=7) and cough (n=8). Seven patients were hospitalized with radiographic evidence of pneumonia and demonstrated clinical or laboratory signs of worsening during the second week of illness. Three were treated with the investigational antiviral remdesivir. All patients had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2-3 weeks after illness onset, with lowest rRT-PCR Ct values often detected in the first week. SARS-CoV-2 RNA was detected after reported symptom resolution in seven patients. SARS-CoV-2 was cultured from respiratory specimens, and SARS-CoV-2 RNA was detected in stool from 7/10 patients. Conclusions: In 12 patients with mild to moderately severe illness, SARS-CoV-2 RNA and viable virus were detected early, and prolonged RNA detection suggests the window for diagnosis is long. Hospitalized patients showed signs of worsening in the second week after illness onset.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.09.20032896",
    "publisher": "medRxiv",
    "title": "First 12 patients with coronavirus disease 2019 (COVID-19) in the United States",
    "URL": "https://doi.org/ggqm6z",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.09.20032896"
  },
  {
    "type": "article-journal",
    "id": "WuHcOc9T",
    "author": [
      {
        "family": "Chen",
        "given": "JIan"
      },
      {
        "family": "Fan",
        "given": "Hua"
      },
      {
        "family": "Zhang",
        "given": "Lin"
      },
      {
        "family": "Huang",
        "given": "Bin"
      },
      {
        "family": "Zhu",
        "given": "Muxin"
      },
      {
        "family": "Zhou",
        "given": "Yong"
      },
      {
        "family": "Yu",
        "given": "WenHu"
      },
      {
        "family": "Zhu",
        "given": "Liping"
      },
      {
        "family": "Cheng",
        "given": "Shaohui"
      },
      {
        "family": "Tao",
        "given": "Xiaogen"
      },
      {
        "family": "Zhang",
        "given": "Huan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "abstract": "Background The illness progress of partial patient of COVID-19 is rapid and the mortality rate is high.we aim to describe the clinical features in death cases with COVID-19. Methods In this single center, observational study, We recruited all Death Cases with COVID-19 from Dec 30, 2019 to Feb 16, 2020 in Intensive care unit of Wuhan Jinyintan Hospital.Demographics, basic diseases, X-ray/CT results, possible therapy strategies and test results when their entrance into admission, ICU and 48 h before death were collected and analyzed. Results This study involved 101 COVID-19 dead cases in Intensive care unit of Wuhan Jinyintan Hospital.47 patients went directly to the ICU because of critical condition, and 54 patients were transferred to ICU with aggravated condition.57 (56.44%) were laboratory confirmed by RT-PCR, and 44 (43.6%) were consistent with clinical diagnostic criteria.The cases included 64 males and 37 females with average age of 65.46 years (SD 9.74). The blood type distribution was significantly different, with type A 44.44%, type B 29.29%, type AB 8.08% and type O 18.19%.The clinical manifestations of new coronavirus pneumonia are non-specific,the common symptom was fever (91 [90.10%] of 101 patients),Cough (69[68.32%]) and dyspnea (75[74.26%]). Neutrophils, PCT, CRP,IL-6,D-dimer gradually increased as time went on.Myocardial enzymes were abnormal in most patients at admission,with the progress of the disease, myocardial damage indicators were significantly increased.61(60.40%) used antiviral drugs,59(58.42%) used glucocorticoids, 63.37% used intravenous immunoglobulins, and 44.55% used thymosin preparations. All patients received antibiotic treatment, 63(62.38%) used restricted antibiotics, 23(22.78%) used antifungal drugs.84(83.17%) used non-invasive ventilator or high-flow oxygen therapy equipment, and 76.24% used invasive mechanical ventilation. 7 patients were treated with ECMO and 8 patients were treated with CRRT.The median time from ARDS to invasive mechanical ventilation was 3.00 days(IQR 0.00-6.00). The duration of invasive mechanical ventilation was 5 days (IQR2.00-8.00). Conclusions Critical COVID-19 can cause fatal respiratory distress syndrome and multiple organ failure with high mortality rate. Heart may be the earliest damaged organ except the lungs. Secondary infection in the later period is worthy of attention.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.09.20033068",
    "publisher": "medRxiv",
    "title": "Retrospective Analysis of Clinical Features in 101 Death Cases with COVID-19",
    "URL": "https://doi.org/ggq64n",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.09.20033068"
  },
  {
    "type": "article-journal",
    "id": "1DbV444Pj",
    "author": [
      {
        "family": "Zhao",
        "given": "Jiao"
      },
      {
        "family": "Yang",
        "given": "Yan"
      },
      {
        "family": "Huang",
        "given": "Hanping"
      },
      {
        "family": "Li",
        "given": "Dong"
      },
      {
        "family": "Gu",
        "given": "Dongfeng"
      },
      {
        "family": "Lu",
        "given": "Xiangfeng"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Liu",
        "given": "Ting"
      },
      {
        "family": "Liu",
        "given": "Yukun"
      },
      {
        "family": "He",
        "given": "Yunjiao"
      },
      {
        "family": "Sun",
        "given": "Bin"
      },
      {
        "family": "Wei",
        "given": "Meilan"
      },
      {
        "family": "Yang",
        "given": "Guangyu"
      },
      {
        "family": "Wang",
        "given": "Xinghuan"
      },
      {
        "family": "Zhang",
        "given": "Li"
      },
      {
        "family": "Zhou",
        "given": "Xiaoyang"
      },
      {
        "family": "Xing",
        "given": "Mingzhao"
      },
      {
        "family": "Wang",
        "given": "Peng George"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "The novel coronavirus disease-2019 (COVID-19) has been spreading around the world rapidly and declared as a pandemic by WHO. Here, we compared the ABO blood group distribution in 2,173 patients with COVID-19 confirmed by SARS-CoV-2 test from three hospitals in Wuhan and Shenzhen, China with that in normal people from the corresponding regions. The results showed that blood group A was associated with a higher risk for acquiring COVID-19 compared with non-A blood groups, whereas blood group O was associated with a lower risk for the infection compared with non-O blood groups. This is the first observation of an association between the ABO blood type and COVID-19. It should be emphasized, however, that this is an early study with limitations. It would be premature to use this study to guide clinical practice at this time, but it should encourage further investigation of the relationship between the ABO blood group and the COVID-19 susceptibility.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.11.20031096",
    "publisher": "medRxiv",
    "title": "Relationship between the ABO Blood Group and the COVID-19 Susceptibility",
    "URL": "https://doi.org/ggpn3d",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.11.20031096"
  },
  {
    "type": "article-journal",
    "id": "JwL9G6bd",
    "author": [
      {
        "family": "Matsuyama",
        "given": "Shutoku"
      },
      {
        "family": "Kawase",
        "given": "Miyuki"
      },
      {
        "family": "Nao",
        "given": "Naganori"
      },
      {
        "family": "Shirato",
        "given": "Kazuya"
      },
      {
        "family": "Ujike",
        "given": "Makoto"
      },
      {
        "family": "Kamitani",
        "given": "Wataru"
      },
      {
        "family": "Shimojima",
        "given": "Masayuki"
      },
      {
        "family": "Fukushi",
        "given": "Shuetsu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "abstract": "Steroid compounds, which are expected to have dual functions in blocking host inflammation and MERS-CoV replication, were screened from a chemical library. Within this library, ciclesonide, an inhaled corticosteroid, suppressed human coronavirus replication in cultured cells, but did not suppress replication of respiratory syncytial virus or influenza virus. The effective concentration of ciclesonide to block SARS-CoV-2 (the cause of COVID-19) replication (EC ) was 6.3 μM. After the eleventh consecutive MERS-CoV passage in the presence of ciclesonide, a resistant mutation was generated, which resulted in an amino acid substitution (A25V) in nonstructural protein (NSP) 15, as identified using reverse genetics. A recombinant virus with the mutation was also resistant to ciclesonide suppression of viral replication. These observations suggest that the effect of ciclesonide was specific to coronavirus, suggesting this is a candidate drug for treatment of patients suffering MERS or COVID-19.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.11.987016",
    "publisher": "bioRxiv",
    "title": "The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15",
    "URL": "https://doi.org/ggq64p",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.11.987016"
  },
  {
    "type": "article-journal",
    "id": "XcuzhxrJ",
    "author": [
      {
        "family": "Wang",
        "given": "Chunyan"
      },
      {
        "family": "Li",
        "given": "Wentao"
      },
      {
        "family": "Drabek",
        "given": "Dubravka"
      },
      {
        "family": "Okba",
        "given": "Nisreen M.A."
      },
      {
        "family": "van Haperen",
        "given": "Rien"
      },
      {
        "family": "Osterhaus",
        "given": "Albert D.M.E."
      },
      {
        "family": "van Kuppeveld",
        "given": "Frank J.M."
      },
      {
        "family": "Haagmans",
        "given": "Bart L."
      },
      {
        "family": "Grosveld",
        "given": "Frank"
      },
      {
        "family": "Bosch",
        "given": "Berend-Jan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          12
        ]
      ]
    },
    "abstract": "The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.11.987958",
    "publisher": "bioRxiv",
    "title": "A human monoclonal antibody blocking SARS-CoV-2 infection",
    "URL": "https://doi.org/ggnw4t",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.11.987958"
  },
  {
    "type": "article-journal",
    "id": "p1c9Nilh",
    "author": [
      {
        "family": "Hu",
        "given": "Xiumei"
      },
      {
        "family": "An",
        "given": "Taixue"
      },
      {
        "family": "Situ",
        "given": "Bo"
      },
      {
        "family": "Hu",
        "given": "Yuhai"
      },
      {
        "family": "Ou",
        "given": "Zihao"
      },
      {
        "family": "Li",
        "given": "Qiang"
      },
      {
        "family": "He",
        "given": "Xiaojing"
      },
      {
        "family": "Zhang",
        "given": "Ye"
      },
      {
        "family": "Tian",
        "given": "Peifu"
      },
      {
        "family": "Sun",
        "given": "Dehua"
      },
      {
        "family": "Rui",
        "given": "Yongyu"
      },
      {
        "family": "Wang",
        "given": "Qian"
      },
      {
        "family": "Ding",
        "given": "Dan"
      },
      {
        "family": "Zheng",
        "given": "Lei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          16
        ]
      ]
    },
    "abstract": "The detection of serum antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is emerging as a new tool for the coronavirus disease-2019 (COVID-19) diagnosis. Since many coronaviruses are sensitive to heat, heating inactivation of samples at 56 ℃ prior to testing is considered a possible method to reduce the risk of transmission, but the effect of heating on the measurement of SARS-CoV-2 antibodies is still unclear. By comparing the levels of SARS-CoV-2 antibodies before and after heat inactivation of serum at 56 ℃ for 30 minutes using a quantitative fluorescence immunochromatographic assay, we shown that heat inactivation significantly interferes with the levels of antibodies to SARS-CoV-2. The IgM levels of all the 34 serum samples (100%) from COVID-19 patients decreased by an average level of 53.56%. The IgG levels were decreased in 22 of 34 samples (64.71%) by an average level of 49.54%. Similar changes can also be observed in the non-COVID-19 diseases group (n=9). Of note, 44.12% of the detected IgM levels were dropped below the cut-off value after heating, suggesting heat inactivation can lead to false-negative results of these samples. Our results indicate that heat inactivation of serum at 56 ℃ for 30 minutes interferes with the immunoanalysis of antibodies to SARS-CoV-2. Heat inactivation prior to immunoanalysis is not recommended and the possibility of false-negative results should be considered if the sample was pre-inactivated by heating.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.12.20034231",
    "publisher": "medRxiv",
    "title": "Heat inactivation of serum interferes with the immunoanalysis of antibodies to SARS-CoV-2",
    "URL": "https://doi.org/ggq646",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.12.20034231"
  },
  {
    "type": "article-journal",
    "id": "1CwCTXPqj",
    "author": [
      {
        "family": "Zhang",
        "given": "Bicheng"
      },
      {
        "family": "Zhou",
        "given": "Xiaoyang"
      },
      {
        "family": "Zhu",
        "given": "Chengliang"
      },
      {
        "family": "Feng",
        "given": "Fan"
      },
      {
        "family": "Qiu",
        "given": "Yanru"
      },
      {
        "family": "Feng",
        "given": "Jia"
      },
      {
        "family": "Jia",
        "given": "Qingzhu"
      },
      {
        "family": "Song",
        "given": "Qibin"
      },
      {
        "family": "Zhu",
        "given": "Bo"
      },
      {
        "family": "Wang",
        "given": "Jun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          16
        ]
      ]
    },
    "abstract": "A recently emerging respiratory disease named coronavirus disease 2019 (COVID-19) has quickly spread across the world. This disease is initiated by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and uncontrolled cytokine storm, but it remains unknown as to whether a robust antibody response is related to clinical deterioration and poor outcome in laboratory-confirmed COVID-19 patients. Anti-SARS-CoV-2 IgG and IgM antibodies were determined by chemiluminescence analysis (CLIA) in COVID-19 patients from a single center in Wuhan. Median IgG and IgM levels in acute and convalescent-phase sera (within 35 days) for all included patients were calculated and compared among severe and nonsevere patients. Immune response phenotyping based on late IgG levels and neutrophil-to-lymphocyte ratio (NLR) was characterized to stratify patients with different disease severities and outcome. Laboratory parameters in patients with different immune response phenotypes and disease severities were analyzed. A total of 222 patients were included in this study. IgG was first detected on day 4 of illness, and its peak levels occurred in the fourth week. Severe cases were more frequently found in patients with high IgG levels, compared to those who with low IgG levels (51.8% versus 32.3%; p=0.008). Severity rates for patients with NLR IgG , NLR IgG , NLR IgG , and NLR IgG phenotype was 72.3%, 48.5%, 33.3%, and 15.6%, respectively (p&lt;0.0001). Furthermore, severe patients with NLR IgG , NLR IgG had higher proinflammatory cytokines levels including IL-2, IL-6 and IL-10, and decreased CD4+ T cell count compared to those with NLR IgG phenotype (p&lt;0.05). Recovery rate for severe patients with NLR IgG , NLR IgG , NLR IgG , and NLR IgG phenotype was 58.8% (20/34), 68.8% (11/16), 80.0% (4/5), and 100% (12/12), respectively (p=0.0592). Dead cases only occurred in NLR IgG and NLR IgG phenotypes. COVID-19 severity is associated with increased IgG response, and an immune response phenotyping based on late IgG response and NLR could act as a simple complementary tool to discriminate between severe and nonsevere COVID-19 patients, and further predict their clinical outcome.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.12.20035048",
    "publisher": "medRxiv",
    "title": "Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19",
    "URL": "https://doi.org/ggq64q",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.12.20035048"
  },
  {
    "type": "article-journal",
    "id": "hRVfFbS",
    "author": [
      {
        "family": "Kim",
        "given": "Dongwan"
      },
      {
        "family": "Lee",
        "given": "Joo-Yeon"
      },
      {
        "family": "Yang",
        "given": "Jeong-Sun"
      },
      {
        "family": "Kim",
        "given": "Jun Won"
      },
      {
        "family": "Kim",
        "given": "V. Narry"
      },
      {
        "family": "Chang",
        "given": "Hyeshik"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          14
        ]
      ]
    },
    "abstract": "SARS-CoV-2 is a betacoronavirus that is responsible for the COVID-19 pandemic. The genome of SARS-CoV-2 was reported recently, but its transcriptomic architecture is unknown. Utilizing two complementary sequencing techniques, we here present a high-resolution map of the SARS-CoV-2 transcriptome and epitranscriptome. DNA nanoball sequencing shows that the transcriptome is highly complex owing to numerous recombination events, both canonical and noncanonical. In addition to the genomic RNA and subgenomic RNAs common in all coronaviruses, SARS-CoV-2 produces a large number of transcripts encoding unknown ORFs with fusion, deletion, and/or frameshift. Using nanopore direct RNA sequencing, we further find at least 41 RNA modification sites on viral transcripts, with the most frequent motif being AAGAA. Modified RNAs have shorter poly(A) tails than unmodified RNAs, suggesting a link between the internal modification and the 3′ tail. Functional investigation of the unknown ORFs and RNA modifications discovered in this study will open new directions to our understanding of the life cycle and pathogenicity of SARS-CoV-2.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.12.988865",
    "publisher": "bioRxiv",
    "title": "The architecture of SARS-CoV-2 transcriptome",
    "URL": "https://doi.org/ggpx9q",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.12.988865"
  },
  {
    "type": "article-journal",
    "id": "unVgVIfU",
    "author": [
      {
        "family": "Deng",
        "given": "Wei"
      },
      {
        "family": "Bao",
        "given": "Linlin"
      },
      {
        "family": "Gao",
        "given": "Hong"
      },
      {
        "family": "Xiang",
        "given": "Zhiguang"
      },
      {
        "family": "Qu",
        "given": "Yajin"
      },
      {
        "family": "Song",
        "given": "Zhiqi"
      },
      {
        "family": "Gong",
        "given": "Shunran"
      },
      {
        "family": "Liu",
        "given": "Jiayi"
      },
      {
        "family": "Liu",
        "given": "Jiangning"
      },
      {
        "family": "Yu",
        "given": "Pin"
      },
      {
        "family": "Qi",
        "given": "Feifei"
      },
      {
        "family": "Xu",
        "given": "Yanfeng"
      },
      {
        "family": "Li",
        "given": "Fengli"
      },
      {
        "family": "Xiao",
        "given": "Chong"
      },
      {
        "family": "Lv",
        "given": "Qi"
      },
      {
        "family": "Xue",
        "given": "Jing"
      },
      {
        "family": "Wei",
        "given": "Qiang"
      },
      {
        "family": "Liu",
        "given": "Mingya"
      },
      {
        "family": "Wang",
        "given": "Guanpeng"
      },
      {
        "family": "Wang",
        "given": "Shunyi"
      },
      {
        "family": "Yu",
        "given": "Haisheng"
      },
      {
        "family": "Liu",
        "given": "Xing"
      },
      {
        "family": "Zhao",
        "given": "Wenjie"
      },
      {
        "family": "Han",
        "given": "Yunlin"
      },
      {
        "family": "Qin",
        "given": "Chuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "abstract": "The outbreak of Corona Virus Disease 2019 caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) is highly transmitted. The potential extra-respiratory transmission routes remain uncertain. Five rhesus macaques were inoculated with 1×10 TCID of SARS-CoV-2 via conjunctival (CJ), intratracheal (IT), and intragastric (IG) routes, respectively. Remarkably, the CJ inoculated-macaques developed mild interstitial pneumonia and viral load was detectable in the conjunctival swabs at 1 days post-inoculation (dpi). Only via IT inoculation, viral load was detected in the anal swab at 1-7 dpi and macaque showed weight loss. However, viral load was undetectable after IG inoculation. Comparatively, viral load was higher in the nasolacrimal system but lesions of lung were relatively mild and local via CJ inoculation compared with that via IT inoculation, demonstrating distinct characteristics of virus dispersion. Both the two routes affected the alimentary tract. Therefore the clinicians need to protect eye while working with patients.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.13.990036",
    "publisher": "bioRxiv",
    "title": "Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in Rhesus macaques",
    "URL": "https://doi.org/ggq64r",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.13.990036"
  },
  {
    "type": "article-journal",
    "id": "3XqFhi8l",
    "author": [
      {
        "family": "Bao",
        "given": "Linlin"
      },
      {
        "family": "Deng",
        "given": "Wei"
      },
      {
        "family": "Gao",
        "given": "Hong"
      },
      {
        "family": "Xiao",
        "given": "Chong"
      },
      {
        "family": "Liu",
        "given": "Jiayi"
      },
      {
        "family": "Xue",
        "given": "Jing"
      },
      {
        "family": "Lv",
        "given": "Qi"
      },
      {
        "family": "Liu",
        "given": "Jiangning"
      },
      {
        "family": "Yu",
        "given": "Pin"
      },
      {
        "family": "Xu",
        "given": "Yanfeng"
      },
      {
        "family": "Qi",
        "given": "Feifei"
      },
      {
        "family": "Qu",
        "given": "Yajin"
      },
      {
        "family": "Li",
        "given": "Fengdi"
      },
      {
        "family": "Xiang",
        "given": "Zhiguang"
      },
      {
        "family": "Yu",
        "given": "Haisheng"
      },
      {
        "family": "Gong",
        "given": "Shuran"
      },
      {
        "family": "Liu",
        "given": "Mingya"
      },
      {
        "family": "Wang",
        "given": "Guanpeng"
      },
      {
        "family": "Wang",
        "given": "Shunyi"
      },
      {
        "family": "Song",
        "given": "Zhiqi"
      },
      {
        "family": "Zhao",
        "given": "Wenjie"
      },
      {
        "family": "Han",
        "given": "Yunlin"
      },
      {
        "family": "Zhao",
        "given": "Linna"
      },
      {
        "family": "Liu",
        "given": "Xing"
      },
      {
        "family": "Wei",
        "given": "Qiang"
      },
      {
        "family": "Qin",
        "given": "Chuan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          14
        ]
      ]
    },
    "abstract": "An outbreak of the Corona Virus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome CoV-2 (SARS-CoV-2), began in Wuhan and spread globally. Recently, it has been reported that discharged patients in China and elsewhere were testing positive after recovering. However, it remains unclear whether the convalescing patients have a risk of “relapse” or “reinfection”. The longitudinal tracking of re-exposure after the disappeared symptoms of the SARS-CoV-2-infected monkeys was performed in this study. We found that weight loss in some monkeys, viral replication mainly in nose, pharynx, lung and gut, as well as moderate interstitial pneumonia at 7 days post-infection (dpi) were clearly observed in rhesus monkeys after the primary infection. After the symptoms were alleviated and the specific antibody tested positively, the half of infected monkeys were rechallenged with the same dose of SARS-CoV-2 strain. Notably, neither viral loads in nasopharyngeal and anal swabs along timeline nor viral replication in all primary tissue compartments at 5 days post-reinfection (dpr) was found in re-exposed monkeys. Combined with the follow-up virologic, radiological and pathological findings, the monkeys with re-exposure showed no recurrence of COVID-19, similarly to the infected monkey without rechallenge. Taken together, our results indicated that the primary SARS-CoV-2 infection could protect from subsequent exposures, which have the reference of prognosis of the disease and vital implications for vaccine design.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.13.990226",
    "publisher": "bioRxiv",
    "title": "Reinfection could not occur in SARS-CoV-2 infected rhesus macaques",
    "URL": "https://doi.org/ggn8r8",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.13.990226"
  },
  {
    "type": "article-journal",
    "id": "6gQxRkWM",
    "author": [
      {
        "family": "Yuan",
        "given": "Meng"
      },
      {
        "family": "Wu",
        "given": "Nicholas C."
      },
      {
        "family": "Zhu",
        "given": "Xueyong"
      },
      {
        "family": "Lee",
        "given": "Chang-Chun D."
      },
      {
        "family": "So",
        "given": "Ray T. Y."
      },
      {
        "family": "Lv",
        "given": "Huibin"
      },
      {
        "family": "Mok",
        "given": "Chris K. P."
      },
      {
        "family": "Wilson",
        "given": "Ian A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          14
        ]
      ]
    },
    "abstract": "The outbreak of COVID-19, which is caused by SARS-CoV-2 virus, continues to spread globally, but there is currently very little understanding of the epitopes on the virus. In this study, we have determined the crystal structure of the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein in complex with CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient. CR3022 targets a highly conserved epitope that enables cross-reactive binding between SARS-CoV-2 and SARS-CoV. Structural modeling further demonstrates that the binding site can only be accessed when at least two RBDs on the trimeric S protein are in the “up” conformation. Overall, this study provides structural and molecular insight into the antigenicity of SARS-CoV-2.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.13.991570",
    "publisher": "bioRxiv",
    "title": "A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV",
    "URL": "https://doi.org/ggq64s",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.13.991570"
  },
  {
    "type": "article-journal",
    "id": "UYD5T2mp",
    "author": [
      {
        "family": "Dong",
        "given": "Lianhua"
      },
      {
        "family": "Zhou",
        "given": "Junbo"
      },
      {
        "family": "Niu",
        "given": "Chunyan"
      },
      {
        "family": "Wang",
        "given": "Quanyi"
      },
      {
        "family": "Pan",
        "given": "Yang"
      },
      {
        "family": "Sheng",
        "given": "Sitong"
      },
      {
        "family": "Wang",
        "given": "Xia"
      },
      {
        "family": "Zhang",
        "given": "Yongzhuo"
      },
      {
        "family": "Yang",
        "given": "Jiayi"
      },
      {
        "family": "Liu",
        "given": "Manqing"
      },
      {
        "family": "Zhao",
        "given": "Yang"
      },
      {
        "family": "Zhang",
        "given": "Xiaoying"
      },
      {
        "family": "Zhu",
        "given": "Tao"
      },
      {
        "family": "Peng",
        "given": "Tao"
      },
      {
        "family": "Xie",
        "given": "Jie"
      },
      {
        "family": "Gao",
        "given": "Yunhua"
      },
      {
        "family": "Wang",
        "given": "Di"
      },
      {
        "family": "Zhao",
        "given": "Yun"
      },
      {
        "family": "Dai",
        "given": "Xinhua"
      },
      {
        "family": "Fang",
        "given": "Xiang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "abstract": "BACKGROUND: The outbreak of COVID-19 caused by a novel Coronavirus (termed SARS-CoV-2) has spread to over 140 countries around the world. Currently, reverse transcription quantitative qPCR (RT-qPCR) is used as the gold standard for diagnostics of SARS-CoV-2. However, the positive rate of RT-qPCR assay of pharyngeal swab samples are reported to vary from 30~60%. More accurate and sensitive methods are urgently needed to support the quality assurance of the RT-qPCR or as an alternative diagnostic approach. METHODS：We established a reverse transcription digital PCR (RT-dPCR) protocol to detect SARS-CoV-2 on 194 clinical pharyngeal swab samples, including 103 suspected patients, 75 close contacts and 16 supposed convalescents. RESULTS: The limit of blanks (LoBs) of the RT-dPCR assays were ~1.6, ~1.6 and ~0.8 copies/reaction for ORF 1ab, N and E genes, respectively. The limit of detection (LoD) was 2 copies/reaction. For the 103 fever suspected patients, the sensitivity of SARS-CoV-2 detection was significantly improved from 28.2% by RT-qPCR to 87.4% by RT-dPCR. For close contacts, the suspect rate was greatly decreased from 21% down to 1%. The overall sensitivity, specificity and diagnostic accuracy of RT-dPCR were 90%, 100% and 93 %, respectively. In addition, quantification of the viral load for convalescents by RT-dPCR showed that a longer observation period was needed in the hospital for elderly patients. CONCLUSION: RT-dPCR could be a confirmatory method for suspected patients diagnosed by RT-qPCR. Furthermore, RT-dPCR was more sensitive and suitable for low viral load specimens from the both patients under isolation and those under observation who may not be exhibiting clinical symptoms.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.14.20036129",
    "publisher": "medRxiv",
    "title": "Highly accurate and sensitive diagnostic detection of SARS-CoV-2 by digital PCR",
    "URL": "https://doi.org/ggqnqh",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.14.20036129"
  },
  {
    "type": "article-journal",
    "id": "14y8UvAbH",
    "author": [
      {
        "family": "Wang",
        "given": "Ke"
      },
      {
        "family": "Chen",
        "given": "Wei"
      },
      {
        "family": "Zhou",
        "given": "Yu-Sen"
      },
      {
        "family": "Lian",
        "given": "Jian-Qi"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Du",
        "given": "Peng"
      },
      {
        "family": "Gong",
        "given": "Li"
      },
      {
        "family": "Zhang",
        "given": "Yang"
      },
      {
        "family": "Cui",
        "given": "Hong-Yong"
      },
      {
        "family": "Geng",
        "given": "Jie-Jie"
      },
      {
        "family": "Wang",
        "given": "Bin"
      },
      {
        "family": "Sun",
        "given": "Xiu-Xuan"
      },
      {
        "family": "Wang",
        "given": "Chun-Fu"
      },
      {
        "family": "Yang",
        "given": "Xu"
      },
      {
        "family": "Lin",
        "given": "Peng"
      },
      {
        "family": "Deng",
        "given": "Yong-Qiang"
      },
      {
        "family": "Wei",
        "given": "Ding"
      },
      {
        "family": "Yang",
        "given": "Xiang-Min"
      },
      {
        "family": "Zhu",
        "given": "Yu-Meng"
      },
      {
        "family": "Zhang",
        "given": "Kui"
      },
      {
        "family": "Zheng",
        "given": "Zhao-Hui"
      },
      {
        "family": "Miao",
        "given": "Jin-Lin"
      },
      {
        "family": "Guo",
        "given": "Ting"
      },
      {
        "family": "Shi",
        "given": "Ying"
      },
      {
        "family": "Zhang",
        "given": "Jun"
      },
      {
        "family": "Fu",
        "given": "Ling"
      },
      {
        "family": "Wang",
        "given": "Qing-Yi"
      },
      {
        "family": "Bian",
        "given": "Huijie"
      },
      {
        "family": "Zhu",
        "given": "Ping"
      },
      {
        "family": "Chen",
        "given": "Zhi-Nan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          14
        ]
      ]
    },
    "abstract": "Currently, COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been widely spread around the world; nevertheless, so far there exist no specific antiviral drugs for treatment of the disease, which poses great challenge to control and contain the virus. Here, we reported a research finding that SARS-CoV-2 invaded host cells via a novel route of CD147-spike protein (SP). SP bound to CD147, a receptor on the host cells, thereby mediating the viral invasion. Our further research confirmed this finding. First, in vitro antiviral tests indicated Meplazumab, an anti-CD147 humanized antibody, significantly inhibited the viruses from invading host cells, with an EC of 24.86 μg/mL and IC of 15.16 μg/mL. Second, we validated the interaction between CD147 and SP, with an affinity constant of 1.85×10 M. Co-Immunoprecipitation and ELISA also confirmed the binding of the two proteins. Finally, the localization of CD147 and SP was observed in SARS-CoV-2 infected Vero E6 cells by immuno-electron microscope. Therefore, the discovery of the new route CD147-SP for SARS-CoV-2 invading host cells provides a critical target for development of specific antiviral drugs.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.14.988345",
    "publisher": "bioRxiv",
    "title": "SARS-CoV-2 invades host cells via a novel route: CD147-spike protein",
    "URL": "https://doi.org/ggq64t",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.14.988345"
  },
  {
    "type": "article-journal",
    "id": "18l4l0nLX",
    "author": [
      {
        "family": "Huang",
        "given": "Lulin"
      },
      {
        "family": "Shi",
        "given": "Yi"
      },
      {
        "family": "Gong",
        "given": "Bo"
      },
      {
        "family": "Jiang",
        "given": "Li"
      },
      {
        "family": "Liu",
        "given": "Xiaoqi"
      },
      {
        "family": "Yang",
        "given": "Jialiang"
      },
      {
        "family": "Tang",
        "given": "Juan"
      },
      {
        "family": "You",
        "given": "Chunfang"
      },
      {
        "family": "Jiang",
        "given": "Qi"
      },
      {
        "family": "Long",
        "given": "Bo"
      },
      {
        "family": "Zeng",
        "given": "Tao"
      },
      {
        "family": "Luo",
        "given": "Mei"
      },
      {
        "family": "Zeng",
        "given": "Fanwei"
      },
      {
        "family": "Zeng",
        "given": "Fanxin"
      },
      {
        "family": "Wang",
        "given": "Shuqiang"
      },
      {
        "family": "Yang",
        "given": "Xingxiang"
      },
      {
        "family": "Yang",
        "given": "Zhenglin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "abstract": "The coronavirus disease 2019 (COVID-19) outbreak is an ongoing global health emergence, but the pathogenesis remains unclear. We revealed blood cell immune response profiles using 5' mRNA, TCR and BCR V(D)J transcriptome analysis with single-cell resolution. Data from 134,620 PBMCs and 83,387 TCR and 12,601 BCR clones was obtained, and 56 blood cell subtypes and 23 new cell marker genes were identified from 16 participants. The number of specific subtypes of immune cells changed significantly when compared patients with controls. Activation of the interferon-MAPK pathway is the major defense mechanism, but MAPK transcription signaling is inhibited in cured patients. TCR and BCR V(D)J recombination is highly diverse in generating different antibodies against SARS-CoV-2. Therefore, the interferon-MAPK pathway and TCR- and BCR-produced antibodies play important roles in the COVID-19 immune response. Immune deficiency or immune over-response may result in the condition of patients with COVID-19 becoming critical or severe.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.15.20033472",
    "publisher": "medRxiv",
    "title": "Blood single cell immune profiling reveals the interferon-MAPK pathway mediated adaptive immune response for COVID-19",
    "URL": "https://doi.org/ggq64v",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.15.20033472"
  },
  {
    "type": "article-journal",
    "id": "dM1rOHmH",
    "author": [
      {
        "family": "Lv",
        "given": "Huibin"
      },
      {
        "family": "Wu",
        "given": "Nicholas C."
      },
      {
        "family": "Tsang",
        "given": "Owen Tak-Yin"
      },
      {
        "family": "Yuan",
        "given": "Meng"
      },
      {
        "family": "Perera",
        "given": "Ranawaka A. P. M."
      },
      {
        "family": "Leung",
        "given": "Wai Shing"
      },
      {
        "family": "So",
        "given": "Ray T. Y."
      },
      {
        "family": "Chun Chan",
        "given": "Jacky Man"
      },
      {
        "family": "Yip",
        "given": "Garrick K."
      },
      {
        "family": "Hong Chik",
        "given": "Thomas Shiu"
      },
      {
        "family": "Wang",
        "given": "Yiquan"
      },
      {
        "family": "Chung Choi",
        "given": "Chris Yau"
      },
      {
        "family": "Lin",
        "given": "Yihan"
      },
      {
        "family": "Ng",
        "given": "Wilson W."
      },
      {
        "family": "Zhao",
        "given": "Jincun"
      },
      {
        "family": "Poon",
        "given": "Leo L. M."
      },
      {
        "family": "Malik Peiris",
        "given": "J. S."
      },
      {
        "family": "Wilson",
        "given": "Ian A."
      },
      {
        "family": "Mok",
        "given": "Chris K. P."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "abstract": "The World Health Organization has recently declared the ongoing outbreak of COVID-19, which is caused by a novel coronavirus SARS-CoV-2, as pandemic. There is currently a lack of knowledge in the antibody response elicited from SARS-CoV-2 infection. One major immunological question is concerning the antigenic differences between SARS-CoV-2 and SARS-CoV. We address this question by using plasma from patients infected by SARS-CoV-2 or SARS-CoV, and plasma obtained from infected or immunized mice. Our results show that while cross-reactivity in antibody binding to the spike protein is common, cross-neutralization of the live viruses is rare, indicating the presence of non-neutralizing antibody response to conserved epitopes in the spike. Whether these non-neutralizing antibody responses will lead to antibody-dependent disease enhancement needs to be addressed in the future. Overall, this study not only addresses a fundamental question regarding the antigenicity differences between SARS-CoV-2 and SARS-CoV, but also has important implications in vaccine development.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.15.993097",
    "publisher": "bioRxiv",
    "title": "Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections",
    "URL": "https://doi.org/ggq64w",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.15.993097"
  },
  {
    "type": "article-journal",
    "id": "UENoLkhz",
    "author": [
      {
        "family": "Duan",
        "given": "Kai"
      },
      {
        "family": "Liu",
        "given": "Bende"
      },
      {
        "family": "Li",
        "given": "Cesheng"
      },
      {
        "family": "Zhang",
        "given": "Huajun"
      },
      {
        "family": "Yu",
        "given": "Ting"
      },
      {
        "family": "Qu",
        "given": "Jieming"
      },
      {
        "family": "Zhou",
        "given": "Min"
      },
      {
        "family": "Chen",
        "given": "Li"
      },
      {
        "family": "Meng",
        "given": "Shengli"
      },
      {
        "family": "Hu",
        "given": "Yong"
      },
      {
        "family": "Peng",
        "given": "Cheng"
      },
      {
        "family": "Yuan",
        "given": "Mingchao"
      },
      {
        "family": "Huang",
        "given": "Jinyan"
      },
      {
        "family": "Wang",
        "given": "Zejun"
      },
      {
        "family": "Yu",
        "given": "Jianhong"
      },
      {
        "family": "Gao",
        "given": "Xiaoxiao"
      },
      {
        "family": "Wang",
        "given": "Dan"
      },
      {
        "family": "Yu",
        "given": "Xiaoqi"
      },
      {
        "family": "Li",
        "given": "Li"
      },
      {
        "family": "Zhang",
        "given": "Jiayou"
      },
      {
        "family": "Wu",
        "given": "Xiao"
      },
      {
        "family": "Li",
        "given": "Bei"
      },
      {
        "family": "Yu",
        "given": "Yanping"
      },
      {
        "family": "Chen",
        "given": "Wei"
      },
      {
        "family": "Peng",
        "given": "Yan"
      },
      {
        "family": "Hu",
        "given": "Yeqin"
      },
      {
        "family": "Lin",
        "given": "Lianzhen"
      },
      {
        "family": "Liu",
        "given": "Xuefei"
      },
      {
        "family": "Huang",
        "given": "Shihe"
      },
      {
        "family": "Zhou",
        "given": "Zhijun"
      },
      {
        "family": "Zhang",
        "given": "Lianghao"
      },
      {
        "family": "Wang",
        "given": "Yue"
      },
      {
        "family": "Zhang",
        "given": "Zhi"
      },
      {
        "family": "Deng",
        "given": "Kun"
      },
      {
        "family": "Xia",
        "given": "Zhiwu"
      },
      {
        "family": "Gong",
        "given": "Qin"
      },
      {
        "family": "Zhang",
        "given": "Wei"
      },
      {
        "family": "Zheng",
        "given": "Xiaobei"
      },
      {
        "family": "Liu",
        "given": "Ying"
      },
      {
        "family": "Yang",
        "given": "Huichuan"
      },
      {
        "family": "Zhou",
        "given": "Dongbo"
      },
      {
        "family": "Yu",
        "given": "Ding"
      },
      {
        "family": "Hou",
        "given": "Jifeng"
      },
      {
        "family": "Shi",
        "given": "Zhengli"
      },
      {
        "family": "Chen",
        "given": "Saijuan"
      },
      {
        "family": "Chen",
        "given": "Zhu"
      },
      {
        "family": "Zhang",
        "given": "Xin-xin"
      },
      {
        "family": "Yang",
        "given": "Xiaoming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "abstract": "Currently, there are no approved specific antiviral agents for 2019 novel coronavirus disease (COVID-19). In this study, ten severe patients confirmed by real-time viral RNA test were enrolled prospectively. One dose of 200 mL convalescent plasma (CP) derived from recently recovered donors with the neutralizing antibody titers above 1:640 was transfused to the patients as an addition to maximal supportive care and antiviral agents. The primary endpoint was the safety of CP transfusion. The second endpoints were the improvement of clinical symptoms and laboratory parameters within 3 days after CP transfusion. The median time from onset of illness to CP transfusion was 16.5 days. After CP transfusion, the level of neutralizing antibody increased rapidly up to 1:640 in five cases, while that of the other four cases maintained at a high level (1:640). The clinical symptoms were significantly improved along with increase of oxyhemoglobin saturation within 3 days. Several parameters tended to improve as compared to pre-transfusion, including increased lymphocyte counts (0.65*109/L vs. 0.76*109/L) and decreased C-reactive protein (55.98 mg/L vs. 18.13 mg/L). Radiological examinations showed varying degrees of absorption of lung lesionswithin 7 days. The viral load was undetectable after transfusion in seven patients who had previous viremia. No severe adverse effects were observed. This study showed CP therapy was welltolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases. The optimal dose and time point, as well as the clinical benefit of CP therapy, needs further investigation in larger well-controlled trials.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.16.20036145",
    "publisher": "medRxiv",
    "title": "The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study",
    "URL": "https://doi.org/dqrs",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.16.20036145"
  },
  {
    "type": "article-journal",
    "id": "Xbkby2Jr",
    "author": [
      {
        "family": "GAUTRET",
        "given": "Philippe"
      },
      {
        "family": "LAGIER",
        "given": "Jean Christophe"
      },
      {
        "family": "PAROLA",
        "given": "Philippe"
      },
      {
        "family": "HOANG",
        "given": "Van Thuan"
      },
      {
        "family": "MEDDED",
        "given": "Line"
      },
      {
        "family": "MAILHE",
        "given": "Morgan"
      },
      {
        "family": "DOUDIER",
        "given": "Barbara"
      },
      {
        "family": "COURJON",
        "given": "Johan"
      },
      {
        "family": "GIORDANENGO",
        "given": "Valerie"
      },
      {
        "family": "ESTEVES VIEIRA",
        "given": "Vera"
      },
      {
        "family": "TISSOT DUPONT",
        "given": "Herve"
      },
      {
        "family": "HONORE",
        "given": "Stephane"
      },
      {
        "family": "COLSON",
        "given": "Philippe"
      },
      {
        "family": "CHABRIERE",
        "given": "Eric"
      },
      {
        "family": "LA SCOLA",
        "given": "Bernard"
      },
      {
        "family": "ROLAIN",
        "given": "Jean Marc"
      },
      {
        "family": "BROUQUI",
        "given": "Philippe"
      },
      {
        "family": "RAOULT",
        "given": "Didier"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          20
        ]
      ]
    },
    "abstract": "Background Chloroquine and Hydroxychloroquine have been found to be efficient on COV-19, and reported to be efficient in Chinese patients infected by this virus. We evaluate the role of Hydroxychloroquine on respiratory viral loads. Patients and methods Patients were included in a single arm protocol to receive 600mg of hydroxychloroquine daily and their viral load in nasal swabs was tested daily. Depending on their clinical presentation azithromycin was added to the treatment. Untreated patients from another center and cases refusing the protocol were included as negative control. Presence and absence of virus at Day-6 was considered the end point. Results Twenty cases were treated in this study and showed a significant reduction of the viral carriage at D-6 compared to controls, and much lower than reported average carrying duration of untreated patients in the literature. Azithromycin added to Hydroxychloroquine was significantly more efficient for virus elimination. Conclusion : Hydroxychloroquine is significantly associated with viral load reduction/disappearance in patients with COVID-19 and its effect is reinforced by Azithromycin.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.16.20037135",
    "publisher": "medRxiv",
    "title": "Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial",
    "URL": "https://doi.org/dqbv",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.16.20037135"
  },
  {
    "type": "article-journal",
    "id": "OuDMtCRl",
    "author": [
      {
        "family": "Zhao",
        "given": "Bing"
      },
      {
        "family": "Ni",
        "given": "Chao"
      },
      {
        "family": "Gao",
        "given": "Ran"
      },
      {
        "family": "Wang",
        "given": "Yuyan"
      },
      {
        "family": "Yang",
        "given": "Li"
      },
      {
        "family": "Wei",
        "given": "Jinsong"
      },
      {
        "family": "Lv",
        "given": "Ting"
      },
      {
        "family": "Liang",
        "given": "Jianqing"
      },
      {
        "family": "Zhang",
        "given": "Qisheng"
      },
      {
        "family": "Xu",
        "given": "Wei"
      },
      {
        "family": "Xie",
        "given": "Youhua"
      },
      {
        "family": "Wang",
        "given": "Xiaoyue"
      },
      {
        "family": "Yuan",
        "given": "Zhenghong"
      },
      {
        "family": "Liang",
        "given": "Junbo"
      },
      {
        "family": "Zhang",
        "given": "Rong"
      },
      {
        "family": "Lin",
        "given": "Xinhua"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "abstract": "The newly emerged pandemic coronavirus, SARS-CoV-2, has posed a significant public health threat worldwide. However, the mode of virus transmission and tissue tropism is not well established yet. Recent findings of substantial liver damage in patients and ACE2+ cholangiocytes in healthy liver tissues prompted us to hypothesize that human liver ductal organoids could serve as a model to determine the susceptibility and mechanisms underlining the liver damage upon SARS-CoV-2 infection. By single-cell RNA sequencing, we found that long-term liver ductal organoid culture preserved the human specific ACE2+ population of cholangiocytes. Moreover, human liver ductal organoids were permissive to SARS-CoV-2 infection and support robust replication. Notably, virus infection impaired the barrier and bile acid transporting functions of cholangiocytes through dysregulation of genes involved in tight junction formation and bile acid transportation, which could explain the bile acid accumulation and consequent liver damage in patients. These results indicate that control of liver damage caused directly by viral infection should be valued in treating COVID-19 patients. Our findings also provide an application of human organoids in investigating the tropism and pathogenesis of SARS-CoV-2, which would facilitate novel drug discovery.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.16.990317",
    "publisher": "bioRxiv",
    "title": "Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids",
    "URL": "https://doi.org/ggq648",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.16.990317"
  },
  {
    "type": "article-journal",
    "id": "3VPi509z",
    "author": [
      {
        "family": "Procko",
        "given": "Erik"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          6
        ]
      ]
    },
    "abstract": "The rapid and escalating spread of SARS coronavirus 2 (SARS-CoV-2) poses an immediate public health emergency. The viral spike protein S binds ACE2 on host cells to initiate molecular events that release the viral genome intracellularly. Soluble ACE2 inhibits entry of both SARS and SARS-2 coronaviruses by acting as a decoy for S binding sites, and is a candidate for therapeutic and prophylactic development. Using deep mutagenesis, variants of ACE2 are identified with increased binding to the receptor binding domain of S. Mutations are found across the interface, in the N90-glycosylation motif, and at buried sites where they are predicted to enhance folding and presentation of the interaction epitope. When single substitutions are combined, large increases in binding can be achieved. The mutational landscape offers a blueprint for engineering high affinity proteins and peptides that block receptor binding sites on S to meet this unprecedented challenge.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.16.994236",
    "publisher": "bioRxiv",
    "title": "The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2",
    "URL": "https://doi.org/ggrbj8",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.16.994236"
  },
  {
    "type": "article-journal",
    "id": "yJW1RVQb",
    "author": [
      {
        "family": "Amanat",
        "given": "Fatima"
      },
      {
        "family": "Nguyen",
        "given": "Thi"
      },
      {
        "family": "Chromikova",
        "given": "Veronika"
      },
      {
        "family": "Strohmeier",
        "given": "Shirin"
      },
      {
        "family": "Stadlbauer",
        "given": "Daniel"
      },
      {
        "family": "Javier",
        "given": "Andres"
      },
      {
        "family": "Jiang",
        "given": "Kaijun"
      },
      {
        "family": "Asthagiri-Arunkumar",
        "given": "Guha"
      },
      {
        "family": "Polanco",
        "given": "Jose"
      },
      {
        "family": "Bermudez-Gonzalez",
        "given": "Maria"
      },
      {
        "family": "Caplivski",
        "given": "Daniel"
      },
      {
        "family": "Cheng",
        "given": "Allen"
      },
      {
        "family": "Kedzierska",
        "given": "Katherine"
      },
      {
        "family": "Vapalahti",
        "given": "Olli"
      },
      {
        "family": "Hepojoki",
        "given": "Jussi"
      },
      {
        "family": "Simon",
        "given": "Viviana"
      },
      {
        "family": "Krammer",
        "given": "Florian"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          18
        ]
      ]
    },
    "abstract": "Introduction: SARS-Cov-2 (severe acute respiratory disease coronavirus 2), which causes Coronavirus Disease 2019 (COVID19) was first detected in China in late 2019 and has since then caused a global pandemic. While molecular assays to directly detect the viral genetic material are available for the diagnosis of acute infection, we currently lack serological assays suitable to specifically detect SARS-CoV-2 antibodies. Methods: Here we describe serological enzyme-linked immunosorbent assays (ELISA) that we developed using recombinant antigens derived from the spike protein of SARS-CoV-2. These assays were developed with negative control samples representing pre-COVID 19 background immunity in the general population and samples from COVID19 patients. Results: The assays are sensitive and specific, allowing for screening and identification of COVID19 seroconverters using human plasma/serum as early as 3 days post symptom onset. Importantly, these assays do not require handling of infectious virus, can be adjusted to detect different antibody types and are amendable to scaling. Conclusion: Serological assays are of critical importance to determine seroprevalence in a given population, define previous exposure and identify highly reactive human donors for the generation of convalescent serum as therapeutic. Sensitive and specific identification of coronavirus SARS-Cov-2 antibody titers will also support screening of health care workers to identify those who are already immune and can be deployed to care for infected patients minimizing the risk of viral spread to colleagues and other patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.17.20037713",
    "publisher": "medRxiv",
    "title": "A serological assay to detect SARS-CoV-2 seroconversion in humans",
    "URL": "https://doi.org/ggpn83",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.17.20037713"
  },
  {
    "type": "article-journal",
    "id": "1EcOLnVXk",
    "author": [
      {
        "family": "Rockx",
        "given": "Barry"
      },
      {
        "family": "Kuiken",
        "given": "Thijs"
      },
      {
        "family": "Herfst",
        "given": "Sander"
      },
      {
        "family": "Bestebroer",
        "given": "Theo"
      },
      {
        "family": "Lamers",
        "given": "Mart M."
      },
      {
        "family": "de Meulder",
        "given": "Dennis"
      },
      {
        "family": "van Amerongen",
        "given": "Geert"
      },
      {
        "family": "van den Brand",
        "given": "Judith"
      },
      {
        "family": "Okba",
        "given": "Nisreen M.A."
      },
      {
        "family": "Schipper",
        "given": "Debby"
      },
      {
        "family": "van Run",
        "given": "Peter"
      },
      {
        "family": "Leijten",
        "given": "Lonneke"
      },
      {
        "family": "Verschoor",
        "given": "Ernst"
      },
      {
        "family": "Verstrepen",
        "given": "Babs"
      },
      {
        "family": "Langermans",
        "given": "Jan"
      },
      {
        "family": "Drosten",
        "given": "Christian"
      },
      {
        "family": "van Vlissingen",
        "given": "Martje Fentener"
      },
      {
        "family": "Fouchier",
        "given": "Ron"
      },
      {
        "family": "de Swart",
        "given": "Rik"
      },
      {
        "family": "Koopmans",
        "given": "Marion"
      },
      {
        "family": "Haagmans",
        "given": "Bart L."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          17
        ]
      ]
    },
    "abstract": "A novel coronavirus, SARS-CoV-2, was recently identified in patients with an acute respiratory syndrome, COVID-19. To compare its pathogenesis with that of previously emerging coronaviruses, we inoculated cynomolgus macaques with SARS-CoV-2 or MERS-CoV and compared with historical SARS-CoV infections. In SARS-CoV-2-infected macaques, virus was excreted from nose and throat in absence of clinical signs, and detected in type I and II pneumocytes in foci of diffuse alveolar damage and mucous glands of the nasal cavity. In SARS-CoV-infection, lung lesions were typically more severe, while they were milder in MERS-CoV infection, where virus was detected mainly in type II pneumocytes. These data show that SARS-CoV-2 can cause a COVID-19-like disease, and suggest that the severity of SARS-CoV-2 infection is intermediate between that of SARS-CoV and MERS-CoV.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.17.995639",
    "publisher": "bioRxiv",
    "title": "Comparative Pathogenesis Of COVID-19, MERS And SARS In A Non-Human Primate Model",
    "URL": "https://doi.org/ggq649",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.17.995639"
  },
  {
    "type": "article-journal",
    "id": "OvFueDLZ",
    "author": [
      {
        "family": "Aguilar",
        "given": "Jacob B"
      },
      {
        "family": "Faust",
        "given": "Jeremy Samuel"
      },
      {
        "family": "Westafer",
        "given": "Lauren M."
      },
      {
        "family": "Gutierrez",
        "given": "Juan B."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          31
        ]
      ]
    },
    "abstract": "Coronavirus disease 2019 (COVID-19) is a novel human respiratory disease caused by the SARS-CoV-2 virus. Asymptomatic carriers of the virus display no clinical symptoms but are known to be contagious. Recent evidence reveals that this sub-population, as well as persons with mild, represent a major contributor in the propagation of COVID-19. The asymptomatic sub-population frequently escapes detection by public health surveillance systems. Because of this, the currently accepted estimates of the basic reproduction number (Ro) of the virus are inaccurate. It is unlikely that a pathogen can blanket the planet in three months with an Ro in the vicinity of 3, as reported in the literature. In this manuscript, we present a mathematical model taking into account asymptomatic carriers. Our results indicate that an initial value of the effective reproduction number could range from 5.5 to 25.4, with a point estimate of 15.4, assuming mean parameters. The first three weeks of the model exhibit exponential growth, which is in agreement with average case data collected from thirteen countries with universal health care and robust communicable disease surveillance systems; the average rate of growth in the number of reported cases is 23.3% per day during this period.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20037994",
    "publisher": "medRxiv",
    "title": "Investigating the Impact of Asymptomatic Carriers on COVID-19 Transmission",
    "URL": "https://doi.org/ggqnvp",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20037994"
  },
  {
    "type": "article-journal",
    "id": "Y9g1sQ1Y",
    "author": [
      {
        "family": "Long",
        "given": "Quan-xin"
      },
      {
        "family": "Deng",
        "given": "Hai-jun"
      },
      {
        "family": "Chen",
        "given": "Juan"
      },
      {
        "family": "Hu",
        "given": "Jieli"
      },
      {
        "family": "Liu",
        "given": "Bei-zhong"
      },
      {
        "family": "Liao",
        "given": "Pu"
      },
      {
        "family": "Lin",
        "given": "Yong"
      },
      {
        "family": "Yu",
        "given": "Li-hua"
      },
      {
        "family": "Mo",
        "given": "Zhan"
      },
      {
        "family": "Xu",
        "given": "Yin-yin"
      },
      {
        "family": "Gong",
        "given": "Fang"
      },
      {
        "family": "Wu",
        "given": "Gui-cheng"
      },
      {
        "family": "Zhang",
        "given": "Xian-xiang"
      },
      {
        "family": "Chen",
        "given": "Yao-kai"
      },
      {
        "family": "Li",
        "given": "Zhi-jie"
      },
      {
        "family": "Wang",
        "given": "Kun"
      },
      {
        "family": "Zhang",
        "given": "Xiao-li"
      },
      {
        "family": "Tian",
        "given": "Wen-guang"
      },
      {
        "family": "Niu",
        "given": "Chang-chun"
      },
      {
        "family": "Yang",
        "given": "Qing-jun"
      },
      {
        "family": "Xiang",
        "given": "Jiang-lin"
      },
      {
        "family": "Du",
        "given": "Hong-xin"
      },
      {
        "family": "Liu",
        "given": "Hua-wen"
      },
      {
        "family": "Lang",
        "given": "Chunhui"
      },
      {
        "family": "Luo",
        "given": "Xiao-he"
      },
      {
        "family": "Wu",
        "given": "Shao-bo"
      },
      {
        "family": "Cui",
        "given": "Xiao-ping"
      },
      {
        "family": "Zhou",
        "given": "Zheng"
      },
      {
        "family": "Wang",
        "given": "Jing"
      },
      {
        "family": "Xue",
        "given": "Cheng-jun"
      },
      {
        "family": "Li",
        "given": "Xiao-feng"
      },
      {
        "family": "Wang",
        "given": "Li"
      },
      {
        "family": "Tang",
        "given": "Xiao-jun"
      },
      {
        "family": "Zhang",
        "given": "Yong"
      },
      {
        "family": "Qiu",
        "given": "Jing-fu"
      },
      {
        "family": "Liu",
        "given": "Xia-mao"
      },
      {
        "family": "Li",
        "given": "Jin-jing"
      },
      {
        "family": "Zhang",
        "given": "De-chun"
      },
      {
        "family": "Zhang",
        "given": "Fan"
      },
      {
        "family": "Cai",
        "given": "Xue-fei"
      },
      {
        "family": "Wang",
        "given": "Deqiang"
      },
      {
        "family": "Hu",
        "given": "Yuan"
      },
      {
        "family": "Ren",
        "given": "Ji-hua"
      },
      {
        "family": "Tang",
        "given": "Ni"
      },
      {
        "family": "Liu",
        "given": "Ping"
      },
      {
        "family": "Li",
        "given": "Qin"
      },
      {
        "family": "Huang",
        "given": "Ai-long"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          20
        ]
      ]
    },
    "abstract": "Background We aim to investigate the profile of acute antibody response in COVID-19 patients, and provide proposals for the usage of antibody test in clinical practice. Methods A multi-center cross-section study (285 patients) and a single-center follow-up study (63 patients) were performed to investigate the feature of acute antibody response to SARS-CoV-2. A cohort of 52 COVID-19 suspects and 64 close contacts were enrolled to evaluate the potentiality of the antibody test. Results The positive rate for IgG reached 100% around 20 days after symptoms onset. The median day of serocon-version for both lgG and IgM was 13 days after symptoms onset. Seroconversion of IgM occurred at the same time, or earlier, or later than that of IgG. IgG levels in 100% patients (19/19) entered a platform within 6 days after seroconversion. The criteria of IgG seroconversion and ≥ 4-fold increase in the IgG titers in sequential samples together diagnosed 82.9% (34/41) of the patients. Antibody test aided to confirm 4 patients with COVID-19 from 52 suspects who failed to be confirmed by RT-PCR and 7 patients from 148 close contacts with negative RT-PCR. Conclusion IgM and IgG should be detected simultaneously at the early phase of infection. The serological diagnosis criterion of seroconversion or ≥ 4-fold increase in the IgG titer is suitable for a majority of COVID-19 patients. Serologic test is helpful for the diagnosis of SARS-CoV-2 infection in suspects and close contacts.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20038018",
    "publisher": "medRxiv",
    "title": "Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice",
    "URL": "https://doi.org/ggpvz3",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20038018"
  },
  {
    "type": "article-journal",
    "id": "1BLNvgEao",
    "author": [
      {
        "family": "OKBA",
        "given": "NISREEN M.A."
      },
      {
        "family": "Muller",
        "given": "Marcel A"
      },
      {
        "family": "Li",
        "given": "Wentao"
      },
      {
        "family": "Wang",
        "given": "Chunyan"
      },
      {
        "family": "GeurtsvanKessel",
        "given": "Corine H."
      },
      {
        "family": "Corman",
        "given": "Victor M."
      },
      {
        "family": "Lamers",
        "given": "Mart M."
      },
      {
        "family": "Sikkema",
        "given": "Reina S."
      },
      {
        "family": "de Bruin",
        "given": "Erwin"
      },
      {
        "family": "Chandler",
        "given": "Felicity D."
      },
      {
        "family": "Yazdanpanah",
        "given": "Yazdan"
      },
      {
        "family": "Le Hingrat",
        "given": "Quentin"
      },
      {
        "family": "Descamps",
        "given": "Diane"
      },
      {
        "family": "Houhou-Fidouh",
        "given": "Nadhira"
      },
      {
        "family": "Reusken",
        "given": "Chantal B. E. M."
      },
      {
        "family": "Bosch",
        "given": "Berend-Jan"
      },
      {
        "family": "Drosten",
        "given": "Christian"
      },
      {
        "family": "Koopmans",
        "given": "Marion P.G."
      },
      {
        "family": "Haagmans",
        "given": "Bart L."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          20
        ]
      ]
    },
    "abstract": "A new coronavirus, SARS-CoV-2, has recently emerged to cause a human pandemic. Whereas molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are important for contact tracing, identifying the viral reservoir and epidemiological studies. Here, we developed serological assays for the detection of SARS-CoV-2 neutralizing, spike- and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed infections of SARS-CoV-2, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrate that most PCR-confirmed SARS-CoV-2 infected individuals seroconverted, as revealed by sensitive and specific in-house ELISAs. We found that commercial S1 IgG or IgA ELISAs were of lower specificity while sensitivity varied between the two, with IgA showing higher sensitivity. Overall, the validated assays described here can be instrumental for the detection of SARS-CoV-2-specific antibodies for diagnostic, seroepidemiological and vaccine evaluation studies.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20038059",
    "publisher": "medRxiv",
    "title": "SARS-CoV-2 specific antibody responses in COVID-19 patients",
    "URL": "https://doi.org/ggpvz2",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20038059"
  },
  {
    "type": "article-journal",
    "id": "K41YFM2N",
    "author": [
      {
        "family": "Belhadi",
        "given": "Drifa"
      },
      {
        "family": "Peiffer-Smadja",
        "given": "Nathan"
      },
      {
        "family": "Lescure",
        "given": "François-Xavier"
      },
      {
        "family": "Yazdanpanah",
        "given": "Yazdan"
      },
      {
        "family": "Mentré",
        "given": "France"
      },
      {
        "family": "Laouénan",
        "given": "Cédric"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "Background: Although a number of antiviral agents have been evaluated for coronaviruses there are no approved drugs available. To provide an overview of the landscape of therapeutic research for COVID-19, we conducted a review of registered clinical trials. Methods: A review of currently registered clinical trials was performed on registries, including the Chinese (chictr.org.cn) and US (clinicaltrials.gov) databases to identify relevant studies up to March, 7th 2020. The search was conducted using the search terms “2019-nCoV”, “COVID-19”, “SARS-CoV-2”, “Hcov-19”, “new coronavirus”, “novel coronavirus”. We included interventional clinical trials focusing on patients with COVID-19 and assessing antiviral drugs or agents. Findings: Out of the 353 studies identified, 115 clinical trials were selected for data extraction. Phase IV trials were the most commonly reported study type (n=27, 23%). However, 62 trials (54%) did not describe the phase of the study. Eighty percent (n=92) of the trials were randomized with parallel assignment and the median number of planned inclusions was 63 (IQR, 36-120). Open-label studies were the most frequent (46%) followed by double-blind (13%) and single blind studies (10%). The most frequently assessed therapies were: stem cells therapy (n=23 trials), lopinavir/ritonavir (n=15), chloroquine (n=11), umifenovir (n=9), hydroxychloroquine (n=7), plasma treatment (n=7), favipiravir (n=7), methylprednisolone (n=5), and remdesivir (n=5). Remdesivir was tested in 5 trials with a median of 400 (IQR, 394-453) planned inclusions per trial, while stem cells therapy was tested in 23 trials, but had a median of 40 (IQR, 23-60) planned inclusions per trial. Lopinavir/ritonavir was associated with the highest total number of planned inclusions (2606) followed by remdesivir (2155). Only 52% of the clinical trials reported the treatment dose (n=60) and only 34% (n=39) the duration. The primary outcome was clinical in 76 studies (66%), virological in 27 (23%); radiological in 9 (8%) or immunological in three studies (3%). Interpretation: Numerous clinical trials have been registered since the beginning of the COVID-19 outbreak, however, a number of information regarding drugs or trial design were lacking. Funding: None",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20038190",
    "publisher": "medRxiv",
    "title": "A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19",
    "URL": "https://doi.org/ggq65b",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20038190"
  },
  {
    "type": "article-journal",
    "id": "eTsOvBVf",
    "author": [
      {
        "family": "Leung",
        "given": "Janice M"
      },
      {
        "family": "Yang",
        "given": "Chen Xi"
      },
      {
        "family": "Tam",
        "given": "Anthony"
      },
      {
        "family": "Shaipanich",
        "given": "Tawimas"
      },
      {
        "family": "Hackett",
        "given": "Tillie L"
      },
      {
        "family": "Singhera",
        "given": "Gurpreet K"
      },
      {
        "family": "Dorscheid",
        "given": "Delbert R"
      },
      {
        "family": "Sin",
        "given": "Don D"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "abstract": "Introduction: Coronavirus disease 2019 (COVID-19) is a respiratory infection caused by the severe acute respiratory syndrome coronavirus2 (SARSCoV-2). This virus uses the angiotensin converting enzyme II (ACE2) as the cellular entry receptor to infect the lower respiratory tract. Because individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of severe COVID19, we determined whether ACE2 expression in the lower airways was related to COPD and cigarette smoking. Methods: Using RNAseq, we determined gene expression levels in bronchial epithelia obtained from cytologic brushings of 6th to 8th generation airways in individuals with and without COPD. We externally validated these results from two additional independent cohorts, which used microarray technologies to measure gene expression levels from 6th to 12th generation airways. Results: In the discovery cohort (n=42 participants), we found that ACE2 expression levels were increased by 48% in the airways of COPD compared with non-COPD subjects (COPD=2.52 (0.66) log2 counts per million reads (CPM) versus non-COPD= 1.70 (0.51) CPM , p=.000762). There was a significant inverse relationship between ACE2 gene expression and FEV1% of predicted (r=negative 0.24; p=0.035). Current smoking also significantly increased ACE2 expression levels compared with never smokers (never current smokers=2.77 (90.91) CPM versus smokers=1.78 (0.39) CPM, p=0.024). These findings were replicated in the two external cohorts. Conclusions: ACE2 expression in lower airways is increased in patients with COPD and with current smoking. These data suggest that these two subgroups are at increased risk of serious COVID19 infection and highlight the importance of smoking cessation in reducing the risk.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20038455",
    "publisher": "medRxiv",
    "title": "ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19",
    "URL": "https://doi.org/dqx2",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20038455"
  },
  {
    "type": "article-journal",
    "id": "18KZGwJ0J",
    "author": [
      {
        "family": "Xu",
        "given": "Yang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          20
        ]
      ]
    },
    "abstract": "In December 2019, a cluster of acute respiratory illness, now known as SARS-CoV-2 pneumonia, occurred in Wuhan, China. World Health Organization (WHO) declared the rapidly spreading coronavirus outbreak a pandemic on March 11, 2020, acknowledging what has seemed clear for some time-the virus will likely spread to all countries on the globe. As of February 11, 2020, the Chinese Center for Disease Control and Prevention (China CDC) has officially reported that there are 2.0% (889) asymptomatic cases, 2.3% (1,023) death cases, and 80.9% mild cases among 44,672 confirmed cases. 51.4% (22,981) were male and 48.6% (21,691) were female. Lymphopenia, in particular T lymphopenia, was common among patients with SARS-COV-2 in the observation. A notable drop in CD4 and CD8 lymphocyte counts occurred early in the course of the syndrome and was associated with adverse outcomes. The appearing a phenomenon of lymphocyte depletion (PLD) suggested severe adverse outcomes. The outcome observed: 60% had discharged and 20% had die.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.18.20038513",
    "publisher": "medRxiv",
    "title": "Dynamic profile of severe or critical COVID-19 cases",
    "URL": "https://doi.org/ggrbj9",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.18.20038513"
  },
  {
    "type": "article-journal",
    "id": "1BJXDZ04c",
    "author": [
      {
        "family": "Fu",
        "given": "Hang"
      },
      {
        "family": "Xu",
        "given": "Huayan"
      },
      {
        "family": "Zhang",
        "given": "Na"
      },
      {
        "family": "Xu",
        "given": "Hong"
      },
      {
        "family": "Li",
        "given": "Zhenlin"
      },
      {
        "family": "Chen",
        "given": "Huizhu"
      },
      {
        "family": "Xu",
        "given": "Rong"
      },
      {
        "family": "Sun",
        "given": "Ran"
      },
      {
        "family": "Wen",
        "given": "Lingyi"
      },
      {
        "family": "Xie",
        "given": "Linjun"
      },
      {
        "family": "Liu",
        "given": "Hui"
      },
      {
        "family": "Zhang",
        "given": "Kun"
      },
      {
        "family": "Fu",
        "given": "Chuan"
      },
      {
        "family": "Hou",
        "given": "Keke"
      },
      {
        "family": "Yang",
        "given": "Zhigang"
      },
      {
        "family": "Yang",
        "given": "Ming"
      },
      {
        "family": "Guo",
        "given": "Yingkun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          23
        ]
      ]
    },
    "abstract": "Abstract Background: Since December 2019, more than 100,000 coronavirus disease 2019 (COVID-19) patients have been confirmed globally based on positive viral nucleic acids with real-time reverse transcriptase-polymerase chain reaction (RT-PCR). However, the association between clinical, laboratory and CT characteristics and RT-PCR results is still unclear. We sought to examine this association in detail, especially in recovered patients. Methods: We analysed data from 52 confirmed patients who had been discharged with COVID-19. The clinical, laboratory, and radiological data were dynamically recorded and compared with the admission and follow-up RT-PCR results. Results: In this cohort, 52 admitted COVID-19 patients who had confirmed positive RT-PCR results were discharged after 2 rounds of consecutively negative RT-PCR results. Compared with admission levels, CRP levels (median 4.93 mg/L [IQR: 1.78-10.20]) decreased significantly (p&lt;0.001). and lymphocyte counts (median 1.50×109/L [IQR: 1.11-1.88]) increased obviously after obtaining negative RT-PCR results (p&lt;0.001). Additionally, substantially improved inflammatory exudation was observed on chest CT except for 2 progressed patients. At the two-week follow-up after discharge, 7 patients had re-positive RT-PCR results, including the abovementioned 2 progressed patients. Among the 7 patients, new GGO was demonstrated in 2 patients. There were no significant differences in CPR levels or lymphocyte counts when comparing the negative and re-positive PCT results (all p &gt;0.05). Conclusion: Heterogeneity between CT features and RT-PCR results was found in COVID-19, especially in some recovered patients with negative RT-PCR results. Our study highlights that both RT-PCR and chest CT should be considered as the key determinants for the diagnosis and management of COVID-19 patients.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.19.20038315",
    "publisher": "medRxiv",
    "title": "Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients",
    "URL": "https://doi.org/ggq65c",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.19.20038315"
  },
  {
    "type": "article-journal",
    "id": "iMCz5Twj",
    "author": [
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Zhou",
        "given": "Shuntai"
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Hill",
        "given": "Collin S."
      },
      {
        "family": "Leist",
        "given": "Sarah R."
      },
      {
        "family": "Schäfer",
        "given": "Alexandra"
      },
      {
        "family": "Dinnon",
        "given": "Kenneth H."
      },
      {
        "family": "Montgomery",
        "given": "Stephanie A."
      },
      {
        "family": "Agostini",
        "given": "Maria L."
      },
      {
        "family": "Pruijssers",
        "given": "Andrea J."
      },
      {
        "family": "Chapell",
        "given": "James D."
      },
      {
        "family": "Brown",
        "given": "Ariane J."
      },
      {
        "family": "Bluemling",
        "given": "Gregory R."
      },
      {
        "family": "Natchus",
        "given": "Michael G."
      },
      {
        "family": "Saindane",
        "given": "Manohar"
      },
      {
        "family": "Kolykhalov",
        "given": "Alexander A."
      },
      {
        "family": "Painter",
        "given": "George"
      },
      {
        "family": "Harcourt",
        "given": "Jennifer"
      },
      {
        "family": "Tamin",
        "given": "Azaibi"
      },
      {
        "family": "Thornburg",
        "given": "Natalie J."
      },
      {
        "family": "Swanstrom",
        "given": "Ronald"
      },
      {
        "family": "Denison",
        "given": "Mark R."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          20
        ]
      ]
    },
    "abstract": "Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2. Herein, we show that the ribonucleoside analog β-D-N -hydroxycytidine (NHC, EIDD-1931) has broad spectrum antiviral activity against SARS-CoV 2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor. In mice infected with SARS-CoV or MERS-CoV, both prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC-prodrug (b-D-N -hydroxycytidine-5’-isopropyl ester), improved pulmonary function, and reduced virus titer and body weight loss. Decreased MERS-CoV yields and were associated with increased transition mutation frequency in viral but not host cell RNA, supporting a mechanism of lethal mutagenesis. The potency of NHC/EIDD-2801 against multiple coronaviruses, its therapeutic efficacy, and oral bioavailability , all highlight its potential utility as an effective antiviral against SARS-CoV-2 and other future zoonotic coronaviruses.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.19.997890",
    "publisher": "bioRxiv",
    "title": "An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus",
    "URL": "https://doi.org/ggrbkb",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.19.997890"
  },
  {
    "type": "article-journal",
    "id": "TH4ymqvJ",
    "author": [
      {
        "family": "Sahafizadeh",
        "given": "Ebrahim"
      },
      {
        "family": "Sartoli",
        "given": "Samaneh"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          29
        ]
      ]
    },
    "abstract": "Background: As reported by Iranian governments, the first cases of coronavirus (COVID-19) infections confirmed in Qom, Iran on February 19, 2020 (30 Bahman 1398). The number of identified cases afterward increased rapidly and the novel coronavirus spread to all provinces of the country. This study aimed to fit an epidemic model to the reported cases data to estimate the basic reproduction number (R_0) of COVID-19 in Iran. Methods: We used data from February 21, 2020, to March 18, 2020, on the number of cases reported by Iranian governments and we employed the SIR (Susceptible-Infectious-Removed) epidemic spreading model to fit the transmission model to the reported cases data by tuning the parameters in order to estimate the basic reproduction number of COVID-19 in Iran. Results: The value of reproduction number was estimated 4.86 in the first week and 4.5 in the second and decreasing from 4.29 to 2.1 in the third and fourth weeks. Conclusions: The results indicate that the basic reproduction number of COVID-19 is significantly larger than one. Based on the results, it is necessary to implement social distancing and a strict restriction on travelling to control the outbreak especially on Nowruz (Persian New Year).",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.20.20038422",
    "publisher": "medRxiv",
    "title": "Estimating the reproduction number of COVID-19 in Iran using epidemic modeling",
    "URL": "https://doi.org/ggqhzx",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.20.20038422"
  },
  {
    "type": "article-journal",
    "id": "LIf5SSUs",
    "author": [
      {
        "family": "Jiang",
        "given": "He-wei"
      },
      {
        "family": "Li",
        "given": "Yang"
      },
      {
        "family": "Zhang",
        "given": "Hai-nan"
      },
      {
        "family": "Wang",
        "given": "Wei"
      },
      {
        "family": "Men",
        "given": "Dong"
      },
      {
        "family": "Yang",
        "given": "Xiao"
      },
      {
        "family": "Qi",
        "given": "Huan"
      },
      {
        "family": "Zhou",
        "given": "Jie"
      },
      {
        "family": "Tao",
        "given": "Sheng-ce"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "COVID-19 is caused by SARS-CoV-2, and has become a global pandemic. There is no highly effective medicine or vaccine, most of the patients were recovered by their own immune response, especially the virus specific IgG and IgM responses. However, the IgG/ IgM responses is barely known. To enable the global understanding of SARS-CoV-2 specific IgG/ IgM responses, a SARS-CoV-2 proteome microarray with 18 out of the 28 predicted proteins was constructed. The microarray was applied to profile the IgG/ IgM responses with 29 convalescent sera. The results suggest that at the convalescent phase 100% of patients had IgG/ IgM responses to SARS-CoV-2, especially to protein N, S1 but not S2. S1 purified from mammalian cell demonstrated the highest performance to differentiate COVID-19 patients from controls. Besides protein N and S1, significant antibody responses to ORF9b and NSP5 were also identified. In-depth analysis showed that the level of S1 IgG positively correlate to age and the level of LDH (lactate dehydrogenase), especially for women, while the level of S1 IgG negatively correlate to Ly% (Lymphocyte percentage). This study presents the first whole picture of the SARS-CoV-2 specific IgG/ IgM responses, and provides insights to develop precise immuno-diagnostics, effective treatment and vaccine.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.20.20039495",
    "publisher": "medRxiv",
    "title": "Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray",
    "URL": "https://doi.org/ggq65g",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.20.20039495"
  },
  {
    "type": "article-journal",
    "id": "ZDP9vSpg",
    "author": [
      {
        "family": "Jeon",
        "given": "Sangeun"
      },
      {
        "family": "Ko",
        "given": "Meehyun"
      },
      {
        "family": "Lee",
        "given": "Jihye"
      },
      {
        "family": "Choi",
        "given": "Inhee"
      },
      {
        "family": "Byun",
        "given": "Soo Young"
      },
      {
        "family": "Park",
        "given": "Soonju"
      },
      {
        "family": "Shum",
        "given": "David"
      },
      {
        "family": "Kim",
        "given": "Seungtaek"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          28
        ]
      ]
    },
    "abstract": "COVID-19 is an emerging infectious disease and was recently declared as a pandemic by WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug repositioning represents the only feasible option to address this global challenge and a panel of 48 FDA-approved drugs that have been pre-selected by an assay of SARS-CoV was screened to identify potential antiviral drug candidates against SARS-CoV-2 infection. We found a total of 24 drugs which exhibited antiviral efficacy (0.1 μM &lt; IC &lt; 10 μM) against SARS-CoV-2. In particular, two FDA-approved drugs - niclosamide and ciclesonide – were notable in some respects. These drugs will be tested in an appropriate animal model for their antiviral activities. In near future, these already FDA-approved drugs could be further developed following clinical trials in order to provide additional therapeutic options for patients with COVID-19.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.20.999730",
    "publisher": "bioRxiv",
    "title": "Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs",
    "URL": "https://doi.org/ggq65h",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.20.999730"
  },
  {
    "type": "article-journal",
    "id": "LYFzvlzE",
    "author": [
      {
        "family": "Munster",
        "given": "Vincent J."
      },
      {
        "family": "Feldmann",
        "given": "Friederike"
      },
      {
        "family": "Williamson",
        "given": "Brandi N."
      },
      {
        "family": "van Doremalen",
        "given": "Neeltje"
      },
      {
        "family": "Pérez-Pérez",
        "given": "Lizzette"
      },
      {
        "family": "Schulz",
        "given": "Jonathan"
      },
      {
        "family": "Meade-White",
        "given": "Kimberly"
      },
      {
        "family": "Okumura",
        "given": "Atsushi"
      },
      {
        "family": "Callison",
        "given": "Julie"
      },
      {
        "family": "Brumbaugh",
        "given": "Beniah"
      },
      {
        "family": "Avanzato",
        "given": "Victoria A."
      },
      {
        "family": "Rosenke",
        "given": "Rebecca"
      },
      {
        "family": "Hanley",
        "given": "Patrick W."
      },
      {
        "family": "Saturday",
        "given": "Greg"
      },
      {
        "family": "Scott",
        "given": "Dana"
      },
      {
        "family": "Fischer",
        "given": "Elizabeth R."
      },
      {
        "family": "de Wit",
        "given": "Emmie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          21
        ]
      ]
    },
    "abstract": "An outbreak of a novel coronavirus, now named SARS-CoV-2, causing respiratory disease and a ∼2% case fatality rate started in Wuhan, China in December 2019. Following unprecedented rapid global spread, the World Health Organization declared COVID-19 a pandemic on March 11, 2020. Although data on disease in humans are emerging at a steady pace, certain aspects of the pathogenesis of SARS-CoV-2 can only be studied in detail in animal models, where repeated sampling and tissue collection is possible. Here, we show that SARS-CoV-2 causes respiratory disease in infected rhesus macaques, with disease lasting 8-16 days. Pulmonary infiltrates, a hallmark of human disease, were visible in lung radiographs of all animals. High viral loads were detected in swabs from the nose and throat of all animals as well as in bronchoalveolar lavages; in one animal we observed prolonged rectal shedding. Taken together, the rhesus macaque recapitulates moderate disease observed in the majority of human cases. The establishment of the rhesus macaque as a model of COVID-19 will increase our understanding of the pathogenesis of this disease and will aid development and testing of medical countermeasures.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.21.001628",
    "publisher": "bioRxiv",
    "title": "Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2",
    "URL": "https://doi.org/ggq65j",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.21.001628"
  },
  {
    "type": "article-journal",
    "id": "wjtVy2v0",
    "author": [
      {
        "family": "Pinto",
        "given": "Bruna GG"
      },
      {
        "family": "Oliveira",
        "given": "Antonio ER"
      },
      {
        "family": "Singh",
        "given": "Youvika"
      },
      {
        "family": "Jimenez",
        "given": "Leandro"
      },
      {
        "family": "Goncalves",
        "given": "Andre NA"
      },
      {
        "family": "Ogava",
        "given": "Rodrigo LT"
      },
      {
        "family": "Creighton",
        "given": "Rachel"
      },
      {
        "family": "Peron",
        "given": "Jean PS"
      },
      {
        "family": "Nakaya",
        "given": "Helder I"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "The pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has resulted in several thousand deaths worldwide in just a few months. Patients who died from Coronavirus disease 2019 (COVID-19) often had comorbidities, such as hypertension, diabetes, and chronic obstructive lung disease. The angiotensin-converting enzyme 2 (ACE2) was identified as a crucial factor that facilitates SARS-CoV2 to bind and enter host cells. To date, no study has assessed the ACE2 expression in the lungs of patients with these diseases. Here, we analyzed over 700 lung transcriptome samples of patients with comorbidities associated with severe COVID-19 and found that ACE2 was highly expressed in these patients, compared to control individuals. This finding suggests that patients with such comorbidities may have higher chances of developing severe COVID-19. We also found other genes, such as RAB1A, that can be important for SARS-CoV-2 infection in the lung. Correlation and network analyses revealed many potential regulators of ACE2 in the human lung, including genes related to histone modifications, such as HAT1, HDAC2, and KDM5B. In fact, epigenetic marks found in ACE2 locus were compatible to with those promoted by KDM5B. Our systems biology approach offers a possible explanation for increase of COVID-19 severity in patients with certain comorbidities.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.21.20040261",
    "publisher": "medRxiv",
    "title": "ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19",
    "URL": "https://doi.org/ggq65k",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.21.20040261"
  },
  {
    "type": "article-journal",
    "id": "vITui6ac",
    "author": [
      {
        "family": "Ma",
        "given": "Shujuan"
      },
      {
        "family": "Zhang",
        "given": "Jiayue"
      },
      {
        "family": "Zeng",
        "given": "Minyan"
      },
      {
        "family": "Yun",
        "given": "Qingping"
      },
      {
        "family": "Guo",
        "given": "Wei"
      },
      {
        "family": "Zheng",
        "given": "Yixiang"
      },
      {
        "family": "Zhao",
        "given": "Shi"
      },
      {
        "family": "Wang",
        "given": "Maggie H"
      },
      {
        "family": "Yang",
        "given": "Zuyao"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          24
        ]
      ]
    },
    "abstract": "Background The outbreak of coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization, while several key epidemiological parameters of the disease remain to be clarified. This study aimed to obtain robust estimates of the incubation period, upper limit of latent period (interval between exposure of infector and infectee), serial interval, time point of exposure and basic reproduction number (R0) of COVID-19. Methods Between late February and early March of 2020, the individual data of laboratory confirmed cases of COVID-19 were retrieved from 10728 publicly available reports released by the health authorities of and outside China and from 1790 publications identified in PubMed and CNKI. To be eligible, a report had to contain the data that allowed for estimation of at least one parameter. As relevant data mainly came from clustering cases, the clusters for which no evidence was available to establish transmission order were all excluded to ensure accuracy of estimates. Additionally, only the cases with an exposure period spanning 3 days or less were included in the estimation of parameters involving exposure date, and a simple method for determining exposure date was adopted to ensure the error of estimates be small (&lt; 0.3 day). Depending on specific parameters, three or four of normal, lognormal, Weibull, and gamma distributions were fitted to the datasets and the results from appropriate models were presented. Findings In total, 1155 cases from China, Japan, Singapore, South Korea, Vietnam, Germany and Malaysia were included for the final analysis. The mean and standard deviation were 7.44 days and 4.39 days for incubation period, 2.52 days and 3.95 days for the upper limit of latent period, 6.70 days and 5.20 days for serial interval, and -0.19 day (i.e., 0.19 day before symptom onset of infector) and 3.32 days for time point of exposure. R0 was estimated to be 1.70 and 1.78 based on two different formulas. For 39 (6.64%) cases, the incubation periods were longer than 14 days. In 102 (43.78%) infector-infectee pairs, transmission occurred before the symptom onsets of infectors. In 27 (3.92%) infector-infectee pairs, symptom onsets of infectees occurred before those of infectors. Stratified analysis showed that incubation period and serial interval were consistently longer for those with less severe disease and for those whose primary cases had less severe disease. Asymptomatic transmission was also observed. Interpretation This study obtained robust estimates of several key epidemiological parameters of COVID-19. The findings support current practice of 14-day quarantine of persons with potential exposure, but also suggest that longer monitoring periods might be needed for selected groups. The estimates of serial interval, time point of exposure and latent period provide consistent evidence on pre-symptomatic transmission. This together with asymptomatic transmission and the generally longer incubation and serial interval of less severe cases suggests a high risk of long-term epidemic in the absence of appropriate control measures.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.21.20040329",
    "publisher": "medRxiv",
    "title": "Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries",
    "URL": "https://doi.org/ggqhzz",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.21.20040329"
  },
  {
    "type": "article-journal",
    "id": "DFhY5nfb",
    "author": [
      {
        "family": "Bian",
        "given": "Huijie"
      },
      {
        "family": "Zheng",
        "given": "Zhao-Hui"
      },
      {
        "family": "Wei",
        "given": "Ding"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Kang",
        "given": "Wen-Zhen"
      },
      {
        "family": "Hao",
        "given": "Chun-Qiu"
      },
      {
        "family": "Dong",
        "given": "Ke"
      },
      {
        "family": "Kang",
        "given": "Wen"
      },
      {
        "family": "Xia",
        "given": "Jie-Lai"
      },
      {
        "family": "Miao",
        "given": "Jin-Lin"
      },
      {
        "family": "Xie",
        "given": "Rong-Hua"
      },
      {
        "family": "Wang",
        "given": "Bin"
      },
      {
        "family": "Sun",
        "given": "Xiu-Xuan"
      },
      {
        "family": "Yang",
        "given": "Xiang-Min"
      },
      {
        "family": "Lin",
        "given": "Peng"
      },
      {
        "family": "Geng",
        "given": "Jie-Jie"
      },
      {
        "family": "Wang",
        "given": "Ke"
      },
      {
        "family": "Cui",
        "given": "Hong-Yong"
      },
      {
        "family": "Zhang",
        "given": "Kui"
      },
      {
        "family": "Chen",
        "given": "Xiao-Chun"
      },
      {
        "family": "Tang",
        "given": "Hao"
      },
      {
        "family": "Du",
        "given": "Hong"
      },
      {
        "family": "Yao",
        "given": "Na"
      },
      {
        "family": "Liu",
        "given": "Shuang-Shuang"
      },
      {
        "family": "Liu",
        "given": "Lin-Na"
      },
      {
        "family": "Zhang",
        "given": "Zhe"
      },
      {
        "family": "Gao",
        "given": "Zhao-Wei"
      },
      {
        "family": "Nan",
        "given": "Gang"
      },
      {
        "family": "Wang",
        "given": "Qing-Yi"
      },
      {
        "family": "Lian",
        "given": "Jian-Qi"
      },
      {
        "family": "Chen",
        "given": "Zhi-Nan"
      },
      {
        "family": "Zhu",
        "given": "Ping"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          24
        ]
      ]
    },
    "abstract": "Background: SARS-CoV-2 is a novel human coronavirus, there is no specific antiviral drugs. It has been proved that host-cell-expressed CD147 could bind spike protein of SARS-CoV-2 and involve in host cell invasion. Antibody against CD147 could block the infection of SARS-CoV-2. We aimed to assess the efficacy and safety of meplazumab, a humanized anti-CD147 antibody, as add-on therapy in patients with COVID-19 pneumonia. Methods: All patients received recommended strategy from Diagnosis and Treatment for 2019 Novel Coronavirus Diseases released by National Health Commission of China. Eligible patients were add-on administered 10 mg meplazumab intravenously at days 1, 2, and 5. Patients hospitalized in the same period were observed as concurrent control. The endpoints include virological clearance rate, case severity, chest radiographic, and laboratory test. This trial was approved by the Ethics Committee of Institution at the Tangdu hospital, and registered with ClinicalTrials.gov, NCT 04275245. Findings:17 patients were enrolled and assigned to meplazumab group between Feb 3, 2020 and Feb 10, 2020. 11 hospitalized patients served as concurrent control. Baseline characteristics were generally balanced across two groups. Compared to control group, meplazumab treatment significantly improved the discharged (p=0.006) and case severity (p=0.021) in critical and severe patients. The time to virus negative in meplazumab group was reduced than that in control group (median 3, 95%CI[1.5-4.5] vs. 13, [6.5-19.5]; p=0.014, HR=0.37, 95%CI[0.155-0.833]). The percentages of patients recovered to the normal lymphocyte count and CRP concentration were also increased remarkably and rapidly in meplazumab group. No adverse effect was found in meplazumab-treated patients. Interpretation:Meplazumab efficiently improved the recovery of patients with SARS-CoV-2 pneumonia with a favorable safety profile. Our results support to carry out a large-scale investigation of meplazumab as a treatment for COVID-19 pneumonia. Funding:National Science and Technology Major Project.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.21.20040691",
    "publisher": "medRxiv",
    "title": "Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial",
    "URL": "https://doi.org/ggq65m",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.21.20040691"
  },
  {
    "type": "article-journal",
    "id": "GhJYjnft",
    "author": [
      {
        "family": "Ju",
        "given": "Bin"
      },
      {
        "family": "Zhang",
        "given": "Qi"
      },
      {
        "family": "Ge",
        "given": "Xiangyang"
      },
      {
        "family": "Wang",
        "given": "Ruoke"
      },
      {
        "family": "Yu",
        "given": "Jiazhen"
      },
      {
        "family": "Shan",
        "given": "Sisi"
      },
      {
        "family": "Zhou",
        "given": "Bing"
      },
      {
        "family": "Song",
        "given": "Shuo"
      },
      {
        "family": "Tang",
        "given": "Xian"
      },
      {
        "family": "Yu",
        "given": "Jinfang"
      },
      {
        "family": "Ge",
        "given": "Jiwan"
      },
      {
        "family": "Lan",
        "given": "Jun"
      },
      {
        "family": "Yuan",
        "given": "Jing"
      },
      {
        "family": "Wang",
        "given": "Haiyan"
      },
      {
        "family": "Zhao",
        "given": "Juanjuan"
      },
      {
        "family": "Zhang",
        "given": "Shuye"
      },
      {
        "family": "Wang",
        "given": "Youchun"
      },
      {
        "family": "Shi",
        "given": "Xuanling"
      },
      {
        "family": "Liu",
        "given": "Lei"
      },
      {
        "family": "Wang",
        "given": "Xinquan"
      },
      {
        "family": "Zhang",
        "given": "Zheng"
      },
      {
        "family": "Zhang",
        "given": "Linqi"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          26
        ]
      ]
    },
    "abstract": "The pandemic caused by emerging coronavirus SARS-CoV-2 presents a serious global public health emergency in urgent need of prophylactic and therapeutic interventions. SARS-CoV-2 cellular entry depends on binding between the viral Spike protein receptor-binding domain (RBD) and the angiotensin converting enzyme 2 (ACE2) target cell receptor. Here, we report on the isolation and characterization of 206 RBD-specific monoclonal antibodies (mAbs) derived from single B cells of eight SARS-CoV-2 infected individuals. These mAbs come from diverse families of antibody heavy and light chains without apparent enrichment for particular families in the repertoire. In samples from one patient selected for further analyses, we found coexistence of germline and germline divergent clones. Both clone types demonstrated impressive binding and neutralizing activity against pseudovirus and live SARS-CoV-2. However, the antibody neutralizing potency is determined by competition with ACE2 receptor for RBD binding. Surprisingly, none of the SARS-CoV-2 antibodies nor the infected plasma cross-reacted with RBDs from either SARS-CoV or MERS-CoV although substantial plasma cross-reactivity to the trimeric Spike proteins from SARS-CoV and MERS-CoV was found. These results suggest that antibody response to RBDs is viral species-specific while that cross-recognition target regions outside the RBD. The specificity and neutralizing characteristics of this plasma cross-reactivity requires further investigation. Nevertheless, the diverse and potent neutralizing antibodies identified here are promising candidates for prophylactic and therapeutic SARS-CoV-2 interventions.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.21.990770",
    "publisher": "bioRxiv",
    "title": "Potent human neutralizing antibodies elicited by SARS-CoV-2 infection",
    "URL": "https://doi.org/ggp7t4",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.21.990770"
  },
  {
    "type": "article-journal",
    "id": "bCYYaFKM",
    "author": [
      {
        "family": "Davidson",
        "given": "Andrew D."
      },
      {
        "family": "Williamson",
        "given": "Maia Kavanagh"
      },
      {
        "family": "Lewis",
        "given": "Sebastian"
      },
      {
        "family": "Shoemark",
        "given": "Deborah"
      },
      {
        "family": "Carroll",
        "given": "Miles W."
      },
      {
        "family": "Heesom",
        "given": "Kate"
      },
      {
        "family": "Zambon",
        "given": "Maria"
      },
      {
        "family": "Ellis",
        "given": "Joanna"
      },
      {
        "family": "Lewis",
        "given": "Phillip A."
      },
      {
        "family": "Hiscox",
        "given": "Julian A."
      },
      {
        "family": "Matthews",
        "given": "David A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          24
        ]
      ]
    },
    "abstract": "Direct RNA sequencing using an Oxford Nanopore MinION characterised the transcriptome of SARS-CoV-2 grown in Vero E6 cells. This cell line is being widely used to propagate the novel coronavirus. The viral transcriptome was analysed using a recently developed ORF-centric pipeline. This revealed the pattern of viral transcripts, (i.e. subgenomic mRNAs), generally fitted the predicted replication and transcription model for coronaviruses. A 24 nt in-frame deletion was detected in subgenomic mRNAs encoding the spike (S) glycoprotein. This feature was identified in over half of the mapped transcripts and was predicted to remove a proposed furin cleavage site from the S glycoprotein. This motif directs cleavage of the S glycoprotein into functional subunits during virus entry or exit. Cleavage of the S glycoprotein can be a barrier to zoonotic coronavirus transmission and affect viral pathogenicity. Allied to this transcriptome analysis, tandem mass spectrometry was used to identify over 500 viral peptides and 44 phosphopeptides, covering almost all of the proteins predicted to be encoded by the SARS-CoV-2 genome, including peptides unique to the deleted variant of the S glycoprotein. Detection of an apparently viable deletion in the furin cleavage site of the S glycoprotein reinforces the point that this and other regions of SARS-CoV-2 proteins may readily mutate. This is of clear significance given the interest in the S glycoprotein as a potential vaccine target and the observation that the furin cleavage site likely contributes strongly to the pathogenesis and zoonosis of this virus. The viral genome sequence should be carefully monitored during the growth of viral stocks for research, animal challenge models and, potentially, in clinical samples. Such variations may result in different levels of virulence, morbidity and mortality.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.22.002204",
    "publisher": "bioRxiv",
    "title": "Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site",
    "URL": "https://doi.org/ggq65n",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.002204"
  },
  {
    "type": "article-journal",
    "id": "phJM8g2Y",
    "author": [
      {
        "family": "Gordon",
        "given": "David E."
      },
      {
        "family": "Jang",
        "given": "Gwendolyn M."
      },
      {
        "family": "Bouhaddou",
        "given": "Mehdi"
      },
      {
        "family": "Xu",
        "given": "Jiewei"
      },
      {
        "family": "Obernier",
        "given": "Kirsten"
      },
      {
        "family": "O’Meara",
        "given": "Matthew J."
      },
      {
        "family": "Guo",
        "given": "Jeffrey Z."
      },
      {
        "family": "Swaney",
        "given": "Danielle L."
      },
      {
        "family": "Tummino",
        "given": "Tia A."
      },
      {
        "family": "Hüttenhain",
        "given": "Ruth"
      },
      {
        "family": "Kaake",
        "given": "Robyn M."
      },
      {
        "family": "Richards",
        "given": "Alicia L."
      },
      {
        "family": "Tutuncuoglu",
        "given": "Beril"
      },
      {
        "family": "Foussard",
        "given": "Helene"
      },
      {
        "family": "Batra",
        "given": "Jyoti"
      },
      {
        "family": "Haas",
        "given": "Kelsey"
      },
      {
        "family": "Modak",
        "given": "Maya"
      },
      {
        "family": "Kim",
        "given": "Minkyu"
      },
      {
        "family": "Haas",
        "given": "Paige"
      },
      {
        "family": "Polacco",
        "given": "Benjamin J."
      },
      {
        "family": "Braberg",
        "given": "Hannes"
      },
      {
        "family": "Fabius",
        "given": "Jacqueline M."
      },
      {
        "family": "Eckhardt",
        "given": "Manon"
      },
      {
        "family": "Soucheray",
        "given": "Margaret"
      },
      {
        "family": "Bennett",
        "given": "Melanie J."
      },
      {
        "family": "Cakir",
        "given": "Merve"
      },
      {
        "family": "McGregor",
        "given": "Michael J"
      },
      {
        "family": "Li",
        "given": "Qiongyu"
      },
      {
        "family": "Naing",
        "given": "Zun Zar Chi"
      },
      {
        "family": "Zhou",
        "given": "Yuan"
      },
      {
        "family": "Peng",
        "given": "Shiming"
      },
      {
        "family": "Kirby",
        "given": "Ilsa T."
      },
      {
        "family": "Melnyk",
        "given": "James E."
      },
      {
        "family": "Chorba",
        "given": "John S."
      },
      {
        "family": "Lou",
        "given": "Kevin"
      },
      {
        "family": "Dai",
        "given": "Shizhong A."
      },
      {
        "family": "Shen",
        "given": "Wenqi"
      },
      {
        "family": "Shi",
        "given": "Ying"
      },
      {
        "family": "Zhang",
        "given": "Ziyang"
      },
      {
        "family": "Barrio-Hernandez",
        "given": "Inigo"
      },
      {
        "family": "Memon",
        "given": "Danish"
      },
      {
        "family": "Hernandez-Armenta",
        "given": "Claudia"
      },
      {
        "family": "Mathy",
        "given": "Christopher J.P."
      },
      {
        "family": "Perica",
        "given": "Tina"
      },
      {
        "family": "Pilla",
        "given": "Kala B."
      },
      {
        "family": "Ganesan",
        "given": "Sai J."
      },
      {
        "family": "Saltzberg",
        "given": "Daniel J."
      },
      {
        "family": "Ramachandran",
        "given": "Rakesh"
      },
      {
        "family": "Liu",
        "given": "Xi"
      },
      {
        "family": "Rosenthal",
        "given": "Sara B."
      },
      {
        "family": "Calviello",
        "given": "Lorenzo"
      },
      {
        "family": "Venkataramanan",
        "given": "Srivats"
      },
      {
        "family": "Lin",
        "given": "Yizhu"
      },
      {
        "family": "Wankowicz",
        "given": "Stephanie A."
      },
      {
        "family": "Bohn",
        "given": "Markus"
      },
      {
        "family": "Trenker",
        "given": "Raphael"
      },
      {
        "family": "Young",
        "given": "Janet M."
      },
      {
        "family": "Cavero",
        "given": "Devin"
      },
      {
        "family": "Hiatt",
        "given": "Joe"
      },
      {
        "family": "Roth",
        "given": "Theo"
      },
      {
        "family": "Rathore",
        "given": "Ujjwal"
      },
      {
        "family": "Subramanian",
        "given": "Advait"
      },
      {
        "family": "Noack",
        "given": "Julia"
      },
      {
        "family": "Hubert",
        "given": "Mathieu"
      },
      {
        "family": "Roesch",
        "given": "Ferdinand"
      },
      {
        "family": "Vallet",
        "given": "Thomas"
      },
      {
        "family": "Meyer",
        "given": "Björn"
      },
      {
        "family": "White",
        "given": "Kris M."
      },
      {
        "family": "Miorin",
        "given": "Lisa"
      },
      {
        "family": "Agard",
        "given": "David"
      },
      {
        "family": "Emerman",
        "given": "Michael"
      },
      {
        "family": "Ruggero",
        "given": "Davide"
      },
      {
        "family": "García-Sastre",
        "given": "Adolfo"
      },
      {
        "family": "Jura",
        "given": "Natalia"
      },
      {
        "family": "Zastrow",
        "given": "Mark von"
      },
      {
        "family": "Taunton",
        "given": "Jack"
      },
      {
        "family": "Schwartz",
        "given": "Olivier"
      },
      {
        "family": "Vignuzzi",
        "given": "Marco"
      },
      {
        "family": "d’Enfert",
        "given": "Christophe"
      },
      {
        "family": "Mukherjee",
        "given": "Shaeri"
      },
      {
        "family": "Jacobson",
        "given": "Matt"
      },
      {
        "family": "Malik",
        "given": "Harmit S."
      },
      {
        "family": "Fujimori",
        "given": "Danica G."
      },
      {
        "family": "Ideker",
        "given": "Trey"
      },
      {
        "family": "Craik",
        "given": "Charles S."
      },
      {
        "family": "Floor",
        "given": "Stephen"
      },
      {
        "family": "Fraser",
        "given": "James S."
      },
      {
        "family": "Gross",
        "given": "John"
      },
      {
        "family": "Sali",
        "given": "Andrej"
      },
      {
        "family": "Kortemme",
        "given": "Tanja"
      },
      {
        "family": "Beltrao",
        "given": "Pedro"
      },
      {
        "family": "Shokat",
        "given": "Kevan"
      },
      {
        "family": "Shoichet",
        "given": "Brian K."
      },
      {
        "family": "Krogan",
        "given": "Nevan J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          22
        ]
      ]
    },
    "abstract": "An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption . There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.22.002386",
    "publisher": "bioRxiv",
    "title": "A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing",
    "URL": "https://doi.org/ggpptg",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.002386"
  },
  {
    "type": "article-journal",
    "id": "RTIk8DTo",
    "author": [
      {
        "family": "Chen",
        "given": "Hongyi"
      },
      {
        "family": "Zhang",
        "given": "Zhicheng"
      },
      {
        "family": "Wang",
        "given": "Li"
      },
      {
        "family": "Huang",
        "given": "Zhihua"
      },
      {
        "family": "Gong",
        "given": "Fanghua"
      },
      {
        "family": "Li",
        "given": "Xiaodong"
      },
      {
        "family": "Chen",
        "given": "Yahong"
      },
      {
        "family": "WU",
        "given": "Jinzi J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          24
        ]
      ]
    },
    "abstract": "As coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), started in China in January, 2020, repurposing approved drugs is emerging as important therapeutic options. We reported here the first clinical study using hepatitis C virus (HCV) protease inhibitor, danoprevir, to treat COVID-19 patients. Danoprevir (Ganovo) is a potent HCV protease (NS3/4A) inhibitor (IC50 = 0.29 nM), which was approved and marketed in China since 2018 to treat chronic hepatitis C patients. Ritonavir is a CYP3A4 inhibitor to enhance plasma concentration of danoprevir while it also acts as a human immunodeficiency virus (HIV) protease inhibitor at high doses. The chymotrypsin-like protease of SARS-CoV-2 shares structure similarity with HCV and HIV proteases. In the current clinical study ( ) conducted at the Nineth Hospital of Nanchang, we evaluated therapeutic effects of danoprevir, boosted by ritonavir, on treatment naive and experienced COVID-19 patients. The data from this small-sample clinical study showed that danoprevir boosted by ritonavir is safe and well tolerated in all patients. After 4 to 12-day treatment of danoprevir boosted by ritonavir, all eleven patients enrolled, two naive and nine experienced, were discharged from the hospital as they met all four conditions as follows: (1) normal body temperature for at least 3 days; (2) significantly improved respiratory symptoms; (3) lung imaging shows obvious absorption and recovery of acute exudative lesion; and (4) two consecutive RT-PCR negative tests of SARS-CoV-2 nucleotide acid (respiratory track sampling with interval at least one day). Our findings suggest that repurposing danoprevir for COVID-19 is a promising therapeutic option.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.22.20034041",
    "publisher": "medRxiv",
    "title": "First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients",
    "URL": "https://doi.org/ggrgbt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.20034041"
  },
  {
    "type": "article-journal",
    "id": "wzHb7Mj5",
    "author": [
      {
        "family": "Chen",
        "given": "Zhaowei"
      },
      {
        "family": "Hu",
        "given": "Jijia"
      },
      {
        "family": "Zhang",
        "given": "Zongwei"
      },
      {
        "family": "Jiang",
        "given": "Shan"
      },
      {
        "family": "Han",
        "given": "Shoumeng"
      },
      {
        "family": "Yan",
        "given": "Dandan"
      },
      {
        "family": "Zhuang",
        "given": "Ruhong"
      },
      {
        "family": "Hu",
        "given": "Ben"
      },
      {
        "family": "Zhang",
        "given": "Zhan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          31
        ]
      ]
    },
    "abstract": "Aims: Studies have indicated that chloroquine (CQ) shows antagonism against COVID-19 in vitro. However, evidence regarding its effects in patients is limited. This study aims to evaluate the efficacy of hydroxychloroquine (HCQ) in the treatment of patients with COVID-19. Main methods: From February 4 to February 28, 2020, 62 patients suffering from COVID-19 were diagnosed and admitted to Renmin Hospital of Wuhan University. All participants were randomized in a parallel-group trial, 31 patients were assigned to receive an additional 5-day HCQ (400 mg/d) treatment, Time to clinical recovery (TTCR), clinical characteristics, and radiological results were assessed at baseline and 5 days after treatment to evaluate the effect of HCQ. Key findings: For the 62 COVID-19 patients, 46.8% (29 of 62) were male and 53.2% (33 of 62) were female, the mean age was 44.7 (15.3) years. No difference in the age and sex distribution between the control group and the HCQ group. But for TTCR, the body temperature recovery time and the cough remission time were significantly shortened in the HCQ treatment group. Besides, a larger proportion of patients with improved pneumonia in the HCQ treatment group (80.6%, 25 of 32) compared with the control group (54.8%, 17 of 32). Notably, all 4 patients progressed to severe illness that occurred in the control group. However, there were 2 patients with mild adverse reactions in the HCQ treatment group. Significance: Among patients with COVID-19, the use of HCQ could significantly shorten TTCR and promote the absorption of pneumonia.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.22.20040758",
    "publisher": "medRxiv",
    "title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial",
    "URL": "https://doi.org/ggqm4v",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.20040758"
  },
  {
    "type": "article-journal",
    "id": "itj26agd",
    "author": [
      {
        "family": "Roques",
        "given": "Lionel"
      },
      {
        "family": "Klein",
        "given": "Etienne"
      },
      {
        "family": "Papaix",
        "given": "Julien"
      },
      {
        "family": "Sar",
        "given": "Antoine"
      },
      {
        "family": "Soubeyrand",
        "given": "Samuel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          7
        ]
      ]
    },
    "abstract": "The first cases of COVID-19 in France were detected on January 24, 2020. The number of screening tests carried out and the methodology used to target the patients tested do not allow for a direct computation of the actual number of cases and the infection fatality ratio (IFR). We develop a 'mechanistic-statistical' approach coupling a SIR ODE model describing the unobserved epidemiological dynamics, a probabilistic model describing the data acquisition process and a statistical inference method. The objective of this model is not to make forecasts but to estimate the actual number of people infected with COVID-19 during the observation window in France and to deduce the IFR associated with the epidemic in France. Main results. The actual number of infected cases in France is probably higher than the observations: we find here a factor x5 (95%-CI: 3.5-7.8) which leads to an IFR in France of 0.5% (95%-CI: 0.3-0.8). Although accurate in France, the SIR model cannot capture the decline in the number of cases observed in South Korea: this points out the strong impact on the epidemic dynamics of the management strategy adopted in South Korea.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.22.20040915",
    "publisher": "medRxiv",
    "title": "Using early data to estimate the actual infection fatality ratio from COVID-19 in France",
    "URL": "https://doi.org/ggqhz2",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.22.20040915"
  },
  {
    "type": "article-journal",
    "id": "lnuNSHEW",
    "author": [
      {
        "family": "Lou",
        "given": "Bin"
      },
      {
        "family": "Li",
        "given": "Tigndong"
      },
      {
        "family": "Zheng",
        "given": "Shufa"
      },
      {
        "family": "Su",
        "given": "Yingying"
      },
      {
        "family": "Li",
        "given": "Zhiyong"
      },
      {
        "family": "Liu",
        "given": "Wei"
      },
      {
        "family": "Yu",
        "given": "Fei"
      },
      {
        "family": "Ge",
        "given": "Shengxiang"
      },
      {
        "family": "Zou",
        "given": "Qianda"
      },
      {
        "family": "Yuan",
        "given": "Quan"
      },
      {
        "family": "Lin",
        "given": "Sha"
      },
      {
        "family": "Hong",
        "given": "Congming"
      },
      {
        "family": "Yao",
        "given": "Xiangyang"
      },
      {
        "family": "Zhang",
        "given": "Xuejie"
      },
      {
        "family": "Wu",
        "given": "Dinghui"
      },
      {
        "family": "Zhou",
        "given": "Guoliang"
      },
      {
        "family": "Hou",
        "given": "Wangheng"
      },
      {
        "family": "Li",
        "given": "Tingting"
      },
      {
        "family": "Zhang",
        "given": "Yali"
      },
      {
        "family": "Zhang",
        "given": "Shiyin"
      },
      {
        "family": "Fan",
        "given": "Jian"
      },
      {
        "family": "Zhang",
        "given": "Jun"
      },
      {
        "family": "Xia",
        "given": "Ningshao"
      },
      {
        "family": "Chen",
        "given": "Yu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "Background Timely diagnosis of SARS-CoV-2 infection is the prerequisite for treatment and preventive quarantine. The serology characteristics and complement diagnosis value of antibody test to RNA test needs to be demonstrated. Method A patient cohort study was conducted at the first affiliated hospital of Zhejiang University, China. Serial sera of COVID-19 patients were collected and total antibody (Ab), IgM and IgG antibody against SARS-CoV-2 were detected. The antibody dynamics during the infection were described. Results The seroconversion rate for Ab, IgM and IgG in COVID-19 patients was 98.8% (79/80), 93.8% (75/80) and 93.8% (75/80), respectively. The first detectible serology marker is total antibody and followed by IgM and IgG, with a median seroconversion time of 15, 18 and 20 day post exposure (d.p.e) or 9, 10 and 12 days post onset, separately. The antibody levels increased rapidly since 6 d.p.o and accompanied with the decline of viral load. For patients in the early stage of illness (0-7d.p.o),Ab showed the highest sensitivity (64.1%) compared to the IgM and IgG (33.3% for both, p&lt;0.001). The sensitivities of Ab, IgM and IgG detection increased to 100%, 96.7% and 93.3% two weeks later, respectively. Conclusions Typical acute antibody response is induced during the SARS-CoV-2 infection. The serology testing provides important complementation to RNA test for pathogenic specific diagnosis and helpful information to evaluate the adapted immunity status of patient. It should be strongly recommended to apply well-validated antibody tests in the clinical management and public health practice to improve the control of COVID-19 infection.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.23.20041707",
    "publisher": "medRxiv",
    "title": "Serology characteristics of SARS-CoV-2 infection since the exposure and post symptoms onset",
    "URL": "https://doi.org/ggrbkc",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.23.20041707"
  },
  {
    "type": "article-journal",
    "id": "aNSdARwe",
    "author": [
      {
        "family": "Blanco-Melo",
        "given": "Daniel"
      },
      {
        "family": "Nilsson-Payant",
        "given": "Benjamin E."
      },
      {
        "family": "Liu",
        "given": "Wen-Chun"
      },
      {
        "family": "Møller",
        "given": "Rasmus"
      },
      {
        "family": "Panis",
        "given": "Maryline"
      },
      {
        "family": "Sachs",
        "given": "David"
      },
      {
        "family": "Albrecht",
        "given": "Randy A."
      },
      {
        "family": "tenOever",
        "given": "Benjamin R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          24
        ]
      ]
    },
    "abstract": "One of the greatest threats to humanity is the emergence of a pandemic virus. Among those with the greatest potential for such an event include influenza viruses and coronaviruses. In the last century alone, we have observed four major influenza A virus pandemics as well as the emergence of three highly pathogenic coronaviruses including SARS-CoV-2, the causative agent of the ongoing COVID-19 pandemic. As no effective antiviral treatments or vaccines are presently available against SARS-CoV-2, it is important to understand the host response to this virus as this may guide the efforts in development towards novel therapeutics. Here, we offer the first in-depth characterization of the host transcriptional response to SARS-CoV-2 and other respiratory infections through , and model systems. Our data demonstrate the each virus elicits both core antiviral components as well as unique transcriptional footprints. Compared to the response to influenza A virus and respiratory syncytial virus, SARS-CoV-2 elicits a muted response that lacks robust induction of a subset of cytokines including the Type I and Type III interferons as well as a numerous chemokines. Taken together, these data suggest that the unique transcriptional signature of this virus may be responsible for the development of COVID-19.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.24.004655",
    "publisher": "bioRxiv",
    "title": "SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems",
    "URL": "https://doi.org/ggq65q",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.004655"
  },
  {
    "type": "article-journal",
    "id": "EWZmuLvu",
    "author": [
      {
        "family": "Zhou",
        "given": "Ying"
      },
      {
        "family": "Yang",
        "given": "Zhen"
      },
      {
        "family": "Guo",
        "given": "Yanan"
      },
      {
        "family": "Geng",
        "given": "Shuang"
      },
      {
        "family": "Gao",
        "given": "Shan"
      },
      {
        "family": "Ye",
        "given": "Shenglan"
      },
      {
        "family": "Hu",
        "given": "Yi"
      },
      {
        "family": "Wang",
        "given": "Yafei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          27
        ]
      ]
    },
    "abstract": "Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, Hubei, China. This study sought to elucidate a novel predictor of disease severity in patients with coronavirus disease-19 (COVID-19) cased by SARS-CoV-2. Methods: Patients enrolled in this study were all hospitalized with COVID-19 in the Central Hospital of Wuhan, China. Clinical features, chronic comorbidities, demographic data, and laboratory and radiological data were reviewed. The outcomes of patients with severe pneumonia and those with non-severe pneumonia were compared using the Statistical Package for the Social Sciences (IBM Corp., Armonk, NY, USA) to explore clinical characteristics and risk factors. The receiver operating characteristic curve was used to screen optimal predictors from the risk factors and the predictive power was verified by internal validation. Results: A total of 377 patients diagnosed with COVID-19 were enrolled in this study, including 117 with severe pneumonia and 260 with non-severe pneumonia. The independent risk factors for severe pneumonia were age [odds ratio (OR): 1.059, 95% confidence interval (CI): 1.036-1.082; p &lt; 0.001], N/L (OR: 1.322, 95% CI: 1.180-1.481; p &lt; 0.001), CRP (OR: 1.231, 95% CI: 1.129-1.341; p = 0.002), and D-dimer (OR: 1.059, 95% CI: 1.013-1.107; p = 0.011). We identified a product of N/L*CRP*D-dimer as having an important predictive value for the severity of COVID-19. The cutoff value was 5.32. The negative predictive value of less than 5.32 for the N/L*CRP*D-dimer was 93.75%, while the positive predictive value was 46.03% in the test sets. The sensitivity and specificity were 89.47% and 67.42%. In the training sets, the negative and positive predictive values were 93.80% and 41.32%, respectively, with a specificity of 70.76% and a sensitivity of 89.87%. Conclusions: A product of N/L*CRP*D-dimer may be an important predictor of disease severity in patients with COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.24.20042119",
    "publisher": "medRxiv",
    "title": "A New Predictor of Disease Severity in Patients with COVID-19 in Wuhan, China",
    "URL": "https://doi.org/ggq65r",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.20042119"
  },
  {
    "type": "article-journal",
    "id": "95sQSGzx",
    "author": [
      {
        "family": "Nie",
        "given": "Shuke"
      },
      {
        "family": "Zhao",
        "given": "Xueqing"
      },
      {
        "family": "Zhao",
        "given": "Kang"
      },
      {
        "family": "Zhang",
        "given": "Zhaohui"
      },
      {
        "family": "Zhang",
        "given": "Zhentao"
      },
      {
        "family": "Zhang",
        "given": "Zhan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          26
        ]
      ]
    },
    "abstract": "Background: The coronavirus disease 2019 (COVID-19) is spreading worldwide with 16,558 deaths till date. Serum albumin, high-density lipoprotein (HDL-C), and C-reactive protein have been known to be associated with the severity and mortality of community-acquired pneumonia. However, the characteristics and role of metabolic and inflammatory indicators in COVID-19 is unclear. Methods: We included 97 hospitalized patients with laboratory-confirmed COVID-19. Epidemiological, clinical, and laboratory indices; radiological features; and treatment were analysed. The differences in the clinical and laboratory parameters between mild and severe COVID-19 patients and the role of these indicators in severity prediction of COVID-19 were investigated. Results: All were Wuhan residents with contact with confirmed COVID-19 cases. The median age was 39 years (IQR: 30-59). The most common presenting symptoms were fever (58.8%), cough (55.7%), and fatigue (33%). Other features were lymphopenia, impaired fasting glucose, hypoproteinaemia, hypoalbuminemia, low high-density lipoproteinemia. Decrease in lymphocyte count, serum total protein, serum albumin, high-density lipoprotein cholesterol (HDL-C), ApoA1, CD3+T%, and CD8+T% were found to be valuable in predicting the transition of COVID-19 from mild to severe illness. Chest computed tomography (CT) images showed that the absorption of bilateral lung lesions synchronized with the recovery of metabolic and inflammatory indicators. Conclusions: Hypoproteinaemia, hypoalbuminemia, low high-density lipoproteinemia, and decreased ApoA1, CD3+T%, and CD8+T% could predict severity of COVID-19. Lymphocyte count, total serum protein, and HDL-C may be potentially useful for the evaluation of COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.24.20042283",
    "publisher": "medRxiv",
    "title": "Metabolic disturbances and inflammatory dysfunction predict severity of coronavirus disease 2019 (COVID-19): a retrospective study",
    "URL": "https://doi.org/ggq65s",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.20042283"
  },
  {
    "type": "article-journal",
    "id": "btVuoX6V",
    "author": [
      {
        "family": "Tan",
        "given": "Wenting"
      },
      {
        "family": "Lu",
        "given": "Yanqiu"
      },
      {
        "family": "Zhang",
        "given": "Juan"
      },
      {
        "family": "Wang",
        "given": "Jing"
      },
      {
        "family": "Dan",
        "given": "Yunjie"
      },
      {
        "family": "Tan",
        "given": "Zhaoxia"
      },
      {
        "family": "He",
        "given": "Xiaoqing"
      },
      {
        "family": "Qian",
        "given": "Chunfang"
      },
      {
        "family": "Sun",
        "given": "Qiangzhong"
      },
      {
        "family": "Hu",
        "given": "Qingli"
      },
      {
        "family": "Liu",
        "given": "Honglan"
      },
      {
        "family": "Ye",
        "given": "Sikuan"
      },
      {
        "family": "Xiang",
        "given": "Xiaomei"
      },
      {
        "family": "Zhou",
        "given": "Yi"
      },
      {
        "family": "Zhang",
        "given": "Wei"
      },
      {
        "family": "Guo",
        "given": "Yanzhi"
      },
      {
        "family": "Wang",
        "given": "Xiu-Hua"
      },
      {
        "family": "He",
        "given": "Weiwei"
      },
      {
        "family": "Wan",
        "given": "Xing"
      },
      {
        "family": "Sun",
        "given": "Fengming"
      },
      {
        "family": "Wei",
        "given": "Quanfang"
      },
      {
        "family": "Chen",
        "given": "Cong"
      },
      {
        "family": "Pan",
        "given": "Guangqiang"
      },
      {
        "family": "Xia",
        "given": "Jie"
      },
      {
        "family": "Mao",
        "given": "Qing"
      },
      {
        "family": "Chen",
        "given": "Yaokai"
      },
      {
        "family": "Deng",
        "given": "Guohong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          26
        ]
      ]
    },
    "abstract": "A pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading over the world. However, the viral dynamics, host serologic responses, and their associations with clinical manifestations, have not been well described in prospective cohort. We conducted a prospective cohort and enrolled 67 COVID-19 patients admitting between Jan 26 and Feb 5, 2020. Clinical specimens including nasopharyngeal swab, sputum, blood, urine and stool were tested periodically according to standardized case report form with final follow-up on February 27. The routes and duration of viral shedding, antibody response, and their associations with disease severity and clinical manifestations were systematically evaluated. Coronaviral particles in clinical specimens were observed by transmission electron microscopy (TEM). The median duration of SARS-CoV-2 RNA shedding were 12 (3-38), 19 (5-37), and 18 (7-26) days in nasopharyngeal swabs, sputum and stools, respectively. Only 13 urines (5.6%) and 12 plasmas (5.7%) were viral positive. Prolonged viral shedding was observed in severe patients than that of non-severe patients. Cough but not fever, aligned with viral shedding in clinical respiratory specimens, meanwhile the positive stool-RNA appeared to align with the proportion who concurrently had cough and sputum production, but not diarrhea. Typical coronaviral particles could be found directly in sputum by TEM. The anti-nucleocapsid-protein IgM started on day 7 and positive rate peaked on day 28, while that of IgG was on day 10 and day 49 after illness onset. IgM and IgG appear earlier, and their titers are significantly higher in severe patients than non-severe patients (p&lt;0.05). The weak responders for IgG had a significantly higher viral clearance rate than that of strong responders (p= 0.011). Nasopharyngeal, sputum and stools rather than blood and urine, were the major shedding routes for SARS-CoV-2, and meanwhile sputum had a prolonged viral shedding. Symptom cough seems to be aligned with viral shedding in clinical respiratory and fecal specimens. Stronger antibody response was associated with delayed viral clearance and disease severity.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.24.20042382",
    "publisher": "medRxiv",
    "title": "Viral Kinetics and Antibody Responses in Patients with COVID-19",
    "URL": "https://doi.org/ggq65t",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.20042382"
  },
  {
    "type": "article-journal",
    "id": "1FZgghazg",
    "author": [
      {
        "family": "Zhang",
        "given": "Dan"
      },
      {
        "family": "Guo",
        "given": "Rui"
      },
      {
        "family": "Lei",
        "given": "Lei"
      },
      {
        "family": "Liu",
        "given": "Hongjuan"
      },
      {
        "family": "Wang",
        "given": "Yawen"
      },
      {
        "family": "Wang",
        "given": "Yili"
      },
      {
        "family": "Dai",
        "given": "Tongxin"
      },
      {
        "family": "Zhang",
        "given": "Tianxiao"
      },
      {
        "family": "Lai",
        "given": "Yanjun"
      },
      {
        "family": "Wang",
        "given": "Jingya"
      },
      {
        "family": "Liu",
        "given": "Zhiqiang"
      },
      {
        "family": "He",
        "given": "Aili"
      },
      {
        "family": "O'Dwyer",
        "given": "Michael"
      },
      {
        "family": "Hu",
        "given": "Jinsong"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          26
        ]
      ]
    },
    "abstract": "Background: Excessive monocyte/macrophage activation with the development of a cytokine storm and subsequent acute lung injury, leading to acute respiratory distress syndrome (ARDS) is a feared consequence of infection with COVID-19. The ability to recognize and potentially intervene early in those patients at greatest risk of developing this complication could be of great clinical utility. Methods: We performed detailed flow cytometric analysis of peripheral blood samples from 28 COVID-19 patients treated at Xian No.8 Hospital and the First Affiliated Hospital of Xian Jiaotong University in early 2020 in an attempt to identify factors that could help predict severity of disease and patient outcome. Findings: While we did not detect significant differences in the number of monocytes between patients with COVID-19 and normal healthy individuals,we did identify significant morphological and functional differences, which are more pronounced in patients requiring prolonged hospitalization and ICU admission. Patients with COVID-19 have larger than normal monocytes, easily identified on forward scatter, side scatter analysis by routine flow cytometry,with the presence of a distinct population of monocytes with high forward scatter (FSC-high). On more detailed analysis, these FSC-high monocytes are CD11b+, CD14+, CD16+, CD68+, CD80+, CD163+, CD206+ and secrete IL-6, IL-10 and TNF-alpha, consistent with an inflammatory phenotype. Conclusions: The detection and serial monitoring of this subset of inflammatory monocytes using flow cytometry could be of great help in guiding the prognostication and treatment of patients with COVID-19 and merits further evaluation.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.24.20042655",
    "publisher": "medRxiv",
    "title": "COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the severity of which correlate with patient outcome",
    "URL": "https://doi.org/ggq65v",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.20042655"
  },
  {
    "type": "article-journal",
    "id": "15gdkEnfn",
    "author": [
      {
        "family": "Miller",
        "given": "Aaron"
      },
      {
        "family": "Reandelar",
        "given": "Mac Josh"
      },
      {
        "family": "Fasciglione",
        "given": "Kimberly"
      },
      {
        "family": "Roumenova",
        "given": "Violeta"
      },
      {
        "family": "Li",
        "given": "Yan"
      },
      {
        "family": "Otazu",
        "given": "Gonzalo H"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          28
        ]
      ]
    },
    "abstract": "COVID-19 has spread to most countries in the world. Puzzlingly, the impact of the disease is different in different countries. These differences are attributed to differences in cultural norms, mitigation efforts, and health infrastructure. Here we propose that national differences in COVID-19 impact could be partially explained by the different national policies respect to Bacillus Calmette-Guerin (BCG) childhood vaccination. BCG vaccination has been reported to offer broad protection to respiratory infections. We compared large number of countries BCG vaccination policies with the morbidity and mortality for COVID-19. We found that countries without universal policies of BCG vaccination (Italy, Nederland, USA) have been more severely affected compared to countries with universal and long-standing BCG policies. Countries that have a late start of universal BCG policy (Iran, 1984) had high mortality, consistent with the idea that BCG protects the vaccinated elderly population. We also found that BCG vaccination also reduced the number of reported COVID-19 cases in a country. The combination of reduced morbidity and mortality makes BCG vaccination a potential new tool in the fight against COVID-19.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.24.20042937",
    "publisher": "medRxiv",
    "title": "Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study",
    "URL": "https://doi.org/ggq65w",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.24.20042937"
  },
  {
    "type": "article-journal",
    "id": "12oDb7aki",
    "author": [
      {
        "family": "Brann",
        "given": "David H."
      },
      {
        "family": "Tsukahara",
        "given": "Tatsuya"
      },
      {
        "family": "Weinreb",
        "given": "Caleb"
      },
      {
        "family": "Logan",
        "given": "Darren W."
      },
      {
        "family": "Datta",
        "given": "Sandeep Robert"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          28
        ]
      ]
    },
    "abstract": "Recent reports suggest an association between COVID-19 and altered olfactory function. Here we analyze bulk and single cell RNA-Seq datasets to identify cell types in the olfactory epithelium that express molecules that mediate infection by SARS-CoV-2 (CoV-2), the causal agent in COVID-19. We find in both mouse and human datasets that olfactory sensory neurons do not express two key genes involved in CoV-2 entry, ACE2 and TMPRSS2. In contrast, olfactory epithelial support cells and stem cells express both of these genes, as do cells in the nasal respiratory epithelium. Taken together, these findings suggest possible mechanisms through which CoV-2 infection could lead to anosmia or other forms of olfactory dysfunction.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.25.009084",
    "publisher": "bioRxiv",
    "title": "Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients",
    "URL": "https://doi.org/ggqr4m",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.25.009084"
  },
  {
    "type": "article-journal",
    "id": "t4vofknR",
    "author": [
      {
        "family": "Smith",
        "given": "Joan C"
      },
      {
        "family": "Sheltzer",
        "given": "Jason Meyer"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          31
        ]
      ]
    },
    "abstract": "The coronavirus SARS-CoV-2 has infected more than 600,000 people and has overwhelmed hospital systems around the world. However, the factors mediating fatal SARS-CoV-2 infections are poorly understood. Here, we show that cigarette smoke causes a dose-dependent upregulation of Angiotensin Converting Enzyme 2 (ACE2), the SARS-CoV-2 receptor, in rodent and human lungs. Using single-cell sequencing data, we demonstrate that ACE2 is expressed in a subset of epithelial cells that line the respiratory tract, including goblet cells, club cells, and alveolar type 2 cells. Chronic smoke exposure triggers a protective expansion of mucus-secreting goblet cells and a concomitant increase in ACE2 expression. In contrast, quitting smoking causes a decrease in lung ACE2 levels. Taken together, these results may partially explain why smokers are particularly likely to develop severe SARS-CoV-2 infections, and they suggest that quitting smoking could lessen coronavirus susceptibility.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.28.013672",
    "publisher": "bioRxiv",
    "title": "Cigarette smoke triggers the expansion of a subpopulation of respiratory epithelial cells that express the SARS-CoV-2 receptor ACE2",
    "URL": "https://doi.org/ggq65x",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.28.013672"
  },
  {
    "type": "article-journal",
    "id": "k1E3DuFN",
    "author": [
      {
        "family": "Liu",
        "given": "Rui"
      },
      {
        "family": "Liu",
        "given": "Xinghui"
      },
      {
        "family": "Han",
        "given": "Huan"
      },
      {
        "family": "Shereen",
        "given": "Muhammad Adnan"
      },
      {
        "family": "Niu",
        "given": "Zhili"
      },
      {
        "family": "Li",
        "given": "Dong"
      },
      {
        "family": "Liu",
        "given": "Fang"
      },
      {
        "family": "Wu",
        "given": "Kailang"
      },
      {
        "family": "Luo",
        "given": "Zhen"
      },
      {
        "family": "Zhu",
        "given": "Chengliang"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "abstract": "Background: As the increasing number of Corona Virus Disease 2019 (COVID-19) patients caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2), which caused an outbreak initiated from Wuhan, China in December, 2019, the clinical features and treatment of COVID-19 patients have been understood. However, it is urgent to need the rapid and accurate detection for SARS-CoV-2 infection diagnosis. We aimed to evaluate the antibodies-based and nucleic acid-based tests (NAT) for SARS-CoV-2-infected patients. Method: We retrospectively and observationally studied 133 patients diagnosed with SARS-CoV-2 and admitted in Renmin Hospital of Wuhan University, China, from Feb 17 to Mar 1, 2020. Demographic data, symptoms, clinical examination, laboratory tests, and clinical outcomes were collected. Data were compared between IgM-IgG antibody test and real-time RT-PCR detection for COVID-19 patients. Results: Of 133 patients with SARS-CoV-2 infection, there were 44 moderate cases, 52 severe cases, and 37 critical cases with no significant difference of gender and age among three subgroups. Overall, the positive ratio in IgM antibody test was higher than in RT-PCR detection. In RT-PCR detection, the positive ratio was 65.91%, 71.15%, and 67.57% in moderate, severe, and critical cases, respectively. Whereas, the positive ratio of IgM/IgG antibody detection in patients was 79.55%/93.18%, 82.69%/100%, and 72.97%/97.30% in moderate, severe, and critical cases, respectively. Moreover, the concentrations of antibodies were also measured in three subgroups. Conclusion: The IgM-IgG antibodies-based test exhibited a comparative superiority to the NAT for COVID-19 diagnosis, which provides an effective complement to the false negative results from NAT for SARS-CoV-2 infection diagnosis.",
    "container-title": "medRxiv",
    "DOI": "10.1101/2020.03.28.20045765",
    "publisher": "medRxiv",
    "title": "The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis",
    "URL": "https://doi.org/ggqtp5",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.28.20045765"
  },
  {
    "type": "article-journal",
    "id": "NLoN4aYj",
    "author": [
      {
        "family": "Li",
        "given": "Jingjiao"
      },
      {
        "family": "Guo",
        "given": "Mingquan"
      },
      {
        "family": "Tian",
        "given": "Xiaoxu"
      },
      {
        "family": "Liu",
        "given": "Chengrong"
      },
      {
        "family": "Wang",
        "given": "Xin"
      },
      {
        "family": "Yang",
        "given": "Xing"
      },
      {
        "family": "Wu",
        "given": "Ping"
      },
      {
        "family": "Xiao",
        "given": "Zixuan"
      },
      {
        "family": "Qu",
        "given": "Yafei"
      },
      {
        "family": "Yin",
        "given": "Yue"
      },
      {
        "family": "Fu",
        "given": "Joyce"
      },
      {
        "family": "Zhu",
        "given": "Zhaoqin"
      },
      {
        "family": "Liu",
        "given": "Zhenshan"
      },
      {
        "family": "Peng",
        "given": "Chao"
      },
      {
        "family": "Zhu",
        "given": "Tongyu"
      },
      {
        "family": "Liang",
        "given": "Qiming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          2
        ]
      ]
    },
    "abstract": "The ongoing coronavirus disease (COVID-19) pandemic caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a global public health concern due to relatively easy person-to-person transmission and the current lack of effective antiviral therapy. However, the exact molecular mechanisms of SARS-CoV-2 pathogenesis remain largely unknown. We exploited an integrated proteomics approach to systematically investigate intra-viral and virus-host interactomes for the identification of unrealized SARS-CoV-2 host targets and participation of cellular proteins in the response to viral infection using peripheral blood mononuclear cells (PBMCs) isolated from COVID-19 patients. Using this approach, we elucidated 251 host proteins targeted by SARS-CoV-2 and more than 200 host proteins that are significantly perturbed in COVID-19 derived PBMCs. From the interactome, we further identified that non-structural protein nsp9 and nsp10 interact with NKRF, a NF-КB repressor, and may precipitate the strong IL-8/IL-6 mediated chemotaxis of neutrophils and overexuberant host inflammatory response observed in COVID-19 patients. Our integrative study not only presents a systematic examination of SARS-CoV-2-induced perturbation of host targets and cellular networks to reflect disease etiology, but also reveals insights into the mechanisms by which SARS-CoV-2 triggers cytokine storms and represents a powerful resource in the quest for therapeutic intervention.",
    "container-title": "bioRxiv",
    "DOI": "10.1101/2020.03.31.019216",
    "publisher": "bioRxiv",
    "title": "Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis",
    "URL": "https://doi.org/ggrgbv",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1101/2020.03.31.019216"
  },
  {
    "type": "article-journal",
    "id": "IJzmtJOr",
    "author": [
      {
        "family": "Chen",
        "given": "Le-Feng"
      },
      {
        "family": "Mo",
        "given": "Ying-Qian"
      },
      {
        "family": "Jing",
        "given": "Jun"
      },
      {
        "family": "Ma",
        "given": "Jian-Da"
      },
      {
        "family": "Zheng",
        "given": "Dong-Hui"
      },
      {
        "family": "Dai",
        "given": "Lie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          7
        ]
      ]
    },
    "container-title": "International Journal of Rheumatic Diseases",
    "DOI": "10.1111/1756-185x.13010",
    "volume": "20",
    "issue": "7",
    "page": "859-869",
    "publisher": "Wiley",
    "title": "Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation",
    "URL": "https://doi.org/f9pbc5",
    "PMID": "28160426",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/1756-185x.13010"
  },
  {
    "type": "article-journal",
    "id": "JNyhLAfe",
    "author": [
      {
        "family": "Calder",
        "given": "Philip C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          3
        ]
      ]
    },
    "container-title": "British Journal of Clinical Pharmacology",
    "DOI": "10.1111/j.1365-2125.2012.04374.x",
    "volume": "75",
    "issue": "3",
    "page": "645-662",
    "publisher": "Wiley",
    "title": "Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?",
    "URL": "https://doi.org/ggqmgg",
    "PMCID": "PMC3575932",
    "PMID": "22765297",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1365-2125.2012.04374.x"
  },
  {
    "type": "article-journal",
    "id": "16CD4voW1",
    "author": [
      {
        "family": "Heesterbeek",
        "given": "J. A. P."
      },
      {
        "family": "Dietz",
        "given": "K."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1996,
          3
        ]
      ]
    },
    "container-title": "Statistica Neerlandica",
    "DOI": "10.1111/j.1467-9574.1996.tb01482.x",
    "volume": "50",
    "issue": "1",
    "page": "89-110",
    "publisher": "Wiley",
    "title": "The concept of R <sub>o</sub> in epidemic theory",
    "URL": "https://doi.org/d29ch4",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1467-9574.1996.tb01482.x"
  },
  {
    "type": "article-journal",
    "id": "3gp7t98X",
    "author": [
      {
        "family": "Hsueh",
        "given": "P.-R."
      },
      {
        "family": "Huang",
        "given": "L.-M."
      },
      {
        "family": "Chen",
        "given": "P.-J."
      },
      {
        "family": "Kao",
        "given": "C.-L."
      },
      {
        "family": "Yang",
        "given": "P.-C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          12
        ]
      ]
    },
    "container-title": "Clinical Microbiology and Infection",
    "DOI": "10.1111/j.1469-0691.2004.01009.x",
    "volume": "10",
    "issue": "12",
    "page": "1062-1066",
    "publisher": "Elsevier BV",
    "title": "Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus",
    "URL": "https://doi.org/cwwg87",
    "PMCID": "PMC7129952",
    "PMID": "15606632",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1469-0691.2004.01009.x"
  },
  {
    "type": "article-journal",
    "id": "DMaiZBE1",
    "author": [
      {
        "family": "Chu",
        "given": "Kwok Hong"
      },
      {
        "family": "Tsang",
        "given": "Wai Kay"
      },
      {
        "family": "Tang",
        "given": "Colin S."
      },
      {
        "family": "Lam",
        "given": "Man Fai"
      },
      {
        "family": "Lai",
        "given": "Fernand M."
      },
      {
        "family": "To",
        "given": "Ka Fai"
      },
      {
        "family": "Fung",
        "given": "Ka Shun"
      },
      {
        "family": "Tang",
        "given": "Hon Lok"
      },
      {
        "family": "Yan",
        "given": "Wing Wa"
      },
      {
        "family": "Chan",
        "given": "Hilda W.H."
      },
      {
        "family": "Lai",
        "given": "Thomas S.T."
      },
      {
        "family": "Tong",
        "given": "Kwok Lung"
      },
      {
        "family": "Lai",
        "given": "Kar Neng"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005,
          2
        ]
      ]
    },
    "container-title": "Kidney International",
    "DOI": "10.1111/j.1523-1755.2005.67130.x",
    "volume": "67",
    "issue": "2",
    "page": "698-705",
    "publisher": "Elsevier BV",
    "title": "Acute renal impairment in coronavirus-associated severe acute respiratory syndrome",
    "URL": "https://doi.org/b7tgtx",
    "PMCID": "PMC7112337",
    "PMID": "15673319",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1523-1755.2005.67130.x"
  },
  {
    "type": "article-journal",
    "id": "10nBT1HbX",
    "author": [
      {
        "family": "Wilson",
        "given": "C. W. M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1975,
          9
        ]
      ]
    },
    "container-title": "Annals of the New York Academy of Sciences",
    "DOI": "10.1111/j.1749-6632.1975.tb29312.x",
    "volume": "258",
    "issue": "1 Second Confer",
    "page": "529-539",
    "publisher": "Wiley",
    "title": "ASCORBIC ACID FUNCTION AND METABOLISM DURING COLDS",
    "URL": "https://doi.org/bjfdtb",
    "PMID": "1106304",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1111/j.1749-6632.1975.tb29312.x"
  },
  {
    "type": "article-journal",
    "id": "7ElRN12v",
    "author": [
      {
        "family": "Vivier",
        "given": "E."
      },
      {
        "family": "Raulet",
        "given": "D. H."
      },
      {
        "family": "Moretta",
        "given": "A."
      },
      {
        "family": "Caligiuri",
        "given": "M. A."
      },
      {
        "family": "Zitvogel",
        "given": "L."
      },
      {
        "family": "Lanier",
        "given": "L. L."
      },
      {
        "family": "Yokoyama",
        "given": "W. M."
      },
      {
        "family": "Ugolini",
        "given": "S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          1,
          6
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.1198687",
    "volume": "331",
    "issue": "6013",
    "page": "44-49",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Innate or Adaptive Immunity? The Example of Natural Killer Cells",
    "URL": "https://doi.org/ckzg9g",
    "PMCID": "PMC3089969",
    "PMID": "21212348",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.1198687"
  },
  {
    "type": "article-journal",
    "id": "14motyCOm",
    "author": [
      {
        "family": "Pejchal",
        "given": "R."
      },
      {
        "family": "Doores",
        "given": "K. J."
      },
      {
        "family": "Walker",
        "given": "L. M."
      },
      {
        "family": "Khayat",
        "given": "R."
      },
      {
        "family": "Huang",
        "given": "P.-S."
      },
      {
        "family": "Wang",
        "given": "S.-K."
      },
      {
        "family": "Stanfield",
        "given": "R. L."
      },
      {
        "family": "Julien",
        "given": "J.-P."
      },
      {
        "family": "Ramos",
        "given": "A."
      },
      {
        "family": "Crispin",
        "given": "M."
      },
      {
        "family": "Depetris",
        "given": "R."
      },
      {
        "family": "Katpally",
        "given": "U."
      },
      {
        "family": "Marozsan",
        "given": "A."
      },
      {
        "family": "Cupo",
        "given": "A."
      },
      {
        "family": "Maloveste",
        "given": "S."
      },
      {
        "family": "Liu",
        "given": "Y."
      },
      {
        "family": "McBride",
        "given": "R."
      },
      {
        "family": "Ito",
        "given": "Y."
      },
      {
        "family": "Sanders",
        "given": "R. W."
      },
      {
        "family": "Ogohara",
        "given": "C."
      },
      {
        "family": "Paulson",
        "given": "J. C."
      },
      {
        "family": "Feizi",
        "given": "T."
      },
      {
        "family": "Scanlan",
        "given": "C. N."
      },
      {
        "family": "Wong",
        "given": "C.-H."
      },
      {
        "family": "Moore",
        "given": "J. P."
      },
      {
        "family": "Olson",
        "given": "W. C."
      },
      {
        "family": "Ward",
        "given": "A. B."
      },
      {
        "family": "Poignard",
        "given": "P."
      },
      {
        "family": "Schief",
        "given": "W. R."
      },
      {
        "family": "Burton",
        "given": "D. R."
      },
      {
        "family": "Wilson",
        "given": "I. A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          10,
          13
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.1213256",
    "volume": "334",
    "issue": "6059",
    "page": "1097-1103",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield",
    "URL": "https://doi.org/bzqv8c",
    "PMCID": "PMC3280215",
    "PMID": "21998254",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.1213256"
  },
  {
    "type": "article-journal",
    "id": "lwH4gcts",
    "author": [
      {
        "family": "Nowak",
        "given": "M. A."
      },
      {
        "family": "Bangham",
        "given": "C. R. M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          1996,
          4,
          5
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.272.5258.74",
    "volume": "272",
    "issue": "5258",
    "page": "74-79",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Population Dynamics of Immune Responses to Persistent Viruses",
    "URL": "https://doi.org/fqgprd",
    "PMID": "8600540",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.272.5258.74"
  },
  {
    "type": "article-journal",
    "id": "Q9tXjG1R",
    "author": [
      {
        "family": "Lo",
        "given": "B."
      },
      {
        "family": "Zhang",
        "given": "K."
      },
      {
        "family": "Lu",
        "given": "W."
      },
      {
        "family": "Zheng",
        "given": "L."
      },
      {
        "family": "Zhang",
        "given": "Q."
      },
      {
        "family": "Kanellopoulou",
        "given": "C."
      },
      {
        "family": "Zhang",
        "given": "Y."
      },
      {
        "family": "Liu",
        "given": "Z."
      },
      {
        "family": "Fritz",
        "given": "J. M."
      },
      {
        "family": "Marsh",
        "given": "R."
      },
      {
        "family": "Husami",
        "given": "A."
      },
      {
        "family": "Kissell",
        "given": "D."
      },
      {
        "family": "Nortman",
        "given": "S."
      },
      {
        "family": "Chaturvedi",
        "given": "V."
      },
      {
        "family": "Haines",
        "given": "H."
      },
      {
        "family": "Young",
        "given": "L. R."
      },
      {
        "family": "Mo",
        "given": "J."
      },
      {
        "family": "Filipovich",
        "given": "A. H."
      },
      {
        "family": "Bleesing",
        "given": "J. J."
      },
      {
        "family": "Mustillo",
        "given": "P."
      },
      {
        "family": "Stephens",
        "given": "M."
      },
      {
        "family": "Rueda",
        "given": "C. M."
      },
      {
        "family": "Chougnet",
        "given": "C. A."
      },
      {
        "family": "Hoebe",
        "given": "K."
      },
      {
        "family": "McElwee",
        "given": "J."
      },
      {
        "family": "Hughes",
        "given": "J. D."
      },
      {
        "family": "Karakoc-Aydiner",
        "given": "E."
      },
      {
        "family": "Matthews",
        "given": "H. F."
      },
      {
        "family": "Price",
        "given": "S."
      },
      {
        "family": "Su",
        "given": "H. C."
      },
      {
        "family": "Rao",
        "given": "V. K."
      },
      {
        "family": "Lenardo",
        "given": "M. J."
      },
      {
        "family": "Jordan",
        "given": "M. B."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          7,
          23
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.aaa1663",
    "volume": "349",
    "issue": "6246",
    "page": "436-440",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy",
    "URL": "https://doi.org/f7kc8d",
    "PMID": "26206937",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.aaa1663"
  },
  {
    "type": "article-journal",
    "id": "CqQVkaqj",
    "author": [
      {
        "family": "Wrapp",
        "given": "Daniel"
      },
      {
        "family": "Wang",
        "given": "Nianshuang"
      },
      {
        "family": "Corbett",
        "given": "Kizzmekia S."
      },
      {
        "family": "Goldsmith",
        "given": "Jory A."
      },
      {
        "family": "Hsieh",
        "given": "Ching-Lin"
      },
      {
        "family": "Abiona",
        "given": "Olubukola"
      },
      {
        "family": "Graham",
        "given": "Barney S."
      },
      {
        "family": "McLellan",
        "given": "Jason S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          19
        ]
      ]
    },
    "abstract": "The outbreak of a novel betacoronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure (MCM) development, we determined a 3.5 Å-resolution cryo-EM structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also show biophysical and structural evidence that the 2019-nCoV S binds ACE2 with higher affinity than SARS-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable rapid development and evaluation of MCMs to address the ongoing public health crisis.",
    "container-title": "Science",
    "DOI": "10.1126/science.abb2507",
    "page": "eabb2507",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation",
    "URL": "https://doi.org/ggmtk2",
    "PMID": "32075877",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb2507"
  },
  {
    "type": "article-journal",
    "id": "mHYmt0mv",
    "author": [
      {
        "family": "Li",
        "given": "Ruiyun"
      },
      {
        "family": "Pei",
        "given": "Sen"
      },
      {
        "family": "Chen",
        "given": "Bin"
      },
      {
        "family": "Song",
        "given": "Yimeng"
      },
      {
        "family": "Zhang",
        "given": "Tao"
      },
      {
        "family": "Yang",
        "given": "Wan"
      },
      {
        "family": "Shaman",
        "given": "Jeffrey"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          16
        ]
      ]
    },
    "abstract": "Estimation of the prevalence and contagiousness of undocumented novel coronavirus (SARS-CoV2) infections is critical for understanding the overall prevalence and pandemic potential of this disease. Here we use observations of reported infection within China, in conjunction with mobility data, a networked dynamic metapopulation model and Bayesian inference, to infer critical epidemiological characteristics associated with SARS-CoV2, including the fraction of undocumented infections and their contagiousness. We estimate 86% of all infections were undocumented (95% CI: [82%–90%]) prior to 23 January 2020 travel restrictions. Per person, the transmission rate of undocumented infections was 55% of documented infections ([46%–62%]), yet, due to their greater numbers, undocumented infections were the infection source for 79% of documented cases. These findings explain the rapid geographic spread of SARS-CoV2 and indicate containment of this virus will be particularly challenging.",
    "container-title": "Science",
    "DOI": "10.1126/science.abb3221",
    "page": "eabb3221",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)",
    "URL": "https://doi.org/ggn6c2",
    "PMID": "32179701",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb3221"
  },
  {
    "type": "article-journal",
    "id": "D4HwvRMd",
    "author": [
      {
        "family": "Cohen",
        "given": "Jon"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          13
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.abb7243",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Did an experimental drug help a U.S. coronavirus patient?",
    "URL": "https://doi.org/ggqm62",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb7243"
  },
  {
    "type": "article-journal",
    "id": "NT5mrVGY",
    "author": [
      {
        "family": "Service",
        "given": "Robert"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          22
        ]
      ]
    },
    "container-title": "Science",
    "DOI": "10.1126/science.abb8400",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "The standard coronavirus test, if available, works well—but can new diagnostics help in this pandemic?",
    "URL": "https://doi.org/ggq9wm",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/science.abb8400"
  },
  {
    "type": "article-journal",
    "id": "1H0NPTMw9",
    "author": [
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Menachery",
        "given": "Vineet D."
      },
      {
        "family": "Gralinski",
        "given": "Lisa E."
      },
      {
        "family": "Case",
        "given": "James B."
      },
      {
        "family": "Leist",
        "given": "Sarah R."
      },
      {
        "family": "Pyrc",
        "given": "Krzysztof"
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Trantcheva",
        "given": "Iva"
      },
      {
        "family": "Bannister",
        "given": "Roy"
      },
      {
        "family": "Park",
        "given": "Yeojin"
      },
      {
        "family": "Babusis",
        "given": "Darius"
      },
      {
        "family": "Clarke",
        "given": "Michael O."
      },
      {
        "family": "Mackman",
        "given": "Richard L."
      },
      {
        "family": "Spahn",
        "given": "Jamie E."
      },
      {
        "family": "Palmiotti",
        "given": "Christopher A."
      },
      {
        "family": "Siegel",
        "given": "Dustin"
      },
      {
        "family": "Ray",
        "given": "Adrian S."
      },
      {
        "family": "Cihlar",
        "given": "Tomas"
      },
      {
        "family": "Jordan",
        "given": "Robert"
      },
      {
        "family": "Denison",
        "given": "Mark R."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          6,
          28
        ]
      ]
    },
    "container-title": "Science Translational Medicine",
    "DOI": "10.1126/scitranslmed.aal3653",
    "volume": "9",
    "issue": "396",
    "page": "eaal3653",
    "publisher": "American Association for the Advancement of Science (AAAS)",
    "title": "Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses",
    "URL": "https://doi.org/gc3grb",
    "PMCID": "PMC5567817",
    "PMID": "28659436",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1126/scitranslmed.aal3653"
  },
  {
    "type": "article-journal",
    "id": "YoCPtq6P",
    "author": [
      {
        "family": "Seiwert",
        "given": "S. D."
      },
      {
        "family": "Andrews",
        "given": "S. W."
      },
      {
        "family": "Jiang",
        "given": "Y."
      },
      {
        "family": "Serebryany",
        "given": "V."
      },
      {
        "family": "Tan",
        "given": "H."
      },
      {
        "family": "Kossen",
        "given": "K."
      },
      {
        "family": "Rajagopalan",
        "given": "P. T. R."
      },
      {
        "family": "Misialek",
        "given": "S."
      },
      {
        "family": "Stevens",
        "given": "S. K."
      },
      {
        "family": "Stoycheva",
        "given": "A."
      },
      {
        "family": "Hong",
        "given": "J."
      },
      {
        "family": "Lim",
        "given": "S. R."
      },
      {
        "family": "Qin",
        "given": "X."
      },
      {
        "family": "Rieger",
        "given": "R."
      },
      {
        "family": "Condroski",
        "given": "K. R."
      },
      {
        "family": "Zhang",
        "given": "H."
      },
      {
        "family": "Do",
        "given": "M. G."
      },
      {
        "family": "Lemieux",
        "given": "C."
      },
      {
        "family": "Hingorani",
        "given": "G. P."
      },
      {
        "family": "Hartley",
        "given": "D. P."
      },
      {
        "family": "Josey",
        "given": "J. A."
      },
      {
        "family": "Pan",
        "given": "L."
      },
      {
        "family": "Beigelman",
        "given": "L."
      },
      {
        "family": "Blatt",
        "given": "L. M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2008,
          9,
          29
        ]
      ]
    },
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.00699-08",
    "volume": "52",
    "issue": "12",
    "page": "4432-4441",
    "publisher": "American Society for Microbiology",
    "title": "Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)",
    "URL": "https://doi.org/btpg52",
    "PMCID": "PMC2592891",
    "PMID": "18824605",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.00699-08"
  },
  {
    "type": "article-journal",
    "id": "2AASZDqa",
    "author": [
      {
        "family": "de Wilde",
        "given": "Adriaan H."
      },
      {
        "family": "Jochmans",
        "given": "Dirk"
      },
      {
        "family": "Posthuma",
        "given": "Clara C."
      },
      {
        "family": "Zevenhoven-Dobbe",
        "given": "Jessika C."
      },
      {
        "family": "van Nieuwkoop",
        "given": "Stefan"
      },
      {
        "family": "Bestebroer",
        "given": "Theo M."
      },
      {
        "family": "van den Hoogen",
        "given": "Bernadette G."
      },
      {
        "family": "Neyts",
        "given": "Johan"
      },
      {
        "family": "Snijder",
        "given": "Eric J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          8
        ]
      ]
    },
    "abstract": "Coronaviruses can cause respiratory and enteric disease in a wide variety of human and animal hosts. The 2003 outbreak of severe acute respiratory syndrome (SARS) first demonstrated the potentially lethal consequences of zoonotic coronavirus infections in humans. In 2012, a similar previously unknown coronavirus emerged, Middle East respiratory syndrome coronavirus (MERS-CoV), thus far causing over 650 laboratory-confirmed infections, with an unexplained steep rise in the number of cases being recorded over recent months. The human MERS fatality rate of ∼30% is alarmingly high, even though many deaths were associated with underlying medical conditions. Registered therapeutics for the treatment of coronavirus infections are not available. Moreover, the pace of drug development and registration for human use is generally incompatible with strategies to combat emerging infectious diseases. Therefore, we have screened a library of 348 FDA-approved drugs for anti-MERS-CoV activity in cell culture. If such compounds proved sufficiently potent, their efficacy might be directly assessed in MERS patients. We identified four compounds (chloroquine, chlorpromazine, loperamide, and lopinavir) inhibiting MERS-CoV replication in the low-micromolar range (50% effective concentrations [EC s], 3 to 8 μM). Moreover, these compounds also inhibit the replication of SARS coronavirus and human coronavirus 229E. Although their protective activity (alone or in combination) remains to be assessed in animal models, our findings may offer a starting point for treatment of patients infected with zoonotic coronaviruses like MERS-CoV. Although they may not necessarily reduce viral replication to very low levels, a moderate viral load reduction may create a window during which to mount a protective immune response.",
    "container-title": "Antimicrobial Agents and Chemotherapy",
    "DOI": "10.1128/aac.03011-14",
    "volume": "58",
    "issue": "8",
    "page": "4875-4884",
    "publisher": "American Society for Microbiology",
    "title": "Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture",
    "URL": "https://doi.org/f59p8v",
    "PMCID": "PMC4136071",
    "PMID": "24841269",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/aac.03011-14"
  },
  {
    "type": "article-journal",
    "id": "WBN5f37b",
    "author": [
      {
        "family": "Huang",
        "given": "Su"
      },
      {
        "family": "Zhu",
        "given": "Bibo"
      },
      {
        "family": "Cheon",
        "given": "In Su"
      },
      {
        "family": "Goplen",
        "given": "Nick P."
      },
      {
        "family": "Jiang",
        "given": "Li"
      },
      {
        "family": "Zhang",
        "given": "Ruixuan"
      },
      {
        "family": "Peebles",
        "given": "R. Stokes"
      },
      {
        "family": "Mack",
        "given": "Matthias"
      },
      {
        "family": "Kaplan",
        "given": "Mark H."
      },
      {
        "family": "Limper",
        "given": "Andrew H."
      },
      {
        "family": "Sun",
        "given": "Jie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          4,
          17
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.00030-19",
    "volume": "93",
    "issue": "9",
    "publisher": "American Society for Microbiology",
    "title": "PPAR-γ in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection",
    "URL": "https://doi.org/ggq652",
    "PMCID": "PMC6475778",
    "PMID": "30787149",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.00030-19"
  },
  {
    "type": "article-journal",
    "id": "16tHVjVzu",
    "author": [
      {
        "family": "Sun",
        "given": "X."
      },
      {
        "family": "Tse",
        "given": "L. V."
      },
      {
        "family": "Ferguson",
        "given": "A. D."
      },
      {
        "family": "Whittaker",
        "given": "G. R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          6,
          16
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.00797-10",
    "volume": "84",
    "issue": "17",
    "page": "8683-8690",
    "publisher": "American Society for Microbiology",
    "title": "Modifications to the Hemagglutinin Cleavage Site Control the Virulence of a Neurotropic H1N1 Influenza Virus",
    "URL": "https://doi.org/drs2zt",
    "PMCID": "PMC2919019",
    "PMID": "20554779",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.00797-10"
  },
  {
    "type": "article-journal",
    "id": "O1whWg6Q",
    "author": [
      {
        "family": "Sutton",
        "given": "Troy C."
      },
      {
        "family": "Lamirande",
        "given": "Elaine W."
      },
      {
        "family": "Bock",
        "given": "Kevin W."
      },
      {
        "family": "Moore",
        "given": "Ian N."
      },
      {
        "family": "Koudstaal",
        "given": "Wouter"
      },
      {
        "family": "Rehman",
        "given": "Muniza"
      },
      {
        "family": "Weverling",
        "given": "Gerrit Jan"
      },
      {
        "family": "Goudsmit",
        "given": "Jaap"
      },
      {
        "family": "Subbarao",
        "given": "Kanta"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          12,
          15
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.01603-17",
    "volume": "91",
    "issue": "24",
    "publisher": "American Society for Microbiology",
    "title": "<i>In Vitro</i> Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice",
    "URL": "https://doi.org/ggqbpt",
    "PMCID": "PMC5709608",
    "PMID": "29046448",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.01603-17"
  },
  {
    "type": "article-journal",
    "id": "hvjXMm9H",
    "author": [
      {
        "family": "Wang",
        "given": "Lingshu"
      },
      {
        "family": "Shi",
        "given": "Wei"
      },
      {
        "family": "Chappell",
        "given": "James D."
      },
      {
        "family": "Joyce",
        "given": "M. Gordon"
      },
      {
        "family": "Zhang",
        "given": "Yi"
      },
      {
        "family": "Kanekiyo",
        "given": "Masaru"
      },
      {
        "family": "Becker",
        "given": "Michelle M."
      },
      {
        "family": "van Doremalen",
        "given": "Neeltje"
      },
      {
        "family": "Fischer",
        "given": "Robert"
      },
      {
        "family": "Wang",
        "given": "Nianshuang"
      },
      {
        "family": "Corbett",
        "given": "Kizzmekia S."
      },
      {
        "family": "Choe",
        "given": "Misook"
      },
      {
        "family": "Mason",
        "given": "Rosemarie D."
      },
      {
        "family": "Van Galen",
        "given": "Joseph G."
      },
      {
        "family": "Zhou",
        "given": "Tongqing"
      },
      {
        "family": "Saunders",
        "given": "Kevin O."
      },
      {
        "family": "Tatti",
        "given": "Kathleen M."
      },
      {
        "family": "Haynes",
        "given": "Lia M."
      },
      {
        "family": "Kwong",
        "given": "Peter D."
      },
      {
        "family": "Modjarrad",
        "given": "Kayvon"
      },
      {
        "family": "Kong",
        "given": "Wing-Pui"
      },
      {
        "family": "McLellan",
        "given": "Jason S."
      },
      {
        "family": "Denison",
        "given": "Mark R."
      },
      {
        "family": "Munster",
        "given": "Vincent J."
      },
      {
        "family": "Mascola",
        "given": "John R."
      },
      {
        "family": "Graham",
        "given": "Barney S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          4,
          27
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.02002-17",
    "volume": "92",
    "issue": "10",
    "publisher": "American Society for Microbiology",
    "title": "Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape",
    "URL": "https://doi.org/ggqbpv",
    "PMCID": "PMC5923077",
    "PMID": "29514901",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.02002-17"
  },
  {
    "type": "article-journal",
    "id": "NzFgXYvQ",
    "author": [
      {
        "family": "McCray",
        "given": "P. B."
      },
      {
        "family": "Pewe",
        "given": "L."
      },
      {
        "family": "Wohlford-Lenane",
        "given": "C."
      },
      {
        "family": "Hickey",
        "given": "M."
      },
      {
        "family": "Manzel",
        "given": "L."
      },
      {
        "family": "Shi",
        "given": "L."
      },
      {
        "family": "Netland",
        "given": "J."
      },
      {
        "family": "Jia",
        "given": "H. P."
      },
      {
        "family": "Halabi",
        "given": "C."
      },
      {
        "family": "Sigmund",
        "given": "C. D."
      },
      {
        "family": "Meyerholz",
        "given": "D. K."
      },
      {
        "family": "Kirby",
        "given": "P."
      },
      {
        "family": "Look",
        "given": "D. C."
      },
      {
        "family": "Perlman",
        "given": "S."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          11,
          1
        ]
      ]
    },
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.02012-06",
    "volume": "81",
    "issue": "2",
    "page": "813-821",
    "publisher": "American Society for Microbiology",
    "title": "Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus",
    "URL": "https://doi.org/b2dr3s",
    "PMCID": "PMC1797474",
    "PMID": "17079315",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.02012-06"
  },
  {
    "type": "article-journal",
    "id": "X8l1n4zY",
    "author": [
      {
        "family": "Watanabe",
        "given": "Akira"
      },
      {
        "family": "Yoneda",
        "given": "Misako"
      },
      {
        "family": "Ikeda",
        "given": "Fusako"
      },
      {
        "family": "Terao-Muto",
        "given": "Yuri"
      },
      {
        "family": "Sato",
        "given": "Hiroki"
      },
      {
        "family": "Kai",
        "given": "Chieko"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          5,
          1
        ]
      ]
    },
    "abstract": "Measles is a highly contagious human disease caused by measles virus (MeV) and remains the leading cause of death in children, particularly in developing countries. Wild-type MeV preferentially infects lymphocytes by using signaling lymphocytic activation molecule (SLAM), whose expression is restricted to hematopoietic cells, as a receptor. MeV also infects other epithelial and neuronal cells that do not express SLAM and causes pneumonia and diarrhea and, sometimes, serious symptoms such as measles encephalitis and subacute sclerosing panencephalitis. The discrepancy between the tissue tropism of MeV and the distribution of SLAM-positive cells suggests that there are unknown receptors other than SLAM for MeV. Here we identified CD147/EMMPRIN (extracellular matrix metalloproteinase inducer), a transmembrane glycoprotein, which acts as a receptor for MeV on epithelial cells. Furthermore, we found the incorporation of cyclophilin B (CypB), a cellular ligand for CD147, in MeV virions, and showed that inhibition of CypB incorporation significantly attenuated SLAM-independent infection on epithelial cells, while it had no effect on SLAM-dependent infection. To date, MeV infection was considered to be triggered by binding of its hemagglutinin (H) protein and cellular receptors. Our present study, however, indicates that MeV infection also occurs via CD147 and virion-associated CypB, independently of MeV H. Since CD147 is expressed in a variety of cells, including epithelial and neuronal cells, this molecule possibly functions as an entry receptor for MeV in SLAM-negative cells. This is the first report among members of the that CD147 is used as a virus entry receptor via incorporated CypB in the virions.",
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.02168-09",
    "volume": "84",
    "issue": "9",
    "page": "4183-4193",
    "publisher": "American Society for Microbiology",
    "title": "CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells",
    "URL": "https://doi.org/dpcsqg",
    "PMCID": "PMC2863760",
    "PMID": "20147391",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.02168-09"
  },
  {
    "type": "article-journal",
    "id": "rXzkS3gA",
    "author": [
      {
        "family": "Subbarao",
        "given": "Kanta"
      },
      {
        "family": "McAuliffe",
        "given": "Josephine"
      },
      {
        "family": "Vogel",
        "given": "Leatrice"
      },
      {
        "family": "Fahle",
        "given": "Gary"
      },
      {
        "family": "Fischer",
        "given": "Steven"
      },
      {
        "family": "Tatti",
        "given": "Kathleen"
      },
      {
        "family": "Packard",
        "given": "Michelle"
      },
      {
        "family": "Shieh",
        "given": "Wun-Ju"
      },
      {
        "family": "Zaki",
        "given": "Sherif"
      },
      {
        "family": "Murphy",
        "given": "Brian"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          4,
          1
        ]
      ]
    },
    "abstract": "Following intranasal administration, the severe acute respiratory syndrome (SARS) coronavirus replicated to high titers in the respiratory tracts of BALB/c mice. Peak replication was seen in the absence of disease on day 1 or 2, depending on the dose administered, and the virus was cleared within a week. Viral antigen and nucleic acid were detected in bronchiolar epithelial cells during peak viral replication. Mice developed a neutralizing antibody response and were protected from reinfection 28 days following primary infection. Passive transfer of immune serum to naïve mice prevented virus replication in the lower respiratory tract following intranasal challenge. Thus, antibodies, acting alone, can prevent replication of the SARS coronavirus in the lung, a promising observation for the development of vaccines, immunotherapy, and immunoprophylaxis regimens.",
    "container-title": "Journal of Virology",
    "DOI": "10.1128/jvi.78.7.3572-3577.2004",
    "volume": "78",
    "issue": "7",
    "page": "3572-3577",
    "publisher": "American Society for Microbiology",
    "title": "Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice",
    "URL": "https://doi.org/b8wr7c",
    "PMCID": "PMC371090",
    "PMID": "15016880",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/jvi.78.7.3572-3577.2004"
  },
  {
    "type": "article-journal",
    "id": "lIko9Imd",
    "author": [
      {
        "family": "Agostini",
        "given": "Maria L."
      },
      {
        "family": "Andres",
        "given": "Erica L."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Graham",
        "given": "Rachel L."
      },
      {
        "family": "Sheahan",
        "given": "Timothy P."
      },
      {
        "family": "Lu",
        "given": "Xiaotao"
      },
      {
        "family": "Smith",
        "given": "Everett Clinton"
      },
      {
        "family": "Case",
        "given": "James Brett"
      },
      {
        "family": "Feng",
        "given": "Joy Y."
      },
      {
        "family": "Jordan",
        "given": "Robert"
      },
      {
        "family": "Ray",
        "given": "Adrian S."
      },
      {
        "family": "Cihlar",
        "given": "Tomas"
      },
      {
        "family": "Siegel",
        "given": "Dustin"
      },
      {
        "family": "Mackman",
        "given": "Richard L."
      },
      {
        "family": "Clarke",
        "given": "Michael O."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      },
      {
        "family": "Denison",
        "given": "Mark R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          3,
          6
        ]
      ]
    },
    "container-title": "mBio",
    "DOI": "10.1128/mbio.00221-18",
    "volume": "9",
    "issue": "2",
    "publisher": "American Society for Microbiology",
    "title": "Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease",
    "URL": "https://doi.org/gc45v6",
    "PMCID": "PMC5844999",
    "PMID": "29511076",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/mbio.00221-18"
  },
  {
    "type": "article-journal",
    "id": "bZMKqj6e",
    "author": [
      {
        "family": "Tisoncik",
        "given": "J. R."
      },
      {
        "family": "Korth",
        "given": "M. J."
      },
      {
        "family": "Simmons",
        "given": "C. P."
      },
      {
        "family": "Farrar",
        "given": "J."
      },
      {
        "family": "Martin",
        "given": "T. R."
      },
      {
        "family": "Katze",
        "given": "M. G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2012,
          3,
          5
        ]
      ]
    },
    "container-title": "Microbiology and Molecular Biology Reviews",
    "DOI": "10.1128/mmbr.05015-11",
    "volume": "76",
    "issue": "1",
    "page": "16-32",
    "publisher": "American Society for Microbiology",
    "title": "Into the Eye of the Cytokine Storm",
    "URL": "https://doi.org/f4n9h2",
    "PMCID": "PMC3294426",
    "PMID": "22390970",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1128/mmbr.05015-11"
  },
  {
    "type": "article-journal",
    "id": "IeML5mBm",
    "author": [
      {
        "family": "Ruiz-Irastorza",
        "given": "G"
      },
      {
        "family": "Ramos-Casals",
        "given": "M"
      },
      {
        "family": "Brito-Zeron",
        "given": "P"
      },
      {
        "family": "Khamashta",
        "given": "M A"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          1
        ]
      ]
    },
    "container-title": "Annals of the Rheumatic Diseases",
    "DOI": "10.1136/ard.2008.101766",
    "volume": "69",
    "issue": "01",
    "page": "20-28",
    "publisher": "BMJ",
    "title": "Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review",
    "URL": "https://doi.org/dfrv2q",
    "PMID": "19103632",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1136/ard.2008.101766"
  },
  {
    "type": "article-journal",
    "id": "yumBaJ6U",
    "author": [
      {
        "family": "Corti",
        "given": "Davide"
      },
      {
        "family": "Lanzavecchia",
        "given": "Antonio"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          3,
          21
        ]
      ]
    },
    "container-title": "Annual Review of Immunology",
    "DOI": "10.1146/annurev-immunol-032712-095916",
    "volume": "31",
    "issue": "1",
    "page": "705-742",
    "publisher": "Annual Reviews",
    "title": "Broadly Neutralizing Antiviral Antibodies",
    "URL": "https://doi.org/gf25g8",
    "PMID": "23330954",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1146/annurev-immunol-032712-095916"
  },
  {
    "type": "article-journal",
    "id": "9czQt5cR",
    "author": [
      {
        "family": "Chen",
        "given": "Yuanyuan"
      },
      {
        "family": "Luo",
        "given": "Guangyan"
      },
      {
        "family": "Yuan",
        "given": "Jiao"
      },
      {
        "family": "Wang",
        "given": "Yuanyuan"
      },
      {
        "family": "Yang",
        "given": "Xiaoqiong"
      },
      {
        "family": "Wang",
        "given": "Xiaoyun"
      },
      {
        "family": "Li",
        "given": "Guoping"
      },
      {
        "family": "Liu",
        "given": "Zhiguang"
      },
      {
        "family": "Zhong",
        "given": "Nanshan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014
        ]
      ]
    },
    "abstract": "Oxidative stress is an important part of host innate immune response to foreign pathogens. However, the impact of vitamin C on oxidative stress and inflammation remains unclear in community-acquired pneumonia (CAP). We aimed to determine the effect of vitamin C on oxidative stress and inflammation. CAP patients were enrolled. Reactive oxygen species (ROS), DNA damage, superoxide dismutases (SOD) activity, tumor necrosis factor-alpha (TNF-α), and IL-6 were analyzed in CAP patients and LPS-stimulated macrophages cells. MH-S cells were transfected with RFP-LC3 plasmids. Autophagy was measured in LPS-stimulated macrophages cells. Severe CAP patients showed significantly increased ROS, DNA damage, TNF-α, and IL-6. SOD was significantly decreased in severe CAP. Vitamin C significantly decreased ROS, DNA damage, TNF-α, and IL-6. Vitamin C inhibited LPS-induced ROS, DNA damage, TNF-α, IL-6, and p38 in macrophages cells. Vitamin C inhibited autophagy in LPS-induced macrophages cells. These findings indicated that severe CAP exhibited significantly increased oxidative stress, DNA damage, and proinflammatory mediator. Vitamin C mitigated oxidative stress and proinflammatory mediator suggesting a possible mechanism for vitamin C in severe CAP.",
    "container-title": "Mediators of Inflammation",
    "DOI": "10.1155/2014/426740",
    "volume": "2014",
    "page": "1-11",
    "publisher": "Hindawi Limited",
    "title": "Vitamin C Mitigates Oxidative Stress and Tumor Necrosis Factor-Alpha in Severe Community-Acquired Pneumonia and LPS-Induced Macrophages",
    "URL": "https://doi.org/f6nb5f",
    "PMCID": "PMC4165740",
    "PMID": "25253919",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1155/2014/426740"
  },
  {
    "type": "article-journal",
    "id": "dY9kXLAS",
    "author": [
      {
        "family": "O’Laughlin",
        "given": "John P."
      },
      {
        "family": "Mehta",
        "given": "Parag H."
      },
      {
        "family": "Wong",
        "given": "Brian C."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016
        ]
      ]
    },
    "abstract": "We present a case of a syncopal episode resulting from significant QT interval prolongation in a patient on hydroxychloroquine for the treatment of systemic lupus erythematosus and end stage renal disease. The patient had been treated with hydroxychloroquine for two years prior to presentation. After thorough workup for secondary causes of QT interval prolongation hydroxychloroquine was discontinued and the patient’s QT interval shortened. The patient was treated with mexiletine to prevent sudden ventricular arrhythmias, which was unique compared to other documented cases in which lidocaine was used. The patient was noted to have mild prolongation of the QT interval on electrocardiogram prior to initiation of hydroxychloroquine therapy which was exacerbated by its use and may have been caused due to toxicity from underlying renal failure.",
    "container-title": "Case Reports in Cardiology",
    "DOI": "10.1155/2016/4626279",
    "volume": "2016",
    "page": "1-4",
    "publisher": "Hindawi Limited",
    "title": "Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine",
    "URL": "https://doi.org/ggqzrc",
    "PMCID": "PMC4960328",
    "PMID": "27478650",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1155/2016/4626279"
  },
  {
    "type": "article-journal",
    "id": "eW4MC6Do",
    "author": [
      {
        "family": "Tanaka",
        "given": "T."
      },
      {
        "family": "Kishimoto",
        "given": "T."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          4,
          3
        ]
      ]
    },
    "container-title": "Cancer Immunology Research",
    "DOI": "10.1158/2326-6066.cir-14-0022",
    "volume": "2",
    "issue": "4",
    "page": "288-294",
    "publisher": "American Association for Cancer Research (AACR)",
    "title": "The Biology and Medical Implications of Interleukin-6",
    "URL": "https://doi.org/f56dzb",
    "PMID": "24764575",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1158/2326-6066.cir-14-0022"
  },
  {
    "type": "article-journal",
    "id": "f61jsRKY",
    "author": [
      {
        "family": "PARK",
        "given": "WILLIAM Y."
      },
      {
        "family": "GOODMAN",
        "given": "RICHARD B."
      },
      {
        "family": "STEINBERG",
        "given": "KENNETH P."
      },
      {
        "family": "RUZINSKI",
        "given": "JOHN T."
      },
      {
        "family": "RADELLA",
        "given": "FRANK"
      },
      {
        "family": "PARK",
        "given": "DAVID R."
      },
      {
        "family": "PUGIN",
        "given": "JEROME"
      },
      {
        "family": "SKERRETT",
        "given": "SHAWN J."
      },
      {
        "family": "HUDSON",
        "given": "LEONARD D."
      },
      {
        "family": "MARTIN",
        "given": "THOMAS R."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2001,
          11,
          15
        ]
      ]
    },
    "container-title": "American Journal of Respiratory and Critical Care Medicine",
    "DOI": "10.1164/ajrccm.164.10.2104013",
    "volume": "164",
    "issue": "10",
    "page": "1896-1903",
    "publisher": "American Thoracic Society",
    "title": "Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome",
    "URL": "https://doi.org/ggqfq7",
    "PMID": "11734443",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1164/ajrccm.164.10.2104013"
  },
  {
    "type": "article-journal",
    "id": "tC5vJmwj",
    "author": [
      {
        "family": "Liu",
        "given": "Li"
      },
      {
        "family": "Wei",
        "given": "Qiang"
      },
      {
        "family": "Lin",
        "given": "Qingqing"
      },
      {
        "family": "Fang",
        "given": "Jun"
      },
      {
        "family": "Wang",
        "given": "Haibo"
      },
      {
        "family": "Kwok",
        "given": "Hauyee"
      },
      {
        "family": "Tang",
        "given": "Hangying"
      },
      {
        "family": "Nishiura",
        "given": "Kenji"
      },
      {
        "family": "Peng",
        "given": "Jie"
      },
      {
        "family": "Tan",
        "given": "Zhiwu"
      },
      {
        "family": "Wu",
        "given": "Tongjin"
      },
      {
        "family": "Cheung",
        "given": "Ka-Wai"
      },
      {
        "family": "Chan",
        "given": "Kwok-Hung"
      },
      {
        "family": "Alvarez",
        "given": "Xavier"
      },
      {
        "family": "Qin",
        "given": "Chuan"
      },
      {
        "family": "Lackner",
        "given": "Andrew"
      },
      {
        "family": "Perlman",
        "given": "Stanley"
      },
      {
        "family": "Yuen",
        "given": "Kwok-Yung"
      },
      {
        "family": "Chen",
        "given": "Zhiwei"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          2,
          21
        ]
      ]
    },
    "container-title": "JCI Insight",
    "DOI": "10.1172/jci.insight.123158",
    "volume": "4",
    "issue": "4",
    "publisher": "American Society for Clinical Investigation",
    "title": "Anti–spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection",
    "URL": "https://doi.org/ggqbpw",
    "PMCID": "PMC6478436",
    "PMID": "30830861",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1172/jci.insight.123158"
  },
  {
    "type": "article-journal",
    "id": "uQFCDDIy",
    "author": [
      {
        "family": "Hume",
        "given": "R."
      },
      {
        "family": "Weyers",
        "given": "Elspeth"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          6,
          25
        ]
      ]
    },
    "container-title": "Scottish Medical Journal",
    "DOI": "10.1177/003693307301800102",
    "volume": "18",
    "issue": "1",
    "page": "3-7",
    "publisher": "SAGE Publications",
    "title": "Changes in Leucocyte Ascorbic Acid during the Common Cold",
    "URL": "https://doi.org/ggqrfj",
    "PMID": "4717661",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1177/003693307301800102"
  },
  {
    "type": "article-journal",
    "id": "134vCyU3E",
    "author": [
      {
        "family": "Wang",
        "given": "Tzu-Fei"
      },
      {
        "family": "Lim",
        "given": "Wendy"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          2
        ]
      ]
    },
    "abstract": "A 35-year-old man presents with an acute unprovoked deep vein thrombosis of the left lower extremity. He is treated with anticoagulation and elects to discontinue treatment after 6 months. He subsequently develops polyarthralgias, fatigue, and a malar rash, and a diagnosis of systemic lupus erythematosus is made based on laboratory and clinical findings. Additional laboratory testing reveals persistent triple positive antiphospholipid antibodies, including lupus anticoagulant, high titer anticardiolipin antibodies, and anti–β2-glycoprotein I antibodies. The patient is reinitiated on anticoagulation, and the patient’s rheumatologist inquires if the addition of hydroxychloroquine could help to prevent recurrent thrombosis.",
    "container-title": "Hematology",
    "DOI": "10.1182/asheducation-2016.1.714",
    "volume": "2016",
    "issue": "1",
    "page": "714-716",
    "publisher": "American Society of Hematology",
    "title": "What is the role of hydroxychloroquine in reducing thrombotic risk in patients with antiphospholipid antibodies?",
    "URL": "https://doi.org/ggrn3k",
    "PMCID": "PMC6142483",
    "PMID": "27913551",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1182/asheducation-2016.1.714"
  },
  {
    "type": "article-journal",
    "id": "nEaG534R",
    "author": [
      {
        "family": "Müller-Calleja",
        "given": "Nadine"
      },
      {
        "family": "Manukyan",
        "given": "Davit"
      },
      {
        "family": "Ruf",
        "given": "Wolfram"
      },
      {
        "family": "Lackner",
        "given": "Karl"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          2
        ]
      ]
    },
    "container-title": "Blood",
    "DOI": "10.1182/blood.v128.22.5023.5023",
    "volume": "128",
    "issue": "22",
    "page": "5023-5023",
    "publisher": "American Society of Hematology",
    "title": "Mechanism of Action of Hydroxychloroquine in the Antiphospholipid Syndrome",
    "URL": "https://doi.org/ggrm82",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1182/blood.v128.22.5023.5023"
  },
  {
    "type": "article-journal",
    "id": "x6nInyCf",
    "author": [
      {
        "family": "Vincent",
        "given": "Martin J"
      },
      {
        "family": "Bergeron",
        "given": "Eric"
      },
      {
        "family": "Benjannet",
        "given": "Suzanne"
      },
      {
        "family": "Erickson",
        "given": "Bobbie R"
      },
      {
        "family": "Rollin",
        "given": "Pierre E"
      },
      {
        "family": "Ksiazek",
        "given": "Thomas G"
      },
      {
        "family": "Seidah",
        "given": "Nabil G"
      },
      {
        "family": "Nichol",
        "given": "Stuart T"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2005
        ]
      ]
    },
    "container-title": "Virology Journal",
    "DOI": "10.1186/1743-422x-2-69",
    "volume": "2",
    "issue": "1",
    "page": "69",
    "publisher": "Springer Science and Business Media LLC",
    "title": ":{unav)",
    "URL": "https://doi.org/dvbds4",
    "PMCID": "PMC1232869",
    "PMID": "16115318",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1186/1743-422x-2-69"
  },
  {
    "type": "article-journal",
    "id": "1AKi0FYUB",
    "author": [
      {
        "family": "Lu",
        "given": "Ruei-Min"
      },
      {
        "family": "Hwang",
        "given": "Yu-Chyi"
      },
      {
        "family": "Liu",
        "given": "I-Ju"
      },
      {
        "family": "Lee",
        "given": "Chi-Chiu"
      },
      {
        "family": "Tsai",
        "given": "Han-Zen"
      },
      {
        "family": "Li",
        "given": "Hsin-Jung"
      },
      {
        "family": "Wu",
        "given": "Han-Chung"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          2
        ]
      ]
    },
    "container-title": "Journal of Biomedical Science",
    "DOI": "10.1186/s12929-019-0592-z",
    "volume": "27",
    "issue": "1",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Development of therapeutic antibodies for the treatment of diseases",
    "URL": "https://doi.org/ggqbpx",
    "PMCID": "PMC6939334",
    "PMID": "31894001",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1186/s12929-019-0592-z"
  },
  {
    "type": "article-journal",
    "id": "l3CzJ5ni",
    "author": [
      {
        "family": "Chen",
        "given": "Wei"
      },
      {
        "family": "Ware",
        "given": "Lorraine B"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          7,
          2
        ]
      ]
    },
    "container-title": "Clinical and Translational Medicine",
    "DOI": "10.1186/s40169-015-0065-2",
    "volume": "4",
    "issue": "1",
    "publisher": "Springer Science and Business Media LLC",
    "title": "Prognostic factors in the acute respiratory distress syndrome",
    "URL": "https://doi.org/ggq653",
    "PMCID": "PMC4534483",
    "PMID": "26162279",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1186/s40169-015-0065-2"
  },
  {
    "type": "article-journal",
    "id": "sgr0mlJK",
    "author": [
      {
        "family": "Hulisz",
        "given": "Darrell"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2004,
          9
        ]
      ]
    },
    "container-title": "Journal of the American Pharmacists Association",
    "DOI": "10.1331/1544-3191.44.5.594.hulisz",
    "volume": "44",
    "issue": "5",
    "page": "594-603",
    "publisher": "Elsevier BV",
    "title": "Efficacy of Zinc Against Common Cold Viruses: An Overview",
    "URL": "https://doi.org/cf6pmt",
    "PMID": "15496046",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1331/1544-3191.44.5.594.hulisz"
  },
  {
    "type": "article-journal",
    "id": "YuJbg3zO",
    "author": [
      {
        "family": "Himmelstein",
        "given": "Daniel S."
      },
      {
        "family": "Rubinetti",
        "given": "Vincent"
      },
      {
        "family": "Slochower",
        "given": "David R."
      },
      {
        "family": "Hu",
        "given": "Dongbo"
      },
      {
        "family": "Malladi",
        "given": "Venkat S."
      },
      {
        "family": "Greene",
        "given": "Casey S."
      },
      {
        "family": "Gitter",
        "given": "Anthony"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          6,
          24
        ]
      ]
    },
    "container-title": "PLOS Computational Biology",
    "DOI": "10.1371/journal.pcbi.1007128",
    "volume": "15",
    "issue": "6",
    "page": "e1007128",
    "publisher": "Public Library of Science (PLoS)",
    "title": "Open collaborative writing with Manubot",
    "URL": "https://doi.org/c7np",
    "PMCID": "PMC6611653",
    "PMID": "31233491",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pcbi.1007128"
  },
  {
    "type": "article-journal",
    "id": "ukZRKllk",
    "author": [
      {
        "family": "Jin",
        "given": "Zhinan"
      },
      {
        "family": "Smith",
        "given": "Lucas K."
      },
      {
        "family": "Rajwanshi",
        "given": "Vivek K."
      },
      {
        "family": "Kim",
        "given": "Baek"
      },
      {
        "family": "Deval",
        "given": "Jerome"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013,
          7,
          10
        ]
      ]
    },
    "container-title": "PLoS ONE",
    "DOI": "10.1371/journal.pone.0068347",
    "volume": "8",
    "issue": "7",
    "page": "e68347",
    "publisher": "Public Library of Science (PLoS)",
    "title": "The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase",
    "URL": "https://doi.org/f5br92",
    "PMCID": "PMC3707847",
    "PMID": "23874596",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pone.0068347"
  },
  {
    "type": "article-journal",
    "id": "J0ibHE3l",
    "author": [
      {
        "family": "Yee",
        "given": "Christine"
      },
      {
        "family": "Main",
        "given": "Nathan M."
      },
      {
        "family": "Terry",
        "given": "Alexandra"
      },
      {
        "family": "Stevanovski",
        "given": "Igor"
      },
      {
        "family": "Maczurek",
        "given": "Annette"
      },
      {
        "family": "Morgan",
        "given": "Alison J."
      },
      {
        "family": "Calabro",
        "given": "Sarah"
      },
      {
        "family": "Potter",
        "given": "Alison J."
      },
      {
        "family": "Iemma",
        "given": "Tina L."
      },
      {
        "family": "Bowen",
        "given": "David G."
      },
      {
        "family": "Ahlenstiel",
        "given": "Golo"
      },
      {
        "family": "Warner",
        "given": "Fiona J."
      },
      {
        "family": "McCaughan",
        "given": "Geoffrey W."
      },
      {
        "family": "McLennan",
        "given": "Susan V."
      },
      {
        "family": "Shackel",
        "given": "Nicholas A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          7,
          10
        ]
      ]
    },
    "container-title": "PLOS ONE",
    "DOI": "10.1371/journal.pone.0215557",
    "volume": "14",
    "issue": "7",
    "page": "e0215557",
    "publisher": "Public Library of Science (PLoS)",
    "title": "CD147 mediates intrahepatic leukocyte aggregation and determines the extent of liver injury",
    "URL": "https://doi.org/ggq654",
    "PMCID": "PMC6619953",
    "PMID": "31291257",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.pone.0215557"
  },
  {
    "type": "article-journal",
    "id": "6aOUJdHa",
    "author": [
      {
        "family": "te Velthuis",
        "given": "Aartjan J. W."
      },
      {
        "family": "van den Worm",
        "given": "Sjoerd H. E."
      },
      {
        "family": "Sims",
        "given": "Amy C."
      },
      {
        "family": "Baric",
        "given": "Ralph S."
      },
      {
        "family": "Snijder",
        "given": "Eric J."
      },
      {
        "family": "van Hemert",
        "given": "Martijn J."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2010,
          11,
          4
        ]
      ]
    },
    "container-title": "PLoS Pathogens",
    "DOI": "10.1371/journal.ppat.1001176",
    "volume": "6",
    "issue": "11",
    "page": "e1001176",
    "publisher": "Public Library of Science (PLoS)",
    "title": "Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture",
    "URL": "https://doi.org/d95x4g",
    "PMCID": "PMC2973827",
    "PMID": "21079686",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1371/journal.ppat.1001176"
  },
  {
    "type": "article-journal",
    "id": "10GnhBctk",
    "author": [
      {
        "family": "Xu",
        "given": "Xiaoyuan"
      },
      {
        "family": "Feng",
        "given": "Bo"
      },
      {
        "family": "Guan",
        "given": "Yujuan"
      },
      {
        "family": "Zheng",
        "given": "Sujun"
      },
      {
        "family": "Sheng",
        "given": "Jifang"
      },
      {
        "family": "Yang",
        "given": "Xingxiang"
      },
      {
        "family": "Ma",
        "given": "Yuanji"
      },
      {
        "family": "Huang",
        "given": "Yan"
      },
      {
        "family": "Kang",
        "given": "Yi"
      },
      {
        "family": "Wen",
        "given": "Xiaofeng"
      },
      {
        "family": "Li",
        "given": "Jun"
      },
      {
        "family": "Tan",
        "given": "Youwen"
      },
      {
        "family": "He",
        "given": "Qing"
      },
      {
        "family": "Xie",
        "given": "Qing"
      },
      {
        "family": "Wang",
        "given": "Maorong"
      },
      {
        "family": "An",
        "given": "Ping"
      },
      {
        "family": "Gong",
        "given": "Guozhong"
      },
      {
        "family": "Liu",
        "given": "Huimin"
      },
      {
        "family": "Ning",
        "given": "Qin"
      },
      {
        "family": "Hua",
        "given": "Rui"
      },
      {
        "family": "Ning",
        "given": "Bo"
      },
      {
        "family": "Xie",
        "given": "Wen"
      },
      {
        "family": "Zhang",
        "given": "Jiming"
      },
      {
        "family": "Huang",
        "given": "Wenxiang"
      },
      {
        "family": "Yang",
        "given": "Yongfeng"
      },
      {
        "family": "Lin",
        "given": "Minghua"
      },
      {
        "family": "Zhao",
        "given": "Yingren"
      },
      {
        "family": "Yu",
        "given": "Yanhong"
      },
      {
        "family": "Jia",
        "given": "Jidong"
      },
      {
        "family": "Yang",
        "given": "Dongliang"
      },
      {
        "family": "Chen",
        "given": "Liang"
      },
      {
        "family": "Ye",
        "given": "Yinong"
      },
      {
        "family": "Nan",
        "given": "Yuemin"
      },
      {
        "family": "Gong",
        "given": "Zuojiong"
      },
      {
        "family": "Zhang",
        "given": "Quan"
      },
      {
        "family": "Hu",
        "given": "Peng"
      },
      {
        "family": "Wang",
        "given": "Fusheng"
      },
      {
        "family": "Li",
        "given": "Yongguo"
      },
      {
        "family": "Li",
        "given": "Dongliang"
      },
      {
        "family": "Jia",
        "given": "Zhansheng"
      },
      {
        "family": "Hou",
        "given": "Jinlin"
      },
      {
        "family": "Chen",
        "given": "Chengwei"
      },
      {
        "family": "Wu",
        "given": "Jinzi J."
      },
      {
        "family": "Wei",
        "given": "Lai"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          9,
          30
        ]
      ]
    },
    "container-title": "Journal of Clinical and Translational Hepatology",
    "DOI": "10.14218/jcth.2019.00033",
    "volume": "7",
    "issue": "3",
    "page": "1-8",
    "publisher": "Xia & He Publishing",
    "title": "Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China",
    "URL": "https://doi.org/ggrbkd",
    "PMCID": "PMC6783683",
    "PMID": "31608212",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.14218/jcth.2019.00033"
  },
  {
    "type": "article-journal",
    "id": "MTcTiS7i",
    "author": [
      {
        "family": "Prabakaran",
        "given": "Ponraj"
      },
      {
        "family": "Zhu",
        "given": "Zhongyu"
      },
      {
        "family": "Xiao",
        "given": "Xiaodong"
      },
      {
        "family": "Biragyn",
        "given": "Arya"
      },
      {
        "family": "Dimitrov",
        "given": "Antony S"
      },
      {
        "family": "Broder",
        "given": "Christopher C"
      },
      {
        "family": "Dimitrov",
        "given": "Dimiter S"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          4,
          8
        ]
      ]
    },
    "container-title": "Expert Opinion on Biological Therapy",
    "DOI": "10.1517/14712590902763755",
    "volume": "9",
    "issue": "3",
    "page": "355-368",
    "publisher": "Informa Healthcare",
    "title": "Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses",
    "URL": "https://doi.org/b88kw8",
    "PMCID": "PMC2705284",
    "PMID": "19216624",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.1517/14712590902763755"
  },
  {
    "type": "article-journal",
    "id": "yBxajVXZ",
    "author": [
      {
        "family": "Grant",
        "given": "William B."
      },
      {
        "family": "Lahore",
        "given": "Henry"
      },
      {
        "family": "McDonnell",
        "given": "Sharon L."
      },
      {
        "family": "Baggerly",
        "given": "Carole A."
      },
      {
        "family": "French",
        "given": "Christine B."
      },
      {
        "family": "Aliano",
        "given": "Jennifer L."
      },
      {
        "family": "Bhattoa",
        "given": "Harjit Pal"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "abstract": "The world is in the grips of the COVID-19 pandemic. Public health measures that can reduce the risk of infection and death in addition to quarantines are desperately needed. This article reviews the roles of vitamin D in reducing risk of respiratory tract infections, knowledge about the epidemiology of influenza and COVID-19, and how vitamin D supplementation might be a useful measure to reduce risk. Through several mechanisms, vitamin D can reduce risk of infections. Those mechanisms include inducing cathelicidins and defensins that can lower viral replication rates and reducing concentrations of pro-inflammatory cytokines that produce the inflammation that injures the lining of the lungs, leading to pneumonia, as well as increase concentrations of anti-inflammatory cytokines. Several observational studies and clinical trials reported that vitamin D supplementation reduced risk of influenza, whereas others did not. Evidence supporting the role of vitamin D in reducing risk of COVID-19 includes that the outbreak occurred in winter, a time when 25-hydroxyvitamin D [25(OH)D] concentrations are lowest; that the number of cases in the Southern Hemisphere near the end of summer are low; that vitamin D deficiency has been found to contribute to acute respiratory distress syndrome, and that case-fatality rates increase with age and with chronic disease comorbidity, both of which are associated with lower 25(OH)D concentration. To reduce risk of infection, it is recommended that people at risk of influenza and/or COVID-19 consider taking 10,000 IU/d of vitamin D3 for a few weeks to rapidly raise 25(OH)D concentrations, followed by 5000 IU/d. The goal should be to raise 25(OH)D concentrations above 40–60 ng/ml (100–150 nmol/l). For treatment of people who become infected with COVID-19, higher vitamin D3 doses might be useful. Randomized controlled trials and large population studies should be conducted to evaluate these recommendations.",
    "DOI": "10.20944/preprints202003.0235.v2",
    "title": "Evidence That Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths",
    "URL": "https://doi.org/ggqmjb",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.20944/preprints202003.0235.v2"
  },
  {
    "type": "article-journal",
    "id": "3RCeQRRc",
    "author": [
      {
        "family": "Narayanan",
        "given": "Naveen"
      },
      {
        "family": "Nair",
        "given": "Deepak T."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          22
        ]
      ]
    },
    "abstract": "COVID-19 is the causative agent for the ongoing pandemic, and this virus belongs to the Coronaviridae family. Like other members of this family, the virus possesses a positive-sense single-stranded RNA genome. The genome encodes for the nsp12 protein, which houses the RNA-dependent-RNA polymerase (RdRP) activity responsible for the replication of the viral genome. A homology model of nsp12 was prepared using the structure of the SARS nsp12 (6NUR) as a model. The model was used to carry out in silico screening to identify molecules among natural products, or FDA approved drugs that can potentially inhibit the activity of nsp12. This exercise showed that vitamin B12 (methylcobalamin) may bind to the active site of the nsp12 protein. A model of the nsp12 in complex with substrate RNA and incoming NTP showed that Vitamin B12 binding site overlaps with that of the incoming nucleotide. A comparison of the calculated energies of binding for RNA plus NTP and methylcobalamin suggested that the vitamin may bind to the active site of nsp12 with significant affinity. It is, therefore, possible that methylcobalamin binding may prevent association with RNA and NTP and thus inhibit the RdRP activity of nsp12. Overall, our computational studies suggest that methylcobalamin form of vitamin B12 may serve as an effective inhibitor of the nsp12 protein.",
    "DOI": "10.20944/preprints202003.0347.v1",
    "title": "Vitamin B12 May Inhibit RNA-Dependent-RNA Polymerase Activity of nsp12 from the COVID-19 Virus",
    "URL": "https://doi.org/ggqmjc",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.20944/preprints202003.0347.v1"
  },
  {
    "type": "article-journal",
    "id": "CtMA3hTi",
    "author": [
      {
        "family": "Bojkova",
        "given": "Denisa"
      },
      {
        "family": "Klann",
        "given": "Kevin"
      },
      {
        "family": "Koch",
        "given": "Benjamin"
      },
      {
        "family": "Widera",
        "given": "Marek"
      },
      {
        "family": "Krause",
        "given": "David"
      },
      {
        "family": "Ciesek",
        "given": "Sandra"
      },
      {
        "family": "Cinatl",
        "given": "Jindrich"
      },
      {
        "family": "Münch",
        "given": "Christian"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          11
        ]
      ]
    },
    "abstract": "A novel coronavirus was recently discovered and termed SARS-CoV-2. Human infection can cause coronavirus disease 2019 (COVID-19), for which, at this point, over 80,000 cases resulting in over 2,500 deaths have been reported in over 40 countries. SARS-CoV-2 shows some similarities to other coronaviruses. However, treatment options and a cellular understanding of SARS-CoV-2 infection are lacking. Here we identify the host cell pathways modulated by SARS-CoV-19 infection and reveal that drugs targeting pathways prevent viral replication in human cells. We established a human cell culture model for infection with SARS-CoV-2 clinical isolate. Employing this system, we determined the SARS-CoV-2 infection profile by translatome and proteome proteomics at different times after infection.These analyses revealed that SARS-CoV-2 reshapes central cellular pathways, such as translation, splicing, carbon metabolism and nucleic acid metabolism. Small molecule inhibitors targeting these pathways were tested in cellular infection assays and prevented viral replication. Our results reveal the cellular infection profile of SARS-CoV-2 and led to the identification of drugs inhibiting viral replication. We anticipate our results to guide efforts to develop therapy options for COVID-19.Authors Denisa Bojkova, Kevin Klann, and Benjamin Koch contributed equally to this workData associated with the preprint has been made available on the authors' website.",
    "DOI": "10.21203/rs.3.rs-17218/v1",
    "title": "SARS-CoV-2 infected host cell proteomics reveal potential therapy targets",
    "URL": "https://doi.org/ggn4ds",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.21203/rs.3.rs-17218/v1"
  },
  {
    "type": "article-journal",
    "id": "nxM0rP5R",
    "author": [
      {
        "family": "Majumder",
        "given": "Maimuna"
      },
      {
        "family": "Mandl",
        "given": "Kenneth D."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "SSRN Electronic Journal",
    "DOI": "10.2139/ssrn.3524675",
    "publisher": "Elsevier BV",
    "title": "Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China",
    "URL": "https://doi.org/ggqhz3",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2139/ssrn.3524675"
  },
  {
    "type": "article-journal",
    "id": "zskgSnle",
    "author": [
      {
        "family": "Liu",
        "given": "Jing"
      },
      {
        "family": "Li",
        "given": "Sumeng"
      },
      {
        "family": "Liu",
        "given": "Jia"
      },
      {
        "family": "Liang",
        "given": "Boyun"
      },
      {
        "family": "Wang",
        "given": "Xiaobei"
      },
      {
        "family": "Li",
        "given": "Wei"
      },
      {
        "family": "Wang",
        "given": "Hua"
      },
      {
        "family": "Tong",
        "given": "Qiaoxia"
      },
      {
        "family": "Yi",
        "given": "Jianhua"
      },
      {
        "family": "Zhao",
        "given": "Lei"
      },
      {
        "family": "Xiong",
        "given": "Lijuan"
      },
      {
        "family": "Guo",
        "given": "Chunxia"
      },
      {
        "family": "Tian",
        "given": "Jin"
      },
      {
        "family": "Luo",
        "given": "Jinzhuo"
      },
      {
        "family": "Yao",
        "given": "Jinghong"
      },
      {
        "family": "Pang",
        "given": "Ran"
      },
      {
        "family": "Shen",
        "given": "Hui"
      },
      {
        "family": "Peng",
        "given": "Cheng"
      },
      {
        "family": "Liu",
        "given": "Ting"
      },
      {
        "family": "Zhang",
        "given": "Qian"
      },
      {
        "family": "Wu",
        "given": "Jun"
      },
      {
        "family": "Xu",
        "given": "Ling"
      },
      {
        "family": "Lu",
        "given": "Sihong"
      },
      {
        "family": "Wang",
        "given": "Baoju"
      },
      {
        "family": "Weng",
        "given": "Zhihong"
      },
      {
        "family": "Han",
        "given": "Chunrong"
      },
      {
        "family": "Zhu",
        "given": "Huabing"
      },
      {
        "family": "Zhou",
        "given": "Ruxia"
      },
      {
        "family": "Zhou",
        "given": "Helong"
      },
      {
        "family": "Chen",
        "given": "Xiliu"
      },
      {
        "family": "Ye",
        "given": "Pian"
      },
      {
        "family": "Zhu",
        "given": "Bin"
      },
      {
        "family": "He",
        "given": "Shengsong"
      },
      {
        "family": "He",
        "given": "Yongwen"
      },
      {
        "family": "Jie",
        "given": "Shenghua"
      },
      {
        "family": "Wei",
        "given": "Ping"
      },
      {
        "family": "Zhang",
        "given": "Jianao"
      },
      {
        "family": "Lu",
        "given": "Yinping"
      },
      {
        "family": "Wang",
        "given": "Weixian"
      },
      {
        "family": "Zhang",
        "given": "Li"
      },
      {
        "family": "Li",
        "given": "Ling"
      },
      {
        "family": "Zhou",
        "given": "Fengqin"
      },
      {
        "family": "Wang",
        "given": "Jun"
      },
      {
        "family": "Dittmer",
        "given": "Ulf"
      },
      {
        "family": "Lu",
        "given": "Mengji"
      },
      {
        "family": "Hu",
        "given": "Yu"
      },
      {
        "family": "Yang",
        "given": "Dongliang"
      },
      {
        "family": "Zheng",
        "given": "Xin"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "SSRN Electronic Journal",
    "DOI": "10.2139/ssrn.3539682",
    "publisher": "Elsevier BV",
    "title": "Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients",
    "URL": "https://doi.org/ggq655",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2139/ssrn.3539682"
  },
  {
    "type": "article-journal",
    "id": "lPexOhy6",
    "author": [
      {
        "family": "Harri",
        "given": "Harri"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2011,
          6,
          23
        ]
      ]
    },
    "container-title": "The Open Respiratory Medicine Journal",
    "DOI": "10.2174/1874306401105010051",
    "volume": "5",
    "issue": "1",
    "page": "51-58",
    "publisher": "Bentham Science Publishers Ltd.",
    "title": "Zinc Lozenges May Shorten the Duration of Colds: A Systematic Review",
    "URL": "https://doi.org/bndmfq",
    "PMCID": "PMC3136969",
    "PMID": "21769305",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2174/1874306401105010051"
  },
  {
    "type": "article-journal",
    "id": "pUnzB8wV",
    "author": [
      {
        "family": "Tang",
        "given": "Xian-Chun"
      },
      {
        "family": "Marasco",
        "given": "Wayne A"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          7
        ]
      ]
    },
    "container-title": "Immunotherapy",
    "DOI": "10.2217/imt.15.33",
    "volume": "7",
    "issue": "6",
    "page": "591-594",
    "publisher": "Future Medicine Ltd",
    "title": "Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy",
    "URL": "https://doi.org/ggqbpz",
    "PMCID": "PMC5068219",
    "PMID": "26098703",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2217/imt.15.33"
  },
  {
    "type": "article-journal",
    "id": "n3v9Thlz",
    "author": [
      {
        "family": "Aranow",
        "given": "Cynthia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          12,
          15
        ]
      ]
    },
    "container-title": "Journal of Investigative Medicine",
    "DOI": "10.2310/jim.0b013e31821b8755",
    "volume": "59",
    "issue": "6",
    "page": "881-886",
    "publisher": "BMJ",
    "title": "Vitamin D and the Immune System",
    "URL": "https://doi.org/f3wh87",
    "PMID": "21527855",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2310/jim.0b013e31821b8755"
  },
  {
    "type": "article-journal",
    "id": "1H8o8TFtM",
    "author": [
      {
        "family": "Tanaka",
        "given": "Toshio"
      },
      {
        "family": "Narazaki",
        "given": "Masashi"
      },
      {
        "family": "Masuda",
        "given": "Kazuya"
      },
      {
        "family": "Kishimoto",
        "given": "Tadamitsu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2013
        ]
      ]
    },
    "container-title": "Inflammation and Regeneration",
    "DOI": "10.2492/inflammregen.33.054",
    "volume": "33",
    "issue": "1",
    "page": "054-065",
    "publisher": "Japanese Society of Inflammation and Regeneration",
    "title": "Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases",
    "URL": "https://doi.org/ggqmgt",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2492/inflammregen.33.054"
  },
  {
    "type": "report",
    "id": "Frya4XA4",
    "categories": [
      "COVID19",
      "CoronaVirus",
      "Europe",
      "Non-pharmaceutical Interventions"
    ],
    "author": [
      {
        "family": "Flaxman",
        "given": "S"
      },
      {
        "family": "Mishra",
        "given": "S"
      },
      {
        "family": "Gandy",
        "given": "A"
      },
      {
        "family": "Unwin",
        "given": "H"
      },
      {
        "family": "Coupland",
        "given": "H"
      },
      {
        "family": "Mellan",
        "given": "T"
      },
      {
        "family": "Zhu",
        "given": "H"
      },
      {
        "family": "Berah",
        "given": "T"
      },
      {
        "family": "Eaton",
        "given": "J"
      },
      {
        "family": "Perez Guzman",
        "given": "P"
      },
      {
        "family": "Schmit",
        "given": "N"
      },
      {
        "family": "Cilloni",
        "given": "L"
      },
      {
        "family": "Ainslie",
        "given": "K"
      },
      {
        "family": "Baguelin",
        "given": "M"
      },
      {
        "family": "Blake",
        "given": "I"
      },
      {
        "family": "Boonyasiri",
        "given": "A"
      },
      {
        "family": "Boyd",
        "given": "O"
      },
      {
        "family": "Cattarino",
        "given": "L"
      },
      {
        "family": "Ciavarella",
        "given": "C"
      },
      {
        "family": "Cooper",
        "given": "L"
      },
      {
        "family": "Cucunuba Perez",
        "given": "Z"
      },
      {
        "family": "Cuomo-Dannenburg",
        "given": "G"
      },
      {
        "family": "Dighe",
        "given": "A"
      },
      {
        "family": "Djaafara",
        "given": "A"
      },
      {
        "family": "Dorigatti",
        "given": "I"
      },
      {
        "family": "Van Elsland",
        "given": "S"
      },
      {
        "family": "Fitzjohn",
        "given": "R"
      },
      {
        "family": "Fu",
        "given": "H"
      },
      {
        "family": "Gaythorpe",
        "given": "K"
      },
      {
        "family": "Geidelberg",
        "given": "L"
      },
      {
        "family": "Grassly",
        "given": "N"
      },
      {
        "family": "Green",
        "given": "W"
      },
      {
        "family": "Hallett",
        "given": "T"
      },
      {
        "family": "Hamlet",
        "given": "A"
      },
      {
        "family": "Hinsley",
        "given": "W"
      },
      {
        "family": "Jeffrey",
        "given": "B"
      },
      {
        "family": "Jorgensen",
        "given": "D"
      },
      {
        "family": "Knock",
        "given": "E"
      },
      {
        "family": "Laydon",
        "given": "D"
      },
      {
        "family": "Nedjati Gilani",
        "given": "G"
      },
      {
        "family": "Nouvellet",
        "given": "P"
      },
      {
        "family": "Parag",
        "given": "K"
      },
      {
        "family": "Siveroni",
        "given": "I"
      },
      {
        "family": "Thompson",
        "given": "H"
      },
      {
        "family": "Verity",
        "given": "R"
      },
      {
        "family": "Volz",
        "given": "E"
      },
      {
        "family": "Walters",
        "given": "C"
      },
      {
        "family": "Wang",
        "given": "H"
      },
      {
        "family": "Wang",
        "given": "Y"
      },
      {
        "family": "Watson",
        "given": "O"
      },
      {
        "family": "Winskill",
        "given": "P"
      },
      {
        "family": "Xi",
        "given": "X"
      },
      {
        "family": "Whittaker",
        "given": "C"
      },
      {
        "family": "Walker",
        "given": "P"
      },
      {
        "family": "Ghani",
        "given": "A"
      },
      {
        "family": "Donnelly",
        "given": "C"
      },
      {
        "family": "Riley",
        "given": "S"
      },
      {
        "family": "Okell",
        "given": "L"
      },
      {
        "family": "Vollmer",
        "given": "M"
      },
      {
        "family": "Ferguson",
        "given": "N"
      },
      {
        "family": "Bhatt",
        "given": "S"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "abstract": "Following the emergence of a novel coronavirus (SARS-CoV-2) and its spread outside of China, Europe is now experiencing large epidemics. In response, many European countries have implemented unprecedented non-pharmaceutical interventions including case isolation, the closure of schools and universities, banning of mass gatherings and/or public events, and most recently, widescale social distancing including local and national lockdowns. In this report, we use a semi-mechanistic Bayesian hierarchical model to attempt to infer the impact of these interventions across 11 European countries. Our methods assume that changes in the reproductive number – a measure of transmission - are an immediate response to these interventions being implemented rather than broader gradual changes in behaviour. Our model estimates these changes by calculating backwards from the deaths observed over time to estimate transmission that occurred several weeks prior, allowing for the time lag between infection and death. One of the key assumptions of the model is that each intervention has the same effect on the reproduction number across countries and over time. This allows us to leverage a greater amount of data across Europe to estimate these effects. It also means that our results are driven strongly by the data from countries with more advanced epidemics, and earlier interventions, such as Italy and Spain. We find that the slowing growth in daily reported deaths in Italy is consistent with a significant impact of interventions implemented several weeks earlier. In Italy, we estimate that the effective reproduction number, Rt, dropped to close to 1 around the time of lockdown (11th March), although with a high level of uncertainty. Overall, we estimate that countries have managed to reduce their reproduction number. Our estimates have wide credible intervals and contain 1 for countries that have implemented all interventions considered in our analysis. This means that the reproduction number may be above or below this value. With current interventions remaining in place to at least the end of March, we estimate that interventions across all 11 countries will have averted 59,000 deaths up to 31 March [95% credible interval 21,000-120,000]. Many more deaths will be averted through ensuring that interventions remain in place until transmission drops to low levels. We estimate that, across all 11 countries between 7 and 43 million individuals have been infected with SARS-CoV-2 up to 28th March, representing between 1.88% and 11.43% of the population. The proportion of the population infected to date – the attack rate - is estimated to be highest in Spain followed by Italy and lowest in Germany and Norway, reflecting the relative stages of the epidemics. Given the lag of 2-3 weeks between when transmission changes occur and when their impact can be observed in trends in mortality, for most of the countries considered here it remains too early to be certain that recent interventions have been effective. If interventions in countries at earlier stages of their epidemic, such as Germany or the UK, are more or less effective than they were in the countries with advanced epidemics, on which our estimates are largely based, or if interventions have improved or worsened over time, then our estimates of the reproduction number and deaths averted would change accordingly. It is therefore critical that the current interventions remain in place and trends in cases and deaths are closely monitored in the coming days and weeks to provide reassurance that transmission of SARS-Cov-2 is slowing.",
    "DOI": "10.25561/77731",
    "publisher": "Imperial College London",
    "title": "Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries",
    "URL": "https://doi.org/ggrbmf",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.25561/77731"
  },
  {
    "type": "article-journal",
    "id": "1AHtg71LX",
    "author": [
      {
        "family": "Corman",
        "given": "Victor M"
      },
      {
        "family": "Landt",
        "given": "Olfert"
      },
      {
        "family": "Kaiser",
        "given": "Marco"
      },
      {
        "family": "Molenkamp",
        "given": "Richard"
      },
      {
        "family": "Meijer",
        "given": "Adam"
      },
      {
        "family": "Chu",
        "given": "Daniel KW"
      },
      {
        "family": "Bleicker",
        "given": "Tobias"
      },
      {
        "family": "Brünink",
        "given": "Sebastian"
      },
      {
        "family": "Schneider",
        "given": "Julia"
      },
      {
        "family": "Schmidt",
        "given": "Marie Luisa"
      },
      {
        "family": "Mulders",
        "given": "Daphne GJC"
      },
      {
        "family": "Haagmans",
        "given": "Bart L"
      },
      {
        "family": "van der Veer",
        "given": "Bas"
      },
      {
        "family": "van den Brink",
        "given": "Sharon"
      },
      {
        "family": "Wijsman",
        "given": "Lisa"
      },
      {
        "family": "Goderski",
        "given": "Gabriel"
      },
      {
        "family": "Romette",
        "given": "Jean-Louis"
      },
      {
        "family": "Ellis",
        "given": "Joanna"
      },
      {
        "family": "Zambon",
        "given": "Maria"
      },
      {
        "family": "Peiris",
        "given": "Malik"
      },
      {
        "family": "Goossens",
        "given": "Herman"
      },
      {
        "family": "Reusken",
        "given": "Chantal"
      },
      {
        "family": "Koopmans",
        "given": "Marion PG"
      },
      {
        "family": "Drosten",
        "given": "Christian"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          23
        ]
      ]
    },
    "container-title": "Eurosurveillance",
    "DOI": "10.2807/1560-7917.es.2020.25.3.2000045",
    "volume": "25",
    "issue": "3",
    "publisher": "European Centre for Disease Control and Prevention (ECDC)",
    "title": "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR",
    "URL": "https://doi.org/ggjs7g",
    "PMCID": "PMC6988269",
    "PMID": "31992387",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.2807/1560-7917.es.2020.25.3.2000045"
  },
  {
    "type": "article-journal",
    "id": "VXDsRwHC",
    "author": [
      {
        "family": "Luo",
        "given": "Yang"
      },
      {
        "family": "Zheng",
        "given": "Song Guo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2016,
          12,
          19
        ]
      ]
    },
    "container-title": "Frontiers in Immunology",
    "DOI": "10.3389/fimmu.2016.00604",
    "volume": "7",
    "publisher": "Frontiers Media SA",
    "title": "Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms",
    "URL": "https://doi.org/ggqmgv",
    "PMCID": "PMC5165036",
    "PMID": "28066415",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fimmu.2016.00604"
  },
  {
    "type": "article-journal",
    "id": "9GEyqic3",
    "author": [
      {
        "family": "Allard",
        "given": "Benoit"
      },
      {
        "family": "Panariti",
        "given": "Alice"
      },
      {
        "family": "Martin",
        "given": "James G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          7,
          31
        ]
      ]
    },
    "container-title": "Frontiers in Immunology",
    "DOI": "10.3389/fimmu.2018.01777",
    "volume": "9",
    "publisher": "Frontiers Media SA",
    "title": "Alveolar Macrophages in the Resolution of Inflammation, Tissue Repair, and Tolerance to Infection",
    "URL": "https://doi.org/gd3bnz",
    "PMCID": "PMC6079255",
    "PMID": "30108592",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fimmu.2018.01777"
  },
  {
    "type": "article-journal",
    "id": "87CJN2CG",
    "author": [
      {
        "family": "Scharenberg",
        "given": "Marlena"
      },
      {
        "family": "Vangeti",
        "given": "Sindhu"
      },
      {
        "family": "Kekäläinen",
        "given": "Eliisa"
      },
      {
        "family": "Bergman",
        "given": "Per"
      },
      {
        "family": "Al-Ameri",
        "given": "Mamdoh"
      },
      {
        "family": "Johansson",
        "given": "Niclas"
      },
      {
        "family": "Sondén",
        "given": "Klara"
      },
      {
        "family": "Falck-Jones",
        "given": "Sara"
      },
      {
        "family": "Färnert",
        "given": "Anna"
      },
      {
        "family": "Ljunggren",
        "given": "Hans-Gustaf"
      },
      {
        "family": "Michaëlsson",
        "given": "Jakob"
      },
      {
        "family": "Smed-Sörensen",
        "given": "Anna"
      },
      {
        "family": "Marquardt",
        "given": "Nicole"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          5,
          17
        ]
      ]
    },
    "container-title": "Frontiers in Immunology",
    "DOI": "10.3389/fimmu.2019.01116",
    "volume": "10",
    "publisher": "Frontiers Media SA",
    "title": "Influenza A Virus Infection Induces Hyperresponsiveness in Human Lung Tissue-Resident and Peripheral Blood NK Cells",
    "URL": "https://doi.org/ggq656",
    "PMCID": "PMC6534051",
    "PMID": "31156653",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fimmu.2019.01116"
  },
  {
    "type": "article-journal",
    "id": "dUnB3gD6",
    "author": [
      {
        "family": "Iacob",
        "given": "Simona A."
      },
      {
        "family": "Iacob",
        "given": "Diana G."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          11,
          27
        ]
      ]
    },
    "container-title": "Frontiers in Microbiology",
    "DOI": "10.3389/fmicb.2017.02323",
    "volume": "8",
    "publisher": "Frontiers Media SA",
    "title": "Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy",
    "URL": "https://doi.org/gcn3kh",
    "PMCID": "PMC5711820",
    "PMID": "29230203",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3389/fmicb.2017.02323"
  },
  {
    "type": "article-journal",
    "id": "roLqYkLt",
    "author": [
      {
        "family": "Sung",
        "given": "Minki"
      },
      {
        "family": "Jo",
        "given": "Seongmin"
      },
      {
        "family": "Lee",
        "given": "Sang-Eun"
      },
      {
        "family": "Ki",
        "given": "Moran"
      },
      {
        "family": "Choi",
        "given": "Bo"
      },
      {
        "family": "Hong",
        "given": "JinKwan"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          12,
          6
        ]
      ]
    },
    "abstract": "In this study, the results of an airflow investigation conducted on 7 June 2015 as part of a series of epidemiologic investigations at Pyeongtaek St. Mary’s Hospital, South Korea, were investigated. The study involved 38 individuals who were infected directly and indirectly with Middle East Respiratory Syndrome (MERS), by a super-spreader patient. Tracer gas experiments conducted on the eighth floor, where the initial patient was hospitalized, confirmed that the tracer gas spread to adjacent patient rooms and rooms across corridors. In particular, the experiment with an external wind direction and speed similar to those during the hospitalization of the initial patient revealed that the air change rate was 17–20 air changes per hour (ACH), with air introduced through the window in the room of the infected patient (room 8104). The tracer gas concentration of room 8110, which was the farthest room, was 7.56% of room 8104, indicating that a high concentration of gas has spread from room 8104 to rooms across the corridor. In contrast, the tracer gas was barely detected in a maternity ward to the south of room 8104, where there was no secondary infected patient. Moreover, MERS is known to spread mainly by droplets through close contact, but long-distance dispersion is probable in certain environments, such as that of a super-spreader patient hospitalized in a room without ventilation, hospitals with a central corridor type, and indoor airflow dispersion due to external wind.",
    "container-title": "International Journal of Environmental Research and Public Health",
    "DOI": "10.3390/ijerph15122757",
    "volume": "15",
    "issue": "12",
    "page": "2757",
    "publisher": "MDPI AG",
    "title": "Airflow as a Possible Transmission Route of Middle East Respiratory Syndrome at an Initial Outbreak Hospital in Korea",
    "URL": "https://doi.org/ggqsnk",
    "PMCID": "PMC6313554",
    "PMID": "30563206",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/ijerph15122757"
  },
  {
    "type": "article-journal",
    "id": "ITh0Anof",
    "author": [
      {
        "family": "Tang"
      },
      {
        "family": "Wang"
      },
      {
        "family": "Li"
      },
      {
        "family": "Bragazzi"
      },
      {
        "family": "Tang"
      },
      {
        "family": "Xiao"
      },
      {
        "family": "Wu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020,
          2,
          7
        ]
      ]
    },
    "abstract": "Since the emergence of the first cases in Wuhan, China, the novel coronavirus (2019-nCoV) infection has been quickly spreading out to other provinces and neighboring countries. Estimation of the basic reproduction number by means of mathematical modeling can be helpful for determining the potential and severity of an outbreak and providing critical information for identifying the type of disease interventions and intensity. A deterministic compartmental model was devised based on the clinical progression of the disease, epidemiological status of the individuals, and intervention measures. The estimations based on likelihood and model analysis show that the control reproduction number may be as high as 6.47 (95% CI 5.71–7.23). Sensitivity analyses show that interventions, such as intensive contact tracing followed by quarantine and isolation, can effectively reduce the control reproduction number and transmission risk, with the effect of travel restriction adopted by Wuhan on 2019-nCoV infection in Beijing being almost equivalent to increasing quarantine by a 100 thousand baseline value. It is essential to assess how the expensive, resource-intensive measures implemented by the Chinese authorities can contribute to the prevention and control of the 2019-nCoV infection, and how long they should be maintained. Under the most restrictive measures, the outbreak is expected to peak within two weeks (since 23 January 2020) with a significant low peak value. With travel restriction (no imported exposed individuals to Beijing), the number of infected individuals in seven days will decrease by 91.14% in Beijing, compared with the scenario of no travel restriction.",
    "container-title": "Journal of Clinical Medicine",
    "DOI": "10.3390/jcm9020462",
    "volume": "9",
    "issue": "2",
    "page": "462",
    "publisher": "MDPI AG",
    "title": "Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions",
    "URL": "https://doi.org/ggmkf4",
    "PMCID": "PMC7074281",
    "PMID": "32046137",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/jcm9020462"
  },
  {
    "type": "article-journal",
    "id": "E9PuVUHF",
    "author": [
      {
        "literal": "Ronan Lordan"
      },
      {
        "literal": "Alexandros Tsoupras"
      },
      {
        "literal": "Ioannis Zabetakis"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          11,
          14
        ]
      ]
    },
    "container-title": "Molecules",
    "DOI": "10.3390/molecules22111964",
    "volume": "22",
    "issue": "11",
    "page": "1964",
    "publisher": "MDPI AG",
    "title": "Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties",
    "URL": "https://doi.org/ggqmgq",
    "PMCID": "PMC6150200",
    "PMID": "29135918",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/molecules22111964"
  },
  {
    "type": "article-journal",
    "id": "DPhRTQw0",
    "author": [
      {
        "family": "Hemilä",
        "given": "Harri"
      },
      {
        "family": "Chalker",
        "given": "Elizabeth"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2019,
          3,
          27
        ]
      ]
    },
    "abstract": "A number of controlled trials have previously found that in some contexts, vitamin C can have beneficial effects on blood pressure, infections, bronchoconstriction, atrial fibrillation, and acute kidney injury. However, the practical significance of these effects is not clear. The purpose of this meta-analysis was to evaluate whether vitamin C has an effect on the practical outcomes: length of stay in the intensive care unit (ICU) and duration of mechanical ventilation. We identified 18 relevant controlled trials with a total of 2004 patients, 13 of which investigated patients undergoing elective cardiac surgery. We carried out the meta-analysis using the inverse variance, fixed effect options, using the ratio of means scale. In 12 trials with 1766 patients, vitamin C reduced the length of ICU stay on average by 7.8% (95% CI: 4.2% to 11.2%; p = 0.00003). In six trials, orally administered vitamin C in doses of 1–3 g/day (weighted mean 2.0 g/day) reduced the length of ICU stay by 8.6% (p = 0.003). In three trials in which patients needed mechanical ventilation for over 24 hours, vitamin C shortened the duration of mechanical ventilation by 18.2% (95% CI 7.7% to 27%; p = 0.001). Given the insignificant cost of vitamin C, even an 8% reduction in ICU stay is worth exploring. The effects of vitamin C on ICU patients should be investigated in more detail.",
    "container-title": "Nutrients",
    "DOI": "10.3390/nu11040708",
    "volume": "11",
    "issue": "4",
    "page": "708",
    "publisher": "MDPI AG",
    "title": "Vitamin C Can Shorten the Length of Stay in the ICU: A Meta-Analysis",
    "URL": "https://doi.org/gfzscg",
    "PMCID": "PMC6521194",
    "PMID": "30934660",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/nu11040708"
  },
  {
    "type": "article-journal",
    "id": "C3szSqIr",
    "author": [
      {
        "family": "Mazahery",
        "given": "Hajar"
      },
      {
        "family": "von Hurst",
        "given": "Pamela"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2015,
          6,
          25
        ]
      ]
    },
    "container-title": "Nutrients",
    "DOI": "10.3390/nu7075111",
    "volume": "7",
    "issue": "7",
    "page": "5111-5142",
    "publisher": "MDPI AG",
    "title": "Factors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation",
    "URL": "https://doi.org/f7sztz",
    "PMCID": "PMC4516990",
    "PMID": "26121531",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/nu7075111"
  },
  {
    "type": "article-journal",
    "id": "aEEZ8Pq9",
    "author": [
      {
        "family": "Hemilä",
        "given": "Harri"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          3,
          29
        ]
      ]
    },
    "container-title": "Nutrients",
    "DOI": "10.3390/nu9040339",
    "volume": "9",
    "issue": "4",
    "page": "339",
    "publisher": "MDPI AG",
    "title": "Vitamin C and Infections",
    "URL": "https://doi.org/gfkb9n",
    "PMCID": "PMC5409678",
    "PMID": "28353648",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/nu9040339"
  },
  {
    "type": "article-journal",
    "id": "13M3VAfY9",
    "author": [
      {
        "family": "Carr",
        "given": "Anitra"
      },
      {
        "family": "Maggini",
        "given": "Silvia"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2017,
          11,
          3
        ]
      ]
    },
    "container-title": "Nutrients",
    "DOI": "10.3390/nu9111211",
    "volume": "9",
    "issue": "11",
    "page": "1211",
    "publisher": "MDPI AG",
    "title": "Vitamin C and Immune Function",
    "URL": "https://doi.org/gfzrjs",
    "PMCID": "PMC5707683",
    "PMID": "29099763",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/nu9111211"
  },
  {
    "type": "article-journal",
    "id": "181QWa7HL",
    "author": [
      {
        "family": "Han",
        "given": "Hui-Ju"
      },
      {
        "family": "Liu",
        "given": "Jian-Wei"
      },
      {
        "family": "Yu",
        "given": "Hao"
      },
      {
        "family": "Yu",
        "given": "Xue-Jie"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2018,
          11,
          30
        ]
      ]
    },
    "abstract": "Since emerging in 2012, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been a global public health threat with a high fatality rate and worldwide distribution. There are no approved vaccines or therapies for MERS until now. Passive immunotherapy with neutralizing monoclonal antibodies (mAbs) is an effective prophylactic and therapeutic reagent against emerging viruses. In this article, we review current advances in neutralizing mAbs against MERS-CoV. The receptor-binding domain (RBD) in the spike protein of MERS-CoV is a major target, and mouse, camel, or human-derived neutralizing mAbs targeting RBD have been developed. A major problem with neutralizing mAb therapy is mutant escape under selective pressure, which can be solved by combination of neutralizing mAbs targeting different epitopes. Neutralizing mAbs are currently under preclinical evaluation, and they are promising candidate therapeutic agents against MERS-CoV infection.",
    "container-title": "Viruses",
    "DOI": "10.3390/v10120680",
    "volume": "10",
    "issue": "12",
    "page": "680",
    "publisher": "MDPI AG",
    "title": "Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection",
    "URL": "https://doi.org/ggp87v",
    "PMCID": "PMC6315345",
    "PMID": "30513619",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3390/v10120680"
  },
  {
    "DOI": "10.3785/j.issn.1008-9292.2020.03.03",
    "ISSN": "1008-9292",
    "URL": "https://doi.org/10.3785/j.issn.1008-9292.2020.03.03",
    "accessed": {
      "date-parts": [
        [
          2020,
          4,
          6
        ]
      ]
    },
    "author": [
      {
        "literal": "CHEN Jun"
      },
      {
        "literal": "LIU Danping"
      },
      {
        "literal": "LIU Li"
      },
      {
        "literal": "LIU Ping"
      },
      {
        "literal": "XU Qingnian"
      },
      {
        "literal": "XIA Lu"
      },
      {
        "literal": "LING Yun"
      },
      {
        "literal": "HUANG Dan"
      },
      {
        "literal": "SONG Shuli"
      },
      {
        "literal": "ZHANG Dandan"
      },
      {
        "literal": "QIAN Zhiping"
      },
      {
        "literal": "LI Tao"
      },
      {
        "literal": "SHEN Yinzhong"
      },
      {
        "literal": "LU Hongzhou"
      }
    ],
    "container-title": "Journal of Zhejiang University (Medical Sciences)",
    "id": "o5gwQA7W",
    "issue": "1",
    "issued": {
      "date-parts": [
        [
          2020,
          3
        ]
      ]
    },
    "title": "A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)",
    "type": "article-journal",
    "volume": "49",
    "note": "This CSL JSON Item was loaded by Manubot v0.3.1 from a manual reference file.\nmanual_reference_filename: manual-references.bib\noriginal_id: doi:10/drbx\noriginal_standard_id: doi:10/drbx\nstandard_id: doi:10.3785/j.issn.1008-9292.2020.03.03"
  },
  {
    "type": "article-journal",
    "id": "B8toe6Mr",
    "author": [
      {
        "family": "Schwerbrock",
        "given": "Nicole M. J."
      },
      {
        "family": "Karlsson",
        "given": "Erik A."
      },
      {
        "family": "Shi",
        "given": "Qing"
      },
      {
        "family": "Sheridan",
        "given": "Patricia A."
      },
      {
        "family": "Beck",
        "given": "Melinda A."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2009,
          8
        ]
      ]
    },
    "container-title": "The Journal of Nutrition",
    "DOI": "10.3945/jn.109.108027",
    "volume": "139",
    "issue": "8",
    "page": "1588-1594",
    "publisher": "Oxford University Press (OUP)",
    "title": "Fish Oil-Fed Mice Have Impaired Resistance to Influenza Infection",
    "URL": "https://doi.org/dv45f4",
    "PMCID": "PMC2709305",
    "PMID": "19549756",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.3945/jn.109.108027"
  },
  {
    "type": "article-journal",
    "id": "Qif5U0Ig",
    "author": [
      {
        "family": "von Bülow",
        "given": "Verena"
      },
      {
        "family": "Dubben",
        "given": "Svenja"
      },
      {
        "family": "Engelhardt",
        "given": "Gabriela"
      },
      {
        "family": "Hebel",
        "given": "Silke"
      },
      {
        "family": "Plümäkers",
        "given": "Birgit"
      },
      {
        "family": "Heine",
        "given": "Holger"
      },
      {
        "family": "Rink",
        "given": "Lothar"
      },
      {
        "family": "Haase",
        "given": "Hajo"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2007,
          9,
          15
        ]
      ]
    },
    "container-title": "The Journal of Immunology",
    "DOI": "10.4049/jimmunol.179.6.4180",
    "volume": "179",
    "issue": "6",
    "page": "4180-4186",
    "publisher": "The American Association of Immunologists",
    "title": "Zinc-Dependent Suppression of TNF-α Production Is Mediated by Protein Kinase A-Induced Inhibition of Raf-1, IκB Kinase β, and NF-κB",
    "URL": "https://doi.org/f3vs45",
    "PMID": "17785857",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.4049/jimmunol.179.6.4180"
  },
  {
    "type": "article-journal",
    "id": "1Hsm2J1sc",
    "author": [
      {
        "family": "Diehl",
        "given": "Malissa C"
      },
      {
        "family": "Lee",
        "given": "Jessica C"
      },
      {
        "family": "Daniels",
        "given": "Stephen E"
      },
      {
        "family": "Tebas",
        "given": "Pablo"
      },
      {
        "family": "Khan",
        "given": "Amir S"
      },
      {
        "family": "Giffear",
        "given": "Mary"
      },
      {
        "family": "Sardesai",
        "given": "Niranjan Y"
      },
      {
        "family": "Bagarazzi",
        "given": "Mark L"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          10,
          27
        ]
      ]
    },
    "container-title": "Human Vaccines & Immunotherapeutics",
    "DOI": "10.4161/hv.24702",
    "volume": "9",
    "issue": "10",
    "page": "2246-2252",
    "publisher": "Informa UK Limited",
    "title": "Tolerability of intramuscular and intradermal delivery by CELLECTRA <sup>®</sup> adaptive constant current electroporation device in healthy volunteers",
    "URL": "https://doi.org/ggrj7h",
    "PMCID": "PMC3906411",
    "PMID": "24051434",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.4161/hv.24702"
  },
  {
    "type": "article-journal",
    "id": "17OQtAY4l",
    "author": [
      {
        "family": "Corcoran",
        "given": "M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          2006,
          7,
          1
        ]
      ]
    },
    "container-title": "American Journal of Occupational Therapy",
    "DOI": "10.5014/ajot.60.4.367",
    "volume": "60",
    "issue": "4",
    "page": "367-368",
    "publisher": "AOTA Press",
    "title": "Using the MAARIE Framework To Read the Research Literature",
    "URL": "https://doi.org/bqh97x",
    "PMID": "16915865",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.5014/ajot.60.4.367"
  },
  {
    "type": "article-journal",
    "id": "aiItPxSY",
    "author": [
      {
        "family": "Gao",
        "given": "Jianjun"
      },
      {
        "family": "Tian",
        "given": "Zhenxue"
      },
      {
        "family": "Yang",
        "given": "Xu"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "BioScience Trends",
    "DOI": "10.5582/bst.2020.01047",
    "publisher": "International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)",
    "title": "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies",
    "URL": "https://doi.org/ggm3mv",
    "PMID": "32074550",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.5582/bst.2020.01047"
  },
  {
    "type": "article-journal",
    "id": "z8XnLYWM",
    "author": [
      {
        "family": "Zheng",
        "given": "Jun"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "International Journal of Biological Sciences",
    "DOI": "10.7150/ijbs.45053",
    "volume": "16",
    "issue": "10",
    "page": "1678-1685",
    "publisher": "Ivyspring International Publisher",
    "title": "SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat",
    "URL": "https://doi.org/ggqspr",
    "PMCID": "PMC7098030",
    "PMID": "32226285",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.7150/ijbs.45053"
  },
  {
    "type": "article-journal",
    "id": "1BdQKtXnY",
    "author": [
      {
        "family": "Yang",
        "given": "Naidi"
      },
      {
        "family": "Shen",
        "given": "Han-Ming"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "container-title": "International Journal of Biological Sciences",
    "DOI": "10.7150/ijbs.45498",
    "volume": "16",
    "issue": "10",
    "page": "1724-1731",
    "publisher": "Ivyspring International Publisher",
    "title": "Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19",
    "URL": "https://doi.org/ggqspm",
    "PMCID": "PMC7098027",
    "PMID": "32226290",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.7150/ijbs.45498"
  },
  {
    "type": "article-journal",
    "id": "iObQU2el",
    "author": [
      {
        "family": "Arabi",
        "given": "Yaseen M."
      },
      {
        "family": "Arifi",
        "given": "Ahmed A."
      },
      {
        "family": "Balkhy",
        "given": "Hanan H."
      },
      {
        "family": "Najm",
        "given": "Hani"
      },
      {
        "family": "Aldawood",
        "given": "Abdulaziz S."
      },
      {
        "family": "Ghabashi",
        "given": "Alaa"
      },
      {
        "family": "Hawa",
        "given": "Hassan"
      },
      {
        "family": "Alothman",
        "given": "Adel"
      },
      {
        "family": "Khaldi",
        "given": "Abdulaziz"
      },
      {
        "family": "Al Raiy",
        "given": "Basel"
      }
    ],
    "issued": {
      "date-parts": [
        [
          2014,
          3,
          18
        ]
      ]
    },
    "container-title": "Annals of Internal Medicine",
    "DOI": "10.7326/m13-2486",
    "volume": "160",
    "issue": "6",
    "page": "389-397",
    "publisher": "American College of Physicians",
    "title": "Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection",
    "URL": "https://doi.org/ggptxw",
    "PMID": "24474051",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: doi:10.7326/m13-2486"
  },
  {
    "id": "RGAUx68v",
    "type": "book",
    "title": "Fields virology",
    "publisher": "Wolters Kluwer Health/Lippincott Williams & Wilkins",
    "publisher-place": "Philadelphia",
    "number-of-pages": "2",
    "edition": "5th ed",
    "source": "Library of Congress ISBN",
    "event-place": "Philadelphia",
    "ISBN": "9780781760607",
    "call-number": "QR360 .V5125 2007",
    "note": "OCLC: ocm71812790\nThis CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: isbn:9780781760607",
    "editor": [
      {
        "family": "Fields",
        "given": "Bernard N."
      },
      {
        "family": "Knipe",
        "given": "David M."
      },
      {
        "family": "Howley",
        "given": "Peter M."
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2007"
        ]
      ]
    }
  },
  {
    "id": "14gthSuhm",
    "type": "book",
    "title": "Introduction to modern virology",
    "publisher": "Blackwell Pub",
    "publisher-place": "Malden, MA",
    "number-of-pages": "516",
    "edition": "6th ed",
    "source": "Library of Congress ISBN",
    "event-place": "Malden, MA",
    "ISBN": "9781405136457",
    "call-number": "QR360 .D56 2007",
    "note": "OCLC: ocm65207057\nThis CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: isbn:9781405136457",
    "author": [
      {
        "family": "Dimmock",
        "given": "N. J."
      },
      {
        "family": "Easton",
        "given": "A. J."
      },
      {
        "family": "Leppard",
        "given": "K. N."
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2007"
        ]
      ]
    }
  },
  {
    "title": "Cancer-related issues of CD147.",
    "volume": "7",
    "issue": "3",
    "page": "157-69",
    "container-title": "Cancer genomics & proteomics",
    "container-title-short": "Cancer Genomics Proteomics",
    "ISSN": "1790-6245",
    "author": [
      {
        "given": "Ulrich H",
        "family": "Weidle"
      },
      {
        "given": "Werner",
        "family": "Scheuer"
      },
      {
        "given": "Daniela",
        "family": "Eggle"
      },
      {
        "given": "Stefan",
        "family": "Klostermann"
      },
      {
        "given": "Hannes",
        "family": "Stockinger"
      }
    ],
    "PMID": "20551248",
    "abstract": "CD147 is involved in many physiological functions, such as lymphocyte responsiveness, spermatogenesis, implantation, fertilization and neurological functions at early stages of development. Here we specifically review the role of CD147 in cancer. We focus on the following aspects: expression of CD147 in malignant versus normal tissues and its possible impact on prognosis, interaction of tumor cell-expressed CD147 with stroma cells and induction of matrix metalloproteinases, as well as the role of CD147 in tumor angiogenesis. The function of CD147 in supercomplexes with monocarboxylate transporters (MCT) and amino acid transporters such as CD98hc and large neutral amino acid transporter 1 (LAT1), as well as the functional contribution of CD147 in complexes with caveolin-1 and integrins, is discussed. Target validation experiments making use of CD147-directed RNAi and monoclonal antibodies are summarized. Finally, the relevance of CD147 as a target for therapeutic intervention in cancer patients is discussed.",
    "URL": "https://www.ncbi.nlm.nih.gov/pubmed/20551248",
    "type": "article-journal",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: pmid:20551248",
    "id": "ETkyotLv"
  },
  {
    "title": "Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.",
    "volume": "1",
    "issue": "4",
    "page": "193-201",
    "container-title": "European cytokine network",
    "container-title-short": "Eur. Cytokine Netw.",
    "ISSN": "1148-5493",
    "author": [
      {
        "given": "B",
        "family": "Klein"
      },
      {
        "given": "X G",
        "family": "Zhang"
      },
      {
        "given": "M",
        "family": "Jourdan"
      },
      {
        "given": "J M",
        "family": "Boiron"
      },
      {
        "given": "M",
        "family": "Portier"
      },
      {
        "given": "Z Y",
        "family": "Lu"
      },
      {
        "given": "J",
        "family": "Wijdenes"
      },
      {
        "given": "J",
        "family": "Brochier"
      },
      {
        "given": "R",
        "family": "Bataille"
      }
    ],
    "PMID": "2104241",
    "abstract": "When bone-marrow cells from patients with multiple myeloma (MM) were seeded in short-term cultures, a spontaneous proliferation of the myeloma cells occurred for most of the patients with active disease and proliferating myeloma cells in vivo. In all cases, this spontaneous proliferation was inhibited by anti-IL-6 monoclonal antibodies (mabs). Moreover, myeloma cell lines, completely dependent upon exogenous IL-6 for their growth, could be reproducibly established by initially stimulating the myeloma cells with both IL-6 and GM-CSF. These results demonstrate that IL-6 is a major paracrine myeloma-cell growth factor in vitro. High serum IL-6 levels were observed in MM patients with active disease, especially patients with terminal disease. High IL-6 mRNA levels were found in bone-marrow cells of MM patients, mainly in myeloid and monocytic cells, in vivo. The myeloma cells did not express IL-6 mRNA. Injection of anti-IL-6 mabs to MM patients with terminal disease and extramedullary proliferation, completely blocked the myeloma-cell proliferation in vivo and completely inhibited the serum IL-6 bioactivity and the serum CRP levels. One patient with plasma cell leukemia and hypercalcemia was treated for two months with anti-IL-6 mabs and maintain in remission for 2 months without major side effects. Interestingly, the serum calcium levels also decreased in these patients. All these results show that IL-6 is the main cytokine responsible not only for the myeloma-cell proliferation in vivo, but presumably also for the large bone resorption processes observed in human MM.(ABSTRACT TRUNCATED AT 250 WORDS)",
    "URL": "https://www.ncbi.nlm.nih.gov/pubmed/2104241",
    "type": "article-journal",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: pmid:2104241",
    "id": "glBmWODR"
  },
  {
    "title": "The effects of hybridoma growth factor in conditioned media upon the growth, cloning, and antibody production of heterohybridoma cell lines.",
    "volume": "4",
    "issue": "1",
    "page": "31-5",
    "container-title": "Human antibodies and hybridomas",
    "container-title-short": "Hum. Antibodies Hybridomas",
    "ISSN": "0956-960X",
    "issued": {
      "date-parts": [
        [
          1993,
          1
        ]
      ]
    },
    "author": [
      {
        "given": "Y",
        "family": "Zhu"
      },
      {
        "given": "B",
        "family": "Jin"
      },
      {
        "given": "C",
        "family": "Sun"
      },
      {
        "given": "C",
        "family": "Huang"
      },
      {
        "given": "X",
        "family": "Liu"
      }
    ],
    "PMID": "8431556",
    "abstract": "Interleukin 6 (IL-6)/hybridoma growth factor (HGF) has been shown to be the requirement for growth of murine hybridomas in vivo or in vitro. In this paper, two kinds of conditioned media (CM) from the culture supernatants of a human fibroblast cell line CRL1506 and a cloned Epstein-Barr virus (EBV) transformed human lymphoblastoid cell line (LCL) N23 were found to have IL-6 activity by strongly promoting the growth, antibody secretion (increase of one- to three-fold), and cloning efficiencies of heterohybridomas secreting human monoclonal anti-hemorrhagic fever with renal syndrome virus antibodies and LCL. Since these CM contained no detectable IL-2, and IL-4 had no effects on the growth of the cell lines, IL-6 was considered to be the main active component of the CM responsible for promoting hybridoma growth. This effect was further confirmed by IL-6-dependent cell line 7TD1 bioassay (IL-6 activity in the CM ranging from 1,000 to 10,000 units/ml). Moreover, we successfully established four EBV-transformed lymphoblastoid cell lines at single-cell level by adding an equal volume of CRL1506-CM to 10% FCS-RPMI1640 in limiting dilution. Finally, it is worth noting that the sensitivity of the heterohybridomas to the two kinds of CM was not the same and was not consistent with that of their parental myeloma cell lines. Thus, it suggests that the CM might contain more than one factor, and the choice of proper conditioned media should be very useful for human monoclonal antibody production.",
    "URL": "https://www.ncbi.nlm.nih.gov/pubmed/8431556",
    "type": "article-journal",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: pmid:8431556",
    "id": "J7evEkJG"
  },
  {
    "title": "Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6.",
    "volume": "6",
    "issue": "1",
    "page": "47-56",
    "container-title": "Immunity",
    "container-title-short": "Immunity",
    "ISSN": "1074-7613",
    "issued": {
      "date-parts": [
        [
          1997,
          1
        ]
      ]
    },
    "author": [
      {
        "given": "L",
        "family": "Morse"
      },
      {
        "given": "D",
        "family": "Chen"
      },
      {
        "given": "D",
        "family": "Franklin"
      },
      {
        "given": "Y",
        "family": "Xiong"
      },
      {
        "given": "S",
        "family": "Chen-Kiang"
      }
    ],
    "PMID": "9052836",
    "DOI": "10.1016/s1074-7613(00)80241-1",
    "abstract": "Cell cycle arrest and cell death are tightly coupled to terminal differentiation of B cells to plasma cells in vivo. This process was recapitulated in vitro by stimulation of IgG-bearing human B lymphoblastoid cells with interleukin-6 (IL-6), which led to orderly cell cycle arrest, differentiation, and apoptosis. In terminally differentiated plasmacytoid cells, phosphorylation of pRb was suppressed, correlating with the activation of the D-type cyclin-dependent kinase (CDK) inhibitors p18(INK4c) and p21(WAF1/CIP1). The expression of CDK6, however, remained unchanged. Activation of p18 by IL-6 was rapid, concomitant with marked enhancement of its association with CDK6 and cell cycle arrest. Overexpression of p18 in IgM-bearing lymphoblastoid cells, which differentiated in response to IL-6 but did not exit the cell cycle, reconstituted coupled differentiation and cell cycle arrest. Thus, CDK inhibitors, in particular p18, are likely to play a pivotal role in controlling cell cycle arrest and cell death in terminal differentiation of late-stage B cells to plasma cells via inhibition of pRb phosphorylation by CDK6.",
    "URL": "https://www.ncbi.nlm.nih.gov/pubmed/9052836",
    "type": "article-journal",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: pmid:9052836",
    "id": "1AVsj9DAP"
  },
  {
    "id": "DvAlA1ad",
    "type": "webpage",
    "title": "Mild/Moderate 2019-nCoV Remdesivir RCT - Full Text View - ClinicalTrials.gov",
    "abstract": "Mild/Moderate 2019-nCoV Remdesivir RCT - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04252664",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04252664"
  },
  {
    "id": "1CJoAQiUA",
    "type": "webpage",
    "title": "Severe 2019-nCoV Remdesivir RCT - Full Text View - ClinicalTrials.gov",
    "abstract": "Severe 2019-nCoV Remdesivir RCT - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04257656",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04257656"
  },
  {
    "id": "19tnPvv1p",
    "type": "webpage",
    "title": "Adaptive COVID-19 Treatment Trial (ACTT) - Full Text View - ClinicalTrials.gov",
    "abstract": "Adaptive COVID-19 Treatment Trial (ACTT) - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04280705",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04280705"
  },
  {
    "id": "8a4WEEFh",
    "type": "webpage",
    "title": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment - Full Text View - ClinicalTrials.gov",
    "abstract": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04292730",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04292730"
  },
  {
    "id": "7LMnOrzx",
    "type": "webpage",
    "title": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) - Full Text View - ClinicalTrials.gov",
    "abstract": "Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04292899",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04292899"
  },
  {
    "id": "HNx8txpX",
    "type": "webpage",
    "title": "Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers - Full Text View - ClinicalTrials.gov",
    "abstract": "Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers - Full Text View.",
    "URL": "https://clinicaltrials.gov/ct2/show/NCT04336410",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://clinicaltrials.gov/ct2/show/NCT04336410"
  },
  {
    "URL": "https://doi.org/10.1101/2020.01.27.20018952",
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://doi.org/10.1101/2020.01.27.20018952",
    "id": "uTI5OuZt"
  },
  {
    "id": "YLbd18g5",
    "type": "entry-encyclopedia",
    "title": "<i>Coronaviridae</i>",
    "container-title": "Wikipedia",
    "source": "Wikipedia",
    "abstract": "Coronaviridae is a family of enveloped, positive-sense, single-stranded RNA viruses. The viral genome is 26–32 kilobases in length. The particles are typically decorated with large (~20 nm), club- or petal-shaped surface projections (the \"peplomers\" or \"spikes\"), which in electron micrographs of spherical particles create an image reminiscent of the solar corona.",
    "URL": "https://en.wikipedia.org/w/index.php?title=Coronaviridae&oldid=949957081",
    "note": "Page Version ID: 949957081\nThis CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://en.wikipedia.org/wiki/Coronaviridae#Taxonomy",
    "language": "en",
    "issued": {
      "date-parts": [
        [
          "2020",
          4,
          9
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    }
  },
  {
    "URL": "https://github.com/parksw3/Korea-analysis/blob/master/v1/korea.pdf",
    "abstract": "On January 20, 2020, the first COVID-19 case was confirmed in South Korea. After a rapid outbreak, the number of incident cases has been consistently decreasing since early March; this decrease has been widely attributed to its intensive testing. We report here on the likely role of social distancing in reducing transmission in South Korea. Our analysis suggests that transmission may still be persisting in some regions.",
    "accessed": {
      "date-parts": [
        [
          2020,
          3,
          30
        ]
      ]
    },
    "author": [
      {
        "family": "Park",
        "given": "Sang Woo"
      },
      {
        "family": "Sun",
        "given": "Kaiyuan"
      },
      {
        "family": "Viboud",
        "given": "Cécile"
      },
      {
        "family": "Grenfell",
        "given": "Bryan T"
      },
      {
        "family": "Dushoff",
        "given": "Jonathan"
      }
    ],
    "container-title": "GitHub",
    "id": "YfOcGRRa",
    "issued": {
      "date-parts": [
        [
          2020
        ]
      ]
    },
    "page": "21",
    "title": "Potential roles of social distancing in mitigating the spread of coronavirus disease 2019 (COVID-19) in South Korea",
    "type": "article-journal",
    "note": "This CSL JSON Item was loaded by Manubot v0.3.1 from a manual reference file.\nmanual_reference_filename: manual-references.bib\nstandard_id: url:https://github.com/parksw3/Korea-analysis/blob/master/v1/korea.pdf"
  },
  {
    "id": "ZUuGRxk9",
    "type": "webpage",
    "title": "Coronaviridae ~ ViralZone page",
    "abstract": "A knowledge resource to understand virus diversity",
    "URL": "https://viralzone.expasy.org/30?outline",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://viralzone.expasy.org/30?outline"
  },
  {
    "id": "vEFSIErd",
    "type": "webpage",
    "title": "Coronavirus Disease 2019 (COVID-19)",
    "container-title": "Centers for Disease Control and Prevention",
    "abstract": "Coronavirus disease 2019 (COVID-19) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China.",
    "URL": "https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html",
    "language": "en-us",
    "author": [
      {
        "family": "CDC",
        "given": ""
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          2,
          11
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html"
  },
  {
    "URL": "https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR",
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-000936-23/FR",
    "id": "1q4PmqTm"
  },
  {
    "URL": "https://www.fda.gov/media/136625/download",
    "issued": {
      "date-parts": [
        [
          2020,
          4,
          7
        ]
      ]
    },
    "author": [
      {
        "family": "James",
        "given": ""
      }
    ],
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.fda.gov/media/136625/download",
    "id": "n6sKSpIk"
  },
  {
    "id": "fez8aZAu",
    "type": "webpage",
    "title": "Coronavirus Update: FDA and FTC Warn Seven Companies Selling Fraudulent Products that Claim to Treat or Prevent COVID-19",
    "container-title": "FDA",
    "abstract": "FDA and FTC issued warning letters to companies for selling fraudulent COVID-19 products.",
    "URL": "https://www.fda.gov/news-events/press-announcements/coronavirus-update-fda-and-ftc-warn-seven-companies-selling-fraudulent-products-claim-treat-or",
    "shortTitle": "Coronavirus Update",
    "language": "en",
    "author": [
      {
        "family": "Commissioner",
        "given": "Office",
        "dropping-particle": "of the"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          3,
          27
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.fda.gov/news-events/press-announcements/coronavirus-update-fda-and-ftc-warn-seven-companies-selling-fraudulent-products-claim-treat-or"
  },
  {
    "id": "JgXCBFEo",
    "type": "post-weblog",
    "title": "Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment",
    "container-title": "GEN - Genetic Engineering and Biotechnology News",
    "abstract": "Genentech, a Member of the Roche Group, is launching a Phase III trial to assess its marketed arthritis drug Actemra® (tocilizumab) as a treatment for adults with severe COVID-19.",
    "URL": "https://www.genengnews.com/virology/coronavirus/genentech-launches-phase-iii-trial-of-actemra-as-coronavirus-treatment/",
    "language": "en-US",
    "issued": {
      "date-parts": [
        [
          "2020",
          3,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.genengnews.com/virology/coronavirus/genentech-launches-phase-iii-trial-of-actemra-as-coronavirus-treatment"
  },
  {
    "id": "10J3hBiMo",
    "type": "webpage",
    "title": "Statement on IJAA paper | International Society of Antimicrobial Chemotherapy",
    "abstract": "Statement on IJAA paper |  International Society of Antimicrobial Chemotherapy",
    "URL": "https://www.isac.world/news-and-publications/official-isac-statement",
    "language": "en",
    "author": [
      {
        "family": "Media",
        "given": "M. T. C."
      }
    ],
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.isac.world/news-and-publications/official-isac-statement"
  },
  {
    "id": "MCuIRGFE",
    "type": "webpage",
    "title": "BCG vaccination to Reduce the impact of COVID-19 in Australian healthcare workers following Coronavirus Exposure (BRACE) Trial | Murdoch Children's Research Institute",
    "abstract": "At Murdoch Children's Research Institute, we're making a real difference to child health through world-leading research and disease prevention.",
    "URL": "https://www.mcri.edu.au/BRACE",
    "language": "en",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.mcri.edu.au/BRACE"
  },
  {
    "id": "1EaIsb9L2",
    "type": "article-journal",
    "title": "Optimal Nutritional Status for a Well-Functioning Immune System is an Important Factor to Protect Against Viral Infections",
    "source": "www.preprints.org",
    "abstract": "Public health practices including handwashing and vaccinations help reduce the spread and impact of infections. Nevertheless, the global burden of infection is high, and additional measures are necessary. Acute respiratory tract infections, for example, are responsible for approximately 2.65 million deaths per year. The role nutrition plays in supporting the immune system is well-established. A wealth of mechanistic and clinical data show that vitamins, including vitamins A, B6, B12, C, D, E, and folate; trace elements, including zinc, iron, selenium, magnesium, and copper; and the omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid play important and complementary roles in supporting the immune system. Inadequate intake and status of these nutrients are widespread, leading to a decrease in resistance to infections and as a consequence an increase in disease burden. Against this background the following conclusions are made: 1) Supplementation with the above micronutrients and omega-3 fatty acids is a safe, effective, and low-cost strategy to help support optimal immune function; 2) Supplementation above the RDA, but within recommended upper safety limits, for specific nutrients such as vitamins C and D is warranted; and 3) Public health officials are encouraged to include nutritional strategies in their recommendations to improve public health.",
    "URL": "https://www.preprints.org/manuscript/202003.0199/v1",
    "language": "en",
    "author": [
      {
        "family": "Calder",
        "given": "Philip C."
      },
      {
        "family": "Carr",
        "given": "Anitra C."
      },
      {
        "family": "Gombart",
        "given": "Adrian F."
      },
      {
        "family": "Eggersdorfer",
        "given": "Manfred"
      }
    ],
    "issued": {
      "date-parts": [
        [
          "2020",
          3,
          12
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.preprints.org/manuscript/202003.0199/v1"
  },
  {
    "id": "123fXWICW",
    "type": "webpage",
    "title": "COVID-19 – Italy launches an independent trial on tocilizumab",
    "container-title": "COVID-19 – Italy launches an independent trial on tocilizumab | Univadis",
    "abstract": "COVID-19 – Italy launches an independent trial on tocilizumab",
    "URL": "https://www.univadis.co.uk/viewarticle/covid-19-italy-launches-an-independent-trial-on-tocilizumab-715741",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.univadis.co.uk/viewarticle/covid-19-italy-launches-an-independent-trial-on-tocilizumab-715741"
  },
  {
    "id": "XnrBoKVk",
    "type": "webpage",
    "title": "WHO | DNA vaccines",
    "container-title": "WHO",
    "URL": "https://www.who.int/biologicals/areas/vaccines/dna/en/",
    "accessed": {
      "date-parts": [
        [
          "2020",
          4,
          12
        ]
      ]
    },
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.who.int/biologicals/areas/vaccines/dna/en"
  },
  {
    "URL": "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf",
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          27
        ]
      ]
    },
    "author": [
      {
        "family": "Cramer",
        "given": ""
      }
    ],
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf",
    "id": "Vb5KFWnO"
  },
  {
    "URL": "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared.pdf",
    "issued": {
      "date-parts": [
        [
          2020,
          1,
          28
        ]
      ]
    },
    "author": [
      {
        "family": "Ikejezie, Mr. Juniorcaius (WDC)",
        "given": ""
      }
    ],
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200128-sitrep-8-ncov-cleared.pdf",
    "id": "fLTiwToY"
  },
  {
    "URL": "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf",
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          11
        ]
      ]
    },
    "author": [
      {
        "family": "Ikejezie, Mr. Juniorcaius (WDC)",
        "given": ""
      }
    ],
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf",
    "id": "x9975iBK"
  },
  {
    "URL": "https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200321-sitrep-61-covid-19.pdf",
    "issued": {
      "date-parts": [
        [
          2020,
          3,
          21
        ]
      ]
    },
    "author": [
      {
        "family": "Ikejezie, Mr. Juniorcaius (WDC)",
        "given": ""
      }
    ],
    "type": "webpage",
    "note": "This CSL JSON Item was automatically generated by Manubot v0.3.1 using citation-by-identifier.\nstandard_id: url:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200321-sitrep-61-covid-19.pdf",
    "id": "11JitNwZt"
  }
]
